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Abstract
This thesis involves the syntheses of new compounds as potential antagonists of the 5- 
HT3 receptor, a sub-group of the serotonin receptors.
The objective of the work can be considered two fold: The primary aim, which can be 
regarded as the principal goal, was the design and chemical synthesis of new molecules 
which could antagonise the 5 -HT3 receptor and thus lead to new drug substances which 
could be effective in the treatment of illnesses associated with this receptor, among 
which may be included the control of emesis in cancer patients receiving chemotherapy. 
Secondly, by carrying out the structural and conformational studies of the synthesised 
compounds and relating these to the biological studies it was hoped to elucidate more 
information on the nature of the 5 -HT3 receptor, the structure of which is unknown. 
Three series of potential antagonists were synthesised. The first series involves a 
tropane spiroimidazoline molecule with various aromatic substituents in the 2 ' position 
of the imidazoline ring (the final compounds of this series have been numbered I a-g 
throughout the text, the number I referring to the number of the series and the letters a-g 
to the individual final products within the series) The structure represents a novel feature 
within the known 5 -HT3 antagonists. A second series of products (II a-g) was 
synthesised in which the tropane function of the molecule was replaced by a bicyclic 
quinuclidine system. The synthetic method developed for the syntheses of these 2'-aryl- 
8-methyl-8-azabicyclo[3.2. l]octane-3-spiro-4'(5')-imidazolines and 2'-aryl-l-azabi- 
cyclo[2.2.2]octane-3-spiro-4'(5')-imidazo-lines takes place via the reaction of an 
azabicyclic 1,2-diamines with aryl imidate salts. Competing reactions in the syntheses of 
the 1,2-diamines such as the reduction of aminonitriles with LiAlFLj lead to some 
anomalous products. In the Pinner synthesis of the imidates, unstable pyridine type 
imidates were stabilised as their A'-oxide derivatives.
A third series of tropane 1,2,4-oxadiazoles (III a-g) was synthesised via the reaction of 
exo-3-carbomethoxy-8-methyl-8-azabicyclo[3.2.1]octane with aryl amidoximes. The 
former tropinone carbomethoxy ester was synthesised in a high yielding stereospecific
synthesis from tropinone, via the intermediacy of 3-(l,3-dithiane-2-ylidene)-8-methyI- 
8-azabicyclo[3.2. ljoctane.
The structural and conformational analysis of the compounds shows that in solution the 
tropinone moiety in both the tropinone spiroimidazolines and the tropinone oxadiazoles 
adopts a chair-envelope conformation for the piperidine and pyrrolidine rings 
respectively, with the piperidine ring in a slightly flattened disposition. The N-methyl 
group adopts an equatorial position with respect to the six membered piperidine ring. X- 
ray structural analysis for one compound in each of the tropinone series showed that a 
similar conformation was observed for the tropinone systems in the solid state. In the 
tropinone imidazoline series the aromatic indole group attached to the imidazoline ring 
was conjugated with the latter thus forming an almost planar structure, a phenomenon 
which was also observed,in solution, and thus provides an important feature for 5 -HT3 
antagonists.
Pharmacological and biochemical studies indicated that one compound in each of the 
spiroimidazoline series (those containing the dichlorophenyl aromatic substituent) 
displayed 5 -HT3 antagonistic properties comparable to MDL 72222 a potent 5 -HT3 
receptor antagonist. These activity results, combined with the structural analysis, led to 
the conclusion that the imidazoline group was acting as an bioisosteric replacement for a 
carbonyl function and as such is the first time this system has been reported in 5 -HT3 
antagonists.
The oxadiazole series likewise displayed several biologically active molecules of which 
the most active was again that containing the dichlorophenyl substituent as the aromatic 
portion of the molecule.
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1.1 5 - H T3 Antagonists
1.1.1 R eview
Not since the pioneering days of serotonin research in the late 1950s, have we enjoyed 
such excitement in this field as we are experiencing today. Since the isolation of 
serotonin from blood in 1948, the whole area has been fraught with controversy, and it 
is only in recent years, with the advent of specific potent antagonists, that huge inroads 
have been made into this fascinating subject.
Shortly after its isolation, it was recognised in 1957 by Gaddum and Picarelli1 that 
serotonin, identified as 5-hydroxytryptamine (5-HT) (1) might act on multiple types of 
5-HT receptors and divided them into two sub divisions, namely D and M receptors. 
Later Bradley et a l l  divided the classification into three categories; 5-HTi, 5 -HT2 , and 
5 -HT3 receptors. Currently, four broad classes are characterised with a fourth group, 5- 
HT4i being added to the above three already mentioned.3' 6 Further subdivisions of some 
of these sub classes have also been proposed.7
NH2
(1 )
It is in the area of 5 -HT3 research that we have focused our attention, with the hope of 
shedding some new light on the efforts to further understand and classify this receptor, 
through the design and synthesis of potential antagonists.
2
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Recently, the 5-HT.-? receptor has attracted considerable attention and its understanding 
has dramatically increased over the past few years due to the discovery and widespread 
availability of potent and selective antagonists such as Ondansetron8 (2), Granisetron9 
(3), Zacopride10 (4), and ICS 205-93011 (5).
OV '
( 2 ) (3 )
N.
, o - c h 3
Cl'
NH-,
(4 ) (5 )
3
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This interest is in grand part due to the effectiveness of these compounds in the control 
of emesis induced by cancer chemotherapy, an event suggested to be modulated by the 
5-HT3 receptors in the areapostrema.]2 In addition, evidence has been presented for the 
therapeutic roles of 5 -HT3 receptor antagonists in migraine, 13 schizophrenia , 14 and 
anxiety. 15
In an effort to qualitatively account for the activity of existing 5 -HT3 antagonists, in 
1990, H ibert16 carried out a structure-activity relationship (SAR) study of existing 5- 
HT3 receptor antagonists using molecular modelling techniques in order to define a 
pharmacophore and receptor map for these compounds. According to the model defined, 
the basic pharmacophore consisted essentially of a carbonyl group coplanar to an 
aromatic ring and a basic centre in the relative positions illustrated in Figure 1.1.
\
Figure 1.1
In 1990 Turconi et al,17 designed and synthesised a series of 2,3-dihydro-2-oxo-ltf- 
benzimidazole-l-carboxylic acid esters and amides containing a basic azacyclo or 
azabicycloalkyl moiety (Figure 1.2).
4
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X = O, NH 
R = azabicyclo or azabicycloalkyl moiety 
R l = H, OCH3, Cl, F, CF3, COCH 3 
R 2 = H, CH3, C2H5
Figure 1.2
A selected member of this series (6 ), R = azabicyclo, Rj = H, R2 = H, which displayed 
high 5 -HT3 antagonistic ability, was subjected to molecular modelling studies to 
ascertain how it might fit the model proposed by Hibert. They found that compound (6 ) 
fitted the model quite well, as measured by the root mean square (R.M.S.) index when 
superimposed on the reference compound (7) (one of the antagonists used to define the 
5 -HT3 pharmacophore16).
Literature review
N-Me
N-Me
O NH
O.
\
H Cl
( 6 ) (7 )
Coplanarity was again emphasised as being important as indicated from the torsional 
angles between the imidazole ring and the amide group. This planarity was assisted by 
an intramolecular H-bond between the imidazole oxygen and the amide nitrogen.
In a communication published in 1990 by Nagel et a / . 18 the then existing 'J-H T 3 
antagonists were classified into two broad structural classes: the aromatic ester/amide 
series represented by ICS-205-930 (5), MDL 7222219 (7), BRL-4369420(3), LY- 
278,58421 (8 ) and Zacopride (4), and the indole-3-ketone series typified by the 
carbazole derivatives Ondansetron (2) and GR-65-63022 (9).
O.
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Nagel presented in this paper a new series of potent 5 -HT3 antagonists where the 
amide/ester function of the ICS-205-930 series and the ketone functionality in the 
ondansetron series were replaced by a thiazole ring system, best represented by 
compounds (10) and (11).
( 10) ( 1 1 )
As such, this series of compounds represented the first group of potent and selective 5- 
HT3 receptor antagonists lacking a carbonyl-containing side chain between the aryl and 
basic portions of the molecule. The same authors concurrently published23 molecular 
modelling studies whereby they proposed a hypothetical model for specific 5 -HT3 
receptor binding based on the structures of known potent 5 -HT3 antagonists. The ability 
of their new thiazole series to fit the model was then examined. The pharmacophore 
model defined by Rizzi and Nagel involved three components. Optimal binding required 
two key electrostatic interactions: a hydrogen bond accepting interaction and a hydrogen 
bond donating interaction. The third component of the model involves the occupancy of
7
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a plane by a lipophilic ring. This model avoided the perception that molecules should 
overlap on an atom for atom basis. On the basis of this model Rizzi found that the 
thiazole nitrogen in this new series of compounds was acting as a replacement for the 
carbonyl portions of previously reported 5 -HT3 antagonists. As the pKa of a thiazole 
ring is generally between 3 and 4 and therefore in the unprotonated form at physiological 
pH, it was expected that this system would act as a weak proton acceptor, similar to a 
carbonyl oxygen, rather than a basic nitrogen which would be protonated at 
physiological pH. This suggested that the thiazole moiety might represent a bioisostere 
for a carbonyl oxygen in the 5-HT3 series.
King et al,24 published an article in which they also classified the existing 5 -HT3 
antagonists, this time into three structural classes. In the first class they included the 
benzoate esters in which the carbonyl group is attached to a six membered aromatic ring 
and is typified by MDL 72222 (7). In the second group are the 6,5-heterobicyclic esters 
and amides in which the carbonyl is connected to a six membered aromatic ring via an 
sp2 hybridised N or C atom, for example ICS 205-930 (5), granisetron (3), and 
indoline (12 ).
( 12)
8
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In the third class are the carbazoles such as ondansetron (2) in which the basic side 
chain nitrogen is provided by an aromatic imidazole.
The above authors reiterated the importance of maintaining coplanarity between the 
carbonyl group and the aromatic moiety in order to confer 5 -HT3 antagonism on these 
compounds.25 They suggested that in benzamide compounds such as BRL 24682 (13) 
that potency was in large part due to the formation of a planar "virtual ring"26 resulting 
from the hydrogen bond between the amidic N-H and the ortho methoxy group, thus 
holding the amide system in the same plane, and hence in conjugation with the aromatic 
ring. Similarly, the carbonyl group in (2) would also be held in plane by its inclusion in 
a fused 6-membered ring.
OS /
N-Me
NH
Cl'
N H,
(1 3 )
Me
N
( 2 )
Bermudez and co-workers thus concluded that the active compounds (14) and ICS 205- 
930 (5) probably adopt an "in plane" orientation of the carbonyl group at the 5 -HT3 
receptor. This necessity for co-planarity, they argued, would account for the lack of 5- 
HT3 antagonism of the methyl isomer (15) in which steric interactions would destabilise 
the "in plane" orientation.
9
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N-Me
CH,
(1 4 ) (1 5 )
Similar results were reported by Bradley et al. in 199227 for 5 -HT3 antagonists derived 
from (2-alkoxybenzoyl)ureas. Structure-activity relationship studies performed on 
compound (16) suggested that the potency-enhancing effect of 2-methoxy substitution 
might be due to conformational restriction induced by intramolecular hydrogen-bond 
formation between the methoxy substituent and the benzamide N-H, a phenomenon well 
known for 2-alkoxybenzamides.28 NMR studies also supported the existence of an 
intramolecular H-bond. 2,6-Dimethoxy substitution (17) reduced activity however, 
possibly reflecting non-planarity arising from steric effects. Similarly, replacement of an 
ortho methoxy substituent by an ortho phenol reduced activity, consistent with the 
expected hydrogen bond weakening effect of this modification.
O
J L
(1 7 )
1 0
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Hayashi el a/.2y, in their search for new 5 -HT3 antagonists developed a new series of 
esters and amides of l-alkyl-2-oxo-l,2-dihydroquinoline-4-carboxylic acid or 2-aIkoxy 
quinoline-4-carboxyIic acid containing a basic azabicycioalkyl moiety. In this study 
Hayashi took two potent antagonists (18) and (19) which they synthesised and 
compared them to two known antagonists (2 0 ) and (2 1 ) in order to examine the co­
planarity of these compounds using molecular modelling techniques.
N-Me
(18) X = O
(19) X =NH
CHi
(20) X = 0
(21) X =NH
1 1
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They showed that for (20) and (21), coplanarity existed between the aromatic and 
carbonyl functions of these molecules and that this was important for 5 -HT3 binding 
affinity, as had previously been shown to be the case.30' 32 However, they found for 
compounds (18) and (19), that the dihedral angles C(4a)-C(4)-C(9)-0(N)(11) in the 
minimum energy conformations were 156.0° and 149.2° respectively. This was a 
surprising result, because the carbonyl moiety was estimated to deviate more than 20° 
from the plane of the aromatic ring. However, the energy difference between the co- 
planar configuration of (2 0 ), which is not a stable one, and the minimum-energy 
conformation was calculated to be ca. 0.5 Kcal. Thus, they felt it reasonable to suppose 
that the molecule could take up the planar configuration on interacting with the 5 -HT3 
receptor, as the energy compensation from binding can be up to 30 Kcal mol"1, 33 much 
greater than that required for the increase in conformational energy.
In 1991 Swain et al.34 in an effort to find new bioisosteric replacements for the carbonyl 
functionality, investigated the possibility of a number of five-membered heterocyclic 
rings as potential candidates. Based on comparisons of their electrostatic maps the 1,2,4- 
oxadiazole group was selected as offering considerable similarity with known systems. 
It had been previously demonstrated in both the cholinomimetic system35 and the 
benzodiazepines36 that the 1,2,4-oxadiazole was an excellent bioisosteric replacement 
for esters. Since most of the known 5 -HT3 receptor antagonists up to then were ester or 
amide derivatives and were thus potentially susceptible to hydrolysis, they speculated 
that this unwanted side property could be obviated by incorporation of H-bond acceptors 
within a five-membered heteroaromatic ring, namely 1,2,4-oxadiazole. Swain 
synthesised several derivatives based on this system with various aromatic and basic 
functionalities (22) and (23), mainly indole and quinuclidine derivatives.
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R
(2 2 ) (2 3 )
They found that these compounds displayed high affinity for 5-HT3 receptors and 
reported a number of S.A.R's. The effect of substitution on the aromatic indole ring 
served to emphasise the steric restrictions of the aromatic binding site. Substitution at the 
5 or 7 positions caused a reduction in binding affinity while groups any larger than 
methyl in the 1 position decreased potency. The authors claimed that the environment of 
the basic nitrogen was optimum when constrained within an azabicylic system.
1.1.2 Research Plan
With a thorough literature search of 5-HT3 antagonists completed, the following project 
was designed with the aim of developing new possible antagonists of this receptor. The 
plan was to synthesise series of compounds and to measure their biological activity by 
means of in vitro binding studies and in vivo pharmacological tests. This in conjunction 
with NMR and X-ray studies should assist in determining a structure activity 
relationship.
Our investigation took two basic approaches. Firstly, we proposed to further the studies 
carried out by Swain et al.34 Their work centred mainly on the use of quinuclidine and
1-azabicyclic systems to provide the nitrogen function, and indole derivatives for the
1 3
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aromatic portion of the molecule. Due to the successful employment of tropinone as the 
nitrogen source in other 5 -HT3 antagonists with amine or ester linking groups, we 
proposed to investigate its use with the 1,2,4-oxadiazole ring as the linking function 
with the aromatic moiety being provided by several substituted phenyl groups ( Series 
III, Figure 1.3).
(Ill)
Figure 1.3
Secondly, a series of compounds was designed which incorporated the novel 
spiroimidazoline structure in figure 1.4. Two series of these compounds were 
proposed: one containing the tropinone azabicyclic system I and the other with the 
quinuclidine structure II.
I II
Figure 1.4
The imidazoline system is unknown in 5-HT3 antagonists but has been employed on ao 
adrenergic central receptors.37' 41 Because the azabicyclic system is attached to the
1 4
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imidazoline ring via a spiro carbon, a planar rigid structure is obtained which should 
assist in the S.A.R. study.
Our hope was that the C=N of the imidazoline ring would act like a carbonyl group at the 
5 -H T 3 receptor thus providing a bioisosteric replacement for this functionality. 
Conjugation of the aromatic function with the N-C-N of the imidazoline ring should 
assist in maintaining co-planarity between these two groups thus forming a completely 
planar structure.
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1.2 2-IM IDAZOLINES
Before expounding the development of the synthesis of imidazolines, it is appropriate to 
give a brief description of the naming and numbering of these compounds and related
chemical systems.
Imidazole (24), imidazoline (25), and imidazolidine (26) are all related structures, the 
latter two being dihydroimidazoles and tetrahydroimidazoles, respectively.
H
(24) (25) (2 6 )
The number 1 position is assigned to the nitrogen connected through single bonds to two 
carbon atoms of the ring, and the number 3 position to the nitrogen connected to one 
carbon atom by a double bond. Due to possible tautomerism the alternate numbering is 
sometimes designated in parenthesis, as for example 4(5)-methylimidazole.
The oldest and most generally used method of entering the imidazoline series is that 
which was first reported in 1875 involving the dry distillation of a suitable acid 
derivative of a 1,2-diamine.42 In general the yields were very poor. While ring closure 
of 1,2 -diamine derivatives of carboxylic acid is a common method of forming this 
heterocyclic ring system, it may be formed by several other synthetic approaches.
Literature review
1.2.1 From 1,2-diam ines
1.2.1.1 By reaction with monocarboxylic acids:
In 1935 Chitwood and Reid43 reported the synthesis of 2-methyl-2-imidazoline by the 
reaction of ethylenediamine with acetic acid, though a yield of only 19% was obtained. 
Riebsomer, in 194844 found that with diamines such as 2,3-dimethyl-2,3-butanediamine 
or 1,2 -butanediamine with acetic acid, that the diacetyl derivatives of the respective 
diamines were isolated in yields between 10-15% with little or none of the 2 - imidazoline 
being obtained. Earlier reports45' 47 employing the distillation of ethylene diamine 
hydrochloride with an excess of sodium acetate furnished 2 -methyl-2 -imidazoline in 
only 8% yield. Waldmann and Chwala48 made an extensive study of the preparation of 
2 -imidazolines from high molecular weight carboxylic acids and free aliphatic amines. 
These reactions were carried out by heating the reactants at 200-300 °C. Condensing 
agents such as aluminium chloride, phosphorous trichloride, stannic chloride, and 
phosphorous pentoxide were employed. A number of l,2-substituted-4,4-dimethyl-2- 
imidazolines (29) have been prepared by heating 1,2-diamines containing one 
secondary and one primary group (27) with organic acids (28) in the presence of 
benzene as shown in schem e[l.l]. The mixtures were heated under conditions to 
remove water by azeotropic distillation.44
NH2C(CH3)2CH2NHR + R'COOH  ►
(27) (28)
R/
H 3C + 2H 20
h 3c  N R' 
(29)
Schem e [1.1]
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In 1975 Bespalyi reported a similar synthesis of 2-imidazolines by treating fatty acids 
with diamines in a 1:3 acid/amine ratio in BuOH initially at 130-130 °C then at 250-270 
°C 49
1.2.1.2 By reaction with dicarboxylic acids:
1.2 -diamines containing one primary and one secondary amino group react with dibasic 
acids containing four or more carbon atoms giving bisimidazolines.50 Chwala reported 
that di- or polycarboxylic acids react at temperatures of about 280 °C with a mixture of
1.2 -diamines and their salts in the presence of strong mineral acids to yield more than 
one 2 -imidazoline per molecule.51
1.2.1.3 By reaction with esters:
In 1950 Morrill52 disclosed in a U.S. patent, a preparation of 2-imidazolines by 
refluxing ethylene diamine with an ester and removing the alcohol and water formed by 
distillation. The reaction was proposed to proceed via initial amide formation followed 
by loss of water and cyclisation to the imidazoline. Pachter and Riebsomer53 found that 
cyanoacetic ester (31) reacts with N-(2-aminoisobutyl)isopropylamine (30) to produce 
2-cyanomethyl-2-imidazoline (32) (Scheme 1.2).
NH 2C(CH3)2CH2NHCH(CH3)2 + C2H5OOCCH2CN -------------------►
(30) (31)
/ CH(CH3)2
N
(32)
Schem e [1.2]
1 8
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In 1981 Neef and co-workers54 presented a variation of this synthesis claiming that the 
original method was very limited in its usefullness, often requiring drastic reaction 
conditions to effect conversion (sealed tube, 160-300 °C). They reported that 
bifunctional units such as 1,2-diaminoethane (33) could be coupled with trimethyl 
aluminium (34) to produce reagents that could be treated with a wide variety of esters to 
give 2-imidazolines under mild reaction conditions according to scheme [1.3].
1.(CH3)3Al (34) 
NHoCH2CH2NH2 --------------------------
2. RCOOR'
(33)
O
il
R - Q
n h 7
CH,
N - C  
H H2
R - < '
IM­
S'
N"i
H
Schem e [1.3]
1.2.1.4 By reaction with imino ethers:
In 1935 Sonn55 obtained a patent for the preparation of 2-substituted imidazolines by the 
action of aliphatic 1,2-diamines (33) on imido ester (imino ether) hydrochlorides (35) 
derived from aryl, aryloxy or carboxyalkyl substituted products (Scheme 1.4). The 
reaction of imino ethers or their hydrochlorides with 1,2 -diamines is a satisfactory 
method of preparing 2 -imidazolines.
1 9
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R
OR'f
NH.HC1
(35)
CH9NH9
I
c h 2n h 2
(33)
/
+ N H 4CI + R'OH
R
R = Aryl, aryloxy or carboxyalkyl substituted products
Schem e [1.4]
R' may be an alkyl group but generally is ethyl. Several authors have synthesised in this 
m anner using various R groups; CICH 2 ,56 C 1(CH 2)3,57 H O C H 2 ,5 8 
C6H5CONH(CH2)2,59 C6H5N H ,60 C 6H 5.61 Other variations of this synthesis have 
been described where the imino ether or imidate, as it may be alternatively named, was 
prepared as the tosylate rather than the hydrochloride salt. In 1987 Lopez Calahorra62 
reported the preparation of 2-(benzo-l,4-dioxan-2-yl)-4,5-dihydro-imidazoles (40) by 
treatment of benzodioxanecarbonitriles (36) with a strong acid such as /?-MeQ,H4S0 3 H
(37) in EtOH, thus forming ethyl(benzo-l,4-dioxane-2-yl) formidate as the tosylate salt
(38), which was subsequently treated with an alcoholic solution of KOH and the 
diamine (39).
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(36)
CN + />-MeC6H4S 0 3H + EtOH
(37)
(38)
r 5n h c h 2c r 3r 4n h 2/ k o h
(39)
Rl = H, OMe, OH, Cl, N 0 2 
R2 = H, Me, Et, C3H7 
R3-R5 = H, Me
R
Schem e [1.5]
1.2.1.5 By reaction with nitriles:
The heating of aromatic or aliphatic nitriles and the salts of 1,2 diamines at 140-250 °C 
was shown to be a very effective method of preparing 2 -imidazolines63 as depicted in 
scheme [1.6 ].
+
+
CHiNH-.
I ‘
CH 2N H 2
Schem e [1.6]
+  RCN + NHi
N R
2 1
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While the free base was found to react with some reactive nitriles, in general this reaction 
was found to be too slow to be useful. The mono or di sulphonic acid salts of 1,2- 
diamines are preferred over the hydrochloride salts as they produce a homogenous 
reaction mixture. A variation of this method was described by Borisova et al.M in 1975 
where imidazolines were produced by treating RCN with H2NCR3R4(CR'R2)nOH at 
40-120 °C in AcOH using either HCIO4 or H2SO4 in catalytic amounts.
The presence of H2S was found to be advantageous in the preparation of 2-imidazolines 
from 1,2-diamines and aliphatic or aromatic nitriles.65' 67 In some instances these 
reactions are carried out under conditions in which hydrogen sulfide is formed by 
hydrolysis of a sulfide.68 A U.S. patent69 describes the formation of imidazoline (43) 
from Ph(PhCH2)N CH 2CSNH 2 (42) and diamine (33), the former being generated 
from the action H2S and NH3 on Ph(PhCH2)NCH2CN (41). The beneficial uses of 
H 2S is again shown by Nakata and co-workers in the synthesis of imidazoline 
derivatives from nitriles70 (Scheme 1.7).
Ph
PhC
(41) (42)
■2
(33) (43)
Schem e [1.7]
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1.2.1.6 By reaction o f  amides:
Aryl acetamides (44) have been treated in the absence of mineral acids or condensing 
agents, with an excess of ethylene diamine at 150-200 °C to yield 2-imidazolines71 
according to scheme [ 1.8 ].
1.2.1.7 By reaction o f amidines and guanidines:
It has been shown that N-substituted amidine salts prepared from the free bases (45) 
and /Moluene sulphonic acid (46) may be heated with 1,2-diamines (33) to yield 2- 
imidazolines (47) and ammonia72 as outlined in scheme [1.9]. This is in accord with the 
suggestion that amidines may be intermediates in some of the reactions of nitriles and 
salts of 1,2 -diamines to form 2 -imidazolines.63
CH2NH2 +  NH2COCH2C6H5 
c h 2n h 2
(33) (44)
Schem e [1.8 |
2 3
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S 0 3H
C,H4119
n h c 6h 4c h 3
NH
(45)
+  (33) +
CH,
(46)
N C^Hy
(47)
+ NH,
Schem e [1.9]
As given in scheme [1.10] Citerio et a / .73 reported the reaction of N-chloroamidines 
(49) with 1,2-amino ethenes (48) or with amidines (51) and a diimmonium bromide 
derivative (50) to give 4,5 substituted 2-imidazolines (52).
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(49)
N
I
CHII
CH
o
(48)
r 0^
N
CH 2 B r ' +
CH
I:
+ N .
C1N
1
/
C -R
HNI
R’
o O 
(50)
HN
%
/ '
HNI
R'
C -R
(51)
Schem e [1.10]
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1.2.2 From monoacyl and diacyl derivatives
Hill and Aspinall74 found that many aromatic and aliphatic monoacyl ethylene diamines 
undergo dehydration and cyclisation to 2 -imidazolines, with the addition of lime being 
necessary for the reaction of the latter. Their preparation from diacetyl ethylene diamine 
was thoroughly investigated by Chitwood and Reid75 who found that the highest yields 
were obtained when diacetyl ethylene diamine was heated with magnesium powder.
1.2.3 From carbonyl containing compounds:
Aromatic aldehydes react with ammonia to yield hydroamides (53) which may be 
cyclised on heating to 2,4,5-triaryl-2-imidazolines (54) 76-77 as shown in scheme
[ l .H ] .
c 6h 5h c = n n
c h c 6h
C6H 5H C — n
(53) (54)
Schem e [1.11]
Hagen et al. in a patent application described in 1973 the synthesis of 2-imidazolines
(57) by reaction of aldehydes (55) with R i, R2 substituted diamino alkanes (56) and 
sulphur78 (Scheme 1.12).
2 6
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/ , °
R _ c ^ + n h 2c h r , c h r 2n h 2 
n h
(55) (56)
(57)
Schem e [1.12]
1.2.4 M iscellaneous Syntheses:
2-Imidazolines have been prepared in yields as high as 94% by reducing the monoacetyl 
derivatives of amino nitriles (58)79>80 (Scheme 1.13).
(58)
Schem e [1.13]
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An unusual method of forming imidazolines shown in scheme [1.14] consists of heating 
to a high temperature a mixture of 2-imidazolidone (59) and a carboxylic acid (60) 
other than formic acid.81
H
(59) (60)
R * H
Schem e [ 1-141
In 1973 Yoshihiko and co-workers82 prepared imidazolines in a single reaction of an
isonitrile (61) with the diamine (33) (Scheme 1.15) assumed to proceed via a carbene
coordinated silver complex intermediate. Hagen et a / .83 simultaneously reported the
synthesis of imidazolines by the reaction of RN:CH2 (62) with an appropriate diamine
and sulphur giving yields of 8 6 % (Scheme 1.16).
+ - AgCN
R— N = C  + NH2CH2CH2NH 2 ------------------
(61 )
I
H
Schem e [1.15]
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H
M
R N = C H 2 +  (33)
(62)
N
Schem e [1.16)
A very elegant synthesis of imidazolines (6 6 ) outlined in scheme [1.17] was reported 
by M urai84 where keteneim ines (63 ) reacted with aziridines (64 ) giving 
imidoylaziridines (65) which subsequently rearranged to imidazolines in good yields.
Ph2C — C— N- 
(63)
Ph2CH— C = N
f
N
ZA
(65)
H
I
N
(64)
( 66 )
Schem e [1.17]
Hill and Johnson85 successfully formed imidazolines from the reaction of diamines (33) 
with orthoesters (67), using mainly aromatic derivatives due to the difficulty of 
obtaining aliphatic orthoesters (Scheme 1.18).
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A r
ArC(OC2H5)3 +  (33)
(67)
N ' N
Schem e [1.18]
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1.3 1,2,4-O X A D IA ZO L E S
1.3.1 Introduction
1,2,4-Oxadiazoles have been known since the last century with the first report being 
made by Tiemann and Kruger86 in 1884 who proposed the name "azoximes" for these 
compounds. Oxadiazoles are five membered heterocyclic compounds containing one 
oxygen and two nitrogen atoms. Four oxadiazole isomers are possible depending on the 
relative positions of the oxygen and nitrogen atoms in the heterocyclic ring.
”  N ~ N  
N 5 ^  N 2 N n N
o  o '  O o
1
1,2,3- 1,2,4- 1,2,5- 1,3,4-
(6 8 ) (69) (70) (71)
Schem e [1.19]
In older French literature, oxadiazoles are considered as a furan nucleus in which two 
CH groups are replaced by nitrogen atoms and therefore are sometimes termed 
furadiazoles or furodiazoles. When these latter names are used, the relative positions of 
the nitrogen atoms are indexed by the letters a  and (3' for the 1,2,4-oxadiazoles for 
example. In the old German literature, the carbon atoms in the ring are considered as 
part of the substituent and thus 1,2,4-oxadiazole would be named as dimethenylazoxim.
The greatest part of the work carried out in the field of 1,2,4-oxadiazoles is due to 
Tiemann and his co- workers.87-90 All the compounds they prepared were substituted in 
the 3- and 5- positions, by two hydrocarbon radicals, at least one of which was an
3 1
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aromatic radical.91 Compounds with only aliphatic substituents were mentioned for the 
first time in 1959.92'93
Two widely used methods of synthesising 1,2,4-oxadiazoles embrace 95% of the 
practical preparations of these compounds: the conversion of amidoximes94 by means of 
carboxylic derivatives to the cyclic structure [shown schematically as the combination of 
two skeletons] (72 a,b) and the cycloaddition of nitrile oxides95 to nitrile (73c,d).
4 3 4 3
N — t\ N  &
/// \W
b 5 C N2 a  d  5 C N 2 c
0  O
1 1
(72) (73)
Schem e [1.20]
The fragments making up the moieties (72a), (72b ), (73c) and (73d) can be 
disguised in a variety of ways. The carbon atom C5 in (72b) can be in the oxidation 
state 4-4, +3, or +2 to give oxadiazoles or the reduced ring oxadiazolines. The sp2 
carbon at C-3 is commonly in an amidoxime or an iminoether. The fragments (73c) and 
(73d) may be triple bonds as shown, but double bonds in either moiety give A2 or A4- 
oxadiazolines, or oxadiazolidine derivatives.
32
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1.3.2 Ring Closure on Carbon
1.3.2.1 From O-Acylamidoximes
An amidoxime (74) is a good starting point for a suitable reagent containing an sp2 
carbon (C-3) with two nitrogen atoms attached. The carbon to end up as C-5 in the +3 
oxidation state may be furnished by an anhydride (75). This is the most frequently used 
preparation of these oxadiazoles since the work of Tiemann.86
The amidoxime which is usually made by heating a nitrile with hydroxylamine in acid 
solution96' 98 is converted to the O-acyl derivative (76), as indicated in scheme [1.21], 
long assumed to be intermediates in the pathways to oxadiazoles86-99 but only proven to 
be the case in 1963.100
4 R R
HtN
HO
(R 'C ),0  
I 5
- h 20
R o
R
(74) (75) (76)
R
(77a) (77b)
Schem e [1.21]
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The O-acyl derivatives are not often isolated, and indeed cannot often be isolated if the 
acylation is carried out above 100 °C. A kinetic study suggests that the rate determining 
step is the proton transfer (77a) —> (77b) following cyclisation . 101 In addition to the 
anhydride102' 105 many other sources for the C-5 carbon can be employed. Ketenes, 106
The reaction of amides112 with an amidoxime salt to give oxadiazoles (78) (Scheme 
1.22) is especially felicitous because no solvent is needed and recovery is simple. The 
two components are melted together at 160-180 °C for 10 minutes, and water is lost at 
the elevated temperature. Both aromatic and aliphatic (di- and monosubstituted) 
amidoximes give yields in the range of 60-90%.
reactive acids such as form ic107 and acrylic, 108 acid chlorides, 109 esters , 110 ortho 
esters , 111 ethyl oxylate , 112 amides, 112 and iminoethers113 may also furnish the C-5 
carbon.
NOH Me
//
M e— C ^
NH2
1 6 0 -  180 °C
10 min
(78)
Schem e [1.22]
A successful innovation of this method outlined in scheme [1.23], with yields of 
oxadiazoles (80) of 81-95% is the use of the fragment (72a) as an N,N- 
dimethylalkanamide dimethyl acetal (79) . 114
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NH-
(80)
Me\  OMe
N^/ a- a /P H +
Me"" OMe +  Ar'
R
(79)
M e \  | || N H 2OH H \  j _  | |
N— C=  N—  C—  Ar ~  *“ N— c — N— c — Ar
Me HOAc HO
R
a N— ■ /
A // ^
--------------------  A r O
Schem e [1.23]
Still another variation of this method115 is the reaction of a mixed imide (81) with 
hydroxylamine shown below in which the R group takes the C-3 position as in (82).
PhCONHCSR + NH.OH ---------------   O^
Ph
^  N 
N"  R
(81> (82)
Schem e [1.24]
The oximino group in (72) can be introduced through nitrosation on carbon if there is 
an active hydrogen at that carbon atom. For example in scheme [1.25], nitrosation of the
3 5
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acylamino half ester of malonic acid gives an intermediate (83) that can isomerise to an 
oxime (84) and then cyclise to a 3-ethoxycarbonyloxadiazole (85).
H2N C H (C 02Et)2 - 2 ^ ------   PhC 0N H C H (C02Et)2
C 0 2Et HONO
PhCONHCH  ^  PhCONHCHCO.Et  _
v c o 2h  ■ COi I
NO
(83)
C 0 2Et
N - /PChOHN— C— C 0 2Et ~ H2Q \Jy
N
P h "  ' o ' '
(84) 
(85)
Schem e [1.25]
When the (72b) fragment is a carbonic acid derivative116 i.e. of oxidation state +4, a 
hydroxy group may be introduced at C-5. Chloroethyl formate (8 6 ) reacts with 
amidoximes to give a carbonate ester that loses a molecule of ethanol in the cyclisation 
shown in scheme [1.26]. The expected oxadiazolone (87a) is a tautomer of the 5- 
hydroxy form (87b).
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* NOH x  n r n  Pi N 0 C 0 2Et - b o h
R - <  +  CIC° 3El  '  R - c t
NHi m j-j
( 86 ) " 2
H R R
NN— /  _____  N— /
^  - —  J L  x n
O O HO O
(87a) (87b)
Schem e [1.26]
In 1965 Grigat et at. 117 obtained compound (8 8 ) (Scheme 1.27) with an ArO group at 
C-3, made using ArO-C(=NOH)NH? in place of amidoxime employed in scheme 
[1.26]. The aryloxy amidoxime was synthesised from ArOCN, unknown until 1964.118
N— OH
// N-
ArO— CN +  C lC 02Et    // \\
OAr
NH2 / NA
HO O
(88)
Schem e [1.27]
P-Ketoesters119 (89) are sufficiently activated to react with amidoximes, particularly at 
the boiling point of toluene, 120 to cyclise with the loss of azeotropic water and ethanol 
yielding the oxadiazole (90) as indicated in the scheme below. O-acylamidoximes were 
proposed as intermediates.
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N O H  toluene
/ /  +  MeC OCH2COOEt ---------Ph—  Cx
N H 2 Ph
N — ^
(8 9 )  Jf +  H 20  +  EtO H
Me-CO-CH;' ^ X 0 /
(90) 
Schem e [1.28]
Cyanuric bromide with an amidoxime gives the 5-amino oxadiazole derivative delineated 
in scheme [1.29].121
R
R - c f  + (CNBr>3    A .  N
N H 2 H 2N o
Schem e [1.29]
5-Amino-3-methylthiooxadiazole (91)122 and 3,5-diamino derivatives123 (93) and 
(94) have been synthesised from the cyanoimino compound (92). When the amine 
was p-nitroaniline, (93) was obtained in 6 8 % yield and with rm-butylamine (94) was 
formed in 52% yield (Scheme 1.30).
38
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N-
SMe
\ \  N H ,O H  
.N
SMe
h 2n  O
(91)
N C N = C (S M e )2 RNH~ — N C N = C
/
(92) n h 2o h  
R =  p-N02e6H4
NHR
n h 2o h
R =  /e /7-B u ly l
NHR NH-
N- W N-
.N \\
/ NH2N O RNH" ' o
(93) (94)
Schem e [1.30]
A new variation represented in scheme [1.31] is the activation of the oximino group in 
the amidoxime by replacement with =N-C1 (96). This was accomplished by oxidation 
of an imino group in a guanidine derivative (95) with sodium hypochlorite. A nitrene
(97) was suggested as an intermediate. 124
NH N-Cl
H 2N C O N H C N H P h
NaOCt
HiNCONHCNHPh
-H C I
(95) (96)
O :N:
II I 
H2N—  c — N = c —  NHPh
(97)
NHPh
A
H2N o
N
Schem e [1.31]
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When employing amidoximes as starting materials in the synthesis of 1,2,4-oxadiaxoles 
it should not be taken for granted that the amidoxime carbon always becomes the C-3 
carbon in the oxadiazole. W arburton125 for exam ple, dem onstrated  that 
benzoyldicyandiamide (98) gave a mixture of two ureido derivatives (99a) and (99b), 
the first predominating.
Dimsdale126 in 1981 made a similar caveat when he showed that mistakes in structure 
have been made by assuming that the anhydride carbon atom always takes the C-5 
position as opposed to the C-3 position (See scheme 1.21). Warburton and co- 
workers127 destroyed another unstated tenet of diazole chemistry, namely that only 
monoacylated amidoximes cyclise, when they found that (100) slowly cyclised to 
(101) merely on standing for 27 days.
O NCN NH2OH . HC1II ^
Ph— C— NH—C ^
n h 2
(98) Ph n h - c o n h 2
(99a) (99b)
Scheme [1.32]
Ar
Ar— C
N-COOEt
^  N-O-COOEt 25 °C
Me
(100) (101)
Schem e [1.33]
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1.3.2.2 From N-acylimino ethers
Another source of the sp2 carbon at C-3 is an N-acylimino ether. The iminoether (102) 
reacts with hydroxylamine to give the intermediate (103) which has not been 
isolated, 128 and then cyclises to the oxadiazole (Scheme 1.34).
Ph-
//
N-COR(Ar)
OEt
NH2OH
( 102)
//
N-COR(Ar)
Ph— C,
NHOH
- h 2o
Me
N-
O
Ph
,N
(103)
Scheme [1.34]
Earlier Beckman and Sandel129 had used N-acyliminochlorides and N-acylbenzamidine 
in the same way with hydroxylamine, but these starting compounds are less stable and 
not so easily obtained as the N-acyliminoethers.
An iminoether may also be used as the source of the C-5 carbon in the final product if an 
amidoxime furnishes the one at C-3. Weidinger and Kranz113 prepared 3-phenyl-5- 
methyloxadiazole (104) in 87% yield and 5-phenyl-3-methyloxadiazole (105) in 6 8 % 
yield by this variation (Scheme 1.35).
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M e—
Ph
+ -  Ph 
NH2C1 NOH A N -
/ /  2 . / /  A  / /  V
+  Ph—  ---------- ^  / /  Vr
OEt NH2 M e ^ o "
(104)
Me
N H oCl” NOH N {
/ /  +  *  A / /  W_
- C . ^  Me— C .  -  J L  .N
OEt N H 2 Ph o
(105)
Scheme [1.35]
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1.3.3 Dipolar Cycloadditions
1.3.3.1 Reaction o f nitrile oxides with nitriles
The second general method of generating the oxadiazole ring is to add the fragments 
(73c) a nitrile oxide to the nitrile (73d) in a 1,3-dipolar cycloaddition. This method has 
been widely exploited130' 137 since Leandri95 first suggested the idea (Scheme 1.36).
R(Ar)
+ • N---- /
(Ar)R— C = N — CT +  R  C = N  ------------------------- // \\
N
(73c) (73d) R o '
Scheme [1.36]
Aliphatic nitrile oxides are usually generated in situ from a primary nitroalkane with 
phenylisocyanate as dehydrating agent. 138’139 Aromatic nitrile oxides are much less 
reactive and can be isolated but again are more often generated in the presence of the 
nitrile by the action of a base or heat on hydroxamic acid140’141 according to scheme 
[1.37].
N 0 H  p. w + +/ /  Et^N ^  —
Ar—  2 Ar — C = N — CT +  Et 3 NHC1
Cl
Scheme [1.37]
In 1957 Leandri142 reported the condensation of aromatic nitriles with benzonitrile oxide 
with yields of the oxadiazole (106) varying from 0.2 to 29% depending on the 
substituent X linked to the aromatic nitrile. The yield increases when X is electron 
withdrawing and decreases when X is electron donating (Scheme 1.38).
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(106) 
Scheme [1.38]
Aliphatic nitriles were found not to react with benzonitrile oxide unless activated by an 
electron withdrawing group . 143 For example, acetylcyanide gives 3-phenyl-5- 
acetyoxadiazole (107) in a yield of 60% .144
C6H5 — C = N — O +  CH^COCN  --
c 6h 5
H3C O C ' ' ( /
(107)
Schem e [1.39]
Cyanamide (108), phenylcyanamide (109) and cyanoguanidine (110) are also 
reported to form oxadiazoles when treated with benzonitrile oxide in accord with scheme 
[1.40].145
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+
C 6H5 — C = N — O
Scheme [1.40]
The reaction is considered as a 1,3-dipolar addition to a mesomeric form of the nitrile 
oxide. 146' 143
+ +
C6H5 — C = N — CT „   C6H5 — C = N — Cf
Scheme [1.41]
Bast et a / . 130 reported yields as high as 8 8 % for aryl nitrile oxides with aryl or 
negatively substituted alkyl cyanides. Yields of 35-40% were reported131 for four 
aliphatic nitriles with benzonitrile oxide, but boron trifluoride etherate was needed as 
catalyst. A novel use of the general method outlined is the addition of an aromatic nitrile 
oxide to the nitrile equivalent tied up in the triazine147 (111). The reaction occurs to 
give good yield but again only in the presence of boron trifluoride etherate whose role is 
illustrated in scheme [1.42].
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c 6h 5
NH2C N  (108) N— /
   x : »
h 2n  o
CfiH,NHCN (109) H\  / C6H5
N- V
N
H N ' 'O ^  
C N N H C(:N H )N H 2 (HO) N~
V
N
H2N(HN:)CHN' ' o '
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N . BP*
K  , +
A i C = N — O
H
^ N N anc* [w'ce niorc
(1 1 1 )
Ar
N
*
O '
\\ +  BF,
N
Scheme [1.42]
1.3.3.2 Reaction o f hydroxamyl chlorides with nitriles
It has been found148 that the formation of nitrile oxides from hydroxamyl chlorides is 
not always necessary. When heated in an inert solvent without any base, an equimolar 
mixture of a nitrile and a hydroxamyl chloride produces the expected oxadiazole with 
evolution of HCl (Scheme 1.43).
* N 0 H  . N - /
R— C +  N = C — R -------------   / /  W +  HCl
R O
Scheme [1.43]
N - ^ N
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The advantage of this method is its applicability to some hydroxamyl chlorides such as 
dichloroglyoxime, the nitrile oxide of which is unknown, and ethyl a -c h lo ro -a -  
isonitrosoacetate which immediately dimerises in the presence of a base.
1.3.3.3 Reaction o f hydroxamyl chlorides with iminoethers.
The process consists in condensing a hydroxamyl chloride with an iminoether at 
comparatively low temperature (Scheme 1.44).
/ 0 H  NH
R - C v CI +  R - c t
OC2H5
R
R o
N
N
+  HCl +  C2H5OH
Scheme [1.44]
The reaction occurs in one step, but an equivalent excess of imino-ether must be used as 
HCl scavenger. The process is limited by the choice of reagents, but when hydroxamyl 
chlorides and iminoethers are easily available, their condensation is the most practical 
way to obtain oxadiazoles. 149 The condensation is particularly suited to aromatic and 
heterocyclic derivatives.
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1.3.3.4 Reaction o f hydroxamyl chlorides with amidines.
D iphenyloxadiazole has been prepared in almost quantitative yields from 
benzhydroxamyl chloride and benzamidine at room temperature in accord with scheme 
[ 1.45j. The reaction occurs apparently in one step as no intermediate product is 
isolated. 150 However as amidines are derived from iminoethers, this method presents 
only little interest.
Schem e [1.45]
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1.3.4 FR O M  OXIDATIONS
A less common and in general a less satisfactory method of entering the oxadiazole 
series is through the oxidation of compounds such as aromatic aldoximes, amidoximes 
and oxadiazolines.
1.3.4.1 From the oxidation o f amidoximes and oximes.
The action of bromine, ferricyanide, 151 and other mild oxidizing agents152 directly on 
benzamidoxime has been reported to give 3,5-diphenyl-5-amino-dihydroxadiazo!e
(112) which on subsequent heating in dilute mineral acid readily loses NH3 to yield 
diphenyl oxadiazole (Scheme 1.46).
H
NOH
4 C6H 5 - C N +  2 [O] 2 H,N +  NiO + H-iO
( 112)
dil. HCl
Schem e [1.46]
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Benzaldoxime (113) can be oxidized with nitrogen dioxide in ether to a dimer that 
thermally decomposes to an oxadiazole as outlined in scheme [1.47] . 153 B oyer154 
proposed the intermediate dimer structure (114) as benzaldoxime anhydride N-oxide 
but an alternative (115) offered by Horner et a / .155 could not be excluded. The dimer is 
converted to the oxadiazole in chloroform or benzene.
N 0 2
C6H5C H = N O H  -------
(113)
+
P h C H =  N — O— N =  CHPh
l_
0  (114)
or
+ -+•
P h C H = N — N = C H P h  
° ~  ° “ (115)
Ph
Scheme [1.47]
The oxidation of benzaldoxime (113) with iodine and sodium carbonate yields, besides 
benzoic acid, at least four substances identified as benzoyl-benzaldoxime (116), 
benzaldoxime peroxide (114), and two distinct oxides of diphenyloxadiazole (117)
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depicted in scheme f 1.48]. The oxides (117) are easily reduced to diphenyl oxadiazole 
with zinc and acetic acid. 156-157
C6H5C H =  NOH 
(113)
C6H5COOH 
(114)
C6H5C H =  NOCOC6H 5 (116)
N-
V
CaH6 n 5
^6 ^5  O 
(117)
.N
+
O
S c h e m e ' [1.48]
Van Meeteren and van der Plas158 oxidised several imidazoles (118) to oxadiazoles. 
They proposed the formylamidine intermediate (119) shown in scheme [1.49], since 
alkaline oxidation of imidazoles is known to produce such derivatives. 159 An additional 
fact supporting the intermediate was that imidazoles disubstituted at C-4, C-5 could not 
be oxidised to oxadiazoles.
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Et
N
N
I
H
Ph
Ph— C
O
II
N— C — H
//
N— C— Et 
I II
H O
(118) (119)
Ph
N-
Et A '
N
Scheme [1.49]
1.3.4.2 Oxidation o f oxadiazolines
Amidoximes readily condense with aliphatic aldehydes in aqueous solution to form 4,5- 
dihydro-l,2,4-oxadiazolines (120) represented pictorially in scheme [1.50]. This 
partially reduced ring can then be oxidised to an oxadiazole by various oxidising agents 
such as potassium  perm anganate , 160 nitrogen dioxide in ether , 161 so d iu m  
hypochlorite, 161 and N-chlorosuccinimide. 161
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NOH
PhCH2CHO +  Ph—  C
*
NH­
Ph
(120)
K M n 0 4
Ph
N-
HOAc PhCH2- " ' \ d * 'N
Scheme [1.50]
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CHAPTER II
Synthesis of 2'Aryl-tropane-3-spiro-4'(5')-imidazolines.
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2.1 Introduction.
Retrosynthetic analysis (Scheme 2.1) indicated that the spirofused imidazoline (I) could 
be prepared in a number of ways, all encompassing the key diamine intermediate (122 ). 
At first examination the monoacylation of the diamine to give compound (121), 
followed by cyclisation with the concurrent loss of water looked an attractive approach.
(122)
X = OH, OR, NH2
Scheme [2.1]
Preliminary investigations to form the amide by condensation of the diamine (122) 
with carboxylic acids, esters or amides however proved unsuccessful due to the high 
temperature required and consequent rupture of the tropinone ring system. Attempts to 
condense the diamine directly with an aromatic nitrile proved unfruitful, again resulting 
in decomposition of the tropinone ring system as a result of the high temperature 
needed.63
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The most successful synthesis of the spiroimidazolines, was found to be that where the 
tropinone diamine was condensed with the hydrochloride salt of an aryl imidate (123) 
as outlined in scheme [2 .2 ].
NH2C1
W  > Ar — +  (122) ______
OMe
(123)
Scheme [2.2]
The imidates were prepared from the corresponding aryl nitriles which were either 
commercially available or were synthesised from the aldehyde. It was proposed that the 
key diamine intermediate (122) could be prepared by reduction of the amino nitrile
(124) which in turn could be made from readily obtainable tropinone (125).
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2.2. Preparation of l//-indole-3-carbonitrile  (126)
Several methods for the conversion of aldehydes into nitriles are known . 162-167 A 
method published by Dauzonne et a l . 168 in 1981 using inexpensive reagents, was 
reported to give high yields of nitriles in one step from aromatic and certain 
heteroaromatic aldehydes via reaction with pyridine hydrochloride and a nitroalkane, 
preferentially nitroethane.
R — c f
O pyridine/HCI
c 2h 5n o 2
H
R — C = N O H  
H
R — C E N
R =
(126)
Scheme [2.3]
The method was reported to be less efficient with aliphatic aldehydes because of partial 
hydrolysis of the product nitriles or incomplete reaction. A typical procedure involves 
mixing the aldehyde with a 15% excess of pyridine hydrochloride in nitroethane and 
heating under reflux for one hour. Work-up involves cooling the reaction to room 
temperature, adding chloroform and 0.1  normal hydrochloric acid followed by 
separation and washing of the organic phase. The product is isolated pure by column 
chromatography.
The title compound was prepared by the above authors in 70% yield, requiring a 
reaction time of 30 min. Using the conditions described we successfully synthesised the 
l//-indole-3-carbonitrile, though the reaction conditions and yields were somewhat at 
variance with those of the published method. Under the conditions described we found
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than only about 15-20% conversion to the nitrile could be achieved in the time outlined 
in the published procedure. Reaction times of six to seven hours were required to 
achieve full conversion of the aldehyde. On thin layer chromatographic plates an intense 
yellow spot was observed as well as the product nitrile. The intensity of this spot 
reached a maximum during the course of the reaction and on continued heating of the 
mixture (after the disappearance of the starting aldehyde) no variation of its intensity 
was observed. This seemed to indicate that, firstly, the compound was not an 
intermediate of the reaction and secondly that the impurity was not derived from 
decomposition or rearrangement of the product nitrile.
The yellow impurity was isolated by column chromatography on silica gel and was 
obtained in 15 % yield as a fine yellow powder. The required nitrile was isolated in 32 
% yield. NMR analysis of the yellow compound in CD3OD showed, as well as the 
aromatic protons of the indole system, a singlet integrating for 3 protons at 8 = 2.50 
ppm and a singlet at 8 = 7.76 ppm integrating for 1 proton. Based on this information 
the structure (127) was proposed.
H
(127 )
Mass spectrometry supported the structure, since electron impact gave a mass ion of 202 
and a base peak of 154 corresponding to the loss of HNO2.
The formation of this 1-indole-2-nitropropene probably takes place via the mechanism 
given in scheme [2.4]. Nucleophilic attack of the a  carbon of the nitronic acid 
intermediate (128) on the protonated carbonyl group leads to the intermediate (129)
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which on loss of H2O gives the proposed compound which from its extended 
conjugated system probably accounts for the intense yellow colour of the product.
(129> (127)
Scheme [2.4]
This side reaction was not reported by Dauzonne et al. in their published synthesis of 
nitriles. However a subsequent report by Karmarkar and coworkers169 employing a 
variation of the Dauzonne synthesis, using NaOAc/AcOH and NfLtOAc/AcOH in place 
of pyridine hydrochloride, showed that while the sodium acetate mixture led exclusively
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to the nitrile the latter gave the aryl nitropropene as the only product. Also noteworthy 
was the fact that when they used nitromethane instead of nitroethane l-aryl-2 - 
nitroethylenes (co-nitrostyrenes) were always isolated even when sodium acetate was 
used.
The mechanism of formation of nitriles from aldehydes is somewhat obscure and 
difficult to elucidate. Dauzonne168 made the assumption that in their reaction using 
pyridine hydrochloride and nitroethane, the reaction proceeded via the intermediacy of 
aldoximes (Scheme 2.3). They based their assumption on the fact that nitroalkanes are 
capable of generating aldoximes under the action of pyridinium halides170 and that 
pyridinium halides can dehydrate aldoximes to nitriles. 171 However no clear mechanism 
was outlined. Similarly, Karmarkar and cow orkers169 were unable to present a 
definitive mechanism for the conversion of aldehydes to nitriles with nitroalkanes. They 
reiterated the idea of an intermediate aldoxime which could be cleaved to give the nitrile 
in the presence of sodium acetate. As evidence for the formation of the aldoxime they 
cited a report172 which claimed that nitroethane reacts with concentrated sulfuric acid to 
give ethanehydroxamic acid. The presence of an intermediate of this type, they claimed, 
could presumably convert the aldehyde into the oxime derivative. To substantiate the 
proposed mechanism they showed that under the conditions used in the reaction in 
question, that the oxime acetate prepared from 2 -m ethoxy-l-naphthaldehyde was 
converted to the same nitrile which was obtained directly from the aldehyde.
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2.3. Imidate salts.
2.3.1 Introduction.
The chemistry of imidates and their salts is well documented and it is proposed that only 
a brief outline of their synthesis plus some practical considerations be given here. The 
first major work on the subject was described by Pinner in his book Die Imidoather und 
ihre Derivate, 173 a work which is however difficult to obtain. A more recent and 
accesible review of imidates was carried out by Roger and Neilson174 and provides a 
comprehensive covering of imidate synthesis.
Imidates may be synthesised in several ways, among which include the condensing of 
a nitrile and an alcohol under anhydrous conditions, known as the Pinner synthesis, 173 
the synthesis of imidates via imino chlorides (Hoesch reaction) , 175 from amides, 176 
o rth o este rs , 177 aldehydes and ketones , 178’179 unsaturated system s180 and by 
transesterifications. 181 Probably the most widely used method of imidate synthesis is 
that of the Pinner synthesis, and it is this method which was exploited to form the 
imidate intermediates required for this project. The method is outlined in scheme [2.5].
/ NH2C1
RCN +  R'OH +  HCl ---------- R — C /
OR' 
Scheme [2.5]
The nitrile is reacted with the alcohol under anhydrous conditions in the presence of 
hydrogen chloride or hydrogen bromide.182 The reaction is normally carried out at 0 °C 
and anhydrous ch loroform , 183 n itrobenzene , 183 d ioxane , 184’185 dim ethyl
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Cellosolve, 186 and in particular benzene187 and ether188 have been used as diluents. It 
was established however, that the use of solvent may be detrimental to the yield and that 
better results accrue in certain cases when the anhydrous diluent is added after several 
days or when the imidate is on the point of crystallisation. 189 Excess alcohol has also 
found use as diluent, 190 but this can be conducive to the formation of ortho esters in 
certain cases. However this problem does not generally exist when the reaction is carried 
out at 0 °C.
Of the alcohols, methanol and ethanol are the most used and in general give satisfactory 
yields of imidate hydrochlorides in the Pinner synthesis, but propyl, 191 isopropyl, 192 
bu ty l , 191 isobutyl, 193 sec-bu ty l, 194 and benzyl alcohols, 195 among the simpler 
members have all been used.
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2.3.2. Preparation o f Imidate salts (123 a-h) using the Pinner synthesis.
The following imidate salts were required as intermediates in the synthesis of the desired 
imidazolines.
Ar —  C
NH2C1
\
OMe
(123)
Ar =
(a)
MeO,
OMe
(e)
(b)
OMe
(f)
V V
Cl OMe
(C) (d)
In general the imidate hydrochlorides outlined were synthesised by passing a stream of 
HCl gas through a solution of the nitrile in anhydrous methanol at 0-5 °C and the 
reaction mixtures were then stored under refrigeration at 0 °C for 24 hours. The progress 
of the reactions were monitored by taking samples o f the reaction mixture and 
evaporating them to dryness in vacuo. IR spectroscopy was then performed on the
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samples to monitor them for the disappearance of the nitrile stretching band at c. 2231 
cm-1 and the development of the C=N stretching band of the imidate at c .1651-1680 cm- 
1. The reaction could also be followed by thin layer chromatography. The imidate 
hydrochlorides were then isolated by precipitation from the methanol solution with 
anhydrous diethyl ether, followed by filtration and washing with several aliquots of 
anhydrous ether. Due to the sensitive nature of imidate hydrochlorides to moisture they 
were stored in vacuo over solid sodium hydroxide, which removes any excess 
hydrogen chloride and also maintains anhydrous conditions.
Depending however on the nature of the starting nitrile, variations in the reaction 
conditions had to be made in order to effect formation of some of the imidates. It was 
found for example that with l//-indole-3-carbonitrile, the reaction had to be carried out 
at a higher temperature than usual to give conversion. At 20 °C complete conversion to 
the imidate salt was observed. Despite the high temperature employed in the reaction, 
none of the competing orthoester formation was observed. In other instances the 
reaction success was found to be very sensitive to the concentration of the nitrile in the 
methanol. The 3-methoxyphenyl imidate (123d) failed to form in solutions of 0.6 
molar concentration, and could only be achieved when the concentration was increased 
to 1.9 molar. A similar problem was encountered with 3,5-dimethoxybenzonitrile 
where, because of the low solubility of the nitrile, high dilutions of the starting material 
in methanol had to be employed. The problem was overcome in this case by carrying out 
the imidate formation in a 50:50 mixture of methanol and diethylether in which the 
starting material was much more soluble and hence higher concentrations of nitrile could 
be used.
The extreme sensitivity of some of the imidate hydrochloride products also required the 
employment of a variation in the general work-up procedure. On working up the imidate 
of 3,5-dichlorobenzene in the usual manner by precipitation with diethyl ether and
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filtration, a second product was observed to form as monitored by TLC. From IR 
spectroscopy a strong band at 1731 cm -1 was observed as well as the band 
corresponding to the imidate C=N at 1651 cm-1 . The band at 1731 cm ' 1 was tentatively 
assigned to the carbonyl stretching frequency of an ester presumably formed during 
work up of the reaction mixture by hydrolysis of the imidate with atmospheric moisture. 
The same band could be seen when a sample of the pure imidate (showing only one 
band at 1651 cm-1 on IR) was stirred in methanol spiked with a few drops of water thus 
reinforcing the idea that the side product formed on work-up was the ester derivative. 
The most successful method of working up the reaction was by evaporating the reaction 
mixture under vacuum leaving a white solid product which was then used directly for 
the next reaction without further purification. The only contaminant in the product was 
traces of the starting nitrile which caused no interference in the next stage of the reaction 
sequence and could easily be recovered by acid extraction of the product.
A similar work up procedure had to be applied in the case of the ortho methoxyphenyl 
imidate hydrochloride (123f). The formation of this imidate was found to be extremely 
slow and showed only about 25 % conversion from the nitrile after 72 hours at 0-5 °C 
plus 24 hours at room temperature. The addition of diethyl ether to the reaction mixture 
failed to precipitate any product. On evaporating the reaction mixture to dryness and 
using it directly in the subsequent reaction again no interference was caused by the ortho 
methoxybenzonitrile which could be recovered in almost quantitative yield. This 
difficulty in synthesising benzimidates containing ortho substituents has been observed 
by several authors. The proximity effect was first observed by Pinner196 who was 
unable to obtain imidates in the normal way from o-substituted benzonitriles (130), 
(131), (132), and from a-cyanonaphthalene (134) although the other positional 
isomers readily yielded imidates. 197
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CN CN CN
V
CH3
V
c h 3
(130) (131) (132)
NHU
(133)
Extending his investigations, Pinner196 discovered that phthalonitrile (134) gave rise to 
a mono imidate salt only Scheme [2.6].
,CN
+  C2H5OH +  HCl ------------
C(=NH2C1)0C2H 5
CNCN
(134 )  
Schem e [2.6]
whereas the iso- and terephthalonitriles furnished diimidate salts (Scheme 2.7).
CN C(=NH2C1)0C2H ;
+  2C2H5OH +  2HC1
CN C(=NH,Cl)OC,H<
Scheme [2.7]
Other examples of this proximity effect were discovered by Lander and Jewson, 198 who 
failed to convert o-chlorobenzonitrile into an imidate, and by Guy and Paris, 199 who 
were similarly unsuccessful in the case of o-cyanobenzenesulfonamide.
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Moreover, steric inhibition of imidate formation of a similar character has been noted 
with 3-chloro- and 3-bromo-l,l-diphenylpropyl cyanides (135) (X = Cl or Br) which 
failed to give imidates via the Pinner method within forty-four days.200
XCH2CH2C(C6H5)2CN
(135 )
The extent of the limitations of this proximity effect has never been fully studied, but it 
is of interest to note that o-ethoxybenzonitrile201 and a-naphthylacetonitrile202 form 
imidates using the Pinner synthesis.
It was with the synthesis of the pyridine imidate hydrochloride (123b) that a lot of 
difficulty was encountered. At first sight it seemed as if this compound presented no 
difficulties in its preparation using the standard procedure. The 4-pyridine nitrile was 
dissolved in methanol and HCl gas was passed through the solution at 0-5 °C. After 
refrigeration for 20  hours a white crystalline solid was precipitated on addition of 
diethyl ether. TLC indicated one clean spot with an Rf value distinct from that of the 
starting material. From infrared spectroscopy no nitrile stretching band could be seen 
and a strong absorbtion at 1668 cm ' 1 seemed to indicate the required product. When 
attempts to condense this product with tropinone diamine in the subsequent reaction 
failed, the identity of the "imidate" was called into question. Closer examination of the 
IR spectrum revealed the presence of two bands at 3340 c m 1 and 3151 cm -1 possibly 
the stretching frequencies of the NH2 group of a primary amide. The suspicion of the
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presence of an amide was substantiated by the evidence provided from mass 
spectroscopy. A strong mass ion of 122 corresponded to the amide (136).
(1 3 6 )  (1 3 7 )
In some of the cases where the reaction was left for longer periods of time, of up to four 
days, the amide was accompanied by the presence of a high ester content, (137) 
presumably formed from methanolysis of the amide in the acid medium. As with 4- 
cyanopyridine, when attempts were made to convert 3-cyanopyridine or 3- 
cyanoquinoline to their respective imidate hydrochlorides only amides and esters of 
these compounds could be isolated.
An explanation for the failure of these reactions is as follows. It has previously been 
reported that imidate hydrochlorides of some compounds containing strongly 
electronegative substituents have been observed to decompose spontaneously to the 
corresponding amide. Steinkopf and Malinowski203 found that acetonitriles substituted 
with either two or more chlorine atoms or with a nitro group tended to give amides 
under the Pinner synthesis (Scheme 2.8).
CC13CN +  EtOH +  HCl ---------^  CCI3 CONH2 +  EtCl
Scheme [2.8]
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When protonated, a-am inonitriles act as an electron sink and spontaneous 
decomposition of the imidate salt takes place giving a-aminoamides204 often in excellent 
yield and in a high state of purity. However, as outlined in scheme [2.9] tosylation or 
acylation of the amino function permits the formation of stable imidate salts.205
f  /  NH2C1
Ph— C— CN +  EtOH +  HCl -------- Ph— C—
I O Ft
NHTs NHTs
Scheme [2.9]
Neilson and Watson206 noted that although mandelimidate salts derived from primary 
alcohols are stable, decomposition to mandelamide takes place readily when secondary 
alcohols are employed. Similarly, attempts to convert ,/V-cyanoamidines into imidates 
gave only the yV-carboxamidoamidines (138).207
NHCONH2Cl
R — Cx +  EtOH +  HCl -------- R — C /
n h 2 xn h 2
(1 3 8 )  
Scheme [2.10]
The decomposition of several imidate hydrochlorides to amides in chloroform and tert- 
butyl alcohol solutions at 60 °C was studied by McElvain and Tate .208 These 
decompositions follow first order kinetics with respect to the disappearance of the halide 
ion, giving straight line plots of log [Ch] vs. time. Thus, either an intramolecular attack 
by the halogen (Scheme 2.11),
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O jh3ci /O
R— c '  )    R — CN +  R'Cl
r XORV NH2
s j
Scheme [2.11]
or a bimolecular process (Scheme 2.12) (wherein the ionisation of the imidate salt is 
considered to be slight) are feasible reaction mechanisms.
_  _ //O R  +
R - C   -  R - C x +  Cl
XOR' NH2
R — C ^  +  R'Cl
NH2
Schem e [2.12]
Support for the Sn2 mechanism (Scheme 2.12) was established when it was found that 
the rates of decomposition of alkyl acetimidate salts were of the same order as for other 
recognised S]\j2 reactions.208
Subsequently, Stevens, Morrow and Lawson194 obtained jec-butyl chloride of high 
optical purity but with inverted configuration from the thermal decomposition of 
optically active seobuty l acetimidate hydrochloride, thereby confirming the S^ 2  
mechanism (Scheme 2.13).
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O i 3
H - C — Cl +  CH3CONH2
c 2h 5
Scheme L2.13]
In an attempt to overcome the inherent instability of the pyridine imidate hydrochlorides 
several alternative synthetic approaches were adopted.
Schaefer and Peters209 reported that the free bases of certain imidates containing 
electronegative substituents, which are more stable than their hydrochloride salt 
counterparts, could be readily prepared by the base catalysed reaction of nitriles with 
alcohols (Scheme 2.14). They pointed out that those nitriles which were unsuited for the 
base-catalysed reaction usually gave excellent results in the Pinner synthesis and 
conversely, the nitriles which were most reactive in the base catalysed process often 
gave unstable imidate hydrochlorides. Thus the two processes complement each other 
very agreeably.
NH
_  B ' II
R C = N  +  R'OH R — C — OR'
Scheme [2.14]
The method described is simple and usually high yielding. A solution of the nitrile and 
sodium methoxide in methanol (not necessarily anhydrous), is left to stand overnight at 
room temperature and the product is isolated by distillation.
Using this method the imidate free bases of the three isomers of cyano pyridine were 
prepared by stirring the respective nitriles in NaOMe/MeOH at room temperature for 24 
hours. The absence of the nitrile spot on TLC (plus the appearance of a new spot ;
/ N H2+
h 3c - c (  h  c h 2
O - C ^ ----- Cl
c 2h 5
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Silica/Hexane/EtOH) and the non-appearance of the stetching band at 2242 cm -1 
indicated complete conversion of the pyridine nitrile. A new band at 1651 cm ' 1 plus the 
lack of any NH2 stretching bands at 3000-3500 cm ' 1 strongly indicated that the 
compound present was the imidate base. NMR analysis confirmed the presence of the 
OMe protons as a singlet appearing at 5 = 3.98 ppm. Mass spectroscopy showed a mass 
ion of 136 corresponding to the imidate and the absence of any peak at 122 for the amide 
product (The above data refers to the 2-cyano isomer).
It should be noted that on evaporating the methanol under vacuum during work up, 
reversal of the imidate to the starting nitrile occurred to the extent of about 70 %. The 
phenomenon was not observed when the imidate was refluxed in methanol and thus the 
reversal is not due to thermal decomposition of the imidate to the nitrile. The reversal of 
the reaction is a result of removing the methanol from the equilibrium, thus favouring 
the displacement of the reaction towards the left (Scheme 2.14) according to the Le 
Chatelier principle. On re-dissolving the "reversed" sample in methanol complete 
rereversal to the imidate occured on standing overnight. The problem of reaction reversal 
was avoided by adding acetic acid to the reaction mixture on work up. Thus, employing 
this synthesis pyridine imidate bases were obtained which were relatively stable, 
showing only slight decomposition to ester on standing for three weeks. When methanol 
HCl was added to the imidate bases immediate decomposition to the expected amides 
was observed thus confirming the compounds as being the required imidates.
Efforts to condense any of the isomers of pyridine imidate free bases with tropinone 
diamine (122) to form the imidazolines (139) were relatively unsuccessful (scheme 
2.15). The only imidate to show any sign of an "imidazoline" product was 2-pyridyl 
imidate free base which after one week at room temperature plus 48 hours at reflux in 
the presence of the diamine in methanol showed only traces of a new product according 
to TLC.
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MeO N-Me
N
H2N
(122) (139)
Scheme [2.15]
It was thus concluded that the pyridine imidate free bases, though stable to 
decomposition were too unreactive to react with the tropinone diamine. It would seem 
that the protonation of the C=NH of the imidate confers increased reactivity on this 
functional group making it a more effective electrophile. With these results in hand an 
alternative approach was taken.
It has been demonstrated that in the case of some nitriles with powerful electron- 
withdrawing groups, the imidate salts of which decomposed with simple alcohols, that 
stable imidate hydrochlorides can be formed using 2 ,2 ,2 -trichloroethanol210 and some 
2-nitroalkanols in place of simple alcohols. Accordingly the Pinner synthesis was 
carried out by dissolving 500 mgs of 4-cyanopyridine in CI3CCH2OH (10 mL) through 
which was passed HCl gas at 0 °C. The reaction was maintained at 0-5 °C for 24 hours 
as normal and the product was precipitated with dry diethylether. Infrared spectroscopy 
on the product revealed it to be isonicotinamide (136).
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N
CN
+  CC13CH20H +  HCl
N
0C H 2CC13
c ^
v  NH2C1
o
II
C
N
NH,
(136 )
Scheme [2,16]
With the failure of 2,2,2-trichloroethanol to stabilise the imidate hydrochloride an 
alternative strategy was proposed. If the reason for the instability of the pyridine imidate 
salts was the electron deficient pyridine ring system then increasing the electron density 
of the ring by forming the /V-oxide derivative (141) should give a more stable imidate 
salt. Condensation of the pyridine A^-oxide imidate salt with the tropinone diamine in the 
subsequent reaction would give (142) which should be easily cleaved to give the 
desired pyridine imidazoline (143) (Scheme 2.17).
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CN
.N,
O '
+ MeOH +  HCl
OCH3
1
C -
NH2C1
O +
(141)
(141) + (122)
(143)
Scheme [2.17]
With this strategy in mind, the Pinner reaction was performed on 4-cyanopyridine-AL 
oxide. The starting material however was quite insoluble in methanol but when HCl gas 
was bubbled into the suspension of alcohol and nitrile, a clear solution formed as the 
reaction progressed. After 24 hours at 0 °C a white solid was precipitated with 
diethylether. The product was pure on TLC and had a lower Rf value than the starting 
nitrile (Silica/EtOH). From IR spectroscopy the product had a band at 1652 cm -1 
possibly corresponding to the C=N stretching frequency, and no bands could be seen in 
the 3100-3400 cm ' 1 region for the NH2 of an amide. The mass spectrum of the product 
gave a mass ion of 152 which represents the molecular weight of the correct product. In 
the subsequent condensation reaction with the diamine the pyridine /V-oxide imidate salt 
reacted smoothly to give the required imidazoline product (See section 2.5). It should be
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pointed out that alLhough this imidate salt is fairly stable it does gradually decompose in 
the solid state to the amide with about 50 % conversion taking place after three months at 
room temperature.
The attempted synthesis of the imidate salt from 3,5-difluorobenzonitrile proved 
unsuccessful using all of the variations developed for the other imidates of the series.
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2.4 Synthesis of a-am inon itr iles
2.4.1 Introduction.
Several reviews on the syntheses of a-aminonitriles have been published, the most 
recent of which are as follows. In 1962 a review was published in Danish but is 
however difficult to access as a literature source.211 The use of a-am inonitriles in 
organic synthesis is the topic of another review which appeared in a Japanese journal 
which unfortunately also has a limited availibility.212 The most recent and accessible 
review of a-aminonitriles appeared in Russian in 1989,213 the English translation of 
which appeared in the same year.214
By far the most widely studied and used method of a-aminonitrile synthesis is that 
known as the Strecker synthesis.
In 1850 Strecker215 carried out the synthesis of glycine and alanine by treatment of 
formaldehyde and acetaldehyde with aqueous solutions of ammonia and hydrocyanic 
acid followed by hydrolysis of the a-aminoacetonitrile formed. This reaction was 
subsequently extended to ketones and amines and became known as the Strecker 
reaction (Scheme 2.18).
R HNR3R4 R l / 0 H
- C
H CN
R, CN
X
R2 NR 3R4
Schem e [2.18]
The replacement of volatile hydrocyanic acid and ammonia by a mixture of potassium or 
sodium cyanide and ammonium salts was proposed by Zelinskii and Stadnikov.216 In 
this case ammonium chlorides or sulphates are reacted directly or are prepared in situ.
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A modification of the Strecker synthesis proposed by Tiemann216 involves changing the 
order of mixing the reagents as outlined in scheme [2.19], It is suggested that the 
increase in yields of a-aminonitriles that often occurs in this case is due to participation 
of a-hydroxynitriles (cyanohydrins) (144) in the reaction.
R 1 / O H  HNR3R4 R iv s ™
C -*■ -  c x
r (  SCN R2 NR3R4
(144 )
Scheme [2.19]
When aldehydes have low reactivity, their bisulphite adducts are subjected to the 
Strecker reaction. For primary and secondary a-aminonitriles, the reaction is carried out 
in water with ammonium or alkylammonium salts in the presence of excess free base. 
This form of the Strecker reaction has become known as the Knoevenagel-Bucherer
method217Scheme [2.20].
R
/
R2
c= o
R 1S H SO 3- R 1 / 0 H  H N R 2 R3
/ C = o  / C x  — =
H H S 0 3
R, S 0 3' kCN R i .CN\  /   ^  \  s
C \  ----------- CN
H VNR3R4 H NR3R4
Scheme [2.20]
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A number of synthesis of a-aminonitriles have been carried out under non-aqueous 
conditions; in alcohols, THF, benzene, in excess amine, and also without any solvent. 
The most significant development of the Strecker synthesis has been the introduction of 
new sources of cyano groups into synthetic use. Acetone cyanohydrin, isobutyrl 
cyanohydrin, benzoyl cyanide, diethylphosphonocyanide, and trimethylsilylcyanide 
(TMSCN) have been used for this.214
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2.4.2 Synthesis o f  3 fi-Amino-8-methyl-azabicyclo[ 3.2.1 ] octane-3 a-carbonitrile (124)
The desired aminonitrile isomer (124) was synthesised using a variation of the Strecker 
synthesis described by Fernandez et a /.218 According to the method described a mixture 
of KCN, NH4CI, and N-methylnortropane, in equivalent molar proportions, is stirred at 
room temperature for 48 hours in an aqueous solution. After this period a white 
inorganic solid precipitates from the reaction which is then filtered off. The aqueous 
filtrate is then cooled to -5 °C until crystallisation of the aminonitrile takes place.
(124) 
Scheme [2.21]
Our initial attempts to form the aminonitrile using the above method resulted in 
extremely low yields (less than 10 %). It was found that the product co-crystallised out 
of the reaction mixture with the inorganic materials and consequently very little product 
was obtained from the aqueous filtrate. The use of larger amounts of H2O in the reaction 
mixture, though successful in preventing precipitation of the product from the reaction 
medium, also resulted in very low yields due to the difficulty in precipitating the 
product.
8 0
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A more successful and consistent procedure was developed whereby on completion of 
the reaction, the products were deliberately caused to precipitate from the reaction 
medium by cooling and were then purified by selective extraction into ethyl acetate. The 
full procedure is as follows: The reagents were mixed in equimolar proportions and 
stirred in an aqueous solution. It was found to be beneficial to leave the reaction mixture 
stirring for a period of 90 hours to improve the degree of conversion. Towards the end 
of the reaction the addition of CH2CI2 helped to mobilise the reaction and improve 
stirring. The reaction was worked up by cooling to 0-10 °C for 1 hour which caused the 
solid products in the reaction to precipitate. The white solids were then filtered off and 
refluxed with ethyl acetate. This served to dissolve the aminonitrile product while 
leaving an insoluble inorganic solid out of solution, which was removed by filtration. 
The product was then isolated by precipitation from the ethyl acetate with petroleum 
ether.
The mechanism of the formation of a-aminonitriles by the Strecker method has been 
widely investigated but the results obtained have been ambiguous. We can propose that 
the synthesis of a-aminonitriles may involve the formation of a cyanohydrin followed 
by substitution by an amino group (Sjy 2 mechanism) or else by initial formation of the 
imine which then undergoes attack by the cyanide ion.
A scheme for the extended Strecker reaction is shown below outlining the possible 
routes of formation. Scheme [2.22]
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Ogata and Kawasaki219 carried out a study in 1971 on the kinetics of the reaction and 
concluded that the most likely intermediate was an imine type compound (145) rather 
than a cyanohydrin (146). Other authors220' 221 endorsed this opinion of the 
intervention of an imine in the Strecker reaction. However, several other investigators 
claimed the cyanohydrin to be the most likely intermediate. Studies by Stewart222 
favoured the formation of the cyanohydrin, while Mowry223 considered that imines and 
their corresponding ions would have no possibility of forming in aqueous solution from 
the three reagents employed. In another major study224 a-aminonitriles obtained by the 
Strecker and Tiemann reactions had the same optical purity. On the basis of this 
experiment the author rejected a mechanism involving stereocontrol of the reaction, due 
to steric hindrance in attack on cyanohydrins (146), and considered the stereoselective 
addition of HCN to geometric isomers of Schiff bases of the type (145) more likely. In 
another study225 it was concluded that cyanide ions most probably add to ketiminium 
cations of the type (147), the presence of which in the reaction mixture was reliably 
detected. Moreover, the authors did not rule out the possibility of a-aminonitriles being 
formed by S/y 2 attack of CN' on aminoalcohols such as (148).
In the synthesis of 3(3-amino-8-methyl-azabicyclo[3.2.1]octane-3a-carbonitrile (124) a 
ketimine type intermediate is proposed.226 It is interesting to note however that in one 
reaction where the reaction was worked up after 18 h reaction time, we obtained 40% of 
a product which was identified as the cyanohydrin. This may indicate that this 
compound is the precursor to the aminonitrile but is not conclusive. The reversal of the 
cyanohydrin to the ketone under aqueous conditions and subsequent ketimine formation 
can not be ruled out as a possibility. In conclusion it seems that the mechanism of the 
aminonitrile formation is not definitive. Shafran and Bakulev214 state that by and large 
the mechanism of the Strecker reaction is not universal and depends on the nature of the 
solvent and the reagents and also the order in which they are mixed.
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2.5 Synthesis of 3a -A m in om eth y l-8 -m eth y l-8 -azab icyc lo [3 .2 .1 ]octy l-  
3P-amine (122).
The diamine (122) was obtained by reduction of the aminonitrile (124) according to 
the scheme given below.
L iA lH 4
(124) ( 122)
Scheme [2.23]
The cyano group in a-aminonitriles has been reduced using various reducing agents. 
Thus for example, a-aminonitriles were reduced with sodium in a water-ether emulsion 
and boiling toluene,227*228 with hydrogen on Raney nickel, platinum, and palladium 229 
However, major by-products formed when using these reagents are the decyanated and 
dimeric products (149) and (150) shown in scheme [2.24].
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r
Ri —  C— CN
N 
/  \
R, R/i
R, —  C— CH2NH 2 
(151)N
R 7 Rh
f2
R, —  C— H
N
R3 R4
R,
(149)
(Ri —  C—  )2 (150)
N
R t Ra
Scheme [2.24]
At the same time there have been reports of the reduction of a-aminonitriles with Raney 
nickel,229 platinum, and palladium ,229 lithium aluminium hydride,230 and also diborane 
and diisopropylbutylaluminium231 giving exclusively "normal" ethylenediamine 
products (151).
The choice of reagent for the reduction of the aminonitrile (124) was lithium aluminium 
hydride. It is a reagent which is cheap and relatively easy to handle, taking the 
appropriate precautions in manipulation and in storing. Different solvents were explored 
as reaction media, the choice solvent being diethyl ether. THF was also found to be an 
effective solvent, considerably reducing the reaction time as compared to diethyl ether. 
However a purer product was obtained when using ether. The reduction procedure 
involved adding the solid aminonitrile in portions to a suspension of O A IH 4 in 
anhydrous ether at 0-10 °C then heating at reflux for a further 48 hours. The reaction 
was worked up by quenching with H2O, NaOH followed by more H2O then filtering 
off the aluminium salts and working up the filtrate. In the initial experiments very low
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yields of the diamine were obtained, some of which were as low as 20 %. It was found 
that in order to obtain good yields of the diamine, simply washing the aluminium salts 
with large quantities of ether was insufficient. It was detected that up to 70 % of the 
product could be retained on the aluminium salts and the only effective method of 
liberating the product from these was by extraction of the diamine with a Soxhlet 
apparatus. Thus after filtration of the quenched reaction mixture, the aluminium salts 
were placed in a Soxhlet finger and extracted with refluxing ether for 5 hours. The 
extract and the reaction filtrate were then combined and worked up and the product was 
purified by high vacuum distillation.
The product obtained from distillation showed only one spot on TLC, and IR 
spectroscopy indicated no nitrile stretching peak. The melting point of the distilled 
product however was not sharp and melted over a range of 28 °C (55-83 °C) implying 
that the product was possibly impure. On analysing the compound by high resolution 
!H NMR there seemed to be two compounds present in the product (Figure 2.2). Two 
singlets at 5 = 2.30 and 2.67 ppm were tentatively assigned to the N-CH3 and the 
CH 2N H 2 respectively. Two more singlets with the same relative proportions were 
present at 5 = 2.35 and 2.97 ppm. The broad singlet at 5 = 3.15 corresponding to H 
1 (5) and integrating for two protons had an intergal equal to the sum of the integrations 
for the two peaks at 5 = 2.97 and 2.67 and likewise the two peaks at 5 = 2.30 and 2.35 
gave a total integral of 3 protons compared to the broad singlet at 5 = 3.15. This implied 
that the broad singlet possibly contained the H 1(5) protons of a mixture of compounds.
On the basis of the above data we postulated that there might have been two isomers of 
the diamine present, namely the required 3a-am inom ethyl-8-m ethyl-8-azabicyclo- 
[3.2. l]octyl-3(3-amine and 3P-aminomethyl-8-methyl-8-azabicyclo[3.2. l]-octyl-3a- 
amine. The origin of these two isomers we speculated could have arose from an 
isomeric starting aminonitrile, or else as a result of epimerisation of the aminonitrile
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under the basic reaction conditions, thus giving a mixture of diamine isomers on
Figure 2.2 ' H NMR o f  the m ixture 
isolated from the U A IH 4  reduction o f (124).
ppm
Figure 2.3 *H N M R  o f  the mixture in fig. 2.2 
after two days refluxing in M eOH
Figure 2.4 *H N M R  o f  the m ixture in Fig. 2.2 after 2 hours refluxin g in M eO H  containing a 
catalytic amount o f  aq. H Cl (free diamine 122)
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We found an example of such epimerisation in the published literature in the synthesis of
chiral aminonitriles .224 The authors found that optical purities of 100 % could be
achieved in the addition reaction of HCN to preformed imines (152). A thermodynamic 
equilibrium was suggested as outlined in scheme [2.25], Preferential crystallisation of 
one of the diastereoisomers shifts the equilibrium, resulting in high optical yields.
H H
| -H CN  HCN |
R — C— C N  ‘ RCH =  N— R* ~ NC — C — R
J rrTT* H CN  ( '1 5 2 ') -H C N  I
NHR NHR
Scheme [2.25]
Geneste et al.225 also observed the epimerisation of a-aminonitriles in the presence of 
one equivalent of H2O. Scheme [2.26]
Buc
CN n h 2
h 2o
y A  NH2 ■  y j CN
Scheme [2.26]
The epimeric starting material was ruled out after a thorough reinvestigation of the amino 
nitrile showed it to contain only one isomer. The epimerisation of the aminonitrile was 
later disfavoured as a possibility when subsequent analysis of the product mixture of the 
reduction by mass spectroscopy using electron impact ionisation, displayed a peak at 
195 mass units along with abundant peaks at 194 and 82 mass units. No peak was 
observed at 169 mass units corresponding to the tropinone diamine (122) (the pure 
diamine was later found to be unstable under electron impact conditions and no
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molecular ion is observed. It is however stable under chemical ionisation and the mass 
ion shows up as the base peak),
Based on the mass spectroscopy data the following structure (153) was tentatively 
proposed which has a molecular weight of 195. The intense peak at 194 could result 
from loss of the aluminium proton.
(153)
From the 1H NMR spectrum (Figure 2.2) a sharp peak at 8 = 1.27 ppm integrated for a 
total of four protons. Taking this into consideration a more probable structure (154) 
given below was postulated.
N— Me
(154)
In this structure a molecule of water is coordinated to the aluminium atom, the two 
protons of which could give a chemical displacement similar to the two nitrogen protons 
thus accounting for the integration of four protons. This structure containing the 
aluminium covalently bonded to nitrogen is more probable than a coordinated complex
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which, like boron complexes of nitrogen compounds would show up as the free base 
under mass spectroscopy.231
It was observed that a sample of the proposed diamine complex which was left in a 
solution of methanol over a period of 2 weeks, yielded a white solid (when the 
methanol had evaporated off) which was more crystalline in nature than the original 
sample. The solid had a melting point which ranged from 155 °C, when the sample 
initially began to melt, to 190 °C when complete melting was observed. This compared 
to a melting point of 55-83 °C for the original sample isolated from the distillation of the 
reaction mixture. It was suggested that the proposed aluminium complex of the diamine 
had been decomplexed by the methanol leaving the free diamine and an aluminium 
methoxide.
In an attempt to benefit from this observation, we refluxed the product obtained from the 
distillation, in methanol for 2 days in an attempt to liberate the diamine from the 
supposed aluminium complex. A product was obtained which by !H NMR had a profile 
as seen in Figure 2.3. It was found that the signals tentatively assigned to the NCH3 
protons (as with the H9 methylene protons) had changed from a ratio of 3:1 (Complex : 
free diamine) in the distilled sample to a ratio of 1:1.5 in the sample refluxed in 
methanol. Complete liberation of the diamine from its complex could be achieved within 
three to five hours by adding a drop of dilute HCl to the methanolic solution of the 
complex.
Thus on filtering the methanolic solution and evaporating the solvent a compound was 
obtained which indicated a single compound by *H NMR analysis and corresponded to 
the required diamine (Figure 2.4). Examination by mass spectroscopy using the 
chemical ionisation technique gave an abundant peak for 170 corresponding to the M++l
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signal for the free base of the diamine while no peak for the complexed compound could 
be observed.
The change in chemical shifts and peak profiles in the 'H  NMR spectra is perfectly 
compatible with complexation at the site indicated. From the spectrum (Fig 2.4) it can 
be seen that the H9 methylene protons (8  = 2.67 ppm) are those which experience the 
largest downfield shift of 0.34 ppm on complexation, while little or no shift is noted for 
the H6(7) endo or exo protons (8 = 1.51 and 2.0 ppm respectively) or the bridge head 
protons H l(5) at 8  = 3.15 ppm. A very slight downfield shift of 0.06 ppm is observed 
for the methyl group while two of the H2(4) (either the axial or equatorial protons) 
experience a shift from 8 = 1.73 in the free base to 8 = 2,0 ppm in the complex. The 
profile of the NH2 protons also changes, from being a broad singlet centered at 8  = 1.36 
ppm in the free base to a very sharp singlet at 8 = 1.21 ppm in the complexed amine. 
This is consistent with the protons being more tightly bound to the nitrogen as a result of 
complexation, resulting in a slower interchange of the protons with consequent 
sharpening of the NMR signal.
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2.6 Synthesis of 2'-Aryl-8-m ethyl-8-azabicyclo[3.2.1]octane-3-spiro-  
4'(5')-im idazolidines (Ia-g)
The tropinone imidazolines (I) were formed by condensation of the diamine (122) with 
the aryl imidates (123) in a methanolic solution [Scheme 2.27].
( 122)
NH2C1
Ar— C
\
MeOH
OMe
(123)
H
(I)
A r =
(a)
O
N
(e)
MeO.
OMe
(b)
O '
(t) (g)
Schem e [2.27]
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The condensations took place at room temperature over a period of about 24 h but in 
some cases it was more favourable to carry out the reaction at reflux. The solvent was 
then removed under reduced pressure and the product was isolated as the free base on a 
basic alumina column. For compounds (Ie, Ig) the products were isolated directly 
from the reaction medium as the dihydrochloride salts by adding a methanolic HCl 
solution which precipitated the pure product salt.
The intermediate amidine of the type (155) reportedly isolated by Bristow232 was not 
observed in any of the reactions even when the reaction was carried out at 10 °C. 
Presumably the reaction proceeds via this amidine type intermediate but immediately 
cyclises with loss of ammonia.
NH
// 
c x
NHCH2CH2NH2 HCl
(1 5 5 )
An interesting aside reported by Neilson et a l233 in the synthesis of some imidazolines 
with chiral imidates as starting materials, was the observation that racemisation tended to 
occur on forming the imidazolines, either due to the diamine or the ammonia liberated in 
the cyclisation reaction. In an endeavour to avoid this they added HCl at intervals to 
neutralise the liberated ammonia.
The only by-products isolated from the interaction of the tropinone diamine with the 
imidate salts were aryl amides resulting from the decomposition of the imidates as 
described in section (2.3.2). The highest amount of amide was isolated from the reaction 
with the imidate salt of 4-pyridine W-oxide, amounting to 18 % of the isolated product. 
2'-(4-pyridyl)-8-methyl-8-azabicylclo[3.2.l]octane-3-spiro-4'(5')-imidazoline (If) was 
synthesised from the corresponding jV-oxide derivative (Ie) by cleavage of the oxygen
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with PCI3 in CHCI3 . The cleavage failed to take place when the dihydrochloride 
derivative was used as substrate and thus had to be liberated from its salt. The free base 
was thus obtained by liberation with K2CO 3, and on subsequent reaction with PCI3 
gave a product which by 'H NMR was indicative of the product required i.e. there was 
a large downfield displacement of 0.44 ppm for the H3'(5’) protons of the aromatic ring 
and very little difference (0.02 ppm) in the H2’(6') shift position as to be expected.
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CHAPTER III
Synthesis of 2'Aryl-l-azabicyclo[2.2.2]- 
octane-3-spiro-4'(5')-imidazolines
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3.1 Introduction.
The chemical synthesis of the quinuclidine imidazolines followed an analagous route to 
that employed for the tropinone series, taking advantage of the developments already 
made for this series. Some notable differences however were observed especially in the 
synthesis of the quinuclidine diamine (159). The overall synthetic pathway is outlined 
in scheme[3.1].
O
A r =
(a)
+
O '
N
(e)
Schem e [3.1]
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Unlike the synthesis of the tropinone aminonitrile (124) the quinuclidine homolog was 
prepared by initially forming the cyanohydrin followed by subsequent nucleophilic 
substitution with ammonia.
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3.2 Synthesis o f 3-h ydroxy-l-azab icyclo[2 .2 .2 ]octan e-3-carbo- 
nitrile (157)
The synthesis of this intermediate was carried out using a slight variation of a method 
described by Grob234 employing KCN in place of NaCN as the nitrile source.
(156) (157)
Schem e [3.2]
The reaction is simple and high yielding, and is achieved by adding an aqueous solution 
of the cyanide salt to the hydrochloride salt of 3-quinuclidinone pre-dissolved in H2O 
and stirred for 3 hours at 0-5 °C. Filtration and washing of the precipitated solid with 
water affords the title compound as the free base.
The reaction proceeded very well giving yields of the crude product greater than 90 % 
which showed only small traces of starting material on TLC (basic alumina). However 
on attempting to recrystallise the product from either ethanol or methanol very low 
yields (30 %) of the cyanohydrin were obtained. Examination of the mother-liquors on 
TLC showed it not to contain aminonitrile but some impurity of lower Rf value than the 
cyanohydrin which corresponded exactly with that of 3-quinuclidinone. Isolation of the 
impurity and analysis by IR spectroscopy conclusively showed it to be quinuclidinone 
formed by dehydrocyanation of the cyanohydrin as outlined in scheme [3.3].
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+ H3o+
h 2o
Schem e [3.3]
A sample of the cyanohydrin which was left in laboratory grade methanol for 5 hours 
transformed completely into the ketone, as did a similar sample in dry methanol. In dry 
THF no reversal was found to occur. Similarly, a sample of the cyanohydrin in H2O- 
methanol containing a drop of acetic acid showed no reversal to the starting material, 
consistent with displacement of the equilibrium in scheme[3.3] towards the left. It was 
later discovered that on basic alumina TLC plates, the cyanohydrin decomposes to the 
ketone to a slight extent. Re-examination of samples of cyanohydrin which earlier 
showed up traces of ketone, were seen to be pure when examined on silica plates. Thus 
the product of the crude reaction was found to be sufficiently pure to enter the following 
reaction without recrystallisation. It may be possible however that in the event of 
recrystallisation being necessary, it could be carried out in ethanol or methanol in the 
presence of acetic acid.
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3.3 Synthesis of 3-A m ino-l-azab icyclo[2 .2 .2]octane-3-carbonitrile
The synthesis of the amino carbonitrile (158) was carried out by nucleophilic 
substitution of the hydroxyl group in (157) with aqueous ammonia.
The reported synthesis of this compound218 describes a method where the cyanohydrin 
is stirred at room temperature for 48 h in a solution of ethanol/aqueous ammonia which 
on work up yielded 63 % of an aminonitrile that melted at 85 °C. We found that by 
following this procedure the starting material was insoluble in the reaction medium and 
the yields quoted could not be obtained. Also, the product obtained was impure, 
containing traces of starting material. It was observed that when the reaction was carried 
out at 50 °C greater conversion and isolated yields could be achieved. The isolated 
product however, still contained traces of cyanohydrin after work up and subsequent 
recrystallisation from acetone. Attempts to eliminate the starting material from the 
aminonitrile by recrystallising from MeCN, acetone/petroleum ether, EtOH, toluene and 
Et2 0  were likewise unsuccessful due the similar solubilities of the two compounds. 
With the failure of recrystallisation to remove the starting material two other options 
were considered; chromatography or complete conversion of the cyanohydrin. The latter 
was chosen as the most feasible, as the resolution of the two compounds was thought
(1 5 8 ) .
/
(157) (158)
Schem e [3.4]
1 0 0
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not to be sufficient enough to give success by column chromatography. Thus attempts 
were made to completely convert the cyanohydrin to the aminonitrile by longer reaction 
times at 50 °C. This proved to be unsuccessful however, and in fact some rereversal of 
the aminonitrile to the cyanohydrin was observed. It was discovered however that 
towards the end of the reaction (after about 90 % conversion), if the reaction temperature 
was lowered to 20 °C for 12 hours, then the remaining traces of starting material could 
be converted. This result can be rationalised in terms of the equilibrium reaction 
involved.
The reaction can be considered as an exothermic reaction since there is no net change in 
entropy. The input of heat into this equilibrium reaction thus favours displacement of the 
equilibrium towards the starting material and conversely removal of heat from the 
reaction by cooling should drive the reaction further towards the aminonitrile.
Employing this variation in the synthesis, yields of 85-89 % could be achieved and a 
pure product was obtained. The melting point of the aminonitrile isolated (after 
recrystallisation from acetone) was 111-113 °C, 26 °C higher than the quoted literature 
value.
Schem e [3.5]
1 0 1
Synthesis o f 2 '-Aryl-1-azabicyclo[2.2.2]octane-3-spiro-4'(5 ')-imidazolines
3.4 Synthesis o f 3-A m inom ethyl-l-azabicycIo[2.2.2]octyl-3-am ine
The synthesis of the quinuclidine diamine (159) was similar to that employed for the 
preparation of the tropinone diamine (1 22 ).
The reduction was carried out by adding solid aminonitrile (158) to a suspension of 
UAIH 4 in Et2 0  at 0-10 °C then heated to reflux for 48 h. However the product profile 
obtained in this reaction, presented a significant difference over that of the tropinone 
counterpart.
TLC analysis of the isolated reaction mixture on basic alumina plates (MeOH, developed 
in I2) indicated that there were at least three major products present.
(1 5 9 ) .
H?i H21
(158) (159)
Schem e [3.6]
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Attempts were made to isolate them by column chromatography but pure fractions could 
not be obtained due to the poor resolution of the components. High vacuum distillation 
proved to be the method of choice in obtaining all the components in a pure state.
At the initial stages of the distillation (60-70 °C; 0.1 mmHg) a white solid appeared in 
the condenser which was removed by dissolving in MeOH. This solid, which 
corresponded to the middle spot on TLC, was estimated to be about 95% pure and was 
further purified by column chromatography on basic alumina. A second fraction which 
distilled at 80-100 °C was then isolated pure and corresponded to the lowest of the three 
spots on TLC, remaining almost on the baseline. Finally, a third product which distilled 
over at c.190 °C was obtained in approximately 80 % purity and was further purified on 
basic alumina. The compound corresponded to the least polar of the three components 
present on TLC. All three compounds were analysed by high resolution !H NMR and 
mass spectrometry.
The [H NMR spectra of the quinuclidine system present a somewhat complicated pattern 
which makes a complete analysis difficult. However, an interpretation can be made 
within reasonable confidence limits. The identification of the diamine could be observed 
by 'H  NMR analysis where the appearance of a pair of doublets centered at 5 = 2.78 
and 5 = 2.56 ppm, each displaying a coupling constant of -12.8 Hz corresponding to 
geminal coupling (Figure 3.1). These signals which integrate for a total of two protons 
were assigned to 2 H9 protons arising from the reduction of the nitrile function. They 
appear as an AB system because of their position alpha to the chiral center C 3.
A pair of double doublets centered at 5 = 2.64 and 8 = 2.52 ppm were assigned to the 
protons H21 and H22 and can be considered as part of the three spin ABX systems 
formed by H21, H22, H62 and H21, H22 and H72 respectively. The primary AB 
coupling between the H21 and H22 proton is split by long distance coupling with the 
H62 and H72 respectively in the form of W coupling235’236 frequently observed in rigid 
bicyclic systems.
1 0 3
Figure 3.1 N M R  o f quinuclidine diamine (159, 300 M H z, CDCI3 )
Figure 3.2 'H N M R  o f  impurity (160) isolated from  the reduction o f  quinuclidine aminonitrile
(CD3 OD).
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Figure 3.3 *H N M R  o f impurity (161) isolated from the reduction o f  quinuclidine aminonitrile.
Analysis of the system using first order rules allowed for the establishment of 2J(H-21, 
H-22), 4J(H-21, H62), and 4J(H-22, H-72) giving -13.7, and 2.5 and 2.5 Hz 
respectively. Apart from the protons mentioned, a multiplet integrating for a further 4 
protons is observed between 8 = 2.64 and 2.94 ppm corresponding to the remaining 
two CH2N groups H61, H62, H71 and H72. The corresponding coupling constant of
2.5 Hz for the W coupling with H21 and H22 is observed. Three further multiplets 
centered at 8 = 1.94, 1.64 and 1.43 ppm can be attributed to the H52, H52, H41, H81 
and H82 protons. A broad singlet integrating for 4 protons and which was 
interchangeable in D2O was assigned to the amine protons.
An analysis of this compound by chemical ionisation mass spectrometry gave a M ++ 1 
peak of 156 along with M++29 and M++41 peaks, and was thus confidently assigned
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as the required quinuclidine diamine (Spectrum 24). The compound corresponded to the 
baseline spot on TLC and was obtained in a yield of 40 %.
With the quniclidine diamine confidently assigned there remained the task of identifying 
the two remaining reaction products. The unequivocal identification of these major by 
products, it was felt, would lend to a better understanding of the reaction and thus 
possibly lead to their elimination and improvement in yield of the diamine.
The solid impurity isolated from the first distillation fraction gave a 1H NMR spectrum 
which though quite complex, was resolvable (Figure 3.2). The most striking 
observation about the spectrum was the absence of any obvious AB system 
corresponding to the H9 methylene protons. IR analysis indicated that the nitrile group 
was absent from the molecule. The total integration indicated the presence of 12 protons, 
the nitrogen protons not being visible as the spectrum was recorded in deuterated 
methanol. The molecule was suspected as being the amine (160) resulting from 
hydrogenolysis of the aminonitrile with LiAlfU. The Cl mass spectrum of the impurity 
gave the expected M++1, M++29 and M++41 peaks, thus confirming the structure 
(Spectrum 25).
As further conclusive evidence, the trihydrochloride salt of the amine was synthesised 
and had a melting point identical to that of a commercial sample (321- 323 °C).
The second impurity isolated from the reaction and which corresponding to the least 
polar of the components on TLC gave a *H NMR spectrum which displayed three series
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of totally unresolvable multiplets in the ratio of 6:2:3 at chemical shifts centred at 6 = 
2.78, 1.92 and 1.5 ppm respectively, as depicted in figure 3.3. Mass spectrometry gave 
a weak M ++l peak for 303 mass units (Spectrum 26). Based on this piece of evidence a 
dimeric structure (161) having a molecular weight of 302 was considered as a possible 
candidate.
HN H 
(1 6 1 )
The structure would be entirely in keeping with the NMR results for 12 downfield 
protons for the 6 CH2N groups and the 10 remaining more shielded protons 
corresponding to the upfield values of 1.92 and 1.5 ppm.
In an attempt to form a hydrochloride of the impurity in methanol or in aqueous HCl, 
decomposition to an almost pure compound occurred. The decomposition product was 
identified as quinuclidine hydrochloride whose formation from the dimeric product 
could theoretically be as outlined in scheme [3.7],
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n h 2+ h 2o o
Schem e [3.7]
Support for the formation of the dimeric structure, which can be considered as a cyclic 
amidine, is found in the fact that amines can condense with nitriles to form amidines 
when there are electron withdrawing groups a  to the nitrile and in the absence of this 
requisite may form in the presence of aluminium trichloride .237 No report of the 
formation of such a dimeric compound in the reduction of a-aminonitriles with LiAlHj 
could be found in the literature.
The formation of hydrogenolysis products (149) have previously been reported in 
reductions of aminonitriles with LiAlH4 238 Welwart carried out a study of the factors 
governing the preference for formation of the reduction product to give diamines or the 
hydrogenolysis product to give the monoamine. Such behaviour of a-aminonitriles can 
be explained as follows.
1 0 8
Synthesis o f 2 '-Aryl-1-azabicyclo[2.2.2 joctane-3-spiro-4'(5')-imidazolines
Schem e [3.8]
Due to the electron donating effect of the lone pair of electrons in the nitrogen, coupled 
with the electron attracting effect of the nitrile group acting on the same a  carbon, the 
bond between this carbon and the nitrile function simultaneously presents both 
electrovalent and covalent caracter. The relative reactivities of the two carbons in 
question depends on the nature of the a-aminonitriles.
The authors report that if the a-carbon is monosubstituted the reduction compound is 
obtained as the exclusive product (Route A). However if the a-carbon is disubstituted 
then the reaction may proceed via either reduction or hydrogenolysis (Route A or B) the 
direction being governed by the substituents on the nitrogen group. If the amine is 
unsubstituted or substituted with methyl groups then normal reduction occurs whereas 
substitution with more sterically demanding groups such as ethyl or butyl functions 
leads to hydrogenolysis. The nature of the substituents on the a-carbon may also 
exercise a certain influence over the nature of the products.
The observations noted may be explained by the steric effect influenced over the nitrile 
group. Thus in the case of the larger diethylamino substituent the attack of the incoming 
LiAlH4 on the nitrile may be impeded while simultaneously the sterically hindered
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environment around the a-carbon may provoke the weakening of the Ca -CN bond 
which would favour the formation of a proposed immonium intermediate which is 
thought to favour the hydrogenolysis product.
By considering the results of the investigation of Welwart238 we attempted to rationalise 
why a hydrogenolysis product was obtained in the reduction of the quinuclidine 
aminonitrile, while none of this by-product was observed in the corresponding reduction 
of the tropinone compound.
Firstly, it is noteworthy that contrary to the findings of Welwart, hydrogenolysis was 
observed in the quinuclidine aminonitrile even though the amine was unsubstituted. We 
could find no other reports of unsubstituted aminonitriles which gave hydrogenolysis 
with LiAlH4 and may thus be the first reported case. On initial examination, an 
explanation of the result is not obvious based on steric differences between the tropinone 
and quinuclidine aminonitriles. In fact the steric impediment to reduction of the nitrile 
group seems to be greater in the case of the tropinone where the approach of the 
reducing agent would be hindered by the methylene protons of the C6(7) atoms. Indeed, 
on looking at a model of the two compounds, access to the nitrile group in tropinone 
was seen to be severely impeded when in the chair conformation. The quinuclidine 
nitrile however, is much more accessible to attack and therefore should be less 
susceptible to hydrogenolysis which was not the case. It was then attempted to explain 
the more selective reduction in the tropinone by supposing that the reduction takes place 
with the tropinone in a boat conformation, where the nitrile function is much more 
exposed and available for reduction. It seems reasonable to assume that the tropinone 
aminonitrile will exist in a state of dynamic equilibrium between the chair (124) and the 
boat (162) conformation with probably the chair in the major amount. Reduction of the 
compound in the boat conformation would thus remove it from the equilibrium thus 
assisting complete reduction of the aminonitrile.
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(162)
Schem e [3.9]
However, it is very probable that the aminonitrile in a boat conformation would form an 
internal hydrogen bond shown in scheme [3.9]. This would have the result of increasing 
the charge density on the primary amine thus assisting the formation of the immonium 
type structure which reportedly leads to the hydrogenolysis product.
An alternative theory involving intermediate complex type structures was then 
considered. It is not an unreasonable assumption to suppose that some type of 
aluminium complex initially forms at the azabicyclic nitrogen (formally shown as a 
trihydride of the aluminium but in reality may be a more complex species).
H H\ /* ?  H H /i I ? 
" A l— N "
Schem e [3.10]
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It can be seen that such a complex has the possibility of coordinating aluminium with 
both nitrogens of the tropinone when it is present in the boat conformation and thus 
forms a stable six membered ring species. The effect of this is to "tie up" the lone pair 
of electrons of the primary amine consequently reducing the polarity of the Ca -CN bond 
by hindering the immonium ion formation which in turn would favour reduction over 
hydrogenolysis. In the quinucludine system, any compiexation would probably take 
place at the tertiary azabicyclic nitrogen which is highly nucleophilic and does not have 
the possibility of forming the same internal cyclic structure as tropinone does. Thus a 
plausible explanation for the distinct behaviours of the two aminonitriles is presented.
Some efforts were spent in attempting to increase the yield of the quinuclidine reduction 
product. The reaction was performed in THF at various temperatures ranging from 0 °C 
to reflux and no improvement in the reaction profile was observed and in fact <?ave an 
inferior yield of the diamine. Reduction of the aminonitrile in Et2 0  at room temperature 
proved to be very sluggish and contained c.95 % starting material after 5 hours reaction 
time. The reduction was carried out in THF with BH3 THF as the reducing agent. 
Following hydrolysis of the borane complex after reduction, an array of products could 
be seen on TLC. In addition, difficulty in isolating the reaction products from the 
aqueous phase, after hydrolysis of the complex, was encountered. Complete saturation 
of the aqueous phase failed to liberate the product into diethyl ether or methylene 
chloride.
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3.5 Preparation of 2 'A ryI-l-azab icyclo [2 .2 .2 ]octan e-3 -sp iro-4 ’(5')- 
im idazolines (Ila-g)
The quinuclidine imidazolines were generally formed by the same procedure developed 
for the tropinone homologs, by condensation of the quinuclidine diamine (159) with 
the corresponding imidate hydrochloride in dry methanol (Scheme 3.1). A notable 
feature of this reaction was the greater reactivity of the quinuclidine diamine over the 
corresponding tropinone derivative towards the imidate hydrochlorides. In general, 
complete consumption of the quinuclidine diamine to form the imidazoline took place 
within 2 hours at room temperature. This augmentation in reactivity can possibly be 
rationalised by the steric impediment to the approach of the imidate caused by the C6 and 
C7 protons in the tropinone system.
The reactions were either worked up by column chromatography purification or by 
directly precipitating the hydrochloride salt of the product from the reaction. In the case 
of the pyridine N-oxide imidazoline (lie) which was isolated as its dihydrochloride salt, 
the compound was found to be extremely hygroscopic and was seen to be more 
manageable in its mono hydrochloride or free base form.
As with the tropinone series, the pyridyl imidazoline (Ilf) was obtained by cleavage of 
the N-oxide group from the free base of (H e). Some unexpected difficulty was 
encountered however in the procedure. In an attempt to liberate the free base of (He), a 
solution in H2O was basified to pH 10 with K2CO 3 as in the case of the tropinone 
equivalent. The free base which was later found to be very soluble in H2O failed to 
extract into methylene chloride, ethyl acetate or toluene and so the "liberated" product 
was isolated by removing the water azeotropically with toluene and then extracting the 
base from the residue with MeOH. The "free base" was subsequently reacted with PCI3, 
the product of which on examination by NMR showed a displacement of the 
azabicyclic protons (compared to an authentic sample of the free base) but no significant 
change in the chemical shift in the aromatic region which should be expected on
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converting from a pyridine /V-oxide to a pyridyl group. On further investigation the 
compound transpired to be the mono hydrochloride salt of the TV-oxide imidazoline 
(He) which failed to completely liberate with K2CO 3 and passed through the next 
reaction unchanged. Similarly, only the monohydrochloride salt was obtained on 
attempting to liberate with NaOH. This lack of success in completely liberating the free 
base from its dihydrochloride salt is due to the high basicity of the quinuclidine nitrogen 
combined with the fact that the ./V-oxide free base is very soluble in H2O and thus cannot 
be removed from the protonated-free base imidazoline equilibrium by extraction into an 
organic solvent. The simplest and highest yielding method of completely liberating the 
free base was by "flashing" the dihydrochloride salt down a basic alumina column with 
CH2Cl2-EtOH.
For the preparation of compounds (lie) and (lid ) the starting imidates were used in 
their unpurified form, i.e. they contained considerable amounts of the corresponding 
nitrile, which however caused no interference in the reaction. The offending nitrile could 
easily be removed and recovered by acidification of the imidazoline reaction mixture and 
extracting with methylene chloride.
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3.6 Preparation of 2 '(3 ,5-D iflu oroph en yl)-l-azab icyclo[2 .2 .2 ]octan e- 
3-sp iro-4 '(5 ')-im idazoline (Ilh ).
Because of the biologically interesting results found for the dichlorophenyl derivative of 
the quinuclidine imidazoline (lid ) (see chapter VI) the synthesis of the difluoro 
congener was considered to be of special interest. As the standard synthesis via the 
imidate failed for this compound due to the increased electronegativity of the fluoro 
group, an alternative synthesis was investigated.
The acylation of the quinuclidine diamine with a suitable acylating agent followed by 
cyclisation was considered as a possibility although previous attempts with the tropinone 
system were unsuccessful. A more reactive acylating agent such as an acid chloride was 
considered more suitable than an ester, carboxylic acid or amide (Scheme 3.11).
F
F
F
F F N-O /
H
(II h)
Schem e [3.11]
The acylation was carried out by adding a dry toluene solution of the difluorobenzoyl 
chloride dropwise at room temperature to a toluene solution of the diamine. A white
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solid precipitated immediately and after 30 minutes the reaction was worked up by 
evaporating the reaction mixture to dryness, adding CH2CI2 and H2O, and then 
acidifying. The aqueous solution was then washed with CH2CI2 , basified with K2CO3 
and extracted into fresh CH2CI2 . On evaporating the solvent a clear oil was obtained 
which contained two spots on TLC.
Diacylated product 
Mono acylated product
Starting diamine
It was considered probable that the top spot was the less polar diacylated product. The 
presence of diacylated product was supported by both the 'H  NMR results and mass 
spectra which indicated approx. 30 % of this impurity (See figures 3.4 to 3.7).
Although the 'H  NMR spectrum of the crude isolated reaction mixture presents a very 
complex pattern the side-chain methylene protons H9 can readily be distinguished and 
provides a useful diagnostic tool to determine the ratio of diacyl to mono acyl product in 
the reaction mixture.
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quinuclidine diamine (159) with 3,5-diflouorobenzoyl chloride (CDCI3 ).
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Figure 3.5 NMR spectrum of the purified monoacvldiamine isolated from the 
reaction of the quinuclidine diamine (159) with. 3,5-difluorobenzoyl 
chloride (CDCI3 ).
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Figure 3.6 NMR spectrum of the purified diacvldiamine isolated from the reaction 
o f the quinuclidine diamine (159) with 3,5-diflouorobenzoyl chloride 
(CDC13).
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Figure 3.7 [H NMR spectrum of the purified diacvldiamine isolated from the reaction 
of the quinuclidine diamine (159) with 3,5-diflouorobenzoyl chloride
(C 6 D 6 ).
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As can be seen from the *H NMR spectrum in figure (3.4) two sets of peaks between 8 
= 3.2 and 5 = 3.4 ppm corresponding to the methylene protons in two different AMX 
systems can be visualised which may be assigned to the side chain methylene protons 
H9 of the monoacylated and the diacylated product. The CH2 protons appear as an 
AMX system due to their position a  to the chiral C3 centre (see full assignment of 
quinuclidine protons in section 3.4.) and the amide nitrogen which can couple with these 
methylene protons. The AM part of the system centred at 8 = 3.98 ppm and 8  = 3.74 
ppm was assigned to the diacylated product due to their downfield position, while the 
AM part of the second AMX system centred at 8 = 3.6 ppm and 8  = 3.28 ppm should 
correspond to the monoacylated product.
The appearance of the side-chain methylene protons as an AMX system in the precursor 
to (II h) is proof that the monoacylation takes place at the NH2 attached to the 
secondary carbon rather than at the amine attached to the quaternary carbon (Scheme 
3.11). The geminal coupling for the diacylated product is -14.7 Hz while that of the 
monoacylated compound is -13.4Hz. The two halves of the AM systems for the diacyl 
are 6.43 Hz and 3.75 Hz while the mono compound has vicinal coupings of 6.03 Hz 
and 4.40 Hz. This significant difference in vicinal coupling between both parts of each 
AM system indicates that there is probably restricted rotation of the amide group.
In an initial attempt to investigate the cyclisation of the amino amide, the crude reaction 
mixture containing the diacylated and monoacylated compounds was used. At first the 
thermal cyclisation with the elimination of H2O was investigated. Heating the crude oil 
in toluene at reflux resulted in no change in the starting material after 6 hours reflux. On 
changing the solvent to xylene to increase the reflux temperature, decomposition of the 
starting materials occurred and the reaction mixture of TLC plates showed an array of 
spots. The JH NMR likewise indicated that the bicyclic system was not intact.
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It was obvious that some milder method of cyclising the amide was required. With this 
aim some condensating agents were considered. Several methods were examined but the 
two which seemed the more attractive were the following: The first involves the use of a 
method for the condensation of amides with amines in the presence of halogenating 
agents to form amidines.239 The reaction involves the intermediacy of an imido chloride 
which subsequently reacts with an amine (Scheme 3.12). Since the imidazoline is a 
cyclic amidine this was obviously a method worth considering.
ff PCI5 or PCI3 C1x  H2NR" "RHN
R — C— NHR' --------------------  J Z —  NR' -----------  C = N R '
R R/
Schem e [3.12]
The second option considered the use of triethyloxonium fluoroborate (Scheme 3.13) to 
give an imido ester fluoroborate which on reacting with an amine yields amidines as 
reported by Weintraub and co-workers.240
+
b f 4-
"RHN
C =  NR'
R
Schem e [3.13]
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On considering this latter method the possibility of methylating the free amine or the 
bridgehead quinuclidine nitrogen with the very powerful alkylating agent was regarded 
as a serious likelyhood. Because of this the first method was investigated.
Preliminary attempts to cyclise the crude mixture of mono and diamide isolated from the 
aforementioned procedure, with PCI3 in toluene proved unsuccessful. However 
subsequent use of one equivalent of pyridine (after the PCI3 addition) gave some 
reaction in which indications were that some of the cyclised product had been formed. 
On examination by mass spectroscopy, using the electron impact technique, a weak 
mass ion of 277 was observed which corresponds to the molecular weight of the 
cyclised product while under chemical ionisation conditions an intense M++ l peak of 
278 m.u. was seen though other extraneous peaks of higher m.u. were also observed 
which did not correspond to the usual M++29 or M++41 peaks (Figures 3.8 and 3.9).
Figure 3.8 Mass spectrum (El) of the crude (II h) cyclisation product.
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Figure 3.9 Mass spectrum (Cl) of the crude (II h) cyclisation product.
With this preliminary success it was decided to purify the amino amide by column 
chromatography on basic alumina. Both the mono and diacylated diamine compounds 
were isolated relatively pure and were analysed by *H NMR and mass spectrometry.
The tentative assignation made for the methylene side chains of the mono acylated and 
the diacylated amine in the crude sample were shown to be correct. NMR spectra of 
both the purified monoacyl and diacyl compounds are shown in figures (3.5 and 3.6). 
An interesting observation was made regarding the splitting pattern of the side-chain 
methylene in the diacylated compound. It has been mentioned that the signals 
corresponding to these protons in the crude reaction mixture, show up as two pairs of 
double doublets centred at 8  = 3.98 and 8  = 3.74 ppm. However when in the pure state,
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each of these peaks in the down field half of the system was further split into two 
signals with a coupling constant of 2.9 Hz, while the upfield half showed only a very 
slight broadening of the peaks (see figure 3.6). This result was curious and is believed 
to result from the following. It is thought that when in the pure state, intramolecular %-tz 
interactions were taking place between the phenyl rings of the diacyl product as depicted 
in figure 3.10. This would have the effect of "locking" the amide methylene into a fixed 
ring. Because of this forced rigidity it is possible that one of these methylene protons 
could occupy a position in which it can undergo long-range coupling with a proton of 
the quinuclidine ring, for example W coupling with the bridgehead H4 proton [the 
protons involved are shown as broken lines in the quinuclidine structure in figure 3.10] 
The coupling constant of 2.9 Hz is consistent with 4J coupling in these systems.
F
F igure 3.10
It may be that in the impure sample the aromatic portion of the monoacylated amine 
causes the rupture of the K-K interactions in the diacylated molecule. To test this 
postulation the *H NMR of the pure diamine was carried out in deuterated benzene 
which is known to break up such K-n interactions. As expected the spectrum (see figure 
3.7) did not show the additional coupling and the methylene splitting pattern looked 
similar to that in the impure sample.
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With a sample of the reasonably pure monoacylated amine in hand, the cyclisation 
experiments with the PCI3 were repeated under the conditions developed for the crude 
sample. Surprisingly however it was found that no cyclisation took place even on 
repeated runs. Hence a new batch of amide was synthesised which again contained c.30 
% diacylated impurity. The cyclisation was repeated on this sample and, as found 
initially, a new product was formed which according to mass spectrometry and !H 
NMR contained the desired cyclised imidazoline.
To explain this strange observation a literature search for some possible answer was 
performed. It was reported by Delaby and co-worker239 that in the synthesis of 
amidines from the reaction of amides with amines using halogenating agents, side 
reactions involving the reaction of a molecule of amide on the intermediate imido 
chloride were observed.
O
II
R — C— NHR'
O
R — C — NHR'
PCI5
Cl
V
C = N R ’
H2NR" r , i h n
R
V
/ C =  NR'
R'HN 0
C — NR' + ||
Rx  R — C — Cl
Schem e [3.14]
Likewise in the absence of an amine the heating of an amide in the presence of a 
halogenating agent gives amidines in high yields.241 Taking these facts into account it 
was thought possible that the compound which was cyclising in the impure reaction
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mixture was the diacylated compound and not the monoacyl derivative as expected, as 
illustrated in scheme[3.15].
The difluorobenzoyl chloride formed as a result of the cyclisation could theoretically 
acylate more monoacylated starting material which could then cyclise to form more 
imidazoline and benzoyl chloride thus acting as a form of catalyst in the cyclisation 
reaction.
In order to test the hypothesis that the diacylated compound was cyclising, a large 
sample of the pure compound was isolated by chromatography and this was used as the 
substrate for the cyclisation reaction. However, on reacting the pure diacylated 
compound with PCI3 in toluene, none of the required imidazoline was obtained but 
rather a mixture of other products was isolated, none of which could be identified by *H 
NMR or mass spectroscopy. This result was surprising and showed that when using 
either pure monoacylated starting material or pure diacylated compound no cyclisation
cr
+
Cl
Schem e [3.15]
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could be achieved. However, when the starting material contained a mixture of the two 
compounds, cyclised product could be obtained. This observed fact is not easy to 
explain but it is of interest to note that Aspinall reported that in the cyclisadon of 
monoacetylenediamines to imidazolines, if a mixture of monoamide and diamide from 
the reaction of ethylenediamine and an ester, is cyclised with lime the yields are much 
higher than those obtained by dehydrating the pure monoamide with lime.242 However 
no explanation as to the reason for this effect was offered.
If the failure of the pure diamide to cyclise is to be rationalised, perhaps the n-K 
interactions observed in the pure sample by 'H  NMR could offer a clue. If we suppose 
that under the conditions of the reaction the pure diacyl compound exists in the "locked" 
form (figure 3.10) already described, then the intramolecular cyclisation may be made 
difficult because of this. If the imido chloride does form, then attack from another 
molecule of diamide might be more favourable giving rise to intermolecular reacnons.
In conclusion, the cyclisation of the mixture of mono- and diamides proved the most 
efficient mixture for the cyclisation. While the required difluoro product was obtained, it 
was never isolated in a pure state and thus requires further development in order to 
optimise the yields and the purity. The method however does provide a possible 
alternative route to the synthesis of 2 -substituted imidazolines and may be useful in the 
synthesis of ortho substituted phenyl imidazoline derivatives which in most cases are not 
formed via the imidate route due to the problem of synthesising ortho substituted 
imidates. 196
1 2 8
Synthesis o f  exo-5'-Tropane-3’-aryl-l,2,4-oxadiazoles.
CHAPTER IV
Synthesis of exo-5'-(8-Methyl-8-azabicyclo[3.2.1]- 
octan-3-yl)-3'-(aryl)-1,2,4-oxadiazoles.
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4.1 . Introduction.
In an attempt to expand the work carried out by Swain et al,34 who prepared 1,2,4 
oxadiazole derivatives of principally quinuclidine and l-azabicyclo[2 .2 .1]heptane 
azabicyclic systems, we focused our attention on the synthesis of a series of 5'-(8- 
methyl-8-azabicyclo[3.2.1]octan-3-yl)-3'-(aryl)-1,2,4-oxadiazoles (IHa-g).
N-Me
(HI)
MeO
HoN
NH,
(e) (g)
Figure 4.1
As was stated in the introduction (section 1.3.2) a very successful method of arriving at 
1,2,4-oxadiazoles is by acylation of an amidoxime with ensuing cyclisation and 
concurrent loss of H2O. The acylating agent can take the form of an acid anhydride,
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ester, carboxylic acid or acid chloride among others. 102-113 From a synthetic standpoint 
an ester or carboxylic acid derivative of tropinone seemed the agent of choice.
A retrosynthetic synthesis of the oxadiazoles from readily available tropinone was thus 
proposed which incorporates the P-tropinone ester (163) as a key intermediate. Scheme
[4.1].
NHOH
//
+  Ar —  Cx
N H 2
(164)
Schem e [4.1]
It was found that the success of the synthetic route proposed was highly dependant on 
encountering an efficient synthesis of the tropinone ester (163). A complete search of 
the literature revealed two reported synthesis of this compound with the ester 
functionality in the desired exo disposition. The method described by Archer et al.243 
involves the nucleophilic substitution of pseudotropinone (165) with thionyl chloride 
giving the chlorotropane (166) with inversion of configuration. This compound is then
MeO
N-Me
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subjected to a further substitution with a cyanide ion furnishing the nitrile (167) which 
may be epimerised to (168), both of which can then yield the desired tropane ester on 
acidic methanolysis (Scheme 4.2).
S O C l2
N-Me
C N '
(166)
N-Me Base
CN
N-Me
(167)
C
C H 3OH
HCl
(168)
^  N-Me
MeO T Q
H ^
/
Schem e [4.2]
Before venturing into the synthesis described, which required the use of pseudotropine 
as starting material we speculated that the endo tropinone alcohol (tropine) which is 
commercially available, could be employed as starting material since the final exo or 13- 
ester can be formed regardless of the stereochemistry of the nitrile precursor (Scheme 
4.2). Though such systems with certain substituents in the exo orientation have been 
reported to ring open in the presence of cyanide ions 244 we hoped that by careful choice
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of solvent and mild reaction conditions, substitution without ring opening could be 
achieved.
Thus, the substitution of tropine with thionyl chloride was successfully carried out 
though in poor yield. The subsequent attempts at nucleophilic substitution of the 3(3- 
chlorotropane with both potassium and sodium cyanide under various conditions of 
solvent and temperature failed to yield the desired tropanyl nitrile. IR and 'H  NMR 
analysis indicated that ring opening to a mixture of 2-allyl-4-cyano-l-methylpyrrolidines 
shown in figure 4.2 had ocurred (See spectrum 38).
Figure 4.2
The failure of the synthesis using tropine as starting material obliged us to carry out the 
preparation commencing with pseudotropine. Accordingly, pseudotropine was obtained 
by equilibrating tropine in Na/n-pentanol by the method described by Beckett et a /.245 
yielding a mixture which contained 90 % of the more thermodynamically stable 
pseudotropine and 10 % of the tropine isomer. After purification by column 
chromatography the pure isomer was obtained in 80 % yield. Chlorination of this 
compound with thionyl chloride gave the chlorotropane (166) though the reaction 
product was difficult to purify and yields were variable. The subsequent cyanation 
occurred smoothly and on methanolysis, the more thermodynamically stable exo ester 
was obtained whose physical characteristics corresponded to those described.243
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However, the overall yields obtained by this method proved to be very disappointing, 
ranging from 5-10% and in some cases total failure, the chief losses being observed in 
the chlorination step. Nevertheless sufficient ester was obtained to successfully acylate 
benzamidoxime which gave the desired oxadiazole on cyclisation (see section 4.5). This 
success spurred us to search for a more efficient method of forming the ester and 
consequently improve the overall yield of oxadiazoles. Examination of the only 
alternative method, described by Zirkle et al,246 though quoting higher overall yields of 
23% revealed the procedure to be very laborious and required the use of very expensive 
a-ecgonine as starting material.
Once again the literature was resorted to, in an endeavour to find a more satisfactory 
method of forming the required ester. The possibility of synthesising the ester in 
question via the intermediacy of a ketene dithiane was presented as an interesting 
prospect. As a result of the pioneering work carried out by Corey and Seebach247 on 2- 
lithio-1,3-dithiane derivatives, ketene dithioacetals (169) have proved to be very useful 
synthetic intermediates for the introduction of a range of functional groups, some of 
which include, carboxylic acids, esters, and aldehydes. Thus for example Seebach248 
converted ketones to ketene thioacetals which on subsequent hydrolysis yielded 
carboxylic acids. Snow et al,249 similarly formed esters by methanolysis of the ketene 
dithiane intermediate (Scheme 4.3).
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Li SiMe3
R.
R,
:c=o
R, S-
> = <
R 2 S-
+  Me3SiOLi
(169)
McOH/HCl
R, H
OMe
H30 +
R, H
OH
Schem e [4.3]
The ketene thioacetals have been synthesised using various R i and R2 substituents 
ranging from aromatic groups to simple alkyl functions to bicyclic systems.250 Bearing 
the above findings in mind we designed a synthesis of the exo-tropinone ester using the 
methodology described.
1 3 5
Synthesis o f exo-5Tropane-3 '-aryl-1,2,4-oxadiazoles.
4.2 Synthesis o f 3-(l,3-d ith iane-2-yIidene)-8-m ethyI-8-azabicyclo-
[3 .2 .1]octane (170)
The reaction was carried out by preforming the carbanion of 2-(trimethylsilyl)-l,3- 
dithiane with n-butyllithium in hexane at -40 °C. The tropinone was then added to the 
dithiane salt at -50 °C following which, the reaction was allowed to warm to room 
temperature and quenched with H2O. The product was isolated by extraction into 
methylene chloride furnishing a white semi-solid on removing the solvent. The final 
product was isolated by purification on a basic alumina column and was obtained in 94 
% yield. Mass spectroscopy showed an M+ of 241 corresponding to the tropinone 
dithiane (Spectrum 29) while lH NMR (Spectrum 9) clearly indicated the identity of the 
desired compound. Small quantities of an impurity (2-4%) were isolated by column 
chromatography (not in every reaction) from the reaction mixture, though not in a pure 
state. Mass spectrometry showed a molecular ion of 382 which could possibly 
correspond to the dimeric structure 171 (Spectrum 30).
(170)
S ch em e[4 .4 ]
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(171)
Such oxidative dimerisation of anions of 1,3-dithiane has been observed251 where the 
dimeric structure (172) was formed by coupling of (173) under the influence of 
oxidising agents such as 1,2-dibromomethane, Cu(II) or I2 .
[O]
(172) 
Schem e [4.5]
Following the successful formation of the ketene thioacetal from tropinone, which 
represents the first reported synthesis of this compound, we sought to explore the 
possibility of a similar synthesis on the related granatanone system, a compound of 
particular interest in 5 -HT3 chemistry. The ketone (174) was synthesised following a 
procedure described by Robinson-Schopf and modified by Ballesteros .252 The 
synthesis o f this amino ketone basically involved reacting glutaraldehyde,
Vs
Me Li
(173)
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acetonedicarboxylic acid and methylamine hydrochloride at room temperature and 
buffering the reaction with sodium acetate/hydrochloric acid at pH 3. The mechanistic 
representation of the reaction is outlined in scheme [4.6].
O
/ /
H
H
w
o
C O O H
CO O H
C O O H
'  C
COOH
C H -------
- V H c = o
/ s
- H \
OH CO O H
CH
o)4
H
/
-CH
C O O H
c ^ H:< 
CO O H
C O O H
y ° "
Me
-L
N c = o
Schem e [4.6]
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The ami noke tone (granatanone) thus obtained was reacted with the lithium salt of the 
dithiane in the manner described for tropinone (Scheme 4.7).
The reaction failed however, under various conditions of temperature and solvent and 
can be rationalised by the steric impediment caused by the H7 protons to the formation 
of the ketene structure (175), thus demonstrating the steric limitations to the preparation 
of such compounds.
N-Me
(174) (175)
Schem e [4.7]
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4 .3 . Synthesis o f exo-3-C arbom ethoxy-8-m ethyl-8-azabicyclo[3.2.11- 
octane (163)
The methanolyis of the tropinone ketene dithioacetal could theoretically lead to either the 
a  (176) or (3 esters (163) of tropinone as outlined in scheme [4.8],
(176) 
Schem e [4.8]
The acidic methanolysis of the dithiane was examined under various conditions of 
temperature and acid concentration in order to determine firstly, if these variables had 
any bearing on the isomeric ratio of esters formed on methanolysis, and secondly to 
find the conditions which gave the best yields of the exo ester.
The degree of conversion was measured by examination on TLC and a qualitative 
analysis of the product was made using !H NMR and IR spectroscopy.(Zirkle et a l 246 
showed that the two isomers could readily be identified by IR analysis by observing 
distinctive peaks in the fingerprint region of the spectrum). It was seen that under all the 
conditions employed, only one isomer was obtained. However in reactions carried out at
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0 °C the methanolysis was found to be very slow and complete conversion to the ester 
was not achieved within 72 hours. The reactions at 30 ° C and 50 °C were found to 
proceed much more rapidly, the best conditions being when a saturated solution of HCl 
in MeOH was use. The optimum conditions were thus found to be as follows. The 
dithiane was stirred in a saturated solution of HCl in dry MeOH at room temperature for 
48 hours after which time the solvent was removed by distillation. The product was then 
dissolved in H2O, neutralised with K2CO3 and extracted into methylene chloride. The 
crude oil obtained after concentration was purified under high vacuum distillation giving 
a product with a boiling point corresponding well to the quoted literature value for the 
exo ester.246 The NMR and mass spectra (Spectra 10 and 30) confirmed the tropinone 
ester as the sole product while IR showed peaks at v = 1736, 1302, 1007, 931, 848, 
798, 762 cm*1 which are distinctive for the product with the ester group in the equatorial 
position.246
As conclusive evidence of the P disposition a sample of the product was refluxed in 
NaOMe /MeOH for 8 hours and no change in the compound structure was observed. It 
has been shown242 that for the a  isomer such treatment results in almost complete 
epimerisation to the more thermodynamically stable (3 epimer.
Noteworthy of mention is the fact that during workup of the reaction, the tropinone ester 
should not be left standing in the aqueous solution and should be extracted with 
methylene chloride as promptly as possible after quenching the reaction with H20 . This 
is because the ester is quite soluble in H20  and in aqueous solution can easily 
hydrolyse, especially at higher temperatures. Thus for example if the ester is left in the 
aqueous solution over the weekend at room temperature a 40% .drop in yield is observed 
while if refluxed in H20 , complete hydrolysis to the corresponding acid takes place 
within 3 hours.
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In conclusion, a facile synthesis of the exo ester from tropinone in two steps, reported 
here for the first time, has been developed giving an overall yield of 94 X 65% = 61 %. 
The stereoselectivity in the hydrolysis is absolute, while the methodology is much 
simpler than either of the reported methods whose syntheses are long and laborious and 
in one case necessitates the formation and recrystallisation of the oxalate salts of the 
epimeric ester mixture in order to obtain the required pure exo ester. The yield obtained 
represents a significant improvement over the available methods, where quoted yields 
range from 15-22% and whose starting materials are considerably more expensive.
At this point it is interesting to consider the mechanisms implicated in the synthesis of 
the ester in both the ketene dithiane formation and in the methanolysis reaction.
The sulphur stabilised anion (177) shown in scheme [4.9] directly reverses the normal 
pattern of reactivity of the carbonyl group and thus is the equivalent of an acyl anion
(178). After reaction with and electrophile the dithioacetal moiety may be hydrolysed to 
provide the corresponding ketone. The term Umpolung was coined by Corey and 
Seebach247 to describe the temporary reversal of the characteristic reactivity pattern of a 
functional group. The overall effect is the addition of an acyl function to an electrophilic 
carbonyl group.
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o
/ \
R H
O
K
R E
(177) (178)
Schem e [4.9]
The mechanism of the hydrolysis of the ketene dithiane provides some interesting 
discussion. An a priori examination of the mechanism of methanolysis indicates the 
existence of several feasible intermediates.
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R OMe
R ' OMe
(179)
R
R
c=o
(180)
O
\
H
(181)
N-Me
/ R
R = H or CH3
R
R
O
\
OMe
H
Schem e [4.10]
Protonation of one of the sulphur atoms followed by nucleophilic attack at the 2 position 
of the dithiane ring with ensuing ring opening, succeeded by a second similar 
substitution could give the ketene acetal (179) whose mechanism of acid catalysed 
hydrolysis to the ester has been studied.253 A second possibility which exists is the 
attack of the methanol as described, which then, rather than being attacked by a second 
molecule of methanol, eliminates CH3S(CH2)3SH or HS(CH2)3SH giving rise to the 
ketene (180) which on subsequent nucleophilic attack by methanol could give the ester. 
A third candidate is the thiol ester (181).
A literature search was performed to find some evidence to substantiate one or other of 
the proposed mechanisms. After a detailed investigation however no study on the acidic 
methanolysis of ketene dithianes could be found. Nevertheless some Japanese 
researchers have carried out detailed kinetic and mechanistic studies of the acidic
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hydrolysis of ketene dithioacetals the findings of which could possibly be extrapolated 
to the corresponding methanolysis.
Okuyama et a l254 found that ketene dithioacetals underwent acid catalysed hydrolysis to 
give thiol esters in a stepwise manner in a similar mechanism to ketene acetals. They 
found hydration of the double bond to be the primary reaction which proceeds through 
carbon protonation and ensuing water attack on the intermediate carbocation (Scheme 
4.11).
SR SR
^  +  H30 + - H— C ( +  +  H20
SR I SR
H — C-
SR
-O H  +  H +  *- H — C
O
+  RSH
1 SR I SR
Schem e [4.11]
They found that in constrast to the hydrolysis of ketene acetals, the initial protonation 
which is reversible, was not the rate determining step in the hydrolysis of ketene 
dithioacetals. It should be noted at this stage that the carbocation formation does not 
always take place at the position a  to the sulphur atoms. Russel and Ochrymowycz255 
in their studies on the hydration of vinyl sulphides found products in the protonation of 
ketene mercaptals which were consistent with protonation at the other carbon. Scheme 
[4.12].
C6H5C(R) =  C(SCH3)2 +  H+ ----------- -
+  H20  -  M eOH , C 6H6
C6H5C(R)CH(SCH3) 2 -------   ^  C6H5OCH(SCH3)2
R = CgHg, OCH3
Scheme [4.12]
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This result can be explained by considering the increased stability conferred on the 
carbonium ion by the two phenyl substituents or the methoxy group.
Expanding their studies on hydrolysis of acyclic ketene dithioacetals, Okuyama et al.256 
investigated the hydrolysis of the cyclic counterparts, namely 2-methylene-1,3-dithiane 
and its derivatives and found a similar stepwise hydrolysis of initial protonation to form 
the carbocation, succeeded by hydration and decay of the 2-hydroxy-1,3-dithiane giving 
the thiol ester. Scheme [4.13]
HS
Schem e [4.13]
As with the acyclic compounds, further hydrolysis to the acid was found to be quite 
slow in acidic solutions. The hydrolysis reactivity of the cyclic compound was found to 
be similar to the acyclic analogue but the reversibility of the protonation step was much 
smaller and was ascribed to the ease of hydration of the carbocation. This acceleration of 
the hydration in the cyclic dithiane carbocation was rationalised by the change in 
hybridisation on going from (182) to (183). The 2-carbon is sp2 hybridised in (182) 
and so are the two adjacent sulphur atoms. However, these three atoms become sp3 
hybridised in (183) and consequently, the forced planarity involving the C-S-S triad 
induces a considerable strain on the dithiane ring of (182), but such a strain does not
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occur in (183). Thus the hydration step relieves the strain in the molecule making this 
step much faster than that of the acyclic analogue.
In conclusion, can any parallel be drawn from these hydrolysis studies to provide a 
mechanism for the methanolysis of the tropinone dithiane (170) ?
It was observed that when the methanolysis of the tropinone dithiane was performed at 
0 °C not only was the reaction much slower than at room temperature as already stated, 
but also an additional spot could be seen on TLC which diminished with time, and can 
probably be considered as an intermediate product. Examination of the IR spectra of the 
low temperature methanolysis reactions all showed, apart from the ester carbonyl at 
1735 cm ' 1 and the distinctive peaks in the fingerprint region for the alpha ester, 
additional bands at 1692, 1351, 1128 and 913 cm -1 (Figure 4.5). The band at 1692 cm-1 
could be assigned to the stretching frequency of the carbonyl group of a thiol ester 
which are characterised by carbonyl bands lower than normal esters due to increased 
resonance from the more polarisable sulphur atom. For aliphatic thiol esters the carbonyl 
normally shows up between 1700-1680 cm-1. The bands at 1128 and 913 cm*1 may 
correspond to the C-C and C-S stretches respectively. These additional bands do not 
correspond to a ketene carbonyl or a ketene diacetal and so the intermediate (181) 
seems to be a more likely candidate as the intermediate in the methanolysis reaction. It is 
not unreasonable therefore to assume a mechanism for the methanolysis of the tropinone 
dithiane similar to that outlined in scheme [4.13]. However in the case of the 
methanolysis of compound (170) the reaction goes further and the thiol ester (181) 
undergoes nucleophilic attack by another molecule of MeOH to give the ester (163) 
with liberation of the mercaptan HS(CH2)3SR where R could be either H or CH3. 
The methanol is probably a better nucleophile than H2O towards the carbonyl group of 
the thiol ester under the acidic reaction conditions and hence the reaction doesn't tend to 
stop at the thiol ester as in the case of the hydrolysis with H2O.
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Figure [4.4] IR spectrum of the tropinone ester 163 following acidic methanolysis of 170 at 40 °C.
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Figure [4.3] IR spectrum of the tropinone ketenedithioacetal 170 (KBr)
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Figure [4.5] IR spectrum of the tropinone ester 163 following acidic methanolysis of 170 at 0 °C.
Figure [4.6] IR spectrum of the tropinone thiol ester 181 following aqueous acidic hydrolysis of 170 
at 40 °C.
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Figure [4.7] IR spectrum of the tropinone thiol ester 181 after stirring in MeOH for 12 h.
Figure [4.8] IR spectrum of the tropinone 3p carboxylic acid zwitterion 184.
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To corroborate this supposition the hydrolysis of the ketene dithiane (170) was carried 
out in aqueous hydrochloric acid which should yield the thiol ester (181) where R = H. 
A compound was obtained which had a strong adsorption on IR at 1692 cm-1 probably 
corresponding to the carbonyl of the expected thiol ester, plus a weak band at 913 cm-1 
and a weak adsorption at 2560 cm -1 corresponding to S-H deformation and S-H 
stretching frequencies respectively (see ir spectrum figure 4.6). All three bands were 
present in the product from the methanolysis of the ketene dithiane carried out at 0°C 
(figure 4.5) implying that the methanolysis intermediate (181) has R = H and not CH3. 
The methanolysis and hydrolysis reaction thus have a common intermediate.
In order to unequivocally confirm that the carbonyl frequency from the 0 °C 
methanolysis resulted from a thiol ester carbonyl and not from any possible carboxylic 
acid whose adsorption frequencies can be very similar, a sample of the tropinone ester 
was hydrolysed to the acid by refluxing in water and studied by IR spectroscopy. 
Surprisingly it was found not only did the aminoacid carbonyl have a uifferent 
adsorption from the thiol ester but that it appeared a full 110  cm ' 1 below the thiol 
carbonyl at 1580 cm -1 (figure 4.8) This value being excessively low for a carboxylic 
acid even in an associated state, indicated that the tropane amino acid probably existed 
in its zwitterionic form 184 (Scheme 4.14).
This being the case, the carbonyl frequency perfectly matches the published figures for 
the anionic form of an acid. Confirmatory evidence should be provided by the chemical
H
(163) (184)
Schem e [4.14]
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shift of the N-CH3 group by iH NMR. Hence the 5 value at 2.74 ppm for a tropinone 
methyl group in deuterated methanol corresponded perfectly to a protonated N-CH3 
rather than the free base .257 This is the first time that this observation has been reported 
for this compound.
If the thiol ester (181) is, as already stated, common to both the methanolysis and 
hydrolysis reactions then addition of methanol to the isolated aqueous hydrolysis 
product should yield the tropane ester (163). This indeed was found to be the case. 
When the thiol ester was stirred overnight in methanol a product was obtained which 
gave an IR spectrum identical to that of the tropinone ester (figure 4.7). On considering 
such evidence an overall reaction mechanism for the acidic methanolysis can be 
proposed as outlined in scheme [4.15].
Cl
R
R
H+
- M eCl / H
/-OH
MeO^H
R H
/ H
HS(CH2)3SH
R'
O
X
R’ H
\
OMe
H 3C - N
R R ’ =
Schem e [4.15]
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Presuming the mechanism outlined is correct, it is not altogether surprising that the only 
isomer obtained from the reaction was the exo ester. From a steric point of view the 
presence of the sterically demanding dithiane carbocation group in the endo orientation 
(185) would seem highly unfavourable, the exo position probably being more 
thermodynamically stable and hence after hydration (which unlike the protonation is 
usually irreversible) would lead ultimately to the exo ester formation.
Apart from the unfavourable steric impediment to the dithiane in the endo position an 
electronic stabilising effect of the exo carbocation (186) is not to be ruled out.
H
+
(1 8 5 )
(1 8 6 )
It can be seen that the nitrogen could donate its lone pair of electrons* to the cationic 
centre of the dithiol thus stabilising the positive charge. This would also have a stability 
effect in that the 2 -position of the dithiane would then be an sp3 rather than an sp2 centre
1 5 3
Synthesis of exo-5'-Tropane-3‘-aryl-l,2,4-oxadiazoles.
thus relieving ring strain alluded to earlier. Such 5 membered systems are known, which 
lend support to the structure. For example, Zirkle et a l.246 formed the tricyclic 
quaternary ammonium chloride (187) by heating the base at reflux for 2 hours. Scheme
primarily in the protonated state. It is reasonable to presume how ever that a certain amount exists in 
equilibrium as the free base at any particular time thus allowing for the formation o f intermediate (186).
Attempts were made to synthesise and identify the hypothesised intermediate (186) by 
stirring the tropinone dithane in HC1 dissolved in a non nucleophilic medium. However, 
only the hydrochloride salt of the starting material was obtained from reactions using 
CH2CI2, MeCN and acetone as solvents. It may be that these solvents are insufficiently 
polar to favour the formation of the carbocation.
H
(187)
Schem e [4.16]
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4.4 Synthesis of aryl amidoximes (164)
Amidoximes are well known and widely used compounds and were first described at the 
end of the ninteenth century. A comprehensive review of amidoximes has been
properties is given here.
Amidoximes can be synthesised by several synthetic approaches which among others 
include, the action of hydroxylamine on nitriles, amides, thioamides, imino ethers or 
amidine hydrochlorides, the reduction of nitrosolic and nitrolic acids or oxyamidoximes, 
the action of ammonia on hydroximic acid chlorides, glyoxime peroxides or 
oximinoethers, and the reaction of formamidoxime with aromatic aldehydes.258 By far 
the most used process and the one which was used in the preparation of the amidoximes 
for this project, is that which reacts hydroxylamine with nitriles.
The method usually consists in liberating the hydroxylamine from its hydrochloride with 
potassium of sodium carbonate and adding an equivalent amount of nitrile and enough 
alcohol to obtain a clear solution, and keeping the mixture at 60-80 °C for a few hours.
In order to synthesise the required oxadiazoles the following amidoximes were 
prepared.
published by Eloy and Lenares258 so a minimal coverage of their synthesis and
RCN +  NH2OH R C ( =  NOH)NH2
Schem e [4.17]
NOH
Ar
NH2
(164 a-h)
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For 164 a-g Ar- refers to the series of aryl groups which are given in figure 4.1. 164 
h refers to the 4-pyridine /V-oxide derivative.
Though some of the amidoximes prepared here have been previously reported, 
considerable comment will be made regarding the methods of preparing the amidoximes 
in question as they represent significant advances over existing methods. Thus for 
example the only reported synthesis of the m eta  and p a ra  amino phenyl 
am idoxim e259'260 employs a method whereby the corresponding nitro amidoxime 
derivative was initially prepared by the action of hydroxylamine on nitrobenzonitrile. 
The nitro compound was subsequently reduced with SnCl2 in dilute HCl to yield after 
precipitation of the tin salts, the dihydrochloride salt of the desired aniline amidoxime. 
Liberation of the salt with sodium carbonate thus yielded the aniline amidoxime which in 
the case of the meta isomer, according to the authors couldn't be obtained in a crystalline 
state but rather as a semi solid. No melting point is consequently quoted.
+
Schem e [4.18]
We found that for conversion of the aminobenzonitriles to the corresponding 
amidoximes it wasn't necessary to proceed via the intermediacy of the nitroamidoxime. 
It was discovered that very reasonable conversion of the aminonitriles to the free base of
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the amidoximes could be achieved directly by reaction with hydroxylamine under the 
conditions described. Thus for the synthesis of 3-aminophenyl amidoxime the method 
involves mixing the nitrile with an equivalent of the hydrochloride salt of hydroxylamine 
and 1.35 equivalents of K2CO3 in absolute ethanol and heating to reflux for 12 hours. 
After this period of time about 60-70% conversion, as monitored by TLC was 
achieved. Unlike the amidoximes (164 a,b,c,d,f) the aminophenyl derivatives were 
soluble in H20  and hence their work-up procedure had to be varied. Thus the reaction 
mixture after 12 h refluxing was cooled to 20 °C and the inorganic salts were filtered off. 
The reaction mixture was then dissolved in H20  and stirred with 3 x CH2C12 which 
selectively extracted the unreacted starting material leaving solely the amidoxime in the 
aqueous phase. Most of the water was then removed by azeotropic distillation with 
toluene until 1-2 volumes of H20  remained from which the amidoxime crystallised in a 
pure crystalline form in 40 % yield giving a sharp melting point of 125-127 °C and the 
required mass spectroscopic analysis.
Under similar reaction conditions the 4-amino benzonitrile failed to give more than c. 
5% conversion after 12 hours reflux. It was found that by adding H20  to the reaction 
about 60% conversion could be achieved after 3 hours at reflux temperature. On further 
heating no further conversion could be achieved. The reaction at this stage formed a 
cream coloured paste from which the supematent liquid was decanted. The liquid was 
then evaporated to dryness and partitioned between CH2C12/H20  at 40 °C which like the 
previous case resulted in selective partitioning of the product into the aqueous phase and 
the starting material into the methylene chloride. The water volume was reduced as 
described and the product was obtained in 48 % yield as a pure crystalline solid on 
crystalliation from H20 .
With the remaining amidoximes variations in the work-up procedure were made 
depending on the solubilities of the products. Thus for compounds (164 a,b,c) the 
reaction products were obtained by filtering off the inorganic products and evaporating
Synthesis o f exo-5 '-Tropane-3 '-aryl- 1,2,4-oxadiazoles.
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the filtrate to dryness. Any remaining inorganic salts were then removed by dissolving 
the residue in methylene chloride followed by filtration of the resulting cloudy solution. 
In the case of compound (164 f) the residue was redissolved in ethanol rather than 
CH2CI2 due to its insolubility in the latter.
Special difficulty was encountered in the case of the pyridine Af-oxide amidoxime (164 
h) which proved to be extremely insoluble in all the organic solvents tried. It was found 
that the amidoxime, as soon as it formed, immediately precipitated from the reaction 
medium and thus the solids filtered from the reaction contained a mixture of inorganic 
salts and amidoxime. Attempts to selectively extract the product with MeOH, CH2CI2, 
EtOAc, acetone or nitromethane all proved unsuccessful. As the amidoxime was also 
found to be insoluble in H2O it was isolated from the inorganic salts by refluxing the 
solid mixture in H2O for two hours which on filtration left the highly insoluble 
amidoxime. The product was then stirred in hot methanol to remove any traces of 
starting material or impurities that might have been present.
The identity of the amidoxime was confirmed by the two typical sharp NH2 bands at 
3418, and 3296 cm '1, the broad OH band at 3160 cm ' 1 and the C=N stretching 
frequency at 1644 c m 1. MS also gave a strong M+ of 153 corresponding to the 
amidoxime along with a perfect elemental analysis. Consistent with the amphoteric 
properties of amidoximes, compound (164 h) was found to be soluble in both dilute 
mineral acid and basic solutions. What was unusual about the pyridine iV-oxide 
compound was that, unlike the remaining amidoximes prepared which could only be 
dissolved in KOH o r  NaOH solutions, (164 h) was soluble in aqueous K2C O 3 
solutions. Moreover, on dissolving in aqueous potassium carbonate, an intense yellow 
solution formed which on acidification with HCl reverted to a colourless solution. 
Rebasification with K2CO3 again produced the yellow colour. The colour produced on 
basifying was thought to be due to a potassium complex of the deprotonated amidoxime, 
since it is known that amidoximes form coloured crystalline compounds with the salts of
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some metals.258 Werner,261 prepared a great number of such compounds with different 
amidoximes and proved that they are internal complexes in which the metal atom is 
linked to the oxime group as well as to the amino group. Certain amidoximes have been 
used as analytical reagents for various cations, such as the quantitative analysis of Ni2+, 
Cu2+, Ag+, Co2+ and for the spectrophotometric determination of uranium.258 The 
synthesis of amidoxime (164 f) has not previously been described in the literature and it 
is quite possible that it may serve as a useful agent in qualitative analysis.
All the amidoximes synthesised were identified by IR spectroscopy (Spectrum 39), 
mass spectroscopy and elemental analysis. A positive identification by all three methods 
was obtained for all the amidoximes except the 3,5-dichlorophenyl amidoxime (164 d). 
This compound though conforming to the required structure by IR and mass spectra 
analysis and which according to TLC analysis seemed to contain only one compound, 
failed to give an accurate elemental analysis even on repeated synthesis.
At this stage the literature was resorted to in an effort to find a solution to the problem. It 
was found that the only reported synthesis of the amidoxime in question was carried out 
by Stephenson et a l262 in 1969. The authors reported a study on the effects of electron 
withdrawing substituents when aromatic nitriles were treated with hydroxylamine in 
anhydrous methanol. They found that when 4-cyanopyridine or nitriles of the type 
X -C 6 H 4CN ( X= 0 -N O 2 ,p -C N , p-C  1 P -C F 3) were treated with an excess of 
hydroxylamine in methanol, the resultant amidoximes were contaminated with 
substantial amounts (17-55 %) of the corresponding amides. The following mechanism 
was proposed to explain the observations. Scheme [4.19]
Synthesis o f exo-5'-Tropane-3'-aryl-1,2,4-oxadiazoles.
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H
R
R— CN
N— OH
NH2OH
RCONH2 +  [ H2N NH OH ]
NH2OH
2 H 20  + NH3 + N2
Schem e [4.19]
They based their proposal on the fact that hydroxylamine can react as an ambident 
nucleophile in displacement and addition reactions and on reports of nucleophilic attack 
by the nitrogen atom of hydroxylamine on other nitrogen atoms bearing electron 
withdrawing groups. The authors proposed that the initial attack at the nitrile by the 
hydroxyl amine could take place at the nitrogen of the hydroxylamine to give the normal 
amidoxime, or attack of the oxygen to give the amide product. An increase in the 
positive charge at the nitrile carbon, they claimed, presumably induces some attack by 
the more electronegative element of the ambident nucleophile hydroxylamine. The 
observation correlated well with the observed proportions of o-, p -, and m- 
nitrobenzamide formed with consideration of the inductive effect of the nitro-group in 
the three positions.
In order to prepare amide free amidoximes containing electron withdrawing substituents 
such as 3,5 dichlorobenzamidoxime, Stephenson used an alternative route whereby the 
nitrile was first converted to the corresponding thioamide which was subsequently 
converted to the amidoxime by reaction with hydroxylamine.262 Scheme [4.20]
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Schem e [4.20]
It seemed clear that a posible impurity in the dichlorobenzamidoxime (164 c) was the 
corresponding amide. Considering that amidoximes are acid soluble, the best way of
doing this some of the solid failed to go into solution and was filtered off. The insoluble 
solid was shown to be the amide as expected and amounted to 5% of the total product 
isolated. After liberating the amidoxime from its HCl salt a pure white solid was 
obtained which gave a perfect result on elemental analysis and a melting point 20 °C 
higher than the original sample. In conclusion, it is certain that the electronegative 
substituents on 3,5-dichlorocyanobenzene leads to some amide formation on reacting 
with hydroxylamine. However the amount of amide formed is small (5 %) and could 
easily be removed by acid extraction giving yields equivalent to the overall yield reported 
by Stephenson via the thioamide route and would seem therefore to be a much more 
practical synthesis as it involves only a single step. It may be that the different reaction 
conditions employed by us (ethanol instead of methanol and the presence of K2CO3 in
isolating any possible amide present was by dissolving the amidoxime in dilute HCl. On
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the reaction) gave rise to the lower presence of amide in the reaction product but no 
attempts were made to prove this.
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4.5 Synthesis o f exo -5 '-(8 -M eth y l-8 -azab icyclo [3 .2 .1 ]octan -3-y l)-3 '- 
(aryl)-l,2 ,4-oxadiazoIes III a-g.
Having developed efficient methods for the syntheses of the tropinone ester (163) and 
the amidoximes (164) an effective method for the condensation of these two moieties to 
give the required oxadiazoles was investigated. Due to the fact that amidoximes are 
indifferent towards non activated esters the presence of a strong base such as NaH to 
increase the nucleophilic nature of the isonitroso group in the amidoxime has previously 
been employed.263
The general method employed for the synthesis of oxadiazoles III a-g, involved the 
initial formation of the sodium salt of the amidoxime in anhydrous THF using NaH as 
base whereupon the reaction appearance changes from a fine greyish suspension of NaH 
to a coarser white suspension on addition of the amidoxime. On termination of the 
evolution of hydrogen, to this mixture was added a solution of the tropinone ester
(163) in dry THF solution (c. 30 % excess) which was then refluxed until no ester 
remained (c. 3-6 hrs). The reaction mixture at this stage forms a thick cream paste, the 
stirring of which in some cases had to be assisted by the addition of extra THF. The 
progress of the reactions were monitored on TLC using silica gel and 10:1 CH2CI2/THF 
as developing solvent. A typical reaction profile is shown below .
Synthesis o f exo-5'-Tropane-3'-aryl-1,2,4-oxadiazoles.
Amidoxime
O xadiazole 
Tropinone ester
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On completion of the reaction, the product was isolated by filtering off the very fine 
suspension and purifying the filtrate by column chromatography on silica gel (8:2 
CH2CI2/ THF). The colourless oil obtained was converted to its hydrochloride salt in 
ethanol/HCl and crystallised from an appropriate solvent. During the development of the 
reaction procedure the following observations were made.
1) As H20  is eliminated in the reaction (see scheme [4.22]) the presence of in situ 
molecular sieves to remove the water was investigated but was found not to have any 
significant effect on the reaction.
2) It was discovered that in order to fully convert the tropinone ester to the oxadiazole, 
an excess of amidoxime had to be used, it being found that a 30 % excess was sufficient 
for complete conversion. When equivalent molar amounts of ester and amidoxime were 
used the reaction only proceeded to about 50% conversion. This may be because the 
formation of the intermediate acylated product (188) is a reversible reaction with the 
intermolecular nucleophilic attack of the NaOMe formed in the reaction competing with 
the intramolecular nucleophilic attack of the NH2 group. Scheme [4.21]
N - O H N — O ' Na +
// NaH // (163)
A r C
\ A r C \
n h 2 n h 2
(164)
+ NaOMe
NH 2
(188)
Schem e [4.21]
3) With regards to the synthesis of the dichlorophenyl derivative III d a large excess of 
NaH had to be used in order to fully convert the ester to the oxadiazole. Attempts to
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carry out the reaction using the standard conditions gave only 20  % conversion after 
several hours refluxing. On addition of a further equivalent of NaH to the reaction 
mixture followed by further heating (Note: newly purchased NaH was used) conversion 
to c.50% was obtained which remained unchanged on continued refluxing. Addition of 
one equivalent more NaH gave 80% conversion with a further equivalent being 
necessary for complete conversion. The reaction was then worked up in the standard 
fashion and isolated as usual.
4) When the 4-pyridin iV-oxide amidoxime 164 h was used to react with the ester using 
the standard procedure, no oxadiazole could be obtained even with large excesses of 
NaH. The amidoxime was found to be highly insoluble in the common organic solvents 
tested (THF, DMF etc.). This insolubility was judged to be cause of the reaction failure. 
Several other mixtures were tested including MeOH/NaOMe and EtOH/ NaOMe none of 
them however being successful. As the amidoxime 164 h was found to be completely 
soluble in H2O/K2CO3 it was attempted to react the tropinone ester in this solution. 
After 8 hours at r.t. only starting materials were observed. On heating the reaction to 
reflux the ester completely converted to the tropinone acid as had been feared. Continued 
reflux failed to produce any reaction of the amidoxime salt (complex) with the acid 
which is probably to be expected as the tropinone acid probably existed in its 
zwitterionic form as had previously been shown (Sec. 4.3).
It should be pointed out that like 164 h the 4-aminophenyl amidoxime was similarly 
insoluble in the reaction solvent (THF) which in the latter case however posed no 
problems as complete conversion to the oxadiazole was obtained. This may suggest that 
the failure of the /V-oxide amidoxime to condense with the ester may not be due to a 
solubility problem but may be a result of electronic effects.
5) In the preparation of III g, although complete conversion of the tropinone ester was 
apparently achieved, very low yields o f the oxadiazole were attained (c.5%). 
Subsequent examination of the tropinone ester used in the reaction showed that on
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standing at room temperature over a period of 1 month it had decomposed to a by­
product which had a similar Rf value on TLC as the amidoxime. The ester was purified 
by column chromatography using silica gel and MeOH: THF (8:2). The ester was found 
to have been only 12% pure, the remainder being a decomposition product which 
seemed to be a single product on TLC. Due to the complex spectrum of the isolated 
impurity a positive identification of its structure was not feasible. Subsequent to this the 
tropinone ester was stored at 0 °C which avoided the aforementioned decomposition. On 
repeating the oxadiazole formation with the repurified ester normal yields of the 
oxadiazole were obtained.
6 ) Although, generally the work-up of the reaction mixture was by filtration and 
purification of the filtrate by column chromatography, it was also possible to isolate the 
oxadiazole product in reasonable purity by evaporating the solvent from the filtrate then 
partitioning the resulting oil between CH2CI2 and H2O, then basifying with NaOH and, 
washing the seperated organic layer with H2O followed by drying and concentration. 
The free base obtained was slightly less pure than that obtained by chromatography, 
however on subsequent HCl salt formation an equally pure oxadiazole salt was isolated.
As outlined in scheme [4.21] the synthetic route to the formation of oxadiazoles occurs 
through acylation of the isonitroso group to give the O-acylated amidoxime which 
subsequently cyclises to the oxadiazole. Though the acylated intermediate can normally 
be isolated none was observed in the synthesis of the oxadiazoles III  a-g.
The thermal cyclisation of acylated amidoximes has been known since 1884 and widely 
used for the formation of 1,2,4-oxadiazoles but the mechanism was not studied until 
1980.264 In this investigation Sim Ooi and Wilson carried out a mechanistic study on the 
formation of 3,5-disubstituted 1,2,4-oxadiazoles from O-acetylarylamidoximes and O- 
aroylacetamidoximes in which the following conclusions were reached. They concluded 
that the cyclisation followed the mechanistic pathway outlined in scheme [4.22].
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Schem e [4.22]
The equilibrium (189) to (190) was found to lie well to the left and the second step, 
the proton transfer, was the rate determining step with the observed rate constant being 
the product kjk^/lei.
That these cyclisations do indeed form polar species was shown by Hammett 
correlations. The effect of ring substitution in (189) (p -  0.79) is in accord with the 
amidoxime NH2 group acting as nucleophile, with decrease of electron density at the 
amidoxime carbon. The rate constants for cyclisations of (189) with various aromatic 
substituents is given in Table (4.1) along with the a  values for the various substituents. 
From these results some conclusions may be made for the formation of oxadiazoles III 
a-g.
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T able  [4.1]
Compound 189 10^ / s -1 Hammett correlation a
Ar = C6H5 2.1
Ar = p-Me2NCgH4 9.0
Ar = p-MeOCftHt 3.4 p - 0.79 (a)
Ar =  p -  BrC6H4 1.35
Ar = m-ClC6H4 1.2
Ar ^-N C bC ftH t 0.46
a U sing a  values p  -M e2 N, - 0.83; p -  -M eO, -0.27; p  -Br, 0.23; m -Cl, 0.37; p  -N O 2 , -0 .78;
As can be seen from the table the electron donating group such as /?-Me2N has a definite 
positive effect on the increase in reaction rate while electron attracting groups such as m- 
Cl, p -Br or p-NCb considerably decrease the reaction rate. As was previously stated the 
formation of the dichloro oxadiazole (H id) was much slower than any of the other 
products containing electron donating substituents or the m-OM e substituted 
amidoximes which, while being electron attracting substituents when in this position are 
much less so than m-C 1. A full explanation is given as follows; If we suppose that the 
formation of the acylated amidoxime (188) is an equilibrium reaction (Scheme 4.21) 
which from previous evidence seems to be the case (i.e. the beneficial use of an excess 
of amidoxime in the reaction) then the acylated amidoxime can either undergo reversal to 
the amidoxime or alternatively cyclise to a polar intermediate similar to (190) which 
according to Sim Ooi and W ilson264 is also reversible. Therefore if the rate of 
cyclisation is disfavoured by the two meta chloro substituents, reversal to the starting 
amidoxime would predominate.
It has been mentioned that the rate of this reaction was substantially increased by the 
addition of a large excess of NaH to the reaction mixture. This observation is not 
entirely unusual as it has previously been observed that the rate of cyclisation of acylated 
amidoximes can be considerably increased by the presence of NaH .264 The effect of
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sodium hydride in these cyclisations is to form an anion at the NH2 of the acylated 
amidoxime which far more readily ring-closes by nucleophilic addition to the carbonyl 
than does the poorly nucleophilic neutral derivative itself.
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CHAPTER V
Structural and conformational study of 
Imidazolines and Oxadiazoles.
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5.1 Introduction
All the potential 5 -HT3 antagonists synthesised have been studied by and 13C NMR 
while a representative compound of the tropane imidazoline and the tropane oxadiazole 
series has been studied by X-ray diffraction. In the case of the series of compounds 
containing the tropinone moiety, a conformational analysis in solution was of particular 
interest since the spatial position of the moieties attached to this bicyclic group is 
dependent on the conformation adopted by the tropane. The quinuclidine series, being a 
more rigid molecule did not necessitate such a conformational analysis in order to 
determine the geometric positions of the groups attached. Thus in order to assist in the 
structure-activity relationship the preferred conformations of series I and III were 
determined in solution and in the solid state.
5.2 Study of Tropane spiroim idazoiines (I).
5.2.1 X-ray study o f 2'(lH-indol-3-yl)-8-methyl-8-azabicyclo[3.2.1 ]octane-3- spiro- 
4'(5')-imidazoline dihydrochloride (I g).
The X-ray crystal structure of (I g) was obtained, verifying the proposed structure for 
this series of compounds. The crystals used for the analysis were developed by slow 
recrystallisation from methanol. The full experimental and structural determination 
procedures and crystallographic data are given in Appendix 1. Selected bond distances, 
bond angles, torsional angles and interatomic distances are shown in Tables 5.1-5.4. 
Figures 5.1 and 5.2 represent the PLUTO view of (Ig) showing atomic numbering and 
the molecular packing diagram for (Ig) respectively. Full crystallographic data has been 
deposited at the Cambridge Crystallographic Data Centre, University Chemical 
Laboratory, Lensfield Road, Cambridge CB21EW, U.K.
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Table [5.1]
Selected Bond Lengths ( A )  for I g
Bond Length /A Bond Length /A
025 - C26 1.43 (2) C 4 -C 1 3 1.60 (2 )
N1 - C2 1.50 (2) C 5 -C 6 1.52 (2)
N1 - C6 1.50 (2) C 6 -C 7 1.52 (2)
N1 - C9 1.51 (2 ) C7 - C8 1.55 (2)
N10 - C4 1.50 (1) C l l  -C 14 1.38 (1)
N 10-C 11 1.36 (2) C 14-C 15 1.39 (2)
N 12-C 11 1.34(1) C 14-C 18 1.44 (2)
N 12-C 13 1.45 (2) C17 - C18 1.40 (1)
N 16-C 15 1.35 (2) C17 - C22 1.40 (2)
N 16-C 17 1.37 (2) C18 -C 19 1.38 (2)
C 2 -C 3 1.54 (2) C 19-C 20 1.37 (2)
C 2 -C 8 1.52 (2) C 20-C 21 1.37 (2)
C 3 -C 4 1.53 (2) C21 -C 22 1.38 (2)
C 4 -C 5 1.53 (2)
Table [5.2]
Selected Bond Angles (°) for I g
Atoms Angle (°) Atoms Angle (°)
C 6-N 1  - C9 1 1 2 ( 1) C6  - C7 - C8 105 (1)
C 2-N 1  -C 9 114(1) C2 - C8 - C7 105 (1)
C2 - N 1 - C6 1 0 2 ( 1) N 10-C 11 -N 12 109(1)
C 4 -N 1 0 -C 1 1 113(1) N 12-C 11 -C 14 127 (1)
C l l  - N12-C13 114(1) N 10-C 11 -C 14 124(1)
C15 - N 16-C 17 1 1 0 ( 1) N 1 2 -C 1 3 -C 4 103 (1)
N 1 - C2 - C8 1 0 2 ( 1) C l l  -C 1 4 -C 1 8 130(1)
N 1 - C2 - C3 109(1) C l l  -C 1 4 -C 1 5 123 (1)
C3 - C2 - C8 115(1) C 1 5 -C 1 4 -C 1 8 106(1)
C2 - C3 - C4 1 1 2 ( 1) N 1 6 -C 1 5 -C 1 4 109(1)
N 1 0 -C 4 -C 3 108(1) N 1 6 -C 1 7 -C 2 2 129(1)
C 3 -C 4 -C 1 3 114(1) N 1 6 -C 1 7 -C 1 8 108 ( 1)
C3 - C4 - C5 1 1 2 ( 1) C 1 8 -C 1 7 -C 2 2 123 (1)
N 1 0 -C 4 -C 1 3 1 0 0 ( 1) C 14-C 18 -C 17 106(1)
N10 - C4 - C5 109(1) C 1 7 -C 1 8 -C 1 9 118(1)
C 5 -C 4 -C 1 3 1 1 2 ( 1) C 1 4 -C 1 8 -C 1 9 135 (1)
C4 - C5 - C6 115(1) C 1 8 -C 1 9 -C 2 0 119(1)
N 1 - C6  - C5 106(1) C 1 9 -C 2 0 -C 2 1 1 2 2 ( 1)
C5 - C6 - C7 114(1) C 20-C 21 -C 22 1 2 1 ( 1)
N 1 - C6 - C7 1 0 2 ( 1) C 1 7 -C 2 2 -C 2 1 116(1)
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Table [5.3]
Selected Torsion Angles (°) for I g
Atoms Angle (°)
C2 - C3 - C4 -N10 - 158 (1)
C 2 -C 3 -C 4 -C 1 3 91(1)
N 1 0 -C 4 -C 5 -C 6 159(1)
C 1 3 -C 4 -C 5 -C 6 -9 0 (1 )
N 12-C 11 -C 1 4 -C 1 5 -1 5 4 (1 )
N 10-C 11 -C 1 4 -C 1 5 27 (2)
N 12-C 11 -C 1 4 -C 1 8 2 1 (2 )
N 10-C 11 -C 1 4 -C 1 8 -1 5 7 (1 )
Table [5.4]
Interatomic Bond Distances and Angles for Ig
N l-H l H I . ..025 N1...025 N l- H l . ..025
1 . 0 ( 1 )  A 1.7(1) A 2.72(1) A 164(1)°
C123-H23 H23...025 C123...025 C123-H23...025
1.7 ( 2 )  A 2.5 ( 1 )  A 3.04(1) A 92 (1)°
N10-H10 H10...C123 N10...C123 N10-H10...C123
1 . 0 ( 1 )  A 2.3 ( 1 )  A 3.24(1) A 168(1)°
N12-H12 H12...C124 N12...C124 N12-H12...C124
1 . 0 ( 1 )  A 2 . 2 ( 1 )  A 3.15 ( 1) A 165 (1) 0
N16-H16 H16...C1241 N16...C1241 N16-H16...C1241
0.7 ( 2 )  A 2.5 (2 ) A 3.18(1) A 165 (1) °
1 -X, 1-Y, -Z
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Figure 5.1 Pluto view of I g showing atomic numbering
1 7 4
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Figure 5.2 Crystal Packing of I  g showing the intermolecular hydrogen bonds.
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As can be seen from the PLUTO view of the compound (Figure 5.1), a molecule of 
methanol is incorporated into the crystal structure. The bicyclic system is in the chair- 
envelope conformation commonly found in these kind of compounds. The chair is 
flattened at the C4 atom to release steric hindrance, C4 and N1 being 0.49(1) and 
0.86(1)A, respectively, from the mean plane defined by the other four atoms. N l, on 
the other hand, is in the flap of the envelope, 0.70(1)A away from the plane defined by 
the rest of the atoms in this ring.
The molecule presents a pseudo-mirror plane, passing through the N l, C4, and C9 
atoms. The imidazoline ring is almost in this plane with an interplanar angle of only 5°. 
The indole moiety deviates from this symmetry defining an interplanar angle of 24°. 
C123 and C124 are in opposite positions with respect to the pseudo-mirror plane, being
0.639(4) and 1.472(3)A respectively out of this plane.
As indicated by the bond lengths (Table 5.1), the electrons are delocalised along N10- 
C11-N12 and the indole moiety, which maintains the interplanar angle of 24° between 
the indole and the imidazoline ring. Consequently, there is no difference between the 
N10, N12 atoms or the C11-N12 and the C11-N10 bond lengths. Both N atoms of the 
imidazoline ring form hydrogen bonds with the two chlorine atoms. However, one of 
them acts as the counter chloride ion (C124), while the other seems to be present as a 
hydrochloride of crystallisation and also interacts with the CH3-O group of the solvent, 
which in turn interacts with the bicyclic N l atom. The hydrogen bonding pattern is 
completed by a hydrogen bond between the indole N16 and the C124 atom from a 
different asymmetric unit. Two molecules related by a center of symmetry form a dimer 
through two hydrogen bonds: N12-H12....C124 and N16-H16....C124. These dimers 
form isolated units stacked along the "a" axis. The first hydrogen bond links the C124 
atom to the N12 one in the same molecule (x,y,z) and the second links the C124 to the 
N 16 of a different asymmetric unit (-x,l-y, -z), the Cl atom acting as the nexus between 
the two molecules (see figure 5.2).
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5.2.2 NMR study o f 2'(aryl)-8-methyl-8-azabicyclo[3.2.1 ]octane-3-spiro-4'(5')- 
imidazolines (I a-g).
The 1H and 13C NMR data of compounds I a-g show great similarity between 
compounds. The assignment of proton and carbon resonances has been made on the 
basis of double resonance experiments on compound Ic and previous studies of tropane 
compounds.265"267 In CD3OD and CDCI3 all the proton resonances could be assigned. 
Figure 5.3 indicates the numbering system used for the assignation of the carbons and 
protons and two typical NMR sprectra are given in Appendix 3 (Spectra 4 and 5)
F ig u re  5.3
The long range couplings between the protons in the W disposition, 47 H 2a-H 4a, 4/  
H2(3-H7x or 4/  H4(3-H6x have not been observed under the conditions used to record 
the spectra. As is frequently observed in tropane systems,267 the protons situated at the 
bridge-head carbon atoms H I(5) appear as a non-resolvable broad singlet, the medium 
width at half height being in the range W 1/2 = 9-11 Hz. It was therefore not possible to 
measure the coupling constants for these protons. The H2(4)oc and H2(4)|3 signals were 
assigned on the basis of the values of the corresponding couplings with H I(5) protons 
for related systems. The H I, H 2a and H2(3 (or H5, H 4a and H4[3 ) atoms form a three 
spin AMX system whose analysis leads to the establishment of their proton magnetic 
parameters. The protons H2(4)P appear as double doublets as a consequence of the 
geminal coupling with H2(a) and the smaller coupling with the vicinal H I(5) proton. 
The geminal couplings l J  H2(4)a-H2(4)(3 are generally in the range -14 to -16 Hz,
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while the vicinal coupling 3J  H2(4)P-H1(5) average around 3-4 Hz. The H 2(4)a 
protons present a similar appearance though the vicinal coupling with H I(5) is smaller, 
being on average 2.0 Hz. The assignment of the H6(7)n and H6(7)x signals was carried 
out from analysis of their shapes: the simpler signal being attributed to H6(7)n since 3/  
H 6(7)n-H l(5) is very small (0.5Hz) in tropane derivatives i.e. practically 
unobserved.267
As with the iH-NMR spectra the 13C NMR spectra all show great similarity between 
each other (See spectrum 13 in Appendix 4 for a representative 13C NMR profile). In 
order to assign the 13C signals steric and electronic effects were taken into consideration 
and a proton-carbon coupled spectrum was carried out on Ic (spectrum 14) to confirm 
the assignation. Previous studies on related systems were also used to aid in the 
designation of signals.265' 267
The coupling constants deduced from first-order analysis of the iH-NMR are compiled 
in Table [5.5] while the [H and 13C NMR data of I a-g are summarised in table [5.6].
Table [5.5] Coupling constants deduced from the first-order analysis of the !H-NMR 
spectra of compounds Ia-g. (CD3OD: 300 MHz)
Coupling 
Constant J  (Hz) I a lb Ic Id Ie I f Ig
H2(4)oc-H2(4)P -14.7 -13.9 -14.4 -13.4 -13.0 -14.2 -16.3
H 2(4)a-H l(5) 2.4 2.4 1.9 2 .6 a 2.5 2.5
H2(4)p-Hl(5) 3.4 3.4 3.4 3.4 2.9 3.1 3.0
a 3J Hl(5)-H2(4)ot could not be established, only a slight broadening of the H2(4)a signal was observed.
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Table [5.5] 13C and 'H  NMR data for compounds I a-g (ppm)
Atoms I a It) I c Id I e a I fa Ig b
H l ( 5 ) b r s 3 . 3 0 3 . 2 4 3 . 2 2 3 . 3 8 3 . 1 8 3 . 3 9 4 . 0 8
C 1 ( 5 ) 6 1 . 9 5 6 1 . 8 5 6 1 . 8 5 6 1 . 8 3 6 1 . 5 6 5 9 . 8 6
W l / 2 ( H z ) 9 . 4 0 9 . 7 9 9 . 7 0 1 1 . 4 0 1 0 . 9 1 1 . 8
H2(4)a  dd 1 . 9 6 1 . 8 7 1 . 8 6 1 . 9 4 2 . 0 1 1 . 9 2 2 . 5 5
C 2 ( 4 ) 4 2 . 5 0 4 2 . 5 8 4 2 . 5 4 4 2 . 4 6 4 1 . 9 6 4 1 . 0
H2(4)P dd 2 . 1 2 2. 08 2. 08 2 . 1 2 2 . 0 7 2 . 4 6 2 . 6 5
C 3 6 2 . 6 7 6 2 . 5 0 6 2 . 4 7 6 0 . 3
H6(7)x m 2 . 1 2 2. 08 2. 08 2 . 1 2 1 . 80 2 . 1 0 2 . 4 2
C 6 ( 7 ) 2 5 . 9 9 2 6 . 2 5 2 6 . 2 6 2 6 . 2 1 2 4 . 8 4 2 4 . 0 4
H6(7)n m 1 . 8 6 1 . 8 4 1 . 83 1 . 9 0 1 . 6 9 1 . 8 6 2 . 2 8
C H 3 N s 2 . 3 9 2 . 3 7 2 . 3 7 2 . 4 6 2 . 2 8 2 . 4 2 2 . 8 6
CH3 N 3 8 . 9 6 3 8 . 8 3 3 8 . 8 3 3 8 . 8 9 3 8 . 6 6
C 2 ' 1 6 4 . 4 9 1 6 4 . 2 2 1 6 4 . 2 2 1 6 1 . 6 7 1 6 0 . 0 1 6 1 . 9 1
H4' s 3 . 9 7 3 . 8 9 3. 8 8 3 . 9 1 3 . 8 7 3 . 9 1 4 . 3 3
C 4 ' 6 5 . 1  I 6 7 . 2 9 6 7 . 2 6 6 7 . 8 7 6 4 . 3 6
C H 3 O s 3 . 8 2 3 . 8 0
CH3 O 5 5 . 8 3 5 5 . 9 4
C l" 1 2 4 . 7 5 1 3 2 . 9 7 1 3 2 . 7 9 1 3 4 . 3 7 1 3 6 . 9
H2 " 7 . 7 7 7 . 3 2 6 . 9 5 7 . 7 2 7 . 6 1 7 . 6 3 8. 83
C2 " 1 2 9 . 8 3 1 1 3 . 4 9 1 0 6 . 2 6 1 2 6 . 9 2 1 2 4 . 1 5 1 3 2 . 3
H4 " 7 . 5 0 7 . 0 3 6 . 5 8 7 . 6 0 7 . 9 3
C4" 1 3 3 . 1 0 1 1 7 . 9 4 1 0 4 . 0 7 1 3 1 . 4 9 1 2 0 . 2
H5 " 7 . 5 0 7 . 3 2 1 6 2 . 3 8 . 1 4 8 . 5 8 7 . 3 4
C5 " 1 2 8 . 5 4 1 3 0 . 5 5 1 3 6 . 4 0 1 5 0 . 1 0 1 2 3 . 9
H 6 " 7 . 7 7 7 . 3 2 6 . 9 5 7 . 7 2 7 . 6 1 7 . 6 3 7 . 3 4
C 6 " 1 2 9 . 8 3 1 3 2 . 9 5 1 0 6 . 2 6 1 2 6 . 9 2 1 2 4 . 1 5 1 2 5 . 1 1
H7 " 7 . 5 7
C7" 1 1 4 . 0 5
C7a" 1 3 8 . 4 4
a In C D C I3 ; b Dihydrochloride salt
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5.2.3 Conformational study o f tropane spiroimidazolines I  a-g.
From the *H and 13C NMR data, it can be proposed that compounds I a-g adopt a 
preferred conformation in solution similar to that observed for compound I g in the 
crystalline state:
a) The pyrrolidine and piperidine rings adopt a flattened N 8 envelope and distorted chair 
conformation puckered at N8 and flattened at C3 as evidenced by the *H NMR spectra 
where the W 1/2 values for the H l(5) signals of 9-12 Hz correspond to a tropane system 
with the piperidine ring in a chair conformation. This is supported by the vicinal 
coupling values for 3/  H2(4)P-H1(5) which do not correspond to dihedral angles of 0 °, 
typical of a boat conformation. In compounds I a-g 3/H 2(4)(3-H l(5) is always greater 
than 3J  H 2(4)a-H l(5), consequently, the dihedral angle H2(4)a-C-C-Hl(5) is greater 
than H2(4)[3-H1(5). From the 13C NMR spectra the chair conformation adopted by the 
piperidine ring is confirmed by the 5C2(4) values. For a boat conformation, these 
carbon signals would be shifted to higher fields as a result of the steric compressing 
effect due to the eclipsing between the C2(4)P and the C l(5) hydrogen atoms.266-268
b) The 5 of the N-substituent is in agreement with an equatorial position for this 
group .269
c) The groups linked to the imidazoline ring are nearly coplanar with respect to this ring,
i.e. partial conjugation between these groups is observed as indicated by the S[H and 
513C values for the aromatic groups in Ia-g.
It is worth pointing out that I g, which is a dihydrochloride salt, has a similar 
conformational behaviour as that deduced for the free bases. The deshielding observed 
for the proton and carbon signals of the protonated derivatives can be mainly ascribed to 
the field effect exerted by the positively charged nitrogen atom. The 3 J  H2(4)[3-H1(5) 
and 3 /H 2 (4 )a -H l(5 )  as well as the W 1/2 of the H l(5) protons remain practically 
unchanged as a result of protonation. Consequently, it seems obvious that the 
protonated forms, which predominate in a physiological medium, and the free base must
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exibit the same predominant chair-envelope conformation of the tropane system slightly 
flattened at C3 and puckered at N8 , with the N-methyl group in an equatorial position.
5.3 Structural and Conformational Study of tropane oxadiazoles (III).
5.3.1 X-ray study of exo-5'-(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl)-3'-(3,5- 
dimethoxyphenyl)-l,2,4-oxadiazole hydrochloride III c.
An X-ray crystal structure of (III c) was obtained which confirmed the proposed exo 
structure for this series of compounds. The crystal used for the analysis was obtained by 
slow recrystallisation from methanol. The experimental and structural determination 
procedures and full crystallographic data are given in Appendix II. Figures 5.4 and 5.5 
represent the PLUTO view of (III c) showing atomic numbering used in the 
crystallographic study and the molecular packing diagram for (III c) respectively. 
Selected bond distances, bond angles and torsion angles are given in tables 5.7 - 5.9. 
The crystallographic data is to be deposited at the Cambridge Crystallographic Data 
Centre, University Chemical Laboratory, Lensfield Rosd, Cambridge CB21EW, U.K.
Table [5.7] Selected Bond distances(A) for IIIc.
Bond Length (A) Bond Length (A)
C1-C2 1.54(1) Cl 1-NI2 1.29(1)
C1-C6 1.53(1) C11-C14 1.47(1)
C1-C9 1.48(1) N12-013 1.409(5)
C2-C3 1.53(1) C14-C15 1.39(1)
C3-N4 1.508(5) C14-C19 1.40(1)
C3-C7 1.52(1) C15-C16 1.39(1)
N4-C5 1.51(1) C16-C17 1.38(1)
C5-C6 1.53(1) C17-C18 1.39(1)
C5-C8 1.53(1) C18-C19 1.39(1)
C7-C8 1.52(1) Cl 8 -0 2 2 1.377(5)
C9-N10 1.291(5) 020-C21 1.41(1)
C9-013 1.342(4) 022-C23 1.42(1)
N10-C11 1.384(5)
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Table [5.8] Selected Bond Angles (degrees) for IIIc.
Bonds Angie f ) Bonds Angle (°)
C 6-C 1  - C9 111.9 (3) N 10 - Cl 1 -C 14 124.6 (4)
C 2-C 1  - C9 109.6 (4) N 10-C 11 -N 12 114.2 (4)
C 2 - C 1 - C6 111.3 (3) N12 - C l l  - C14 121.2 (4)
Cl -C 2 -C 3 111.4 (4) C l l  -C 1 2 -0 1 3 103.5 (3)
C2 - C3 - C7 113.3 (4) C 9 -0 1 3  -N 12 106.5 (3)
C2 - C3 - N4 107.1 (3) C l l  - C 14-C 19 118.1 (4)
N4 - C3 - C7 102.8 (4) C l l  -C 1 4 -C 1 5 119.9 (4)
C3 - N4 - C24 113.4 (3) C15 -C 1 4 -C 1 9 122.0 (4)
C3 - N4 - C5 101.2 (3) C 14-C 15 - C16 118.8 (4)
C5 - N4 - C24 113.6 (3) C 15 - C 16 - 0 2 0 124.3 (5)
N4 - C5 - C8 102.4 (4) C 1 5 -C 1 6 -C 1 7 120.3 (4)
N4 - C5 - C6 107.2 (4) C 1 7 -C 1 8 -0 2 0 115.4 (4)
C6 - C5 - C8 114.0 (4) C 1 6 -C 1 7 -C 1 8 120.2 (5)
C l -C 6 -C 5 110.7 (3) C 1 7 -C 1 8 -0 2 2 115.1 (4)
C 3 -C 1  - C8 105.5 (4) C 1 7 -C 1 8 -C 1 9 120.9 (5)
C5 - C8 - C l 105.5 (5) C 1 9 -C 1 8 -0 2 2 123.9 (4)
C l - C 9 -0 1 3 115.5 (4) C 1 4 -C 1 9 -C 1 8 117.6 (4)
C l -C 9  -N10 131.7 (4) C16 - 0 2 0 -C 2 1 117.2 (40
N 1 0 -C 9 -0 1 3 112.7 (4) C 1 8 -0 2 2 -C 2 3 118.8 (4)
C 9 -N 1 0 -C 1 1 130.0 (3)
Table [5.9] Selected Torsion Angles (degrees) for IIIc.
Bonds Angle O Bonds Angie (°)
C 2- C l -C 6 -C 5 -46.5 (5) C 8 -C 5 -C 6 -C 1 -50(1)
C 6 -C 1  -C 2 -C 3 46.1 (5) C6  - C5 - C8 - C l 8 8 ( 1)
C l - C2 - C3 - N4 -61.3 (4) C3 - C7 - C8 - C5 -0 (1)
C l - C2 - C3 - C l 51(1) C 6 -C 1  -C 9 -N 1 0 -9(1)
C2 - C3 - C7 - C8 -87(1) C 2 -C 1  -C 9 -N 1 0 -132.9(5)
C2 - C3 - N4 - C5 74.2 (4) C 6-C 1  - C 9 - 0 1 3 170.8 (4)
N4 - C3 - C7 - C8 28.2 (5) C 2-C 1  - C 9 - 0 1 3 46.8 (5)
C7 - C3 - N4 - C5 -45.5 (4) N 10-C 11 -C 1 4 -C 1 5 -8 ( 1)
C3 - N4 - C5 - C6 -75.2 (4) N 10-C 11 -C 1 4 -C 1 9 171.9 (4)
C3 - N4 - C5 - C8 45.1 (4) N 12-C 11 -C 1 4 -C 1 5 172.8 (4)
N4 - C5 - C6 - C l 62.6 (4) N 12-C 11 -C 1 4 -C 1 9 -7 (1 )
N4 - C5 - C8 - C l - 27.5 (5)
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Figure 5.4 Pluto view of IIIc  showing atomic numbering.
Structural and conformational study
Figure 5.5 Unit cell packing of IIIc viewed down the c axis.
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The bicyclic system consists of two rings, one of five and the other of six atoms. The 
five membered ring has an envelope conformation with N4 at the flap and at a distance 
of 0.689(3)A from the plane defined by the other four atoms C3, C5, C l  and C8 , while 
the six membered ring has a chair conformation with C l and N4 out of the plane defined 
by C2 , C3, C5 and C6  by -0.586(4) A  and 0.885(3) A  respectively. Rings 3 and 4 are 
planar, forming an angle of 7.4°(1) between them. They are in the equatorial position 
with respect to the bicylic ring system. The two methoxy groups are also coplanar to the 
phenyl ring.
The H atom of the Cl migrates towards N4 and forms an intramolecular hydrogen bond
between N4 Cl (see Appendix II) ; their is also an intramolecular short contact
between C2....013. Figure 5.5 shows the molecular packing viewed down the c axis. 
The molecules are held together by van der Waals forces.
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5.3.2 NMR and conformational study o f exo-5'-(8-Methyl-8-azabicyclo[3.2.1 Joctan- 
3-yl)-3'-(aryl)-l,2,4-oxadiazole hydrochlorides III a-g.
iH nmr (300 MHz) and 13C nmr (75 MHz) spectroscopy was performed on all the 
samples in the series using deuterated methanol as solvent. From the 1H NMR spectra 
all the signals could be assigned, although the resolution of the signals in the tropinone 
moiety was not as good as for the series of imidazolines. Because of this it was difficult 
to measure some of the coupling constants, but nevertheless the chair conformation of 
the tropinone could be deduced.
All the compounds show very similar NMR profiles with respect to the tropinone 
moiety. Compound III d is thus taken as a typical example. The JH NMR and 13C 
NMR spectra are to be found in Appendixes III and IV respectively (Spectra 12, 16 and 
17) In the *H NMR spectrum the aromatic portion of this molecule shows a doublet at 8 
= 7.98 ppm integrating for 2 protons and a triplet centered at 8  = 7.65 ppm 
corresponding to 1 proton. Only meta coupling i.e.2 Hz can be observed which is in 
accord with the structure of the aromatic portion of the molecule. The signals can thus be 
assigned as the doublet corresponding to the H"2 and H "6 protons and the triplet to the 
H"4 proton.
At 8 = 4.06 ppm the protons corresponding to the bridge-head carbons H I(5) appear as 
a broad non-resolvable singlet with W 1/2 = 10.0 Hz. This is again indicative of the 
tropinone system with the piperidine ring in a chair conformation. This was supported 
by the chemical shift displacement of the C2(4) and the C l(5) carbons in the 13C 
spectra .265' 268 The signal centered at 8 = 2.40 ppm integrating for 6  protons was 
assigned to the H2(4) a  and (3 protons and the H6(7) exo protons. The multiplet 
showed a complex pattern which did not permit the extraction of any coupling constants. 
H2(4) a  and H2(4) (3 may be considered as the AB part of an ABXY system which 
between them display geminal coupling and vicinal coupling with both H 1 (5) and H3
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giving rise to the complicated pattern. The 2 protons corresponding to the H6(7) endo 
protons are centered at 8 = 2.21 ppm. A multiplet centered at 5 = 3.77 ppm and 
integrating for 1 proton was assigned to the endo H3 proton of the tropinone and whose 
spin-spin splitting provides valuable information as regards to the orientation of the 
oxadiazole with respect to the bicyclic system as well as giving evidence as to the 
piperidine ring conformation.
The H3 proton can be considered as the X part of two ABX systems. As already 
mentioned the W 1/2 of the peak for H I(5) and the 13C NMR shift values indicate that the 
tropinone six membered ring is in a chair conformation. Using this knowledge we can 
examine the following two situations;
For a compound in the chair conformation and with the oxadiazole in the endo position 
at C3 the exo H3 proton would have a dihedral angle of 60 0 with respect to the H2(4) 
alpha and beta protons thus giving rise to a quintuplet with coupling constants of about
1.5 - 2.0 Hz according to the Karplus equation. If on the other hand the oxadiazole is in 
the exo position then we should be able to see a large splitting corresponding to axial- 
axial coupling of the H3 endo proton with the H2(4) P or axial protons thus giving a 
triplet. Each of these signals should then be split into a further triplet with a smaller 
splitting (c.2Hz) arising from the axial-equatorial coupling between H3 and H2(4) a .
On examination of the multiplet at 8  = 3.75 ppm for H3 we can observe 9 signals with 
two large coupling constants of 10.8 Hz for the axial axial coupling and 6  smaller 
splittings of 6.5 Hz corresponding to the axial-equatorial coupling (Figure 5.6).
Figure 5.6 Multiplet coresponding to H3 of III d under 300 Mz *H NMR.
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The fact that the a-e coupling is 6.5 Hz implies a dihedral angle of 35-40 ° and would 
thus indicate that the piperidine ring exists in a slightly flattened chair rather than in a 
perfectly non distorted chair conformation.
In order to confirm the conformation of the bicyclic system and the oxadiazole 
orientation, double resonance and NOE experiments were performed. By saturating the 
signal for the H3 proton at 8 = 3.77 ppm the multiplet at 8 = 2.2 ppm simplified to the 
more familiar ABX system seen in the tropinone imidazoline series. A coupling constant 
of 3.6 Hz for 37 H2(4)[3-H1(5) was obtained while 37 H 2(4 )a-H l(5 ) could not be 
measured, a slight broadening of the signals only being observed. These coupling 
constants are again confirmation of the the chair conformation of the piperidine ring.
180°
F ig u re  5.7
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Nuclear Overhauser effect (N.O.E.) experiments were performed to confirm the exo 
orientation of the oxadiazole group with respect to the piperidine ring. Irradiation of the 
signal corresponding to the H6(7)endo protons caused a 22 % enhancement in the signal 
for the H3 proton thus confirming their spatial proximity and consequently the axial 
orientation of H3 while simultaneously lending support to the chair conformation of the 
piperidine ring. Similarly, irradiating H3 resulted in 9.8% enhancement of the H6(7) 
endo signal.
The singlet at 5 = 2.84 ppm integrating for three protons is in accord with an N-methyl 
group in the protonated form .257 From the displacements of the protons in the aromatic 
portions of molecules III e, III f, and III g it can be seen that the pyridine and aniline 
moities of these groups exist in their protonated state. This was confirmed by the 
elemental analysis where the compounds were found to be dihydrochloride salts.
The 13C NMR spectra all display a similar appearance. The signals for the C3'and C51 
of the oxadiazole appear well downfield at c.167 ppm and 182 ppm. The C5' peak was 
assigned to that appearing at 182 ppm as it is situated between the nitrogen and the more 
electronegative oxygen atom. The signals for the tropinone fraction appear similar to 
those found in the imidazoline series257 except for carbon C3 which changes from 
approximately 62 ppm in the imidazolines to about 27.0 ppm in the oxadiazole series 
probably arising from the lower electronegativity of the oxadiazole function. The C2(4) 
carbons also experience a slight upfield shift of c. 6.6  ppm again probably due to the 
smaller electron withdrawing effect of the oxadiazole group. The assignment of the 13C 
signals was confirmed by double resonance techniques where the coupling with the 
hydrogens gave the expected multiplicities (Spectrum 17).
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CHAPTER VI
Pharmacology, Biochemical Studies 
and Structure-Activity Relationship
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6.1 Introduction.
The importance of serotonin (5-hydroxytryptamine) as a neurotransmitter stems from its 
role as a mediator in numerous physiological processes including eating behaviour, 
sexual behaviour, pain and stress. Thus there has been an explosion of research aimed at 
characterising serotonin receptors, identifying receptor subtypes and utilising the 
functional information as a basis for targeting specific therapeutic disorders at the 
receptor level. As is the case with many areas of pharmaceutical research, the 
serotonergic field has been enormously facilitated by the development of radioligand 
binding techniques.
What is now classified as the 5 -HT3 receptor has been known to exist in the periphery 
since the late 1950s.1 However, the recent discovery of 5 -HT3 receptors in the brain has 
stimulated great excitement in this field. Selective ligands for the receptor have become 
available only very recently, so the majority of potential indications for these 
compounds, based on behavioural, electrophysiological and anatomical evidence have 
yet to be validated clinically .270 The one indication for which the class of agents has 
demonstrated efficacy is the blockade of chemotherapy-induced emesis (nausea and 
vomiting), an event suggested to involve activation of 5 -HT3 receptors in the area 
postrema .12
There exists very little basic research into the mechanisn by which cancer chemotherapy 
and radiation produce vomiting and nausea. The most accepted theory is that cytotoxic 
drugs and radiation cause cellular lesions probably in the enterocromaffin cells in the 
cells of the gut mucosa, producing the liberation of serotonin which activates 5 -HT3 
receptors in the afferent vagus nerve which produces the vomiting reflex.271 This theory 
is supported by studies which show a marked increase of the plasma concentration of 
serotonin in patients undergoing chemotherapy272 and a significant rise in the urinary 
level of 5-hydroxyindoleacetic acid,273 the principal metabolite of serotonin. The 5 -HT3
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antagonists function as anti-emetics in cancer patients by competing with serotonin and 
blocking the 5-HT3 receptors thus inhibiting the actions of the serotonin.
Another possible site of action is the 5-HT3 receptors located centrally in the NTS 
(nucleus of the solitary tract) or the area subpostrema in the brain stem. If 5-HT is 
involved in the central processing of information in vomiting, blocking 5 -HT3 receptors 
would effectively prevent this and control vomiting. It is quite possible that 5 -HT3 
receptor antagonists are acting at both sites (Figure 6.1, Taken from Glaxo training 
manual for nurses, 1991).
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G astro-intestinal 
vagal afferent 
term inals
B lo c k in g  5 H T 3 r e c e p to r s  in  
th e  N T S  o r  a r e a  s u b p o s tr e m a  
p r e v e n t s  c e n tr a l p r o c e s s in g  
o f  in fo r m a tio n
B lo c k i n g  5 H T 3 r e c e p to r s  
lo c a te d  o n  g a s t r o ­
in t e s tin a l v a g a l  a ffe r e n t  
te r m in a ls  w il l  p r e v e n t  
a c t i v a t i o n  o f  th e  5 H T 3 
r e c e p to r s  a n d  th u s  th e  
v o m it in g  p a t h w a y  w ill  
n o t  b e  s tim u la te d .
Figure [6.1] Possible sites of 5-HT3 antagonist action.
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6.2 Pharmacological Studies of Series I, II, and II I  (in vivo ).
The method employed to provide an in vivo measure of a drug's functional activity at 
the 5 -HT3 receptor was a method known as the von Bezold-Jarish (B-J) reflex .274 
Administration of serotonin to rat (or several other species, including man) results in a 
rapid and transient reflex bradycardia (decrease in heart rate), an event mediated by 
reflex stimulation of the vagus nerve following activation of the sensory nerve located in 
the right ventricle wall. Prior treatment with a 5-HT3 antagonist will block this effect. A 
compound's potency is defined by its ability to inhibit (% inhibition) this response 
(bradycardia) at a given dose. The evaluation of the antagonistic properties of I, II  and 
I I I  were carried out and compared to known potent antagonists using a modified 
version of the von Bezold-Jarish reflex test described by Saxena and Lewang .275 
Basically the method involved orally administering mice with the potential antagonists, 
followed 45 minutes later by an intravenous injection of serotonin. The % inhibition of 
the bradycardia produced is measured by comparing to a standard. The results are 
displayed in table [6 .1] for the three series of compounds.
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Table [6.1]
Product Dose (mg/kg) Inhibition ( % )
M etaclopram ide 1 0 66.61 S (p < 0.001)
Zacopride l 76.74 S (p < 0.001)
M D L  72 2 2 2 5 66.74 S (p < 0.001)
1 66.03 S (p < 0.010)
I b 25 - 7.55 NS
I c 25 7.55 NS
I d 25 63.97 S (p < 0.001)
1 0 63.85 S (p < 0 .0 0 1)
5 - 0 . 0 1 NS
I e 25 - 3.05 NS
I f 25 5.01 N S
I g 25 11.43 NS
II a 25 13.11 NS
II b 25 - 12.53 N S
* 1 1  c
II d 25 74.81 S (p < 0.001)
1 0 59.44 S (p < 0.010)
5 61.61 S (p < 0.001)
1 5.21 NS
II e 25 0.06 NS
II f 25 3.98 NS
II g 25 7.59 NS
ni a 25 70.00 S (p < 0 .0 0 1)
1 0 70.01 S (p < 0.001)
5 20.83 NS
III b 25 71.7 9 S ( p <  0.001)
10 79.69 S (p < 0.001)
5 48.26 S (p < 0.001)
1 14.09 NS
III c 25 64.60 S ( p <  0.001)
1 0 52.34 S (p < 0.001)
5 30.66 S (p < 0.001)
1 1 2 . 2 2 NS
III d 25 71.2 7 S (p < 0.001)
1 0 53.69 S (p < 0.001)
5 55.58 S (p < 0.001)
1 30.49 S (p < 0.001)
in e 25 69.0 S (p < 0.001)
1 0 6 8 . 0 S (p < 0.001)
5 50.0 S (p < 0.001)
1 1 0 . 2 S (p < 0.001)
III f 25 9.06 NS
HI g 25 4.01 NS
*B -J results w ere not # S = sign ifican t
available at the time o f result ; N S = non
writing. significant result
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6.3 . Binding studies on compounds I, II and III (in vitro).
The compounds synthesised were evaluated for 5 -HT3 receptor binding affinity by 
determining their affinity to displace the radioligand [3H]GR65630 bound to membranes 
from the brain stem area postrema.276 In three duplicate experiments, the binding of 
increasing concentrations of [3H]GR65630 was measured in order to produce a 
saturation equilibrium curve (Figure 6.2). From this a dissociation constant, Kq = 1.39 
± 0.5. 10 _9 M and the maximum number of binding sites Bmax = 84.32± 21.9 fmol. 
mg p r o t w a s  obtained. In the initial screening, displacement of [3H ]-G R 65630 
binding by the compounds I, II and III was studied at two concentrations of each 
compound, 30 |J.M and 3^iM (Figures 6 .3-6.5). For series I  a full concentration- 
displacement curve was performed on compounds I d, MDL 72222, metoclopramide 
and zacopride in order to determine the IC50, and the K; values (Figure 6 .6 ).
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Figure [6.2] Saturable specific binding of [3H]GR65630 to membranes of bovine area posirema (2 
mg wet weight. 174.62 (ig protein) using filtration binding methodology.
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Figure [6.3] Com petition experim ents at tw o concentrations o f  com pounds I a-g, M D L  72222, 
zacopride and m etoclopram ide using [3H ]GR65630 at InM . Data are normalised as percentage specific 
binding; the non sp ecific binding was obtained in the presence o f  30 [J.M M D L  72222. They are the 
means o f three triplicate experiments.
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Figure [6.4] Com petition experim ents at two concentrations o f  com pounds l ib , l id , l ie ,  M D L  
72222, zacopride and m etoclopram ide using [3H]GR65630 at InM . D ata are normalised as percentage 
specific binding; the non specific binding was obtained in the presence o f  30 (iM  M D L  72222. They are 
the means o f  three triplicate experiments.
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120 -
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dn jg
F ig u r e  [6.5] Com petition experim ents at two concentrations o f  com pounds I l l a - g ,  M D L  72222, 
zacopride and m etoclopram ide using [3H ]GR65630 at InM . Data are normalised as percentage specific 
binding; the non sp ecific  binding was obtained in the presence o f  30|J.M M D L  72222. They are the 
means o f three triplicate experiments.
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«l t^octaprarnicte 
■ id 
W L  72222
X Sacopridra
•3 -7 -CJ
t-ofl a » u g 3 )  (Wl>
F ig u re  (6.6] R epresentative com petition curves for M D L  72222, m etoclopram ide, zacopride and 
com pound Id, using [3 H ]G R 6 5 6 3 0  ( i n M)  as radioligand.D ata are means (SE M ) o f  the number o f  
experiments shown in parentheses.
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6.4 D iscussion of B iological resu lts.
The in vivo and in vitro data presented above show some very interesting results. 
Considering those of the tropinone imidazolines I a-g the following observations can 
be made. In the binding studies, at 3 [ iM  concentrations, compounds I  a, lb , I  e  and 
If which correspond to tropane spiroimazolines with phenyl, 3-methoxy, 4-pyridine-N- 
oxide and 4-pvridyl aromatic substituents respectively, none show any ability to displace 
the binding of [-HJGR65630. The 3-indoyl (I g) and 3,5 dimethoxy (I c) congeners 
displaced binding by 20 %, while the dichloro compound (I d) showed the greatest 
displacement of 50 %. This is comparable to that exibited by the potent selective 5-HT3 
atagonist MDL 72222 (60%) and much greater than that of metoclopramide which 
displaced binding by 20%. These figures collate well with the in vivo von Bezold-Jarish 
(B-J) studies where the most active compound was found to be (I d) which at a 
concentration of 10 mg/kg inhibited the induced bradycardia by 64 %. None of the other 
compounds in the series showed any significant inhibitory effect.
In the quinuclidine imidazoline series the same pattern is repeated. Of the products 
tested, (Note: biological results for the ortho substituted derivatives are awaiting 
finalisation) the only compound showing significant activity both in the in vivo and the 
in vitro studies was the dichlorophenyl compound (II d). At 3iiM this compound 
displaces binding by 68 % which is greater than either MDL 72222 or Metoclopramide 
and less than the very potent antagonist Zacopride which diplaced binding by 90 %. The 
B-J in vivo studies confirm the potency of the dichloro compound which demonstrated 
the ability to inhibit the bradycardia reflex by 75 % at a dosage level of 25 mg/kg.
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In the o x ad iaz o le  series  (III) seve ra l  c o m p o u n d s  s h o w e d  a n ta g o n is t ic  p ro p e r t ie s .  
C o m p o u n d s  (III a). (Ill b) and (III d) w h ich  co r re sp o n d  to phenyl,  3 -m e th o x y p h e n y l  
and  3.5 d ich lo rophenv l  substituents  respectively , were able to d isp lace  b in d in g  by 50- 
60 % w hile  the ana logue  with the m eta  an il ine  subs t i tuen t  d isp laced  c .40  % b ind ing .  
A ga in  the in vivo  s tudies support these findings. C o m p o u n d s  (III f) and  (III g) w hich  
refer to the the 3-pyridyl and 4 -am inophenyl derivatives respectively  dem onstra te  alm ost 
no ability to displace binding or l ikew ise any reduction  in the induced  bradycard ia .  T h e
3,5 d im ethoxy  congener  (IIIc) w hich  gave 65 %  inhibition in the von B ezo ld-Ja rish  test 
sh o w ed  very  little capacity  to d isp lace  the b in d in g  (10  9c) o f  the ra d io l ig an d  H ]- 
G R 6 5 6 3 0 .
6.5 S tru c tu re-A ctiv ity  R elationship  (SAR)
The selective 5 -HT3 receptor antagonists reported to date may generally be represented 
by the structure Ar-(Carbonyl)-N in which an aromatic group is linked by a carbonyl- 
containing moiety to a basic amine. This simple model can be further refined by 
considering the three-dimensional aspects of the pharmacophore. The carbonyl group is 
coplanar to an aromatic group, and the interatomic distances in the 5 -HT3 receptor 
antagonist pharmacophore are in adequate ranges (carbonyl oxygen-an aromatic centre,
0 # o
ca.3-4 A; carbonyl oxygen -basic nitrogen centre, ca.5A: basic nitrogen centre-aromatic 
centre, ca.7-8A27‘30. One of the most important structural factors is the coplanarity 
between the aromatic ring and the carbonyl moiety. Bearing in mind that, as deduced 
from conformational studies using 'H  and 13C NMR the more stable conformation of 
the tropane imidazoline compounds Ia-g in solution is similar to that found for Ig in the
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solid state, and by considering the interatomic distances (Table 6 .2 ) deduced from the 
X-ray data in compound Ig it can be seen that the C=N group of the imidazoline ring
closely approximates the position of the ester or amide carbonyl group of the 
pharmacophore model.
Table [6.2] Selected Interatomic Distances for Ig in the solid state.
Atom a 1 Atom 2 Interatomic distance A
N 8 X b 9.2
N 8 Yc 7.6
N 8 N 3 1 4.1
N 8 N r 5.3
N3' X 5.2
N l ' X 4.4
N 3' Y 3.5
N l ' Y 3.6
a The numeration o f the atoms is based on the N M R  numbering system 
°  X=Gravim etric center o f the indol six membered aromatic ring. 
c Y =  Gravimetric center o f  the indol five membered ring.
Given that compound Id  demonstrates 5-HT3 receptor antagonism comparable to that of 
MDL72222 and metoclopramide, it is likely that the imidazoline ring may provide a 
useful bioisosteric replacement for the carbonyl group in 5 -HT3 antagonists. The ability 
of the imidazoline group to act as a biosteric replacement for a carbonyl group is 
supported by the biological activity of the corresponding analogue in the quinuclidine
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series. This is the first time277 that such a functionality has been employed in 5 -HT3 
antagonists and to the best of our knowledge represents the first reported case of 
imidazolines acting as bioisosteric replacements for a carbonyl group. It is very 
interesting to note that the only compounds showing 5 -HT3 antagonism in the 
imidazoline series were those carrying a dichlorophenyl group as the aromatic moiety. 
The slightly better potency of the quinuclidine derivative over the tropane equivalent is 
consistent with previously reported results where highest activity was found in systems 
having the nitrogen at the bridgehead position within the azabicyclic system .34 
The results of the oxadiazole series also provided several biologically interesting 
compounds. The use of an unsubstituted phenyl group (Ilia) as the lipophilic aromatic 
moiety afforded a compound which displayed binding abilities similar to that of MDL 
72222 and gave B-J inhibition similar to that of Metoclopramide. This finding is very 
interesting given that several investigators have noted that as in the case of the 
imidazolines la  and Ha, an unsubstituted phenyl derivative results in significant drops 
in binding abilities. Thus for example replacement of indole in ICS 205-930 (5) with a 
phenyl group resulted in a 100 fold drop in binding affinity .270 Swain et al.34 also 
noted a dramatic drop in affinity when they introduced an unsubstituted benzene into the 
quinuclidine oxadiazole series. However Rosen et al 278 did have a similar finding to 
ours when a phenyl group was employed in 5 -HT3 derivatives containing the thiazole 
function. They found a significant increase over the indole derivative in both binding 
and B-J inhibition when an unsubstituted phenyl was present as the aromatic function.
In order to increase the electron density of the aromatic centre, thus mimicking the 
electron rich indole nucleus, a methoxy substituent (IHb) was introduced. This had no 
significant effect on the binding ability, compared to the unsubstituted phenyl 
substituent. However, some slight increase in the inhibition of the B-J reflex was 
observed. Further enhancement of of the electron density in the aromatic nucleus by
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replacing the 3-methoxy group with a 3-NH2 (Ille) function resulted in a reduction in 
binding affinity and B-J antagonism. An NH2 group (Illg) in the para position caused 
an almost complete loss of activity possibly arising from steric limitations in this 
position and may also account for the complete inactivity of the 4-pyridyl ,/V-oxides in 
the imidazoline series, though in these cases the deleterious effect may also arise from 
the reduction in the lipophilic nature of the iV-oxide. This para effect has previously been 
observed by other authors.34’270 The introduction of a K deficient pyridine system 
(IHf) into the molecule also causes a lack of activity, a fact which is repeated with the 
imidazoline series.
On going from mono- to disubstituted derivatives such as 3,5 dichlorophenyl (Hid), 
this compound was shown to have the highest activity of the series based on both the in 
vivo and in vitro studies. Changing the dichloro for the corresponding dimethoxy 
caused a drop in the binding ability so that only 10 % of the radioligand was displaced 
compared to 58 % for the mono methoxy compound and thus again may reflect a 
possible steric interaction in this region with the receptor. However, an interesting fact is 
that in the B-J reflex studies the dimethoxy compound was found to be a moderately 
potent antagonist, comparable to the monomethoxy at low dosage levels. This is 
somewhat surprising, as Turconi et a / . 17 described good correlation between ligand 
binding studies and in vivo B-J experiments for 5-HT3 antagonism. There have been 
some cases reported however where compounds display the ability to effectively 
displace binding and are inactive in the Bezold-Jarish test. Thus for example Hayashi et 
a l ,29 showed two of their compounds to have higher activity than the reference 
compound Ondansetron in binding studies while giving much lower activity in the in 
vivo  studies. This observation can be explained by considering that either the 
compounds are not stable in vivo or else they are acting as partial agonists of the 5 -HT3 
receptor. This however is the opposite to what was found for the dimethoxy phenyl
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oxadiazole III c where the higher activity was found in the in vivo studies. The 
correlation of the binding of 5 -HT3 antagonists with their abilities to inhibit 5-HT- 
induced depolarisations of rat isolated vagus nerve was tested by Kilpatrick et a l 22 They 
again found good correlation (correlation efficient = 0.92) but found that it was not 
absolute. They found that two of their compounds mCPP and MDL 72222 were 
equipotent in the binding model but 20 fold different in the functional model. They 
attributed the anomaly to either simple experimental error or, alternatively, to the fact that 
the two antagonists might have different affinities for the putative subtypes of the 5 -HT3 
receptor, as proposed by Richardson and Engel.3
This anomalous result found for III c is very interesting but would have to be repeated 
to eliminate the possibility of experimental error. It may be a that the inhibition of the 
bradycardia took place via some other receptor type or maybe by interacting with a 
hypothesised subgroup of the 5 -HT3 receptor. Caution should however be taken in such 
an interpretation and further studies will have to be carried out.
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7.1 M ateria ls  and  m ethods.
Except where otherwise stated, the following procedures were adopted throughout. ’H 
NMR (600 MHz) were recorded on a Bruker AM -600 spectrom eter in 
perdeuteriomethanol. Spectral parameters included sweep widths of 7000Hz in 16K 
memory and acquisition times of 1 min 32 s over 32 transients. The 13C NMR (75.429 
MHz) and 1H NMR (300 MHz) spectra were obtained on a Varian UNITY 300 
spectrometer in perdeuteriomethanol or deuterated chloroform. Chemical shifts are 
reported in ppm relative to methanol or chloroform. Coupling constants were evaluated 
by first order rules with an estimated accuracy of 0.5Hz. Mass spectra were recorded on 
a Hewlett-Packard 5890 mass spectrometer and elemental analyses were performed on a 
Perkin-Elmer Elemental Analyzer model 2409E. The IR spectra were recorded on a 
Perkin Elmer 883 spectrophotometer. Organic solvents were purified when necessary by 
the methods described by Perrin (Purification o f  Laboratory Chemicals; Pergamon: 
Oxford 1986) or were purchased from Aldrich Chemical Co. Thin layer and preparative 
chromatography were performed on basic alumina or silica gel plates and gravity 
columns. Melting points were taken in open capillary tubes on an Electrothermal IA6304 
apparatus, and are uncorrected.
7.2 l /f-indole-3-carbonitr ile  (126).
A mixture of l/f-indole-3-carboxaldehyde (lO.Og, 69.0 mmol), pyridine hydrochloride 
(79.7 mmol) and E tN 0 2 (6  g, 80.0 mmol) was heated at reflux for 7 h. CH2CI2 (50 
mL) and 0. IN HCl (120 mL) were then added and the organic layer was separated. The 
aqueous layer was then extracted with CH2C12 (3 X 50 mL) and the combined organic 
phases were washed with H2O and dried (MgS0 4 ). The solvent was evaporated and the
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residue was purified by column chromatography (Silica; CH2CI2) yielding the nitrile 
(126) (3.12 g) as an off-white solid, and a yellow impurity ( 127) (2 g).
Yield 32%. mp 178 °C, (Lit. mp, 168 178 °C)
IR (K Br):\) = 2 2 I0 cn v l
Compound 127 'H  NMR (300 MHz, CD3OD): 6 = 2.50 (3H, s, CH3), 7.21 (2 H, 
m, H5, H6 ), 7.45 (1H, dd, H7), 7.74 (1H, dd, H4), 7.77 (1H, s, HVinyl ), 8.51 (1H, 
s, H2)
MS (El): m/z (%) = 202 (M+, 65), 155 (73), 154 (100), 145 (52), 144 (52), 128 (97).
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7.3 Synthesis of carboximidate hydrochlorides (123 a, c-f, h, 141).
Phenyl  carboxim idate  hydrochloride (123a)
Dry hydrogen chloride gas was bubbled through a solution of benzonitrile (1.0 g, 9.7 
mmol) in dry MeOH (5.0 mL) at 0 °C. The solution was allowed to stand at 0 °C for 24 
h. Addition of dry Et2 0  (15 mL) precipitated the title compound which was filtered and 
washed with dry Et2 0 .
Yield 82 %
3,5-D ichloropheny l  carboximidate  hydroch lor ide  (123c)
Dry hydrogen chloride gas was bubbled through a solution of dichlorobenzonitrile (0.25 
g, 1.45 mmol) in dry MeOH (5.0 mL) at 0 °C. The solution was allowed to stand at 0 °C 
for 24 h. The solvent was then evaporated from the reaction mixture in vacuo at 35 °C 
and the crude reaction mixture was used directly in the subsequent reaction.
IR(KBr): -0 = 1651 c m 1
3 -M eth oxyph en y l  carboxim ida te  hydrochlor ide  (123d)
Dry hydrogen chloride gas was bubbled through a solution of 3-methoxybenzonitrile 
(2.0 g, 15.0 mmol) in dry MeOH (8.0 mL) at 0 °C. The solution was allowed to stand at
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0 °C for 24 h. Addition of dry Et2 0  (15 mL) precipitated the title compound which was 
filtered and washed with dry Et2 0 .
Yield 54 %
IR(KBr): u =  1640 cm-1
3 ,5 -D im ethoxyph en y l  carboxim idate  h ydroch lor ide  (123e).
Dry hydrogen chloride gas was bubbled through a so lu tion  o f 3,5- 
dimethoxybenzonitrile (1.50 g, 9.2 mmol) in dry MeOH (15.0 mL) and dry Et2 0  (15 
mL) at 0 °C. The solution was allowed to stand at 0 °C for 36 h. Addition of dry Et2 0  
(20 mL) precipitated the title compound which was filtered and washed with dry Et2 0 .
Yield 54 %
IR (KBr): u = 1642 cm-1
2-M eth oxyph en y l  carboxim idate  hydrochlor ide  (123f).
Dry hydrogen chloride gas was bubbled through a solution of 2-methoxybenzonitrile 
(2.0 g, 15.0 mmol) in dry MeOH (8.0 mL) at 0 °C. The solution was allowed to stand at 
0 °C for 72h then 24 h at r.t. The solvent was then evaporated from the reaction mixture 
in vacuo at 35 °C and the crude reaction mixture was used directly in the subsequent 
reaction.
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lH - in d o le -3 -ca r b o x im id a te  hydrochlor ide  (123h).
Dry hydrogen chloride gas was bubbled through a solution of lH-indole-3-carbonitrile 
(0.5 g, 3.52 mmol) in dry MeOH (20 mL). The solution was allowed to stand at r. t. for 
24 h. Addition of dry Et2 0  (15 mL) precipitated the title compound which was filtered 
and washed with dry Et2 0 .
Yield 65% . mp 176-177 °C.
IR (KBr): v = 1677 cm-1
N-oxido  4-Pyr idy l  carboxim idate  hydrochlor ide  (141).
Dry hydrogen chloride gas was bubbled through a suspension of 4-cyanopyridine N- 
oxide (2.0 g, 16.7 mmol) in dry MeOH (150.0 mL) at 0 °C. On addition of the HCl gas 
a complete solution eventually formed. The solution was allowed to stand at 0 °C for 24
h. Addition of dry Et2 0  (80 mL) precipitated the title compound which was filtered and 
washed with dry Et2 0 .
Yield 96 %
IR (KBr): D = 1652 cm ' 1
MS (El); m/z (%) = 152 (100, M+), 121 (99), 104 (32), 94 (12)
2 1 3
Experimental
7.4 3p-Am ino-8-m ethyl-8-azabicyclo[3 .2 .1]octane-3a-carbonitriIe
(1 2 4 )
A mixture of potassium cyanide (4.48g, 68.9 mmol), ammonium chloride (3.69g, 
68.9mmol) and iV-methyltropinone (10.Og, 68,9mmol) was added to H2O (14.0 mL) 
and agitated at 20 °C for 48 h in a stoppered flask. The suspension was then cooled to 
0-5 °C  for 1 h and filtered. The resulting solid was taken up into EtOAc (100 mL), 
filtered and dried (MgS0 4 ). The amino nitrile was then precipitated from solution with 
petroleum ether (50 mL).
Yield: 83% mp 72-74 °C
>H NMR (300 MHz, CDCI3): 5 = 1.8 (2 H, bs, NH2), 1.6-1.88 (2 H, m), 2.06-2.16 
(6 H, m), 2.29 (3 H, s, CH3), 3.2 [2H, bs, Hl(5)]
7.5. 3a-A m inom ethyl-8-m ethyl-8-azabicyclo[3 .2 .1]octy l-3P-am ine  
( 1 2 2 )
The amino nitrile (124) (4.5 g, 27.3 mmol) was added in portions over 0.5 h to a 
suspension of LiAlH4 (2.5  g, 67.5 mmol) in anhydrous Et20  (30.0 mL) at 0-10 °C 
under N2 . The reaction was refluxed for 48h and then quenched at 0-10 °C with H20
2 1 4
Experimental
(2.5 mL), followed by 4N NaOH (2.5mL) then H2O (2.5 mL). The inorganic salts 
were filtered off and extracted with refluxing Et2 0  (80 mL) in a Soxhlet apparatus for 5 
h then refiltered. The filtrates were combined, dried over MgSC>4 and stripped to 
dryness. The residue was then distilled under high vacuum (90-100°C, 0.5 mm Hg) and 
the product was refluxed in methanol (50 mL) containing a drop of dilute HCl for 24 h 
to give the required product as a low melting solid.
Yield: 85%
1H NMR (300 MHz, CDC13): 5 = 1.36 (4 H, br s, 2NH2), 1.52 [2 H, m, H6(7)endoL 
1.72 [4 H, m, H2(4)ax,eq], 2.00 [2 H, m, H6(7)exo], 2.28 (3 H, s, Me), 2.62 (2 H, s, 
CH2NH2), 3.12 [2 H, br s, Hl(5)]
IR (film): x> = 3300, 2940, cm-*
MS:(Cl) m/z (%) = 170 (M++1, 100), 198 (M++29, 2), 210 (M++41, 5), 153 (25), 
139 (10), 122 (10)
Compound (154) : lU NMR (300 MHz, CDCI3): 5 = 1.38 (4H, s, 2NH2) 1.41-1.60 
(2 H, m, H6(7)endo), 1.90-2.11 [6 H, m, H6(7)ex0, H2(4)ax, eq] 2.29 (3 H, s, Me), 
2.98 (2 H, s, CH2NH), 3.15 [2 H, br s, H l(5)]
IR (film):!) = 3320, 2960, cm ' 1
MS:(El) m/z (%) = 194 (M+, 69), 177 (11), 163 (4), 139 (8 ), 122 (22)
2 1 5
Experimental
7.6. Synthesis of 2 'A ryl-8-m ethyl-8-azabicyclo[3.2.1]octane-3-spiro-  
4'(5)-imidazolines (I a-g)
2 ' -P h e n y l -8 -m e th y l-8 -a za b ic y c lo [ 3 .2 .1 ] o c ta n e -3 - sp ir o -4 '(5 ') - im id a z o ­
line (la).
The carboximidate (123a) (1.03 g, 6.0 mmol) and the tropinone 1,2-diamine (122) 
(1.01 g, 6.0 mmol) were added to dry methanol (25.0 mL) and stirred at room 
temperature for 24 h under Ar. The solvent was removed under reduced pressure and 
the residue purified by column chromatography using basic alumina and CH2CI2 : EtOH 
as eluent. Trituration of the resulting oil with Et2 0  afforded a white solid which was 
recrystallised from acetone (5.0 mL).
Yield 43%, mp 175-177°C
MS (El): m/z (%) = 255 (25, M+), 227 (3), 185 (6), 174 (35), 173 (44), 158 (100), 
104 (35), 82 (67)
!H NMR (300 MHz, CD3OD): 6 = 3.30 [2H, bs, Hl(5)] 1.96 [2 H, dd, H2(4)a], 2.12 
[2 H, dd, H2(4)p], 2.12 [2H, m, H6(7)ex0] 1-86 (2 H, m, H6(7)endo), 2.39 (3 H, s, 
C H 3,), 3.97 (H, s, H4'), 7.77 (1H, H2"), 7.50 (1H, H3"), 7.50 (1H, H4"), 7.50 
(1H, 7.50, H5"), 7.77 (1H, H6 ").
2 1 6
Experimental
13C NMR (75.429 MHz, CD3OD) 5 = 25.99 (C6,7), 38.96 (NCH3), 42.50 (C2,4), 
61.95 (C l,5), 62.67 (C3), 65.11 (C4'); 124.75 (C l"), 128.54 (C3"), 128.54 (C5"), 
129.83 (C2"), 129.83 (C6 "), 133.10 (C4"), 164.49 (C2')
A n a l  C i6H2 iN3: Calc. C, 75.26; H, 8.29; N, 16.46.
Found: C, 75.46; H, 8.49; N, 16.51.
2 1 7
Experimental
2 ' - ( 3 - M e t h o x y p h e n y l ) - 8 - m e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t a n e - 3 - s p i r o  
4'(5' ) - imidazoline ( lb)
The carboximidate (123d) (0.5 g, 2.5 mmol) and the tropinone 1,2-diamine (122) 
(0.42 g, 2.5 mmol) were added to dry MeOH (10.0 mL) and stirred at r.t. for 24 h 
under Ar. The solvent was removed under reduced pressure and the residue purified by 
column chromatography using basic alumina and CH2CI2 : EtOH as eluent. Trituration 
of the resulting oil with Et20  afforded a pure white solid.
Yield 41%, mp 152-154°C (from acetone)
MS (El): m/z (%) = 285 (34, M+), 230 (5), 203 (37), 189 (6 6 ), 188 (100), 147 (7), 
134 (16), 98 (26), 82 (54), 70 (13)
*H NMR (300 MHz, CD3OD): 8 = 3.24 [2H, bs, H l(5), W 1/2 = 9.40] 1.87 [2 H, dd, 
H2(4)a ], 2.08 [2 H, dd, H2(4)p], 2.08 [2H, m, H6(7)exo] 1-84 (2  H, m, H6(7)endo),
2.37 (3 H, s, CH3), 3.89 (1 H, s, H4'), 3.82 (3 H, s, OCH3) 7.32 (1H, H2"), 7.03 
(1H, H4"), 7.32 (1H, H5"), 7.32 (1H, H6 ").
13C NMR (75.429 MHz, CD3OD) 8 = 61.85 (C l,5), 42.58(C2,4), 62.50 (C3), 26.25 
(C6,7), 38.83 (NCH3), 164.22 (C2’), 67.29 (C41), 55.83 (OCH3), 132.97 (C l"), 
113.49 (C2"), 161.5 (C3"), 117.94 (C4"), 130.55 (C5"), 132.95 (C6 ")
Anal. C 17H 23N 3O: Calc. C, 71.55; H, 8.12; N, 14.72.
Found C, 71.46; H, 8.32; N, 14.67.
2 1 8
Experimental
2 ' - ( 3 , 5 - D i m e t h o x y p h e n y l ) - 8 - m e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t a n e - 3 - s p i r o -  
4'(5' ) - imidazoline (Ic)
The carboximidate (123e) (0.4 g, 1.7 mmol) and the tropinone 1,2-diamine (122) 
(0.29 g, 0.17 mmol) were added to dry MeOH (8.0 mL) and stirred at r.t. for 48 h 
under Ar. The solvent was removed under reduced pressure and the residue purified by 
column chromatography using basic alumina and CH2CI2 : EtOH as eluent. Trituration 
of the resulting oil with Et2 0  afforded a pure white solid.
Yield 48%, mp 167-168 °C (from acetone)
MS (El): m/z (%) = 315 (40, M+), 260 (5), 233 (32), 219 (60), 218 (100), 164 (14), 
122 (3), 98 (36), 82 (81)
!H NMR (300 MHz, CD3OD): 6  = 3.22 [2H, bs, H l(5), W 1/2 = 9.79] 1.86 [2 H, dd, 
H 2(4)a ], 2.08 [2 H, dd, H2(4)p], 2.08 [2H, m, H6(7)exo] 1-83(2 H, m, H6(7)endo),
2.37 (3 H, s, CH3,), 3.88 (1 H, s, H4'), 3.80 (6  H, s, 2 OCH3) 6.95 (1H, H2"), 6.58 
(1H, H4"), 6.95 (1H, H6 ”).
13C NMR (75.429 MHz, CD3OD) 8 = 26.26 (C6,7), 38.83 (NCH3), 42.54 (C2,4),
55.94 (OCH3), 61.85 (C l,5), 62.47 (C3), 67.26 (C4’), 104.07 (C4"), 106.26 (C2"), 
106.26 (C6 "), 132.79 (C l"), 162.3 (C3"), 162.3 (C5"), 164.22 (C2')
Anal. C 18H 23N 3O2: Calc. C, 68.54; H, 7.99 N, 13.20.
Found C, 68.30 H, 8.30 N, 13.21.
2 1 9
Experimental
2 ’- ( 3 , 5 - D i c h l o r o p h e n y  l ) - 8 - m e  thy  l - 8 - a z a b i c y c l o [  3 . 2 .1 ]  o c t a n e - 3 - s p i r o -  
4 ' (5 ' ) - im idazo l in e  (Id)
The crude carboximidate (123c) (0.36 g, ) and the tropinone 1,2-diamine (122) (0.24 
g, 0.145 mmol) were added to dry MeOH (8.0 mL) and stirred at r.t. for 48 h under Ar. 
The solvent was removed under reduced pressure and the residue purified by column 
chromatography using basic alumina and CH2CI2 : EtOH as eluent. Trituration of the 
resulting oil with Et20  afforded a pure white solid.
Yield 38%, mp 139 -140 °C (from acetone)
'H  NMR (300 MHz, CD3OD): 5 = 3.38 [2H, bs, H l(5), W j/2 = 9.70] 1.94 [2 H, dd, 
H2(4)„], 2.12  [2 H, dd, H2(4)p], 2.12 [2H, m, H6(7)exo] 1-90 (2  H, m, H6(7)endo),
2.46 (3 H, s, CH3), 3.91 (1 H, s, H4'), 7.72 (1H, H2"), 7.60 (1H, H4"), 7.72 (1H, 
H 6 ").
13C NMR (75.429 MHz, CD3OD) 5 = 26.21 (C6,7), 38.89 (NCH3), 42.46 (C2,4),
55.94 (OCH3), 61.83 (C l,5), 67.26 (C4'), 126.92 (C2"), 126.92 (C6 "), 131.49 
(C4"), 134.37(C1"), 136.4 (C3"), 136.4 (C5"), 161.67 (C21)
MS (El): m/z (%) = 323 (1, M+> Cp5), 229 (1), 227 (4), 225 (1), 147 (2), 147 (6), 
145 (9), 100 (5), 98 (19), 96 (24), 82 (100)
Anal. C ]6H ,9Cl2N 3:H20 Calc. C, 56.14; H, 6.14 N, 12.28
Found C, 56.02, H, 6.10 N, 12.18
2 2 0
Experimental
2 ' - (N -o x id o -4 -p y r id y I)-8 -m e th y l-8 -a z a b ic y c lo [3 .2 .1  ]o c ta n e -3 -sp iro  - 
4 '(5 ')-im idazo line  dihydrochloride (Ie)
The crude carboximidate (141) (1.0 g, 6.6  mol ) and the tropinone 1,2-diamine (122) 
(1.1 g, 6 .6  mmol) were added to dry MeOH (30.0 mL) and stirred at reflux for 3 h 
under Ar. The reaction mixture was cooled to r.t. and 5 mL saturated methanolic HCl 
was added to the reaction mixture. The reaction was then stirred for 1 h , cooled to 0-5 
°C for a further 1 h and the precipitated HCl salt was filtered and washed with MeOH.
Yield 29%, mp 232 °C (Dec.) (from methanol)
MS: (El) m/z (%) = 272 (40, M+), 256 (5), 191 (50), 175 (100), 160 (50), 105 (20), 
98 (40), 82 (65)
!H NMR Free base.(300 MHz, CDC13): 5 = 3.18 [2H, bs, H l(5), W 1/2 = 11.40]
2.01 [2 H, dd, H2(4)a], 2.07 [2 H, dd, H2(4)p], 1.80 [2H, m, H6(7)exo] 1-69 (2 H, m, 
H6(7)endo)> 2.28 (3 H, s, CH3), 3.87 (1 H, s, H4'), 7.61 (1H, m, H2"), 8.14 (1H, m, 
H3"), 8.14 (1H, m, H5"), 7.61 (1H, m, H6 ").
Anal. Q 5H22CI2N4O: Calc. C, 52.18; H, 6.42 N, 16.23.
Found: C, 52.18, H, 6.48 N, 16.44.
2 2 1
Experimental
2 '- ( lH - in d o l - 3 - y  I)-8 -m e thy  I -8 -azab icyc lo  [3 .2 .1]  o c ta n e - 3 -s p ir o - 4 '  (5 ')- 
imidazoline dihydrochloride (Ig)
The crude carboximidate (123h) (0.5 g, 1.61 mol ) and the tropinone 1,2-diamine 
(122) (0.27 g, 1.61 mmol) were added to dry MeOH (6.0 mL) and stirred at r.t. for 24 
h then at reflux for 3 h under Ar. The reaction mixture was cooled to r.t. and 5 mL 
saturated methanolic HCl was added to the reaction mixture. The reaction was then 
stirred for 1 h , cooled to 0-5 °C for a further 3 h and the precipitated HCl salt was 
filtered and washed with MeOH.
Yield 52%, mp 255-257 °C (from methanol)
MS: (El) m/z (%) = 294 (30, M+), 266 (5), 212 (20), 197 (90), 142 (30), 115 (10), 82 
(100), 55 (35)
>H NMR (300 MHz, CD3OD): 8 = 4.08[2H, bs, H l(5), W 1/2 = 11.8] 2.55 [2 H, dd, 
H2(4)«], 2.65 [2 H, dd, H2(4)p], 2.42 [2 H, m, H6(7)exo] 2.28 (2 H, m, H6(7)endo), 
2.86 (3 H, s, CH3), 4.33 (1 H, s, H4'), 8.83 (1H, m, H2"), 7.93 (1H, m, H4"), 7.34 
(1H, m, H5"), 7.34 (1H, m, H6 "), 7.57 (1H, m, H7")
13C NMR (75.429 MHz, CD3OD) 8  = 24.04 (C6,7), 41.0 (C2,4), 59.85 (C l,5), 64.36 
(C4'), 99.34 (C3"), 114.05 (C7"), 120.2 (C4"), 123.9 (C5"), 125.11 (C 6 "), 
132.3(C2"), 138.44 (C7a"), 161.91 (C2')
Anal. C ,8H24Cl2N4-MeOH: Calc. C, 57.14; H, 7.04, N, 14.03.
Found C, 57.39, H, 7.14, N, 14.06.
2 2 2
Experimental
2 ' - ( 4 - p y r i d y l ) - 8 - m e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t a n e - 3 - s p i r o - 4 ' ( 5  ')- 
imidazoline (If)
Compound (Ie) ( 0.5 g, 1.83 mmol) was liberated from its hydrochloride salt by 
dissolving in H2O (2 mL), basifying to pH 10 and extracting with CH2CI2. The organic 
solution was then dried and concentrated to dryness. The free base was dissolved in 
CHCI3 (3.0 mL) and PCI3 (0.28 g, 2.0 mmol) was added dropwise while maintaining 
the temperature between 0-10 °C . The reaction was heated to reflux for 2 h then 
carefully quenched with H20  (1.0 mL), basified to pH 10 with NaOH (10%) and 
extracted with CHC13 (5.0 ml). The organic solution was dried (Na2S 0 4 ) and 
evaporated to dryness to give a low melting solid which was sufficiently pure for 
characterisation.
Yield: 91%
•H NMR Free base.(300 MHz, C DC I3 ): 8 = 3 .39  [2H, bs, H l( 5 ) ,  W 1/2 = 10.90]  
1.92[2 H, dd, H 2 (4 )a ], 2 .46  [2 H, dd, H2(4)p], 2 .1 0  [2H, m, H 6 (7 )exo] 1.86 (2 H, m, 
H 6 (7 )endo), 2 .42 (3 H, s, CH3), 3.91 (1 H, s, H4'), 7 .63 (1H, m, H2"), 8.58 (1H, m, 
H3"), 8 .58 (1H, m, H5"), 7 .63 (1H, m, H 6 ").
13C NMR (75.429 MHz, CDCI3) 8 = 61.56 (C l,5), 41.96 (C2,4), 24.84 (C6,7), 
38.66 (NCH3), 160.0 (C2'), 67.87 (C4'), 136.9 (C l"), 124.15 (C2M), 150.1 (C3"),
150.1 (C5"), 124.15 (C6 ")
Anal. C {5H20N4: Calc. C, 70.31; H,7.81, N, 21.88.
Found C, 69.70, H, 8.56, N, 21.67.
2 2 3
Experimental
7.7 3-H ydroxy-l-azabicyclo[2 .2 .2]octane-3-carbon itr ile  (157)
3-Quinuclidinone hydrochloride (0.186 mol) was dissolved in water (40 mL) and the 
solution was cooled to 0 °C. Potassium cyanide (0.186 mol) in water (40 mL) was 
added dropwise to this solution, and the contents were stirred at 0 °C for 3 h. The 
resulting solid was isolated by filtration, washed with water, and dried under vacuum to 
afford the title compound as the free base.
Yield: 99%, mp. 153-156 °C, Lit.234 mp 152-155 °C
7.8 3-A m ino-l-azabicyclo[2 .2 .2]octane-3-carbonitr ile  (158)
To a solution of 3-cyano-3-hydroxyquinuclidine (8.0g, 42.0 mmol) in absolute ethanol ( 
40.0mL) was added a solution of 28% aqueous ammonia (6.0mL). The mixture was 
stirred at 50°C for 72h then for a further 12h at 20°C. The solvent was then removed 
under reduced pressure and the residue was recrystallised from acetone (30mL).
Yield: 89%, mp. 111-113°C, Lit. mp .218 85°C
IR (KBr): u max.= 3348, 3242, 2202 cm- 1
C8H i3N 3 Calc. C, 63.55; H, 8 .6 6 ; N, 27.79.
Found C, 63.50; H, 8.56; N, 27.72.
2 2 4
Experimental
MS: (El) m/z (%) = 151 (35, M+), 136 (5), 125 (4), 107 (6 ), 94 (10), 81 (20), 70 
(100), 58 (85)
7.9 3-A m inom ethyl-l-azabicyclo[2 .2 .2]octy l-3-am ine (159)
The procedure for the synthesis of (159) is identical to that for the preparation of the 
diamine (1 2 2 ) with the exception that the final step of heating the distilled base under 
reflux in methanol is not required. The crude oil obtained on concentrating the solvent 
was distilled under high vacuum (0.1 mmHg). A first fraction which appears between 
60-70 °C condenses in the condenser and can be removed by dissolving in methanol and 
corresponds to the impurity (160). A second fraction distilling at 80-100 °C is the 
required diamine (159) while the third fraction at c.190 °C corresponds to the impurity 
(1 6 1 ) .
Yield: 40%
!H NMR (300 MHz, CDC13): 5 = 1.30-1.70 (4 H, m, 2 x CH2), 1.46 (4 H, br s, 2 x 
N H 2), 1.94 (1 H, m, CH), 2.56 (1 H, d, C H H N H 2J  = 12.8 Hz), 2.78 (1 H, 
d,CHHNH2,7  = 12.8 Hz), 2.64 (1 H, dd, CHHN, 7, = 13.6 Hz, J2 = 2.5 Hz), 2.52 (1 
H, dd, CHHN, J { = 13.6 Hz, J2 = 2.5 Hz), 2.64-2.94 (4 H, m, 2 x CH2N)
IR(film): umax.= 3200, 2936, 1594, 1456 cm-1
MS:(Cl) m/z (%) = 156 (M++1, 100), 184 (M++29, 5), 196 (M++41, 2), 138 (25), 
96(4)
2 2 5
Experimental
Compound (161) :[H NMR (300 MHz, CD3OD): 5 = 1.35-1.61 (6  H, m ), 1.80-2.01 
(4 H, m), 2.62-3.0 (12 H, m)
MS:(Cl) mJz (%) = 303 (M++1, 5), 263 (14), 229 (17), 201 (100)
Compound (1 6 0 ) : ^H NMR (300 MHz, CD3OD): 5 = 1.42-1.55 (1 H, m ), 1.55-1.70 
(1 H, m), 1.7-1.82 (2 H, m), 1.82-2.0 (1 H, m) 2.38-2.48 (1H, m) 2.68-2.97 (4H, 
m), 2.98-3.6 (1H, m)
MS:(Cl) m/z (%) = 127 (M++1, 100), 155 (M++29, 14), 167 (M++41, 3), 111 (49)
2 2 6
Experimental
7.10 2'-Aryl-l-azabicyclo[2 .2 .2]octane-3-spiro-4'(5')-im idazolines  
(Ha-g).
2 '-Pheny l -  1 -a z a b ic y c lo [ 2 .2 . 2 ] o c t a n e - 3 - s p i r o -4 ' (5 ' ) - i m id a z o l in e  ( I la ) .
A solution of the imidate hydrochloride (123a) (0.5 g, 2.87 mmol) in dry methanol 
(2.0mL) was added to a solution of the diamine (159) (0.45 g, 2.87 mmol) in dry 
methanol (3.0 mL) at ambient temperature under argon and stirred for 2 hours. The 
solvent was then removed under vacuum and the product was isolated by column 
chromatography using basic silica and CH2CI2 :MeOH (9:1) as eluting solvent. Yield 
71%, mp 162-164 °C
MS:(El) m/z (%) = 241 (15, M+), 226 (21), 213 (11), 185 (14), 171 (100), 145 (9), 
104 (28), 71 (33), 70 (25)
>H NMR (300 MHz, CD3OD): 8 = 1.50-1.70 (2 H, m, CH2), 1.70-1.90 (2 H, m 
CH 2), 2.10-2.24 (1 H, m, CH), 2.72-2.90 (3 H, m ), 2.90-3.10 (3H, m ), 3.55 (IH , 
d, CHH imidazoline)* 3.95 (IH , d, CHH imidazoline)
13C NMR (3 0 0  MHz, C D 3OD): 8 = 2 2 .6 4  (C5), 23 .25  (C 8) 32 .8  (C4), 4 7 .0  (C7 or 
C 6 ), 4 7 .2  (C7 or C 6 ), 62 .3  (C 3), 6 4 .7  (C 2) 66 .5  (C4';midazoline.weak), 1 28 .3  
(C3",C5"), 129.2 (C2",C6"), 131.1 C(C1"), 131.8 (C4), 165.0  (C 2 1, imidazoiine)
Anal. C 15H 19N 3: Calc. C,74.69; H ,7 .90 , N ,17 .4 .
Found: C,74.19, H,7.71, N,17.3.
2 2 7
Experimental
2 ' - ( 3 - M e t h o x y p h e n y l ) -  1 - a z a b i c y c l o [ 2 .2 . 2 ] o c t a n e - 3 - s p i r o - 4 ' (5 ')- 
im idazoline  d ihydrochlor ide  (l i b ).
A solution of the imidate hydrochloride (123d) (0.5 g, 2.5 mmol) in dry methanol 
(2.0mL) was added to a solution of the diamine (159) (0.39 g, 2.5 mmol) in dry 
methanol (2.0 mL) at ambient temperature under argon and stirred for 2 hours. HCl gas 
was bubbled through the reaction solution until the solvent was saturated. The solvent 
was then removed and replaced with EtOH (5 mL). Some undissolved grey solid was 
removed by filtration and the product was allowed to crystallise from the filtrate by 
standing at 10 °C overnight. The product was filtered and washed with ice-cold EtOH 
and dried under vacuum.
Yield 59%, mp 270-272°C
MS: (El) mJz (%) = 271 (13, M+), 256 (19), 243 (12), 201 (100), 134 (15), 77 (21), 
71 (67), 70 (55)
>H NMR (300 MHz, CD3OD): 8  = 2.05-2.18 (3 H, m), 2.38-2.45 (1H, m ), 2.50 (1H, 
m), 3.35 (2H, m), 3.45 (1H, m ),’ 3.55 (1H, m ), 3.88 (3H, s, CH3), 3.70 (1H, dd, 
CHHN, 71=14.5 Hz, 72=1.74 Hz ), 3.79 (1H, dd, CHHN, /!  = 14.5 Hz, 72=1.74 Hz ),
4.15 (1H, d, CHH imidazoline* 7=12.4 Hz), 4.40 (1H, d, CHH imidazoline, 7=12.4 Hz), 
7.32 (1H), 7.55 (3H)
Anal. C i7H23N 30 2 -2 HCl: Calc. C, 54.55; H, 6.73; N, 11.23.
Found: C, 54.54; H, 6.72; N, 11.38.
2 2 8
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2 '-( 2 - M e  t h o x y p h e n y  I) -1 - a z a b i c y c l o  [ 2 .2 . 2 ]  o c t a n e - 3 - s p i r o - 4 '(5 ')- 
imidazoline (He)*
A solution of the crude imidate hydrochloride (123f) (2.5 g; contains c. 20% imidate) 
in dry methanol (4.0mL) was added to a solution of the diamine (0.93 g, 6.0 mmol) in 
dry methanol (5.0 mL) at ambient temperature under argon and stirred for 2 hours. The 
solvent was removed under reduced pressure, then dissolved in H2O (5mL) and 
acidified to to pH 2. Unreacted starting nitrile was then extracted with 3 x 10 mL 
CH2CI2 and the required product was isolated by liberating into CH2CI2 with K2CO3 . 
The solvent was removed under reduced pressure leaving the product as a viscous oil.
Yield 20 %, mp-viscous oil
MS: (El) m/z (%) = 271 (13, M+), 256 (19), 243 (12), 201 (100), 134 (15), 77 (21), 
71 (67), 70 (55)
MS:(Cl) m/z (%) = 272 (M++1, 100), 300 (M++29, 11), 312 (M++41, 1.8)
*On standing for a period of time at room temperature this compound was found to 
decompose to a new compound. According to mass spectrometry the compound seemed 
to have hydrolysed to the corresponding 2-hydroxy compound by cleavage of the OMe 
bond.
2 2 9
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2 ' - ( 3 , 5 - D i c h l o r o p h e n y l ) - l - a z a b i c y c l o [ 2 . 2 . 2 ] o c t a n e - 3 - s p i r o - 4 ' ( 5 ')- 
imidazoline  ( l id) .
A solution of the crude imidate hydrochloride (123c) (2.0 g) in dry methanol (4.0mL) 
was added to a solution of the diamine (0.46 g, 3.0 mmol) in dry methanol (5.0 mL) at 
ambient temperature under argon and stirred for 2 hours. The solvent was removed 
under reduced pressure, then the residue was dissolved in H2O (5mL) and acidified to 
pH 2. Unreacted starting nitrile was then extracted with 3 x 10 mL CH2CI2 and the 
required product was isolated by liberating into CH2CI2 with NaOH. The organic phase 
was dried over MgSC>4 and the solvent was removed under vacuum giving a white solid 
which was recrystallised in ethanol.
Yield 56%, mp 103-106°C
MS:(El) m/z (%) = 311 (M+,C137,11), 309 (M+,C135,17), 296 (21), 294 (2.8), 243 
(12), 242 (14), 241 (70), 240 (18), 239 (95), 149 (8 ), 147 (20), 145 (38), 99 (16), 98
(12), 97 (61), 96 (60), 71 (100), 70 (90)
lU NMR (300 MHz, CD3OD): d = 1.54-1.72 (2H, m, CH2), 1.72-1.90 (2 H, m,
C H 2), 2.10-2.22 (1 H, m, CH), 2.75-2.95 (3 H, m, CH2N), 2.95-3.10 (3H, m,
C H 2N), 3.58 (IH , d, CHH imidazoline, J=12.7Hz), 3.98 (IH , d, CHH imidazoline, 
J=12.7Hz), 7.57 (IH, t), 7.76 (2H, d)
13C NMR (300  MHz, C D 3OD): 5 =  22 .79  (C5), 2 3 .3 0  (C 8 ) 32 .97  (C4), 47 .18  (C7),
4 7 .4 6  (C6 ), 6 2 .7  (C3)weak, 6 4 .8 4  (C 4', imidazoiine w eak), 1 2 7 .1 5  C 2" (C 6" ),  
131.49(C4"), 136.65 (C l"), 136.33, C3"(5"), 162 .50  (C2'irnidazoline)
Anal. C i5H 17N3C12: Calc. C,58.08; H, 5.52; N, 13.54.
Found C,58.01; H, 5.58; N, 13.48.
2 3 0
Experimental
2 ’- ( N - o x i d o - 4 - p y r i d y I)- 1 - a z a b i c y c l o [ 2 . 2 . 2 ] o c t a n e - 3 - s p i r o - 4  '(5 ')- 
imidazol ine ( l i e )
A solution of the imidate hydrochloride (141) (0.5 g, 2.87 mmol) in dry methanol 
(2.0mL) was added to a solution of the diamine (159) (0.45 g, 2.87 mmol) in dry 
methanol (3.0 mL) at ambient temperature under argon and stirred for 2 hours. The 
solvent was then removed under vacuum and the product was isolated by column 
chromatography using basic silica and CH2CI2 :MeOH (75:25) as eluting solvent.
Yield 31%, mp 60-62 °C
M S:(El) m/z (%) = 258 (17, M+), 243 (18), 227 (7), 188 (46), 172 (33), 145 (5), 
105(14), 97 (27), 71 (98), 70 (100)
!H NMR (300 MHz, CD3OD): 5 = 1.57-1.75 (2 H, m, CH2), 1.75-1.90 (2 H, m 
CH 2), 2.10-2.24 (1 H, m, CH), 2.78-2.95 (3 H, m ), 2.96-3.10 (3H, m ), 3.62 (1H, 
d, J  — 12.5 Hz, CHH imidazoline)* 4.00 (1H, d, J  = 12.5 Hz, CHH imidazoline)
13C NMR (300 MHz, CD3OD): 8 = 22.80 (C5), 23.24 (C8 ) 33.0 (C4), 47.13 (Cl), 
47.45 (C6 ), C3(absent), 67.5 (C4',weak), 123.3 C2"(C6"), 140.0 (C l"), 150.7 
C3"(C5"), 161.1 (C21,imidazoline)
Anal. C i4H i8N40 : Calc. C, 65.09; H, 7.07; N, 21.69.
Found: C, 65.41; H, 7.14; N, 21.15.
Experimental
2 ' - (4 -p y r id y I ) -1 - a z a b i c y c l o [ 2 . 2 . 2 ] o c t a n e - 3 - s p i r o - 4 ' ( 5 ' ) - i m i d a z o l i n e
( Hf )
The free base of He (0.47g, 1.83 mmol) was dissolved in CHCI3 (3.0 mL) and PCI3 
(0.28 g, 2.0  mmol) was added dropwise while maintaining the temperature between 0 - 
10 °C . The reaction was heated to reflux for 2 h then carefully quenched with H2O (1.0 
mL), basified to pH 10 with NaOH (10%) and extracted with CHCI3 (5.0 ml). The 
organic solution was dried (Na2S0 4 ) and evaporated to dryness to give a low melting 
solid which was purified on basic alumina using CH2Cl2 :MeOH (9:1) as the eluting 
solvent.
Yield 93% (oil)
!H NMR (300 MHz, CD3OD): 5 = 1.54-1.72 (2 H, m, CH2), 1.74-1.90 (2 H, m 
CH 2), 2.08-2.22 (1 H, m, CH), 2.76-2.94 (3 H, m ), 2.94-3.05 (3H, m ), 3.62 (1H, 
d, CHH imidazoline> J= 12.0 Hz), 4.01 (1H, d, CH li imidazoline, J= 12.0 Hz), 7.78 (2H, 
dd, H2"(6"), 8.65 (2H, dd, H3"(5").
13C NMR (300 MHz, CD3OD): 8 = 22.85 (C5), 23.31 (C8) 33.0 (C4), 47.18 (C7),
47.47 (C6 ), C3(absent), 64.90 (C2), 67.5 (C4',weak), 126.3 C2”(C6"), 131.5(C1"),
140.5 (C3"), 161.1 (C2',im idazoiine)
A n a l  C i4H i8N4: Calc. C, 69.39; H, 7.49; N, 23.12.
Found C, 69.01; H, 7.44; N, 23.15.
2 3 2
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2 ' - ( l H - I n d o l - 3 - y l ) - l - a z a b i c y c l o [ 2 . 2 . 2 ] o c t a n e - 3 - s p i r o - 4 ' ( 5  ' ) - i m id a z o l i n e  
( U g )
A solution of the imidate hydrochloride (123h) (0.6 g, 2.87 mmol) in dry methanol 
(2.0mL) was added to a solution of the diamine (159) (0.45 g, 2.87 mmol) in dry 
methanol (3.0 mL) at ambient temperature under argon and stirred for 2 hours. The 
solvent was then removed under vacuum and the product was isolated by column 
chromatography using basic silica and CH2CI2 :MeOH (9:1) as eluting solvent. The 
dihydrochloride salt was then formed by dissolving the residue in ethanol and saturating 
with dry HCl gas. The product was slowly precipitated with acetone then filtered and 
washed with ethanol.
Yield 65 %, mp 263-265 °C
MS: (free base)(CI) m/z (%) = 281 (15, M++1), 309 (15, M++29), 321 (2, M++41),
>H NMR (300 MHz, CD3OD): 8 = 2.05-2.25 (3 H, m), 2.40-2.58 (2H, m ), 3.35-3.68 
(6H, m), 3.74 (IH , d, CHHN, Ji=14.6 Hz), 3.84 (IH , d, CHHN, J,=14.6 Hz, 4.15 
(IH , d, CHH imidazoline, J=H -9 Hz), 4.36 (IH , d, CHH imidazoline, 1 = ^ . 9  Hz), 8.49 
(IH , H2"), 7.93 (IH , m, H4”), 7.34 (IH, m, H5"), 7.34 (IH , m, H 6 "), 7.56 (IH , m, 
H7")
13C NMR (300  MHz, C D 3OD): 8 =  19.4 (C5), 20 .0  (C8) 31.5 (C4), 4 6 .9  (C7 or C6),
4 7 .3  (C7 or C 6), 5 6 .6  (C 3), 59 .3  (C 2) 62 .7  (C4'jmjdazoime>weak), 1 6 2 .0  (C 2 1 
im id a zo lin e), 9 9 .3 6  (C3"), 120.2 (C4"), 123 .9  (C5"), 125.11 (C6"), 114.05 (C7"), 
138.43 (C7a"),
Anal. Q 7H20N4 -2HC1 Calc. C, 57.95; H, 6.25; N ,15.90
Found C, 57.83; H, 6.25; N ,15.93.
2 3 3
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7.11. Synthesis o f am idoxim es (164a-h)
NHOH
//
A r — C
s n h 2
B enzam idox im e  (164a).
To a solution of hydroxylamine hydrochloride (0.83 g, 12.0 mmol) in H2O (4.0 mL) 
was slowly added potassium carbonate (1.67 g, 12.1 mmol), followed by a solution of 
benzonitrile (1.0 g, 9.7 mmol ) in abs. EtOH (30 mL). The reaction mixture was 
refluxed for 18 h then the solution was cooled to r.t., filtered and the filtrate 
concentrated under vacuum. The residue was dissolved in CH2CI2 (50 mL) and then 
washed with water. The organic layer was dried (MgS0 4 ) and concentrated to dryness 
to give an oily residue which was recrystallised from H20 .
Yield: 93 %, mp 79-81 °C Lit.258 mp 79-80 °C
IR (KBr): \) = 3455, 3363 (NH2), 3150 (OH), 1648 (C=N), cm ' 1
MS (El): m/z (%) = 136 (100, M+), 121 (38), 120 (10), 119 (85), 106 (54), 105 (100), 
104 (76), 103 (12), 91 (28), 77 (91)
Anal. C7H8N20  Calc. C, 61.75; H, 5.92 ; N, 20.57
Found C, 61.55; H, 5.89; N, 20.57
2 3 4
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3 -M eth oxyph en y l -c arboxam ide  Oxim e (164b )
A suspension of hydroxylamine hydrochloride (1.30g, 18.0 mmol), potassium 
carbonate (2.5g, 18.0 m m ol), and 3-methoxybenzonitrile (1.70g, 12.8 mmoL ) in abs. 
EtOH (100 mL) was stirred at r.t. for 12 h. The reaction mixture was cooled to 0-5 °C 
and the inorganic solids were filtered off. The resulting cloudy solution was 
concentrated under vacuum to give a clear oil to which was added CH2CI2 (30 mL ), 
causing any remaining inorganic salts to precipitate. The solution was refiltered and the 
solvent evaporated to dryness, affording a residue which was purified by column 
chromatography (Silica Gel; CH2Cl2-EtOH; 9:1). The amidoxime obtained was slurried 
in diethyl ether (20 mL), filtered and dried, yielding the required compound as a pure 
white solid.
Yield: 70 %, mp 103-105 °C
IR (KBr): u = 3470, 3360 (NH2), 3190 (OH), 1643 (C=N) cm-1
MS (El): m/z (%) = 166 (100, M+), 151 (13), 150 (11), 149 (81), 136 (7), 135 (22), 
134 (6 8 ), 133 (7), 119 (10), 107 (15), 92 (18), 91 (18), 77 (15), 63 (11)
JH NMR (300 MHz, CDCI3): 5 = 3.83 (3 H, s, OMe), 4.90 (2 H, bs, NH2), 6.97 (1 
H, m, H4'), 7.19 (2H, m, H2',6'), 7.31 (1 H, m, H5')
Anal. C8HioN2 0 2 Calc. C, 57.81; H, 6.07; N, 16.86
Found C, 57.56; H, 6.17; N, 16.63
2 3 5
Experimental
3 .5 -D im eth oxyphen y l -carboxam ide  Oxime (164c)
Potassium carbonate (1.80 g, 12.6 mmol), hydroxylamine hydrochloride (0.65 g, 8.2 
mmol), and 3,5-dimethoxybenzonitrile (1.04 g, 6.4 mmol) in abs. EtOH (50 mL) were 
reacted as in the preparation of (164b) affording the required product as a white solid. 
Yield: 65 %, mp 135-137 °C
IR (KBr): v  =3455, 3354 (NH2), 3200 (OH), 1679 (C=N), cm ' 1
MS (El): m/z (%) = 196 (96, M+), 179 (62), 164 (100), 149 (25), 137 (25), 122 (41).
>H NMR (300 MHz, CDC13): 8  = 3.81 (6  H, s, 20M e), 4.83 (2 H, bs, NH2), 6.51 (1 
H, t, H4', J  = 2.5 Hz), 6.77 (2H, d, H2’,6', J = 2.5 Hz), 7.31 (1H, dd, H5')
Anal. C9H 12N2O3 Calc. C, 55.09; H, 6.16 ; N, 14.28
Found: C, 54.81; H, 6.14; N, 14.02
3 .5 -D ich loropheny l -carboxam ide  Oxime (164d).
Potassium carbonate (0.436 g, 3.2 mmol), hydroxylamine hydrochloride (0.227 g,
0.326 mmol), and 3,5-dichlorobenzonitrile (0.386 g, 2.24 mmol) in abs. EtOH (20 
mL) were stirred at r.t. for 3 h. The reaction mixture was cooled to 0-5° C and filtered to 
remove the inorganic solids and the solution was concentrated to dryness under vacuum. 
The residue was dissolved in 2N HCl (25 mL), stirred for 1 h and the undissolved 
amide remaining was filtered off. The filtrate was basified (K2CO3) to pH 10 and the 
liberated amidoxime was filtered and washed with hot water, then ethanol.Yield: 89 %, 
mp 194-195 °C Lit. mp21 195 °C
IR (KBr): v  = 3487, 3387 (NH2), 3120 (OH), 1664 (C=N), cm-1
2 3 6
Experimental
MS (El): m/z (%) = 204 (M+, Cl35, 82), 206 (M+, Cl35*37, 55), 208 (M+, Cl37  10),
191 (14), 189 (71), 187 (100), 176 (11), 174 (56), 172 (75), 149 (7), 147 (32), 145
(46)
Anal. C7H6CI2N2O Calc. C, 41.18; H, 2.96 ; N, 13.73
Found: C, 41.17; H, 2.90; N, 13.70
3-Am inoph en y l -carboxam ide  Oxime (164e).
Potassium carbonate (3.6 g, 26.1 mmol), hydroxylamine hydrochloride (1.30 g, 18.7 
mmol ), and 3-aminobenzonitrile (1.5 g, 13.0 mmol) in abs. EtOH (100 mL) were 
refluxed for 15 h. The reaction mixture was cooled to 0-5 °C, filtered and the filtrate 
concentrated to dryness under vacuum. The resulting oil was partitioned between 
CH2CI2 (100 mL) and H20  (30 mL ) at 35° C, resulting in the organic phase selectively 
extracting the unreacted starting material. The aqueous phase was extracted with CH2CI2 
(2 x 20mL ) and the volume of the aqueous solution was then reduced to 5 mL under 
vacuum and the product was allowed to ciystallise overnight giving the amidoxime after 
filtration and washing with diethyl ether.
Yield: 40 %, mp 125-127 °C
IR (KBr): V = 3489, 3389 (NH2), 3170 (OH), 1648 (C=N), cm ' 1
MS (El): m/z (%) = 151 (100, M+), 135 (14), 134 (95), 120 (13), 119 (76), 118 (24),
105 (16), 94 (22), 93 (13), 92 (43), 91 (19), 80 (17), 79 (20), 65 (51)
Anal. C7H9N3O Calc. C, 55.62; H,6.00 ; N, 27.80
Found C, 55.60; H, 5.98; N, 27.77
2 3 7
Experimental
3 -Pyr idy l -carboxam ide  Oxime (164f).
Potassium carbonate (3.60 g, 26.0 mmol), hydroxylamine hydrochloride (18.7 m m ol), 
and 3-cyanopyridine (1.33 g, 13.0 mmol) in abs. EtOH (100 mL) were stirred at reflux 
for 4 h. The reaction mixture was cooled to 0-5° C and filtered to remove the inorganic 
solids and the solution was concentrated to dryness under vacuum. EtOH (30 mL) was 
added to the residue and the resulting cloudy solution was refiltered to remove any 
remaining traces of inorganic material. The filtrate was evaporated to dryness to give an 
oil which on trituration with CH2CI2 (40 mL) gave a white product which was filtered to 
yield pure (4e).
Yield: 90 %, mp 128-129 °C Lit.258 mp 128 °C
IR (KBr): u = 3420, 3250 (NH2), 3180 (OH), 1645 (C=N) cm-'
MS (El): m/z (%) = 137 (99, M+), 122 (5), 121 (9), 120 (38), 106 (12), 105 (100), 92 
(14), 78 (69), 76 (31), 66  (15)
Anal. C6H7N30  Calc. C, 52.55; H, 5.14 ; N, 30.64
Found: C, 52.25; H, 5.04; N, 30.55
4-Am inoph eny l -carboxam ide  Oxime (164g).
Potassium carbonate (6.0 g, 43.4 mmol), hydroxylamine hydrochloride (2.17 g, 31.2 
mmol), and 4-aminobenzonitrile (2.5 g, 24.0 mmol) in abs. EtOH (160 mL) were 
refluxed for 12 h. H2O (20 mL) was then added and the reaction was re fluxed for a 
further 12 h. The liquid was decanted from the tacky solid and concentrated to dryness. 
The resulting oil was partitioned between CH2C12 (1 0 0  mL) and H2O (100 mL) at 40° 
C, and the aqueous phase was extracted with CH2CI2 (2 x 20 mL). The volume of the 
aqueous phase was then reduced to about 15 mL and the product was allowed to
2 3 8
Experimental
crystallise overnight giving the product amidoxime after filtration and washing with 
methanol. Yield: 48 %, mp 166-168 °C Lit.258 mp 160-174 °C
IR (KBr): v  = 3464, 3389 (NH2), 3210 (OH), 1651 (C=N), cm-'
MS (El): m/z (%) = 151 (100, M+), 135 (8), 134 (79), 133 (11), 120 (11), 119 (39), 
118 (19), 105 (21), 92 (27), 91 (11), 79 (19), 65 (33)
!H NMR (300 MHz, CD3OD): 8 = 6.67 [2 H, m, H3'(5’)], 7.35 [2 H, m, H2'(6')]
Anal. C7H9N3O Calc. C, 55.62; H,6.00 ; N, 27.80
Found: C, 55.39; H, 6.04; N, 27.71
N -O xido -4 -pyr idy l -carboxam ide  O xim e (164h)
Potassium carbonate (3.5 g, 25.3 mmol), hydroxylamine hydrochloride (1.3 g, 18.7 
m m o l), and 4-cyanopyridine N-oxide (1.53 g, 18.7 mmol) in abs. EtOH were stirred 
at r.t. for 48 h. The reaction mixture was concentrated under vacuum and the resulting 
solid residue was stirred at 50 °C in H20  (100 ml). The undissolved solid remaining 
was refluxed in MeOH for 20 min. then filtered, yielding a white solid which was 
insoluble in MeOH, DMF, THF and soluble in dil. HCl and aq. K2C0 3 . Yield: 95 %, 
mp 260-262 °C
IR (KBr): v  = 3418, 3296 (NH2), 3160 (OH), 1644 (C=N), cm*1
MS (El): m/z (%) = 153 (M+,19), 136 (60), 121 (330), 105 (13), 94 (150), 77 (21), 
63 (64), 52 (100).
Anal. C7H9N3O Calc. C, 47.06; H, 4.61; N, 27.44
Found: C, 46.81; H, 4.60; N, 27.71
2 3 9
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7.12 3-(l,3-dithiane-2-ylidene)-8-m ethyl-8-azabicycIo[3.2.1]octane  
(170 )
A solution of n-butyllithium in hexane (1.6 M, 21.1 mL, 34.6 mmol) was added to a 
stirred solution of 2-(trimethylsilyl)-l,3-dithiane (6.8  mL, 34.9 mmoL) in dry THF 
(128 mL), at -40 to -35 °C under N2. After 1 h, a solution of tropinone (125) (4.0 g) in 
THF (25 mL) was added dropwise at -50 C° and stirred for 1 h. The solution was 
warmed to 25 C° and stirred for a further 1 h, and then quenched with H2O ( 30 mL). 
The aqueous solution was extracted with CH2CI2 (6  x 30 mL) and the combined 
organic phases were dried (MgS0 4 ), and concentrated to dryness under vacuum. The 
residue obtained was chromatographed on basic alumina in CH2Cl2/EtOH (95:5) to give 
the intermediate 3-(l,3-dithiane-2-ylidene)-8-methyl-8-azabicyclo[3.2.1]octane (170).
Yield: 94 %, mp 63-64 0 C
»H NMR (300 MHz, CDCI3): 5 = 1.40-1.48 [2 H, m, H 6 (7 )endoL 1-88-1.94 [2 H, m, 
H6(7)exo]> 2.08-2.18 [2 H, m, CH2(dithiane)L 2.20-2.28 (2  H, dd, H2(4)eq. /  1 = 14.7 
Hz, J 2  = 2.8 Hz)] 2.32 (3 H, s, NCH3), 2.76-2.94 [6  H, m, 2 X CH2S, H2(4)ax], 
3.18 [2 H, bs, H2(4)].
IR (Film): x> = 1771 cm ' 1
MS (El): m/z (%) = 241 (11, M+), 184 (3), 160 (19), 82 (100)
2 4 0
Experimental
7.13 exo-3-Carbomethoxy-8-methyI-8-azabicyclo[3.2.1]octane (163)
M eO '"'^ - r "
H k l
A solution of (170) ( 1.0 g, 4.2 mmol) in a saturated solution of methanolic HCl (25 
mL) was stirred at 30 °C for 24 h. The solvent was removed under vacuum in a 
fumehood then the residue was taken up into H2O ( 5 mL) and washed with CH2CI2 (5 
mL). The aqueous phase was basified with K2CO3, and extracted (6x) with CH2CI2 . 
The extracts were dried (MgS0 4 ) then concentrated to a colourless liquid which was 
purified by high vacuum distillation affording the pure exo ester (163).
Yield: 65 %, bp 82 °C (2.0 mm Hg)
IR (Film): v  = 1736, 1302, 1007, 931, 848, 798, 762 cm ' 1 Lit 246 1302 , 1004, 929, 
849, 796, 762 cm '1.
MS (El): m/z (%) = 183 (M+,19), 152 (8), 124 (47), 96 (93), 83 (51), 82 (100).
JH NMR (300 MHz, CDCI3): 8  = 1.50-1.58 [2 H, m, H6(7)endo], 1.59-1.68 [2 H, 
ddd, H2(4)eq], 1.84-1.95 [2 H, m, H2(4)ax], 2.00-2.08 [2 H, m, H6(7)exo] 2.28 [3 H, 
s, NCH3], 2.54-2.66 (1 H, m, H3), 3.18 [2 H, bs, H l(5)]
2 4 1
Experimental
7.14. Synthesis of tropane 1,2,4-oxadiazoles (III)
N-MeV
N - 0  H V l
e x o - 5  ' - ( 8 - M e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t a n e - 3 - y l ) - 3  ' - p h e n y l - 1 , 2 ,4 -  
oxadiazole Hydroch lor ide  ( I l ia )
Sodium hydride (80% dispersion in oil, (56.0 mg, 1.86 mmol) was added to dry THF 
(5 mL) containing 4 A powdered molecular sieves (0.3 g) and stirred for 10 min. under 
N 2.T h e  amidoxime 164a (0.231 g, 1.70 mmol ) was dissolved in anhydrous 
tetrahydrofuran (10 mL) and the mixture was added dropwise to the NaH suspension 
and stirred at r.t. until the hydrogen evolution had subsided. The reaction mixture was 
heated to 50 °C for 0.5 h then cooled to 20 °C. A solution of the tropinone ester (163) 
(0.237 g, 1.3 mmol ) in dry tetrahydrofuran (2 mL) was then added dropwise. The 
resulting mixture was heated at reflux for 2  h, cooled and filtered and the filtrate 
concentrated under vacuum. The residue was partitioned between CH2CI2 (10 mL) and 
H20  (5 mL) and basified to pH 10 with 2N NaOH. The aqueous phase was removed 
and the organic layer was washed with 2 x 10 mL H2O. The organic layer was thyen 
dried over Na2SC>4 and concentrated to dryness. The residue was dissolved in EtOH and 
HCl gas was bubbled through this mixture at 0 0 C until saturation. The hydrochloride 
salt was allowed to crystallise overnight at 0-5 0 C. The white solid was filtered and 
washed with Et2 0 .
Yield 37%, mp 246-248 °C
IR (KBr): \)=  1591 (Ar), 1567 (C=N), cm ' 1
2 4 2
Experimental
MS (El): m/z (%) = 269 (25, M+), 240 (3), 174 (5), 149 (6 ), 121 (45), 119 (20), 96 
(70), 83 (82), 82 (100).
'H  NMR (300 MHz, CD3OD) 5 = 2.22 [2 H, m, H(6)7endoL 2.39 [6 H, m, H2(4)a>p 
,H6(7) exo], 2.84 (3 H, s, NCH3), 3.74 (1 H, m, H3 endo), 4.08 [2 H, bs, H l(5) , 
W 1/2 = 10.1 Hz], 7.51 (3 H, m, H3",4",5") 8.04 (2 H, d, H2",6")
I3C NMR (75.429 MHz, CD3OD) 6 = 24.89 (C6,7), 27.21 (C3), 34.59, (C2,4), 39.69 
(N C H 3), 64.75 (C l,5), 127.90 (C l"), 128.29 (C2"), 128.29 (C6 "), 130.05 (C3"),
130.05 (C5"), 132.51 (C41), 169.54 (C3‘), 181.75 (C5')
Anal. C 16H 19N 3O HCI H20  Calc. C, 59.35; H, 6.85; N, 12.98
Found C, 59.36; H, 6.82; N, 12.91
e x o - 5 ’- ( 8 - M e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t a n e - 3 - y l ) - 3  ' - ( 3 -m e th o x y -  
p h e n y l ) - l , 2 ,4 -o x a d i a z o l e  H ydroch lor ide  (I l l b )
Sodium hydride (60% dispersion in oil, (86  mg, 2.15 mmol) was added to dry THF (10 
mL) containing 4 A powdered molecular sieves (0.4 g) and stirred for 10 min.under N2. 
The amidoxime 164b (0.327 g, 1.96 mmol ) was dissolved in anhydrous 
tetrahydrofuran ( 10 mL) and the mixture was added dropwise to the NaH suspension 
and stirred at r.t. until the hydrogen evolution had subsided, the grey NaH giving way 
to a white precipitate. A solution of the tropinone ester (163) (0.250 g, 1.37 m m ol) in 
dry tetrahydrofuran (2 mL) was then added dropwise. The resulting mixture was heated 
at reflux for 5 h, then cooled and filtered through celite and the filtrate concentrated 
under vacuum. The residue was purified by column chromatography [silica gel; MeOH- 
THF; 8:2], affording a colourless oil which was converted to its hydrochloride salt in an 
EtOH-HCl solution and allowed to crystallise from the alcoholic solution overnight. The
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product was filtered off and washed with ice cold EtOH to give a white crystalline 
compound.
Yield 41 % , mp 233-234 °C
IR (KBr): \) = 1604 (Ar), 1574 (C=N), cm ' 1
MS (El): m/z (%) = 299 (15, M+), 270 (2), 204 (2), 149 (12), 134 (7), 133 (5), 122 
(14), 121 (28), 97 (22), 96 (60), 95 (21), 94 (48), 93 (17), 83 (72), 82 (100).
IH NMR (300 MHz, CD3OD) 5 = 2.21 [2 H, m, H(6)7endoL 2.39 [6 H, m, H2(4)a ,p
,H6(7) exo], 2.84 (3 H, s, NCH3), 3.74 (1 H, m, H3 endo), 3.85 (3 H, s, OCH3), 4.03 
(2 H, bs, H I,5, W 1/2 = 11.0 Hz), 7.10 (1 H, m, H4"), 7.42 (1 H, t, H5"), 7.56 (1 H, 
dd, H2"), 7.62 (1 H, m, H6 ")
13C NMR (75.429 MHz, CD3OD) 5 = 24.87 (C6,7), 27.21 (C3), 34.65 (C2,4), 39.68 
(N C H 3), 55.92 (OMe), 64.78 (C l,5), 113.54 (C2"), 118.26 (C4"), 120.61 (C6 "), 
129.01(C1"), 131.25 (C5"), 161.54 (C31), 169.51 (C3'), 181.72 (C51).
Anal. C i7H2 iN 30 2-HCl. Calc. C, 60.80; H, 6.60 ; N, 12.51
Found: C, 60.52; H, 6.44; N, 12.45
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e x o - 5 ' - ( 8 - M e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t a n e - 3 - y l ) - 3  ' - ( 3 , 5 - d i m e t h o x y -  
p h e n y l ) - l , 2 ,4 -o x a d ia z o le  H ydroch lor ide  (IIIc)
Sodium hydride (60% dispersion in oil, (68.8  mg, 1.72 mmol) was added to dry THF 
(10 mL) containing 4 A powdered molecular sieves (0.3 g) and stirred for 10 min. under 
N 2. The amidoxime 164c (0.309 g, 1.57 mmol ) was dissolved in anhydrous 
tetrahydrofuran ( 8 mL) and the mixture was added dropwise to the NaH suspension 
and stirred at r.t. until the hydrogen evolution had subsided, the grey NaH giving way 
to a white precipitate. A solution of the tropinone ester (163) (0.20 g, 1.10 m m o l) in 
dry tetrahydrofuran (2 mL) was then added dropwise. The resulting mixture was heated 
at reflux for 5 h, then cooled and filtered through celite and the filtrate concentrated 
under vacuum. The residue was purified by column chromatography [silica gel; MeOH- 
THF; 8:2], affording a colourless oil which was converted to its hydrochloride salt in an 
EtOH-HCl solution to which was added Et20  and allowed to crystallise overnight. The 
product was filtered off and washed with ice cold EtOH to give a white crystalline 
compound.
Yield, 48% mp 255-256 °C
IR (KBr): t) = 1614 (Ar), 1572 (C=N), cm ' 1
M S (El): m/z (%) =  3 29  (31, M +), 3 00  (2), 207  (4), 2 3 4  (3), 179 (5), 147 (9), 121 
(34), 96  (6 6 ), 82 (100).
!H  N M R  (300  MHz, C D 3O D ) 5  =  2.21 [2 H, m, H (6 )7 endoL 2 .40  [6  H, m, H 2 (4 )a ,p 
,H6(7) exo], 2 .84  (3 H, s, N C H 3), 3 .74  (1 H, m, H3 endo), 3 .83 (6  H, s, O C H 3), 4 .06  
[2 H, bs, H l( 5 )  , W i/2 = 9.08  Hz], 6 .6 6  (1 H, t, H 4 ”) 7 .17  [2 H, d, H2"(6")]
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13C NMR (75.429 MHz, CD3OD) 8  = 24.85 (C6,7), 27.19 (C3), 29.50 (C l’), 34.68 
(C2,4), 39.64 (NCH3), 56.01 (OMe), 64.72 (C l,5), 104.35 (C4"), 106.20 (C2"), 
106.20 (C6 "), 162.80 (C3"), 162.80 (C5"), 169.10 (C3'), 181.72 (C5')
Anal. C 18H23N3O3 HCI H2O Calc. C, 56.32; H, 6.83 ; N, 10.95
Found; C, 56.61; H, 6.75; N, 11.04
e x o - 5 ' - ( 8 - M e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t a n e - 3 -y l ) -3  ’- ( 3 , 5 - d i c h l o r o -  
p h e n y l ) - l , 2 ,4 -o x a d i a z o l e  H ydroch lor ide  ( H id )
Sodium hydride (60% dispersion in oil, (74.5 mg, 1.86 mmol) was added to dry THF 
(10 mL) containing 4 A powdered molecular sieves (0.3 g) and stirred for 10 min. under 
N 2 -T he amidoxime 164d (0.35 g, 1.7 mmol) was dissolved in anhydrous 
tetrahydrofuran ( 10 mL) and the mixture was added dropwise to the NaH suspension 
and stirred at r.t. then at reflux for 1 h until the hydrogen evolution had subsided. The 
reaction was then cooled to r.t. A solution of the tropinone ester (163) (0.237 g, 1.30 
m m ol) in dry tetrahydrofuran (2 mL) was then added dropwise. The resulting mixture 
was heated at reflux for 3 h, after which time there was about 20 % reaction which did 
not increase on further refluxing. A second addition of NaH (1.86 mmol) was made and 
the reaction was stirred for a further 3 hours. A third addition of NaH (1.86 mmol) was 
then made and the reaction was refluxed for a further 4 h at which point there only 
remained c. 5 % starting ester. The remainder of the experimental procedure was similar 
to that for compound (IIIc).
Yield 61%, mp 272-274 °C
IR (KBr): = 1586 (Ar), 1562 (C=N), cm ' 1
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MS (El): m/z (%) = 337 (M+, Cl35, 10), 339 (M+, Cl35-37> 6), 341 (M+, Cl37 1), 308 
(2), 189 (2), 187 (3), 149 (3), 121 (19), 96 (41), 83 (74), 82 (100),
*H NMR (300 MHz, CD3OD) 8 = 2.21 [2 H, m, H(6)7endoL 2.40 [6 H, m, H2(4)a ,p, 
H6(7) exo], 2.84 (3 H, s, NCH3), 3.76 (1 H, m, H3 endo), 4.06 [2 H, bs, H l(5), W 1/2 
= 10.0 Hz], 7.65 (1 H, t, H4") 7.97 (2 H, d, H2",6")
13C NMR (75.429 MHz, CD3OD) 8 = 24.84 (C6,7), 27.24 (C3), 34.60 (C2,4), 39.65 
(N C H 3), 64.74 (C l,5), 126.70 (C2M), 126.70 (C6 "), 131.1 (C l"), 132.18 (C4"),
137.03 (C3"), 137.03 (C5"), 167.65 (C3'), 182.50 (C5').
Anal. C i6H i7N3OCl2-HCl-0.5  H20  Calc. C, 50.08; H, 5.01 ; N, 10.95
Found: C, 50.16; H, 4.99; N, 10.76
e x o - 5 ' - ( 8 - M e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t a n e - 3 - y l ) - 3  ' - ( 3 - a m i n o p h e n y l ) -
1,2 ,4 -oxadiazo le  D ihydroch lor ide  ( I l le ) .
Sodium hydride (80% dispersion in oil, (47 mg, 1.56 mmol) was added to dry THF (10 
mL) and stirred for 10 min. under N2. The amidoxime 164e (0.196 g, 1.3 mmol) was 
dissolved in anhydrous tetrahydrofuran (8  mL) and added dropwise to the NaH 
suspension and stirred at reflux until the hydrogen evolution had subsided. A solution of 
the tropinone ester (163) (0.20 g, 1.10 m m ol) in dry tetrahydrofuran (2 mL) was then 
added dropwise. The resulting mixture was heated at reflux for 2 h, then cooled and 
filtered through celite and the filtrate concentrated under vacuum. The residue was 
purified by column chromatography [silica gel; MeOH-THF; 8:2], affording a colourless 
oil which was converted to its hydrochloride salt in an Acetone/EtOH-HCl solution and 
allowed to crystallise overnight. The product was filtered off and washed with ice cold 
EtOH to give a white crystalline compound.
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Yield 6 8 % , mp 268-270 °C
IR (KBr): x> = 1605 (Ar), 1570 (C=N), cm-'
MS (El): m/z (%) = 284 (6 , M+), 202 (6), 202 (1), 189 (2), 149 (2), 134 (12), 121 
(18), 96 (46), 94 (43), 83 (59), 82 (100).
1H NMR (300 MHz, CD30D ) 5 = 2.22 [2 H, m, H(6)7cndo], 2.42 [6 H, m, H2(4)a jp 
,H6(7) exo], 2.84 (3 H, s, NCH3), 3.77 (1 H, m, H3 endo), 4.08 [2 H, bs, H l(5), W 1/2 
= 9.2 Hz], 7.6 [1 H, H6 " or (H4M)], 7.72 (1 H, t, H5"), 8.11 (1 H, t, H2"), 8.17, [1 
H, m, H4"or (H6 ")]
13C NMR (75.429 MHz, CD3OD) 5 = 24.65 (C6,7), 27.03 (C3), 34.31 (C2,4), 39.47 
(N C H 3), 64.51 (C l,5), 122.58 (C5"), 126.70 (C6 "), 128.51 (C4"), 129.84 (C l"), 
131.93 (C2"), 132.91 (C3"), 168.12 (C31), 182.15 (C51)
Anal. C i6H2oN40-2HCl-0.5 H20  Calc. C, 52.47; H, 6.33 ; N, 15.30
Found C, 52.10; H, 6.40; N, 15.41
e x o - 5 ' - ( 8 - M e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1 ] o c t a n e - 3 - y l ) - 3 ' - (3 - p y r i d y  I ) -1 ,2 ,4 -  
oxadiazole Dihydrochlor ide  ( I l l f )
Sodium hydride (80% dispersion in oil, (70.6 mg, 2.30 mmol) was added to dry THF 
(13 mL) and stirred for 10 min. under N2. The amidoxime 164f (0.295 g, 2.15 mmol 
) was dissolved in anhydrous tetrahydrofuran (8 mL) and the mixture was added 
dropwise to the NaH suspension and stirred at r.t. for 1 h until the hydrogen evolution 
had subsided, the grey NaH giving way to a white precipitate. A solution of the 
tropinone ester (163) (0.30 g, 1.65 mmol) in dry tetrahydrofuran (2 mL) was then 
added dropwise. The resulting mixture was heated at reflux for 1 h after which time
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more THF (lOmL) was added to improve stirring. The reaction was refluxed for a 
further 3 h then cooled and filtered through celite and the filtrate concentrated under 
vacuum. The residue was purified by column chromatography [silica gel; MeOH-THF; 
8 :2 ], affording a colourless oil which was converted to its hydrochloride salt in an 
Acetone/EtOH-HCl solution and allowed to crystallise overnight. The product was 
filtered off and washed with ice cold EtOH to give a white crystalline compound.
Yield 29% , mp 213-215 °C
IR (KBr): v =  1613 (Ar), 1568 (C=N), cm ' 1
MS (El): m/z (%) = 270 (5, M+), 241 (1), 174 (3), 149 (2), 121 (18), 120 (9), 96
(47), 83 (74), 82 (100).
IH NMR (300 MHz, CD3OD) 8  = 2.25 [2 H, m, H(6)7endo], 2.46 [6 H, m, H2(4)a ,p 
,H6(7) exo], 2.85 (3 H, s, NCH3), 3.85 (1 H, m, H3 endo), 4.10 [2 H, bs, H l(5) , 
W 1/2 = 12.9 Hz], 8.29 (1 H, m, H5"), 9.07 (1 H, m, H4"), 9.22 (1 H, m, H6 "), 9.50 
(1 H, m, H2")
13C NMR (75.429 MHz, CD3OD) 8  = 24.80 (C6,7), 27.40 (C3), 34.38 (C2,4), 39.72 
(N CH 3), 64.71 (C l,5), 128.48 (C l"), 129.28 (C5"), 142.02 (C2"), 145.25 (C4"), 
145.25 (C6 "), 165.42 (C3'), 183.56 (C5‘)
Anal. C i5H i8N40 -2HCl H20  Calc. C, 49.87; H, 6.14 ; N, 15.51
Found C, 49.65; H, 6.21; N, 15.50
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e x o - 5 ' - ( 8 - M e t h y l - 8 - a z a b i c y c l o [ 3 . 2 . 1  ] o c t a n e - 3 - y l ) - 3 '-(4 - a m i n o p h e n y l )-
1,2 ,4 -oxadiazo le  D ihydroch lor ide  (HIg).
Sodium hydride (80% dispersion in oil, (47 mg, 1.56 mmol) was added to dry THF (10 
mL) and stirred for 10 min. under N2. The amidoxime 164g (0.196 g, 1.3 m m ol) was 
slurried in anhydrous tetrahydrofuran ( 8 mL) and the slurry was added dropwise to the 
NaH suspension and stirred at reflux until the hydrogen evolution had subsided. A 
solution of the tropinone ester (163) (0.20 g, 1.10 mmol ) in dry tetrahydrofuran (2 
mL) was then added dropwise. The resulting mixture was heated at reflux for 5 h, then 
cooled and filtered through celite and the filtrate concentrated under vacuum. The residue 
was purified by column chromatography [silica gel; MeOH-THF; 8:2], affording a 
colourless oil which was converted to its hydrochloride salt in an Acetone/EtOH-HCl 
solution and allowed to crystallise overnight. The product was filtered off and washed 
with ice cold EtOH to give a white crystalline compound. Yield 51%, mp 275-2T7 °C
IR (KBr): ^  = 1614 (Ar), 1580 (C=N), cm ' 1
MS (El): m/z (%) = 284 (97, M+), 255 (6 ), 202 (20), 189 (17), 149 (7), 134 (42), 121 
(52), 96 (100), 83 (64), 82 (89).
!H NMR (300 MHz, CD3OD) 8 = 2.21 [2 H, m, H(6)7endo], 2.41 [6 H, m, H2 (4 )a ,(3 
,H6(7) exo], 2.84 (3 H, s, NCH3), 3.75 (1 H, m, H3endo), 4.08 (2 H, bs, H I,5 , W 1/2 
= 10.0 Hz), 7.56 [2 H, m, H3"(5")], 8.20 [2 H, m, H2"(6")]
13C NMR (75.429 MHz, CD3OD) 8 = 24.90 (C6,7), 27.27 (C3), 34.58 (C2,4), 39.72 
(N CH 3), 64.77 (C l,5), 124.73 (C2"), 124.73 (C6 "), 128.48 (C l"), 130.13 (C3"),
130.13 (C5"), 135.37 (C4"), 168.52 (C3'), 182.23 (C5').
Anal. C 16H2oN40 • 2HC1 Calc. C, 53.91; H,6.23 ; N, 15.73
Found: C, 53.76; H, 6.23; N, 15.71
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7.15 P harm acolog ical M ethods.
7.16 Serotonin-Induced von Bezold-Jarisch Reflex  in mice.
The compounds were evaluated for antagonism of the Bezold-Jarisch reflex evoked by 
serotonin (5-HT) in anaesthetized mice by a modification of the method of Saxena and 
Lawang .275 Female Swiss CD-I mice (23-28 g, Charles River) were fasted for 15 h 
before the experiment, but water was freely available. The compounds to be examined 
(20mg/Kg) were suspended in 0.25% aqueous Xanthan gum (Sanofi) solution and were 
given orally. Metoclopramide (Sigma) and Zacopride (Glaxo) were used as reference 
compounds. One group received only vehicle and was used as control.
Forty five minutes later, the mice were anaesthetized with urethane (Aldrich) (1.25g/Kg,
i.p.) and electrocardiogram and heart rate were continuously monitored and recorded 
(Hugo Sachs Electronik: HSE-571, HSE-567, HSE-WR3310). Fifteen minutes later (1 
hour after oral treatment) serotonin (Sigma) (0.25 mg/Kg) was given intravenously and 
changes in heart rate were quantified.
On injection of the serotonin an intense transitory reflex is induced; the initial cardio 
frequency value (CFo) and the minimum value in the reflex (CF) were measured.
With the values of CFo and CF the percentage reflex (R) was calculated as
The average intensity of the reflex calculated for each experimental group (R) was 
compared with the corresponding average for the control group (Rc): the activity for
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each product and dosage is expressed as the percentage inhibition in relation to the 
aforementioned control.
Statistical significance was determined by Student's t test for non-paired data. 
Significance level was considered as Ps < 0.05%.
7.17. [3H ]-G R65630 B ind ing .
[3H]-GR65630 (63.74 Ci/mmol) was obtained from Dupont. MDL 72222 was 
purchased from Research Biochemicals Inc. Calf brains were obtained in ice from a 
local slaughterhouse and dissected on ice, using a procedure adapted from the method of 
Glowinsky and Iverson.279 The area postrema was scraped away from the surrounding 
tissues and placed in cold buffer. Approximately lOOmg of wet weight tissue was 
dissected per brain. The tissue was homogenized in ice-cold 50 mM Tris-HCl, 0.5 mM 
EDTA, lOmM MgSO^ at pH 7.4 and centrifuged at 30,000# for 15 min. The pellet was 
resuspended in buffer (in a homogenizer), incubated at 37 °C for 15 min, and then 
recentrifuged twice at 30,000# for 15 min (with a resuspension between each 
centrifuging). The final pellet was resuspended in 50 mM Tris-HCl, 0.5 mM EDTA, 10 
mM MgSO^O.1% ascorbate, 10' 5 M paragyline, and 140 mM NaCl, aliquoted and 
frozen.
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Assays were performed three times, with sets of tubes in triplicate in competition 
experiments, and in duplicate in saturation experiments, in a 2.0 ml volume containing 2 
mg of wet weight tissue (added last).
Tubes were incubated at room temperature for 30 minutes, filtered on glass microfibre 
filters (Whatman GF/C) and washed three times with 7 ml of ice-cold buffer. The filters 
were counted in a liquid scintillation analyzer (Packard Tri-carb 1500) in 4 ml of 
aqueous counting scintillation fluid (Beckman Ready Micro), following 12 h of 
equilibration.
Kinetic saturation constants and competition experiments were analyzed by a computer 
program. Protein determinations were performed following the method of Lowry et 
al.28() using bovine serum albumin (BSA) as a standard.
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1) A series o f 2'aryl-tropane-3-spiro-4'(5 ')-im idazolines, which have not 
previously been reported, were synthesised via the condensation of aryl imidate 
hydrochlorides (129) with 3oc-aminomethyl-8-methyl-8-azabicyclo[3.2.l]octane-3(3- 
amine (122). The condensation occurs smoothly in anhydrous methanol, and generally 
requires heating to complete the reactions. The crude reaction products which were 
present as the mono hydrochloride salts were purified and simultaneously liberated by 
column chromatography on basic alumina.
2) The preparation of the tropinone diamine precursor (122) was carried out by 
performing the Strecker synthesis on N-methyl tropinone (125) to give the tropinone 
aminonitrile (124) followed by reduction. The synthesis of the aminonitrile leads 
exclusively to a single isomer with the nitrile function in the axial position with respect 
to the piperidine ring. The reduction of this compound with UAIH4 to give the diamine 
gave rise to the isolation of an interesting intermediate where both nitrogens of the 1,2 - 
diamine were complexed with aluminium thus forming a five membered cyclic structure 
(154). This complex was easily converted to the free diamine by refluxing in methanol 
containing a catalytic amount of HCl.
3) A series of imidate salts were synthesised as precursors to the tropinone 
imidazoles. The optimal experimental conditions for the synthesis of each imidate were 
developed, it being found that the reaction was particularly sensitive to the nature of both 
the starting nitrile and to the nature of the product. In particular, the synthesis of imidate 
salts with pyridine substituents proved fruitless. Because of the electronegative nature of 
the pyridine ring, the imidate salt derivatives, on formation, immediately decomposed to 
the corresponding amides. The problem was overcome indirectly by stabilising the 
pyridine imidate salt as the iV-oxide derivative which after subsequent condensation with 
the diamine was cleaved with PCI3.
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4) The aforementioned work comprised part of an article published in the chemical 
journal Synthesis 1994, 832-836.
5) A series of 2Aryl-l-azabicyclo[2.2.2]octane-3-spiro-4,(5')-imidazolines was 
synthesised (Ila-g) using a similar synthetic route to that developed for the tropinone 
imidazole series (I). The condensation reaction of the quinuclidine diamine with the 
imidate salts was much faster than with the tropinone congener. The increased reactivity 
was thought to be due to steric factors.
6 ) The formation of the quinuclidine diamine (159) by the reduction of the
corresponding aminonitrile (158) with LiAlH4 did not give rise to the isolation of the 
aluminium complex described for the tropine diamine. This reaction proved to be 
especially troublesome and two major side products were isolated from the reaction 
resulting from hydrogenolysis and dimerisation of the aminonitrile under the reaction 
conditions to give the impurities (160) and (161) respectively. The difference in 
behaviour of the tropinone and quinuclidine aminonitriles under the reduction conditions 
has been rationalised.
7) The work described for this series of compounds made up part of an article
published in Synthesis 1994, 832-836.
8 ) Due to the difficulty of forming stable imidate salts from difluorobenzonitrile an 
alternative synthetic route was investigated for the synthesis of the quinuclidine spiro- 
imidazoline with the difluorophenyl substituent in the 2  position of the imidazoline ring. 
The alternative route involved the acylation of the diamine (159) with difluorobenzoyl 
chloride followed by cyclisation to the imidazoline using PCI3 as condensing agent. It 
was discovered that when pure mono acylated diamine was used as the starting material 
for cyclisation none of the required product was obtained. Only when the starting 
material was contaminated with diacylated diamine was there any cyclisation to the 
desired product. The cyclisation precursor was found to be the diacylated compound 
which however also failed to give the required imidazoline when attempting to cyclise in
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the pure state. It was thought that ji-tc interactions of the two difluorophenyl rings of 
the diacylated compound in the pure state prevented the cyclisation while the rupture of 
these interactions in the sample contaminated with monoacylated compound permitted 
the desired cyclisation.
The required compound was isolated though not in a pure state and the reaction requires 
further optimisation. It may provide a useful alternative route to imidazolines which are 
not available via the imidate route such as in the case of ortho substituted phenyl 
derivatives.
9) A convenient synthesis of exo-5'-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-3'- 
(aryl)-l,2,4-oxadiazoles (III) from tropinone has been developed. The method involves 
the intermediacy of the hitherto unreported compound 3-(l,3-dithiane-2-ylidene)-8- 
methyl-8-azabicyclo[3.2.1]octane (170) which on acidic methanolysis lead exclusively 
to exo-3-carbomethoxy-8-methyl-8-azabicyclo[3.2.1]octane (163). The condensation 
of this tropinone ester (163) with aryl amidoximes (164) gave rise to the exo-5'-(8- 
methyl-8-azabicyclo[3.2.1]octan-3-yl)-3'-(aryl)-l,2,4-oxadiazoles (III) again as the 
exclusive isomer.
10) A series of aryl amidoximes (164) were synthesised as precursors to the 
oxadiazoles, the synthesis of which were carried out by the action of hydroxylamine on 
aryl nitriles. Although some of the aminonitriles described have previously been 
reported the methods described herein show some considerable advances over existing 
methods. Thus for example the synthesis of the 3-aminophenyl (164e) and 4- 
aminophenyl amidoximes (164g) which to date have been formed by the action of 
hydroxylamine on the nitrophenyl nitrile followed by subsequent reduction to the amine 
derivative, were synthesised here directly in one step from the aniline nitrile. Likewise 
the 3,5-dichlorophenyl amidoxime (164d), whose literature synthesis takes place by 
converting the nitrile to the thioamide which was then succeeded by reaction with 
hydroxylamine, has been prepared here directly in one step from the nitrile.
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11) An in depth sructural and conformational analysis has been performed on both 
the tropane spiro-imidazolines (I) and on the tropane oxadiazoles (III) series.
X-ray analysis of the spiroimidazoline (Ig) revealed that the bicyclic system is in the 
chair-envelope conformation commonly found in these kinds of compounds while the 
chair is flattened at the C4 atom. The aromatic indole moiety has its electrons delocalised 
along the N 10-C 11-N 12 of the imidazoline ring thus helping to maintain an interplanar 
angle of 24 °. From high resolution !H and 13C NMR the tropane imidazolines display 
in CD3OD solution the same preferred conformation as that found in the solid state. The 
pyrrolidine and piperidine rings adopt an envelope conformation flattened at N 8 and a 
distorted chair conformation puckered at C3 respectively, with the N-substituent in the 
equatorial position with respect to the piperidine ring.
X-ray analysis and NMR studies of the tropane oxadiazoles demonstrate that the tropane 
system adopts a similar conformation to that found in the imidazoline series. The 
oxadiazole ring was shown by both X-ray and NMR analysis to be in the exo position 
with respect to the piperidine ring.
12) The in vivo pharmacological studies and the in vitro binding tests of the two 
imidazoline series showed that the dichlorophenyl derivative of each of these series have 
5 -HT3 antagonistic activity comparable to metochlopramide or to the potent antagonist 
MDL 72222. Structure-activity relationship studies have shown that the C=N of the 
imidazoline function in these compounds was mimicking the function of the carbonyl 
group present in most 5 -HT3 receptor antagonists. Thus the imidazoline was found to be 
a biosteric replacement for the carbonyl and is the first time that such a group has been 
employed in 5-HT3 antagonists.
13) These findings have been published in the American Journal o f Pharmaceutical 
Sciences (in press; planned for November 1994)
14) The in vivo pharmacological studies and the in vitro binding tests of the series 
of oxadiazoles (III) showed several of these compounds to have potent 5 -HT3
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antagonistic activity (In preparation for publication). The results of this series as well as 
the imidazolines clearly demonstrate the sensitivity of the antagonistic properties of the 
molecule to changes in the aromatic moiety. In all cases, those molecules containing the 
3,5-dichlorophenyl group as the lipophilic aromatic function were shown to demonstrate 
highest antagonism of the 5-HT3 receptor. The replacement of the chlorine atoms with 
bulkier groups such as OMe, or compounds with para substitution, causes a reduction in 
activity. It was thus felt that the difluoro counterpart which could offer similar electronic 
characteristics but with less steric requirements could offer some interesting results. 
Efforts to acquire a sufficient amount of this product in the pure state are on-going.
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APPENDIXES
Appendix I
Table A Experimental Data and Structural Refinement Procedure for
(Ig)
PARAMETER VALUE
Crystal Structure Data for 2'-(lH-indol-3-yl)-8-methyl-8-azabicyclo-
[3.2.1]octane-3-spiro-4'(5')-im idazoline dihydrochloride (Ig).
Crystal data 
Formula 
Symmetry
Unit cell determinations:
Unit cell dimensions (A)
Packing: V(A3), Z 
Dc (g.cnr3), M, F (000)
|i (cm-1)
Experimental data 
Technique
Number of reflections: 
Measured
Observed 
Range of hkl 
Value of Rint 
Max.- min. transmission 
factors 
Solution and refinement 
Solution 
Refinement
H atoms
w-scheme
Final AF peaks 
Final R and Rw 
Computer and programs
C 19 H28 N4 O CI2 
Monoclinical, P2 ]/n 
Least squares fit from 60 reflections 
(6 <15°)
7.661 (1), 26.432 (4), 9.986 (2), 90.0, 
98.43(1), 90.0 
2000.3(6), 4 
1.3261, 399.36, 848
3.389
Four circle difractometer: Enraf- 
Nonius, Cad-4. Bisecting geometry. 
Grafite orientated monochromator
:MoKa co scans, scan width : 1° up 
max. 28°
4773
1026 (2a (I) criterion)
0 10, 0 34, -13 13 
0.01
1.244, 0.555
Direct methods and Fourier synthesis 
Full-matrix L.S. on Fobs. Anisotropic 
thermal paramaters of C6 fixed 
Difference synthesis. H52, H92, H93 
and H262 not refined 
Empirical as to give no trends in <w a F>
vs. <Fobs> and <sin Q/X>
0.3 e/A3 
0.054, 0.013
Vax 6410, Difabs, Multan80 
Dirdif, Xray System, Pesos,
Parst
I I
Scattering factors Int.Tables for X-Ray Crystallography
Anomalous dispersion Int.Tables for X-Ray Crystallography
I I I
Atomic parameters for non H-Atoms for (Ig).
Atom X Y z Ueq
CL23 0 .3296 5) 0 .2 900  ( 1) 0 .0 439  ( 3) 50 ( 1)
CL24 0 .1 582 4) 0 .5 693  ( 1) 0 .4 115  ( 3) 39 ( 1)
025 0 .2 725 13) 0 .2 338  ( 3) 0 .3 002  ( 8) 50 ( 3)
C26 0.3802 24) 0 .1 8 9 6  ( 6) 0 .3 161  ( 17) 62 ( 6)
Nl 0 .3 190 12) 0 .2 848  ( 3) 0 .5 396  ( 10) 31 3)
N10 0 .2 882 15) 0 .3 882  ( 4) 0 .2318 10) 41 ( 4)
N12 0 .2 993 14) 0 .4 655  ( 4} 0 .3 139  ( 10) 38 ( 3)
N16 0 .1 148 16) 0 .4 5 7 2  ( 5) - 0 .1 4 9 0  ( 10) 48 ( 4)
C2 0.4798 16) 0 .3 1 7 6 ( 5) 0 .5 513  ( 12) 36 ( 4)
C3 0 .4 789 17) 0 .3 4 6 6  ( 4) 0 .4 169  ( 11) 35 ( 4)
C4 0 .3 120 15) 0 .3 783  ( 4) 0 .3 807  ( 10) 29 4)
C5 0 .1 478 17) 0 .3 514( 5) 0 .4 1 6 6 ( 12) 40 ( 4)
C6 0 .1 752 15) 0 .3 228  ( 5) 0 .5 501  ( 11) 36
C7 0 .2 5 5 6 16) 0 .3 543  ( 6) 0 .6709{ 14) 44 ( 5)
C8 0 .4 579 17) 0 .3 505  ( 6) 0 .6 7 2 7  ( 13) 43 ( 5)
C9 0 .3 277 25) 0 .2 443  { 6) 0 .6 464  ( 15) 66 6)
C l l 0 .2 693 14) 0 .4 3 8 1  ( 5) 0 .2 001  { 11) 31 4)
C13 0.3283 24) 0 .4 3 5 2  ( 5) 0 .4 367  ( 13) 53 ( 5)
C14 0 .2 296 16) 0 .4 563  ( 4) 0 .0 693  ( 11) 33 ( 4)
C15 0 .1 362 16) 0 .4 287  ( 5) - 0 .0 3 6 1  ( 12) 39 ( 4)
C17 0 .1 864 16) 0 .5 0 4 4  ( 5) - 0 .1 2 2 0  ( 10) 34 4)
C18 0 .2 599 15) 0 .5 0 5 6  ( 5) 0 .0 147  ( 10) 31 ( 4)
C19 0 .3 443 20) 0 .5 4 9 4  ( 5) 0 .0 6 4 9 ( 13) 43 ( 5)
C20 0 .3 535 23) 0 .5 895  { 6) - 0 . 0 2 0 9  ( 17) 55 ( 6)
C21 0 .2 785 21) 0 .5 8 7 9  ( 7) - 0 .1 5 4 5  ( 16) 57 6)
C22 0 .1 910 17) 0 .5 4 5 5  ( 6) - 0 .2 0 9 3  ( 12) 44 { 5)
Coordinates and thermal parameters as
Ueq=(1/3).Sum[Uij.ai*.aj*.ai.aj.cos (ai,aj)].10**3
IV
Thermal parameters for (Ig).
Atom a n U22 033 012 013 U23
CL23 58 ( 2) 43 ( 2) 50 ( 2) -3 ( 2) 10 ( 2) -5 ( 2)
CL24 37 ( 2) 40 ( 2) 39 ( 2) 2 ( 2) 0< 1) -9 ( 1)
025 51 ( 6) 42 ( 6) 56 ( 5) “ 5 ( 5) 4 ( 4) ~3| 4)
C2S 51 ( 10) 52 ( 10) 79 ( 11) 7 ( 9) -5  ( 9) -15 ( 3)
N1 29 ( 5) 34 ( 5) 28 ( 4) 1( 5) 2 ( 4) 3 ( 4)
Ml 0 63 ( 8) 26 ( 6) 31 ( 5) 12 ( 5) 13 ( 5) 2 ( 5)
Ml 2 35 < 6) 41 ( 6) 38 ( 6) 15 ( 5) 7 ( 5) 1( 5)
Ml 6 49 ( 7) 63 ( 9) 31 ( 6) 15 ( 6) 5 ( 5) -6  ( 6)
C2 28 ( 7) 42 { 7) 34 { 7) 5 { 7) -10 ( 5) 7 ( 5)
C3 36 { 7) 40 { 7} 30 ( 6) -3 { 7) 9 ( 5) 3 ( 6)
C4 34 ( 7) 29 ( 6) 24 ( 6) - 2  ( o) 4 ( 5) -5 ( 5)
C5 32 ( 8) 53 ( 7) 33 ( 6) 5 ( 7) - 1 ( 6) -9 ( 6)
C6 26 42 34 4 -13 3
C7 23 ( 8) 57 ( 9) 53 ( 9) 15 ( 7) 7 ( 6) -10 ( 3)
C8 37 ( 8) 51 ( 9) 37 ( 7) 2 ( 7) -3 ( 6) 2 ( 7)
C9 70 ( 12) 58 ( 10) 65 ( 9) “ 7 ( 9) -6  ( 8) 17 ( 8)
C l l 23 ( 6) 39 ( 8) 34 { 6) -6 ( 5) 6 { 5) -10 ( 6J
C13 78 ( 12) 40 ( 3) 40 { 7) 1( 3) 1 { 7) 4 { 6)
C14 36 ( 8) 34 ( 7) 29 ( 7) 16 ( o) 8 ( 6) 4 ( 6)
C15 35 ( 7) 52 { 3) 33 ( 6) 13 ( 7) 12 ( 5) -3 ( 7)
C17 30 ( 7) 41 { 8) 37 ( 7) 14 ( 6) 22 ( 6) -3 ( 6)
C18 30 ( 7) 39 ( 3) 24 ( 6) 10 ( 6) -2  ( 5) 5)
C19 57 ( 10) 44 ( 7) 27 ( 7) 0< "7 N 4 ( 6) -5 ( 6)
C20 58 ( 11) 47 ( 3) 65 ( 11) 3 ( 3) 30 { 9) 14 ( 3)
C21 44 ( 9) 62 ( 10) 66 ( 11) 20 ( 3) 17 { 3) 2  ( 9)
C22 37 ( 8) 7-3 ( 10) 30 ( 7) 6 ( 3) 26 ( 6) “ 1 ( 7)
Thermal parameters as exp[ -2.pi**2. Sum( U i j . ai* aj*.hi • h j ) .10**3]
V
Coordinates and thermal parameters for H-atoms in (Ig)
Atom X V z U
H23 0 171 ( 22) 0 303 ( 5) 0 137 ( 16) 52
H261 0 524 28) 0 196 ( 6) 0 344 ( 18) 68
H262 0 333 0 165 0 215 68
H263 0 370 25) 0 174 ( 7) 0 403 ( 18) 68
HI 0 322 ( 18) 0 263 ( 6) 0 457 { 14) 36
H10 0 282 ( 20) 0 360 ( 6) 0 172 ( 14) 41
H12 0 238 ( 20) 0 497 ( 6) 0 331 ( 13) 36
H16 0 060 ( 23} 0 446 ( 7) -0 208 ( 17) 48
H2 0 610 ( 21) 0 298 ( 6) 0 590 ( 14) 35
H31 0 588 ( 20) 0 3 65 ( 5) 0 389 ( 14) 3 6
H32 0 479 ( 19) 0 315 ( 5) 0 339 ( 14) 36
H51 0 108 ( 20) 0 331 ( 6) 0 347 ( 15) 42
H52 0 040 0 387 0 424 42
H6 0 058 21) 0 303 ( 6) 0 529 ( 14) 43
H71 0 225 ( 21) 0 390 ( 6) 0 657 ( 15) 40
H72 0 241 ( 19) 0 346 ( 6) 0 7 69 ( 16) 40
H81 0 528 ( 19) 0 334 ( 6) 0 750 15) 47
H82 0 506 ( 21) 0 386 ( 6) 0 674 ( 15) 47
H91 0 215 ( 24) 0 220 ( 7) 0 639 ( 17) 66
H92 0 420 0 228 0 631 66
H93 0 349 0 258 0 752 66
H131 0 447 ( 24) 0 442 ( 6) 0 461 15) 58
H132 0 215 ( 22) 0 443 ( 6) 0 505 16) 58
H15 0 104 ( 19) 0 384 ( 6) -0 035 13) 40
HI 9 0 359 ( 21) 0 553 ( 6) 0 145 ( 16) 42
H20 0 410 ( 25) 0 621 ( 7) 0 011 ( 17) 59
H21 0 280 ( 22) 0 620 ( 7) -0 213 ( 18) 54
H22 0 195 ( 21) 0 535 ( 6) -0 .288 15) 40
Coordinates and thermal parameters as 
exp[-8.pi**2.U.(sin(theta)/lambda)**2 ,10**3]
VI
C r y s t a l  d a t a
a  -  7 . 6 6 1 0 ( 0 . 0 0 1 0 )  a l p h a =  9 0 . 0 0 0 ( 0 .
b  =■ 2 6 . 4 3 2 0  ( 0 . 0 0 4 0 )  b e t a  = 9 8 . 4 3 0 ( 0 ,
c  = 9 . 9 8 6 0 ( 0 . 0 0 2 0 )  gamma= 9 0 . 0 0 0 ( 0 .
V = 2 0 0 0 . 2 7 (  0 . 5 7 )  c u b i c - A n g s t r o m
N i g g l i r e d u c e d  c e l l : 7 . 6 6 1  9 . 9 8 6  2 6 . 4 3 2 90 . 0 0 9 0 . 0 0  98
N i g g l i m a t r i x : 5 8 . 6 9 0 9  9 9 . 7 2 0 2 698 . 6 5 0 6
0 . 0 0 0 0  0 . 0 0 0 0 - 1 1  . 2 1 5 4
T r a n s f o r m a t i o n  m a t r i x : - 1 . 0 0  0 . 0 0 0 . 0 0
0 . 0 0  0 . 0 0 1  . 0 0
0 . 0 0  1 . 0 0 0 . 0 0
H 2 8 . C 1 9 .  N 4 .  C 1 . C L  2 .
M = 3 9 9 . 3 6 2 ( A t o m i c  w e i g h t s  1 9 7 7 )
Z = 4 . 00
D ( c a l c • ) = 1 . 3 2 6 1 M g / m * * 3
F ( 0 0 0 ) = 848 . 0
mu = 3.  3 8 9 c m * * - l  ( I n t . T a b . V o l . I V , p . 5 5 )
L a m b d a = 0 . 7 1 0 7 0 0 0 A n g s t r o m
N u m b e r o f a t o m s :  54
A t o m i c c o o r d i n a t e s
A t o m X / a Y / b Z / c
C L 2 3 0 . 3 2 9 6 0 ( 5 1 0 . 2 9 0 0 1  ( 1 3 ) 0 . 0 4 3 8 6
H23 0 . 1 7 1 1 7  ( 2 2 2 8 0 . 3 0 2 6 5  < 5 2 3 ) 0 . 1 3 6 5 8
CL2 4 0 . 1 5 8 1 8  ( 42 0 . 5 6 9 3 1  ( 1 1 ) 0 . 4 1 1 4 7
0 2 5 0 . 2 7 2 4 5  ( 1 2 6 0 . 2 3 3 8 4  ( 34 ) 0 . 3 0 0 1 7
C2 6 0 . 3 8 0 2 3  ( 2 3 8 0 . 1 8 9 6 2  ( 60) 0 . 3 1 6 0 7
H2 6 1 0 . 5 2 4 3 0  ( 2 7 8 2 0 . 1 9 6 3 1  ( 6 3 6 ) 0 . 3 4 4 3 2
H2 62 0 . 3 3 2 8 0  ( 0 0 . 1 6 5 3 0  ( 0 ) 0 . 2 1 4 8 0
H263 0 . 3 7 0 2 6  ( 2 4 5 2 0 . 1 7 3 6 8  ( 7 2 7 ) 0 . 4 0 3 2 6
N l 0 . 3 1 8 9 7  ( 1 2 4 0 . 2 8 4 8 5  ( 34) 0 . 5 3 9 5 8
HI 0 . 3 2 2 2 6  ( 1 8 2 2 0 . 2 6 2 9 9 ( 5 7 3 ) 0 . 4 5 7 2 8
N1 0 0 . 2 8 8 1 8  ( 1 5 0 0 . 3 8 8 2 0  ( 40) 0 . 2 3 1 7 9
H1 0 0 . 2 8 2 3 2  ( 1 9 7 9 0 . 3 5 9 8 1  ( 6 1 5 ) 0 . 1 7 1 5 7
N 1 2 0 . 2 9 9 2 6  ( 1 4 4 0 . 4 6 5 5 1  ( 4 1 ) 0 . 3 1 3 8 9
H12 0 . 2 3 8 2 9  ( 1 9 8 7 0 . 4 9 6 8 4  ( 606) 0 . 3 3 0 6 2
N l  6 0 . 1 1 4 7 8  ( 1 6 1 0 . 4 5 7 2 5  ( 4 7 ) - 0 . 1 4 9 0 5
HI 6 0 . 0 5 9 5 8  { 2 2 7 5 0 . 4 4 5 8 2 ( 6 8 3 ) - 0 . 2 0 7 5 1
C2 0 . 4 7 9 7 9  ( 1 6 0 0 . 3 1 7 6 3  ( 48) 0 . 5 5 1 2 9
H2 0 . 6 1 0 2 1  ( 2 0 6 6 0 . 2 9 8 2 7  ( 5 5 1 ) 0 . 5 9 0 2 1
C3 0 . 4 7 8 9 2  ( 1 6 5 0 . 3 4 6 5 8  ( 4 5 ) 0 . 4 1 6 9 0
H31 0 . 5 8 7 9 9  ( 1 9 9 2 0 . 3 6 4 7 7  ( 5 3 7 ) 0 . 3 8 8 8 8
H32 0 . 4 7 8 7 4  ( 1 8 7 2 0 . 3 1 5 2 4  ( 5 0 2 ) 0 . 3 3 8 6 3
C4 0 . 3 1 1 9 8  ( 1 5 4 0 . 3 7 8 2 9  ( 40) 0 . 3 8 0 7 2
C5 0 . 1 4 7 7 8  ( 1 6 6 0 . 3 5 1 3 7  < 4 7 ) 0 . 4 1 6 5 7
H51 0 . 1 0 8 2 6  ( 1 9 7 6 0 . 3 3 0 7 2  < 5 6 4 ) 0 . 3 4 6 8 4
H52 0 . 0 3 9 6 8  ( 0 0 . 3 8 7 0 0  ( 0 ) 0 . 4 2 3 5 2
C 6 0 . 1 7 5 1 6  ( 1 5 3 0 . 3 2 2 7 8  ( 50) 0 . 5 5 0 0 9
H6 0 . 0 5 7 9 9  ( 2 1 1 5 0 . 3 0 3 1 9  ( 5 6 4 ) 0 . 5 2 9 1 9
C7 0 . 2 5 5 6 3  ( 1 6 4 0 . 3 5 4 3 0  ( 59) 0 . 6 7 0 9 1
H7 1 0 . 2 2 5 2 3  < 2 0 7 9 0 . 3 8 9 8 1 < 6 4 7 ) 0 . 6 5 7 0 9
H7 2 0 . 2 4 1 3 2  ( 1 8 5 4 0 . 3 4 5 7 8  ( 5 6 5 ) 0 . 7 6 9 4 7
C 8 0 . 4 5 7 9 2  { 1 6 6 0 . 3 5 0 5 3  ( 5 6) 0 . 6 7 2 7 5
H81 0 . 5 2 8  3 3  ( 1 9 0 4 0 . 3 3 4 0 8  ( 5 5 2 ) 0 . 7 4 9 7 5
H82 0 . 5 0 6 1 1  ( 2 1 4 2 0 . 3 8 6 2 4  { 6 4 9 ) 0 . 6 7 3 9 2
C9 0 . 3 2 7  6 6  ( 2 4 9 0 . 2 4 4 3 1  ( 6 1 ) 0 . 6 4 6 4 4
H91 0 . 2 1 4 8 4  { 2 3 5 6 0 . 2 1 9 8 3  ( 7 0 0 ) 0 . 6 3 9 0 4
H92 0 . 4 1 9 8 0  ( 0 0 . 2 2 7 6 0  ( 0 ) 0 . 6 3 1 2 0
H93 0 . 3 4 8 5 0  ( 0 0 . 2 5 7 9 0  < 0 ) 0 . 7 5 1 9 0
C l l 0 . 2 6 9 3 0  ( 1 4 1 0 . 4 3 8 0 9  ( 4 5 ) 0 . 2 0 0 0 5
C l  3 0 . 3 2 8 3 5  ( 2 4 0 0 . 4 3 5 2 0  ( 5 1 ) 0 . 4 3 6 7 2
0 0 0 )
0 1 0 )
0 0 0 )
43
33 ) ,
1 5 6 5 )
28)
3 3 )
1 6 7 )
1 7 7 1 )
0)
1 7 5 8 )
9 5 )  
1 3 6 4 )
96)  
1 4 2 3 )
9 7 )  
1 2 9 5 )
1 0 5 )
1 7 2 0 )
1 1 7 )
1 4 0 5 )
1 0 5 )  
1 3 6 4 )  
1 3 7 6 )
101)
121)
1 4 8 1 )
0)
112)
1 4 1 2 )
1 4 4 )
1 4 6 0 )
1 5 7 3 )
1 2 6 )
1 4 9 0 )
1 5 2 0 )
1 5 3 )
1 7 2 9 )
0)
0)
1 0 6 )  
1 2 9 )
VII
HI 3 1
HI 32
C 1 4
C 1 5
H1 5
C l  7
C 1 8
C 1 9
H1 9
C20
H20
C 2 1
H21
C 2 2
H22
0 . 4 4 6 6 7  ( 
0 . 2 1 5 0 4  ( 
0 . 2 2 9 5 7  ( 
0 . 1 3 6 1 7  ( 
0 . 1 0 4 1 5  ( 
0 . 1 8 6 4 2  ( 
0 . 2 5 9 9 0  ( 
0 . 3 4 4 3 2  ( 
0 . 3 5 9 5 0  ( 
0 . 3 5 3 4 6  ( 
0 . 4 0 9 6 0  ( 
0 . 2 7 8 5 1  ( 
0 . 2 8 0 0 4  ( 
0 . 1 9 0 9 8  ( 
0 . 1 9 5 2 0 (
2 3 5 1 ) 0 . 4 4 1 5 2 ( 6 1 4 ) 0 . 4 6 0 6 8  ( 1 4 6 9 )
2 2 3 9 ) 0 . 4 4 2 5 4  ( 6 4 7 ) 0 . 5 0 4 8 7 ( 1 6 1 0 )
1 6 0 ) 0 . 4 5 6 3 1 ( 45 ) 0 . 0 6 9 2 8  ( 1 0 7 )
1 6 0 ) 0 . 4 2 8 7 5  ( 50) - 0  . 0 3 6 1 1  ( 1 1 5 )
1 9 1 7 ) 0 . 3 8 3 7 7  { 602) - 0 . 0 3 4 6 0  ( 1 3 3 4 )
1 5 6 ) 0 . 5 0 4 3 9  ( 50) - 0 . 1 2 2 0 1  ( 1 0 1 )
1 5 1 ) 0 . 5 0 5 6 1  ( 4 7 ) 0 . 0 1 4 6 6  ( 9 7 )
1 9 6 ) 0 . 5 4 9 3 9  ( 49) 0 . 0 6 4 8 6 ( 1 2 8 )
2 0 8 0 ) 0 . 5 5 2 5 2 ( 5 8 5 ) 0 . 1 4 4 8 3  ( 1 5 7 1 )
2 2 5 ) 0 . 5 8 9 5 1  ( 59) - 0 . 0 2 0 8  6  { 1 6 9 )
2 5 2 0 ) 0 . 6 2 1 4 4 ( 7 0 3 ) 0 . 0 1 1 2 1  { 1 7 1 0 )
2 1 1 ) 0 . 5 8 7 9 2  ( 6 6 ) - 0 . 1 5 4 4 6  { 1 6 5 )
2 1 7 7 ) 0 . 6 2 0 2 4  ( 6 93) - 0 . 2 1 3 0 6 ( 1 8 0 6 )
1 7 0 ) 0 . 5 4 5 4 6  ( 5 9) - 0  . 2 0 9 3 0  ( 1 2 4 )
2 0 5 2 ) 0 . 5 3 5 0 4  ( 5 6 2 ) - 0  . 2 8 7 7 8  { 1 5 3 7 )
O r t h o g o n a l  c o o r d i n a t e s  ( A n g s t r o m )  
O r t h o g o n a l i z a t i o n  m a t r i x :
a  b  c o s g a m m a  c  c o s b e t a  7 . 6 6 1 0 0
0 b  s i n g a m m a  - c  s i n b e t a  c o s a l p h a *  0 . 0 0 0 0 0
0 0 c  s i n b e t a  a i n a l p h a *  0 . 0 0 0 0 0
0 . 0 0 0 0 0  - 1 . 4 6 3 9 6
2 6 . 4 3 2 0 0  0 . 0 0 0 0 0
0 . 0 0 0 0 0  9 . 8 7 8 1 1
A t o m X Y Z
C L 2 3 2 . 4 6 0 9 0 . 0 0 4 0 ) 7 . 6 6 5 5 0 . 0 0 3 5 ) 0 . 4 3 3 3 0 . 0 0 3 3
H23 1 .  1 1 1 4 0 . 1 7 2 2 ) 7 . 9 9 9 6 0 . 1 3 8 2 ) 1 . 3 4 9 2 0 . 1 5 4 6
C L 2 4 0 . 6 0 9 4 0 . 0 0 3 3 ) 1 5 . 0 4 8 0 0 . 0 0 2 9 ) 4 . 0 6 4 5 0 . 0 0 2 8
0 2 5 1 . 6 4 7 8 0 . 0 0 9 7 ) 6 . 1 8 0 9 0 . 0 0 9 0 ) 2 . 9 6 5 1 0 . 0 0 8 2
C2 6 2 . 4 5 0 2 0 . 0 1 8 4 ) 5 . 0 1 2 0 0 . 0 1 5 9 ) 3 . 1 2 2 2 0 . 0 1 6 5
H2 61 3 . 5 1 2 6 0 . 2 1 4 7 ) 5 . 1 8 8 9 0 . 1 6 8 1 ) 3 . 4 0 1 2 0 . 1 7 4 9
H2 62 2 . 2 3 5 1 0 . 0 0 0 4 ) 4 . 3 6 9 2 0 . 0 0 0 4 ) 2 . 1 2 1 8 0 . 0 0 0 5
H2 63 2 . 2 4 6 2 0 . 1 8 9 6 ) 4 . 5 9 0 7 0 . 1 9 2 2 ) 3 . 9 8 3 4 0 . 1 7 3 7
N l 1 . 6 5 3 7 0 . 0 0 9 6 ) 7 . 5 2 9 2 0 . 0 0 9 0 ) 5 . 3 3 0 0 0 0 9 4
HI 1 . 7 9 9 4 0 . 1 4 1 0 ) 6 . 9 5 1 4 0 . 1 5 1 5 ) 4 . 5 1 7 1 0 . 1 3 4 7
N1 0 1 . 8 6 8 4 0 . 0 1 1 6 ) 1 0 . 2 6 0 9 0 . 0 1 0 6 ) 2 . 2 8 9 6 0 . 0 0 9 5
H1 0 1 . 9 1 1 7 0 . 1 5 3 0 ) 9 . 5 1 0 5 0 . 1 6 2 6 ) 1 . 6 9 4 8 0 . 1 4 0 6
N 1 2 1 . 8 3 3 1 0 . 0 1 1 1 ) 1 2 . 3 0 4 4 0 . 0 1 0 8 ) 3 . 1 0 0 6 0 . 0 0 9 6
H1 2 1 . 3 4 1 5 0 . 1 5 3 4 ) 1 3 . 1 3 2 5 0 . 1 6 0 2 ) 3 . 2 6 5 9 0 . 1 2 7 9
N 1 6 1 . 0 9 7 5 0 . 0 1 2 4 ) 1 2 . 0 8 6 0 0 . 0 1 2 4 ) - 1 . 4 7 2 3 0 . 0 1 0 4
HI 6 0 . 7 6 0 2 0 . 1 7 6 1 ) 1 1 . 7 8 3 9 0 . 1 8 0 5 ) - 2 . 0 4 9 8 0 . 1 6 9 9
C2 2 . 8 6 8 6 0 . 0 1 2 4 ) 8 . 3 9 5 6 0 . 0 1 2 7 ) 5 . 4 4 5 7 0 . 0 1 1 6
H2 3 . 8 1 0 8 0 . 1 5 9 6 ) 7 . 8 8 3 9 0 . 1 4 5 6 ) 5 . 8 3 0 2 0 . 1 3 8 8
C3 3 . 0 5 8 7 0 . 0 1 2 7 ) 9 . 1 6 0 8 0 . 0 1 1 9 ) 4 . 1 1 8 2 0 . 0 1 0 4
H31 3 . 9 3 5 3 0 . 1 5 3 9 ) 9 . 6 4 1 6 0 . 1 4 1 9 ) 3 . 8 4 1 4 0 . 1 3 4 7
H32 3 . 1 7 1 9 0 . 1 4 4 8 ) 8 . 3 3 2 4 0 . 1 3 2 7 ) 3 . 3 4 5 0 0 . 1 3 5 9
C4 1 . 8 3 2 7 0 . 0 1 1 9 ) 9 . 9 9 9 0 0 . 0 1 0 6 ) 3 . 7 6 0 8 0 . 0 1 0 0
C5 0 . 5 2 2 3 0 . 0 1 2 8 ) 9 . 2 8 7 4 0 . 0 1 2 4 ) 4 . 1 1 4 9 0 . 0 1 2 0
H5 1 0 . 3 2 1 6 0 . 1 5 2 9 ) 8 . 7 4 1 6 0 . 1 4 9 1 ) 3 . 4 2 6 1 0 . 1 4 6 3
H52 - 0 . 3 1 6 0 0 . 0 0 0 4 ) 1 0 . 2 2 9 2 0 . 0 0 0 4 ) 4 . 1 8 3 6 0 . 0 0 0 5
C 6 0 . 5 3 6 6 0 . 0 1 1 8 ) 8 . 5 3 1 7 0 . 0 1 3 2 ) 5 . 4 3 3 8 0 . 0 1 1 1
H6 - 0 . 3 3 0 5 0 . 1 6 3 3 ) 8 . 0 1 3 9 0 . 1 4 9 1 ) 5 . 2 2 7 4 0 . 1 3 9 5
C 7 0 . 9 7 6 2 0 . 0 1 2 7 ) 9 . 3 6 4 9 0 . 0 1 5 6 ) 6 . 6 2 7 3 0 . 0 1 4 2
H7 1 0 . 7 6 3 5 0 . 1 6 0 7 ) 1 0 . 3 0 3 5 0 . 1 7 1 0 ) 6 . 4 9 0 8 0 . 1 4 4 2
H72 0 . 7 2 2 3 0 . 1 4 3 9 ) 9 . 1 3 9 7 0 . 1 4 9 3 ) 7 . 6 0 0 9 0 . 1 5 5 4
C 8 2 . 5 2 3 2 0 . 0 1 2 9 ) 9 . 2 6 5 2 0 . 0 1 4 8 ) 6 . 6 4 5 5 0 . 0 1 2 5
H81 2 . 9 4 9 9 0 . 1 4 7 5 ) 8 . 8 3 0 4 0 . 1 4 5 9 ) 7 . 4 0 6 1 0 . 1 4 7 2
H82 2 . 8 9 0 7 0 . 1 6 5 6 ) 1 0 . 2 0 9 1 0 . 1 7 1 5 ) 6 . 6 5 7 1 0 . 1 5 0 1
C9 1 . 5 6 3 8 0 . 0 1 9 2 ) 6 . 4 5 7 6 0 . 0 1 6 1 ) 6 . 3 8 5 6 0 . 0 1 5 1
H9 1 0 . 7 1 0 4 0 . 1 8 2 3 ) 5 . 8 1 0 5 0 . 1 8 5 0 ) 6 . 3 1 2 5 0 . 1 7 0 8
H92 2 . 2 9 2 0 0 . 0 0 0 4 ) 6 . 0 1 5 9 0 . 0 0 0 4 ) 6 . 2 3 5 1 0 . 0 0 0 5
H93 1 . 5 6 9 1 0 . 0 0 0 4 ) 6 . 8 1 6 8 0 . 0 0 0 4 ) 7 . 4 2 7 3 0 . 0 0 0 5
C l l 1 . 7 7 0 2 0 . 0 1 0 9 ) 1 1 . 5 7 9 6 0 . 0 1 1 9 ) 1 . 9 7 6 1 0 . 0 1 0 5
C l  3 1 . 8 7 6 1 0 . 0 1 8 5 ) 1 1 . 5 0 3 2 0 . 0 1 3 5 ) 4 . 3 1 4 0 0 . 0 1 2 8
H 1 3 1 2 . 7 4 7 5 0 . 1 8 1 4 ) 1 1 . 6 7 0 3 0 . 1 6 2 3 ) 4 . 5 5 0 6 0 . 1 4 5 1
H 1 3 2 0 . 9 0 8 3 0 . 1 7 3 1 ) 1 1 . 6 9 7 2 0 . 1 7 1 0 ) 4 . 9 8 7 2 0 . 1 5 9 0
C 1 4 1 . 6 5 7 3 0 . 0 1 2 4 ) 1 2 . 0 6 1 2 0 . 0 1 1 9 ) 0 . 6 8 4 4 0 . 0 1 0 6
C 1 5 1 . 0 9 6 1 0 . 0 1 2 4 ) 1 1 . 3 3 2 7 0 . 0 1 3 2 ) - 0 . 3 5 6 7 0 . 0 1 1 4
HI  5 0 . 8 4 8 5 0 . 1 4 8 2 ) 1 0 . 1 4 3 8 0 . 1 5 9 1 ) - 0 . 3 4 1 8 0 . 1 3 1 8
C l  7 1 . 6 0 6 8 0 . 0 1 2 1 ) 1 3 . 3 3 2 0 0 . 0 1 3 2 ) - 1 . 2 0 5 2 0 . 0 1 0 0
C l  8 1 . 9 6 9 6 ( 0 - 0 1 1 7 ) 1 3 . 3 6 4 3 ( 0 . 0 1 2 4 ) 0 . 1 4 4 8 ( 0 . 0 0 9 6 )
C l  9 2 . 5 4 2 9 ( 0 . 0 1 5 1 ) 1 4 . 5 2 1 5  (0 . 0 1 3 0 ) 0 . 6 4 0 7 ( 0 . 0 1 2 7 )
H1 9 2 . 5 4 2 1  ( 0 . 1 6 1 0 ) 1 4 . 6 0 4 2 ( 0 . 1 5 4 6 ) 1 . 4 3 0 6 ( 0 . 1 5 5 2 )
C20 2 . 7 3 8 4  ( 0 . 0 1 7 4 ) 1 5 . 5 8 1 9 ( 0 . 0 1 5 6 ) - 0 . 2 0 6 1 ( 0 . 0 1 6 7 )
H20 3 . 1 2 1 5  ( 0 . 1 9 4 7 ) 1 6 . 4 2 5 9 ( 0 . 1 8 5 8 ) 0 . 1 1 0 7  ( 0 . 1 6 8 9 )
C 2 1 2 . 3 5 9 8 ( 0 . 0 1 6 4 ) 1 5 . 5 3 9 9  (0 . 0 1 7 4 ) - 1 . 5 2 5 8  ( 0 . 0 1 6 3 )
H21 2 . 4 5 7 3 ( 0 . 1 6 8 9 ) 1 6 . 3 9 4 2 ( 0 . 1 8 3 2 ) - 2 . 1 0 4 6 ( 0 . 1 7 8 4 )
C 2 2 1 . 7 6 9 5 ( 0 . 0 1 3 2 ) 1 4 . 4 1 7 6  (0 . 0 1 5 6 ) - 2 . 0 6 7 5 ( 0 . 0 1 2 3 )
H22 1 . 9 1 6 7  ( 0 . 1 5 8 8 ) 1 4 . 1 4 2 2  (0 . 1 4 8 5 ) - 2 . 8 4 2 7 ( 0 . 1 5 1 8 )
B o n d  d i s t a n c e s  ( A n g s t r o m )
D i s t a n c e  e . : s . d .
C L 2 3 - H23 1 . 6 6 4 8 0 . 1 7 5 1
0 2 5 - C 2 6 1 . 4 2 6 4 0 . 0 1 8 9
C2 6 - H 2 6 1 1 . 1 1 2 5 0 . 2 0 6 9
C2 6 - H2 6 2 1 . 2 0 8 4 0  . 0 1 6 0
C2 6 - H 2 6 3 0 . 9 8 0 3 0 . 1 8 3 2
N1 - HI 1 . 0 0 8 0 0 . 1 4 3 1
N1 - C2 1 . 4 9 6 7 0 . 0 1 5 5
N1 - C 6 1 . 5 0 4 6 0 . 0 1 5 7
N1 - C9 1 . 5 0 6 8 0 . 0 1 8 3
N 1 0 - H10 0 . 9 5 8 6 0 . 1 5 5 3
N1 0 - C4 1 . 4 9 4 7 0 . 0 1 3 9
N 1 0 - C l l 1 . 3 5 9 0 0 . 0 1 5 8
N 1 2 - H1 2 0 . 9 7 7 1 0 . 1 5 9 3
N 1 2 - C l l - 1 . 3 3 9 3 0 . 0 1 4 7
N 1 2 - C 1 3 1 . 4 5 4 6 0 . 0 1 6 3
N 1 6 - H1 6 0 . 7 3 3 8 0 . 1 6 4 2
N 1 6 - C 1 5 1 . 3 4 6 1 0 . 0 1 6 3
N 1 6 - C 1 7 1 . 3 7 2 3 0 . 0 1 7 8
C2 - H2 1 . 1 3 9 0 0 . 1 4 9 8
C2 - C3 1 . 5 4 4 0 0 . 0 1 6 3
C2 - C 8 1 . 5 2 1 5 0 . 0 1 8 3
C3 - H31 1 . 0 3 7 4 0 . 1 5 4 6
C3 - H32 1 . 1 3 8 8 0 . 1 3 6 2
C3 - C4 1 . 5 2 7 5 0 . 0 1 6 5
C4 - C5 1 . 5 3 2 6 0 . 0 1 7 6
C4 - C 1 3 1 . 6 0 3 3 0 . 0 1 7 0
C5 - H5 1 0 . 9 0 1 5 0 . 1 4 4 4
C5 - H52 1 . 2 6 2 7 0 . 0 1 2 7
C5 - C 6 1 . 5 2 0 1 0 . 0 1 6 7
C 6 - H6 1 . 0 3 0 8 0 . 1 5 6 3
C 6 - C l 1 . 5 2 0 4 0 . 0 1 8 1
C l - H7 1 0 . 9 7 2 0 0 . 1 7 0 2
C l - H72 1 . 0 3 1 0 0 . 1 6 0 4
C l - C 8 1 . 5 5 0 4 0 . 0 1 8 1
C 8 - H8 1 0 . 9 7 4 5 0 . 1 3 9 9
C 8 - H82 1 . 0 1 3 0 0 . 1 7 1 3
C9 - H91 1 . 0 7 3 5 0 . 1 8 2 8
C9 - H92 0 . 8  64 9 0 . 0 1 8 6
C9 - H93 1 . 1 0 1 9 0 . 0 1 5 2
C l l - C 1 4 1 . 3 8 3 2 0 . 0 1 5 0
C l  3 - H 1 3 1 0 . 9 1 8 3 0 . 1 7 5 2
C 1 3 - H 1 3 2 1 . 1 9 4 8 0 . 1 7 9 4
C 1 4 - C 1 5 1 . 3 8 9 0 0 . 0 1 5 8
C 1 4 - C 1 8 1 . 4 4 4 5 0 . 0 1 7 0
C l  5 - H 1 5 1 . 2 1 4 5 0 . 1 5 9 3
C 1 7 - C 1 8 1 . 3 9 8 3 0 . 0 1 3 5
C l  7 - C 2 2 1 . 3 9 5 9 0 . 0 1 8 9
C 1 8 - C 1 9 1 . 3 8 3 3 0 . 0 1 7 6
C l  9 - H 1 9 0 . 7 9 4 3 0 . 1 5 5 7
C l  9 - C2 0 1 . 3 7 1 0 0 . 0 2 0 9
C 2 0 - H20 0 . 9 7 9 5 0 . 1 8 3 3
C20 - C 2 1 1 . 3 7 3 6 0 . 0 2 2 4
C 2 1 - H2 1 1 . 0 3 6 5 0 . 1 8 3 7
C 2 1 - C 2 2 1 . 3 7 8 9 0 . 0 2 2 1
C 2 2 - H22 0 . 8 3 5 8 0 . 1 5 5 9
Number o f  b o n d  d i s t a n c e s : 55
IX
B o n d  a n g l e s  ( d e g r e e s )
( e . s . d .  f o l l o w i n g  C r u i c k s h a n k ,  I n t e r n a t .  T a b l e s ,  1 1 ,  1 9 5 9 ,  p . 3 3 1 )
A n g l e e .  s . '
0 2 5 - C2 6 -  H2 63 1 0 9 . 3 8 1 0 . 8 6
0 2 5 - C2 6 -  H2 62 1 0 4 . 1 6 1 . 2 1
0 2 5 - C2 6 -  H2 61 1 1 5 . 7 6 8 . 9 1
H2  62 - C 2 6 -  H2 63 1 1 7 . 4 9 1 1 . 3 1
H2 61 - C2 6 -  H263 92 . 6 8 1 3 . 8 8
H2 6 1 - C2 6 -  H2 62 1 1 7 . 5 3 9 . 1 8
C 6 - N l -  C9 1 1 2  . 4 1 0 . 98
C2 - N l -  C9 1 1 3 . 9 5 0 . 9 9
C2 - N l -  C 6 1 0 2 . 2 2 0 . 8 9
HI - N l -  C9 9 9 . 5 5 8 . 3 1
HI - N l -  C 6 1 2 3 . 0 2 8 . 0 9
HI - N l -  C2 1 0 6 . 0 7 8 . 1 6
C4 - N1 0 -  C l l 1 1 3 . 2 9 0 . 8 9
HI 0 - N1 0 -  C l l 1 2 8 . 3 0 8 . 90
H10 - N1 0 -  C4 1 1 8 . 3 4 8 . 9 0
C l l - N 1 2 -  C 1 3 1 1 3 . 8 1 1 . 0 2
H1 2 - N 1 2 -  C 1 3 1 0 9 . 9 1 7 . 7 0
H12 - N 1 2 -  C l l 1 2 5  . 2 4 7 . 7 8
C 1 5 - N l  6 -  C l  7 1 1 0 . 3 2 1 . 0 0
HI 6 - N l  6 -  C 1 7 1 3 4 . 2 3 1 3 .  94
HI 6 - N 1 6 -  C l  5 1 1 4 . 9 2 1 3 . 8 8
Nl - C2 -  C 8 1 0 1 . 9 8 0.  95
N l - C2 -  C3 1 0 8 . 6 9 0 . 9 3
N l - C2 -  H2 1 1 5 . 9 4 7 . 3 8
C3 - C2 -  C 8 1 1 5 . 0 0 1 . 0 4
H2 - C2 -  C 8 1 0 0 . 2 7 7 . 1 3
H2 - C2 -  C3 1 1 4  . 2 7 7 . 3 2
C2 - C3 -  C4 1 1 1 . 9 8 0.  92
C2 - C3 -  H32 1 0 3 . 6 2 6 . 7 5
C2 - C3 -  H31 1 2 4  . 2 7 7 . 9 9
H32 - C3 -  C4 1 0 8 . 6 7 7 .  1 6
H31 - C3 -  C4 1 1 1  . 1 9 8 . 0 2
H31 - C3 -  H32 94 . 1 3 1 0 . 4 3
N10 - C4 -  C3 1 0 7 . 9 0 0 . 8 7
C3 - C4 -  C l  3 1 1 4 . 3 5 0 . 9 9
C3 - C4 -  C5 1 1 2 . 1 7 0 . 9 3
N l  0 - C4 -  C l  3 1 0 0 . 0 5 0.  85
N10 - C4 -  C5 1 0 9 . 2 2 0 . 8 9
C5 - C4 -  C 1 3 1 1 2  . 2 7 1.00
C4 - C5 -  C 6 1 1 5 . 0 4 1.00
C4 - C5 -  H52 1 0 3  . 5 3 0.  92
C4 - C5 -  H5 1 1 0 7  . 1 5 9 . 5 3
H52 - C5 -  C 6 1 0 9 . 2 6 0.  95
H51 - C5 -  C 6 1 1 1 . 3 5 9 . 4 8
H5 1 - C5 -  H52 1 1 0 . 2 0 9 .  6 8
N l - C 6 -  C5 1 0 6 . 1 6 0 . 9 4
C5 - C 6 -  C l 1 1 4 . 2 9 1 . 0 8
C5 - C 6 -  H6 9 3 . 9 0 8 . 1 1
N l - C 6 -  C l 1 0 1 . 8 1 0 . 9 4
N l - C 6 -  H6 1 0 6 . 0 2 8 . 3 3
H6 - C 6 -  C l 1 3 2 . 5 1 8 . 0 3
C 6 - C7 -  C 8 1 0 5 . 2 2 1 . 0 9
C 6 - C l -  H72 1 2 3 . 3 9 8 . 3 0
C 6 - C l -  H7 1 1 1 0 . 8 3 8 . 8 3
H72 - C l -  C 8 1 0 2 . 7 5 8 . 1 1
H7 1 - C l -  C 8 1 0 6  . 3 8 9 . 5 9
H7 1 - C l -  H7 2 1 0 6 . 8 4 1 2 . 1 0
C2 - C 8 -  C l 1 0 4 . 7 1 1 . 0 4
C7 - C 8 -  H82 1 0 7 . 5 9 9 .  62
C7 - C 8 -  H81 1 1 8 . 3 4 8 . 7 3
C2 - C 8 -  H82 1 1 7 . 3 4 8 . 8 7
C2 - C 8 -  H8 1 1 0 5 . 1 3 8 . 6 8
H81 - C 8 -  H82 1 0 4 . 3 6 1 2 . 5 2
X
N l - C9 - H93 1 1 5  . 4 8 1 . 2 7
N l - C9 - H92 1 0 1 . 0 1 1 . 3 4
N l - C9 - H91 1 1 5 . 3 6 9 .  45
H92 - C9 - H93 1 0 9 . 0 9 1 .  78
H91 - C9 - H93 1 0 5 . 3 5 9 .  28
H91 - C9 - H92 1 1 0 . 4 7 9 .  92
N l  0 - C l l - N 1 2 1 0 9 . 1 5 0.  98
N 1 2 - C l l - C 1 4 1 2 6 . 8 4 1 . 1 0
N10 - C l l - C l  4 1 2 4  . 0 0 1 . 0 6
N1 2 - C l  3 - C4 1 0 3 . 1 9 0 . 93
C4 - C 1 3 - HI 32 1 0 8 . 9 5 8 . 30
C4 - C l  3 - H 1 3 1 1 0 6  . 58 1 0 . 5 9
N l  2 - C 1 3 - HI 32 1 1 0  . 8 9 8 . 2 6
N 1 2 - C 1 3 - H 1 3 1 98 . 2 1 1 0 . 1 0
H 1 3 1 - C 1 3 - HI 32 1 2 6 . 4 4 1 2  . 1 8
C l l - C 1 4 - C l  8 1 3 0 . 1 8 1 . 0 2
C l l - C 1 4 - C l  5 1 2 3 . 3 9 1 . 1 0
C l  5 - C 1 4 - C l  8 1 0 6 . 2 9 0 . 9 5
N l  6 - C 1 5 - C l  4 1 0 9 . 1 0 1 . 1 0
C 1 4 - C 1 5 - HI  5 1 2 5 . 9 1 6 . 56
N l  6 - C 1 5 - HI 5 1 2 3 . 9 3 6 . 5 1
N l  6 - C l  7 - C 2 2 1 2 8 . 9 9 1 . 0 6
N l  6 - C 1 7 - C l  8 1 0 7 . 7 7 1 . 0 7
C 1 8 - C l  7 - C 2 2 1 2 3 . 2 4 1 . 1 1
C l  4 - C l  8 - C l  7 1 0 6 . 4 8 1 . 0 3
C l  7 - C 1 8 - C l  9 1 1 8  . 2 2 1 . 0 3
C 1 4 - C 1 8 - C l  9 1 3 5 . 2 6 1 . 0 1
C 1 8 - C l  9 - C20 1 1 8 . 9 9 1 . 2 4
C l  8 - C l  9 - HI 9 1 1 6 . 3 1 1 1 . 3 3
HI 9 - C l  9 - C20 1 2 2 . 2 6 1 1 . 2 6
C l  9 - C2 0 - C 2 1 1 2 2 . 0 3 1 . 4 6
C l  9 - C20 - H20 1 2 1 . 5 0 1 0 . 06
H2 0 - C20 - C 2 1 1 1 6 . 4 2 1 0 . 1 5
C20 - C 2 1 - C 2 2 1 2 1 . 3 5 1 . 4 9
C20 - C 2 1 - H21 1 1 9 . 0 4 1 0 . 0 6
H21 - C 2 1 - C 2 2 1 1 9 . 4 5 9 . 9 2
C 1 7 - C 2 2 - C 2 1 1 1 6 . 1 2 1 . 2 1
C 2 1 - C 2 2 - H22 1 2 3 . 8 6 1 0 .  64
C l  7 - C 2 2 - H22 1 0 9 . 7 1 1 0 . 2 9
N u m b e r  o f  a n g l e s :  1 0 2
T o r s i o n  a n g l e s  ( d e g r e e s )
( r i g h t - h a n d  r u l e ,  K l y n e  S P r e l o g .  ( 1 9 6 0 )  . E x p e r i e n t i a , 1 6 , 5 2 1 )  
( e . s . d .  f o l l o w i n g  S t a n f o r d  & W a a e r ,  A c t a  C r y s t . ( 1 9 7 2 ) . A 2 8 , 2 1 3 )
A n g l e  e . s . d .
C 6 - N l - C 9 - H 9 1 6 5 . 4 4 1 0 . 7 3
C2 - N l - C 9 - H 9 1 - 1 7 8 . 8 6 1 0 .  67
HI - N l - C 9 - H 9 1 - 6 6 . 4 1 1 3 . 5 0
C 6 - N l - C 9 - H 9 2 - 1 7 5 . 4 5 1 . 2 1
C2 - N l - C 9 - H 9 2 - 5 9 . 7 5 1 .  63
HI - N l - C 9 - H 9 2 5 2 . 7 0 8 . 3 5
C 6 - N l - C 9 - H 9 3 - 5 7 . 9 5 1 .  65
C2 - N l - C 9 - H 9 3 5 7 . 7 5 1 .  67
HI - N l - C 9 - H 9 3 1 7 0  . 2 0 8 . 3 1
C2 - N l - C 6 - H 6 1 7 2 . 1 8 8 . 78
HI - N l - C 6 - H 6 5 3 . 5 9 1 3 . 1 0
C2 - N l - C 6 - C l - 4 6 . 7 2 1 . 0 9
HI - N l - C 6 - C l - 1 6 5 . 3 1 9 . 7 2
C9 - N l - C 6 - C 5 - 1 6 4 . 2 6 1 . 0 4
C2 - N l - C 6 - C 5 7 3  . 1 6 1 . 0 6
HI - N l - C 6 - C 5 - 4 5 . 4 3 9 .  76
HI - N l - C 2 - H2 - 7 4  . 8 4 1 1 . 8 9
HI - N l - C 2 - C 3 5 5 . 4 8 8 . 5 1
HI - N l - C 2 - C 8 1 7 7 . 3 4 8 . 4 8
C 6 - N l - C 2 - C 8 4 7  . 3 6 1 . 0 7
C 6 - N l - C 2 - C 3 - 7 4 . 5 1 1 . 0 6
C 6 - N l - C 2 - H 2 1 5 5 . 1 7 8 . 3 5
C9 - N l - C 2 - C 8 - 7 4 . 1 8 1 . 2 3
XI
C9 - N 1 - C 2 - C 3 1 6 3 . 9 6 1 .  04
C9 - N 1 - C 2 - H2 3 3 . 6 4 6 . 42
C9 - N 1 - C  6 -Cl 7 5  . 8 7 1 . 2 2
C9 - N 1 - C 6 - H 6 - 6 5 . 2 3 8 . 83
C4 - N I O - C l l - C 1 4 - 1 7 3 . 8 6 1 . 0 5
H10 - N I O - C l l - C 1 4 2 . 8 9 1 1 .  7 7
C4 - N I O - C l l - N 1 2 7 . 58 1 .  34
HIO - N I O - C l l - N 1 2 - 1 7 5 . 6 7 1 1 . 6 6
HIO - NI O - C 4 - C 5 - 6 6 . 0 2 1 0 .  43
HIO - N I O - C 4 - C 1 3 1 7 5  . 98 1 0  . 40
C l l - N I O - C 4 - C 3 - 1 2 6 . 7 4 1 .  03
HIO - N I O - C 4 - C 3 5 6 . 1 6 1 0  . 43
C l l - N I O - C 4 - C 1 3 - 6  . 92 1 .  23
C l l - N I O - C 4 - C 5 1 1 1 . 0 8 1 . 0 9
H12 - N 1 2 - C l l - N I O - 1 4 4  . 80 1 0  . 67
C l  3 - N 1 2 - C l l - N I O - 4 . 6 6 1 .  44
C l l - N 1 2 - C 1 3 - H 1 3 1 1 0 9 . 4 6 1 0 .  39
H12 - N 1 2 - C 1 3 - H 1 3 1 - 1 0 4  . 37 1 3 .  89
C l l - N 1 2 - C l  3 - H 1 3 2 - 1 1 6 . 3 2 8 . 70
H12 - N 1 2 - C 1 3 - H 1 3 2 2 9 . 8 5 1 2  . 7 1
C l l - N 1 2 - C l  3 - C 4 0 . 2 0 1 .  39
H12 - N 1 2 - C 1 3 - C 4 1 4 6 . 3 7 9 . 2 7
H12 - N 1 2 - C l l - C 1 4 3 6 . 6 9 1 0 . 79
C l  3 - N 1 2 - C l l - C 1 4 1 7 6 . 8 3 1 . 1 9
C 1 5 - N 1 6 - C 1 7 - C 1 8 1 . 0 8 1 . 4 3
HI 6 - N 1 6 - C 1 7 - C 1 8 1 7 1 . 9 6 1 9 .  20
C l  5 - N 1 6 - C 1 7 - C 2 2 - 1 7 9 . 1 2 1 . 2 8
HI 6 - N 1 6 - C 1 7 - C 2 2 - 8  . 2 4 1 9 . 3 2
HI 6 - N 1 6 - C l  5 - H 1 5 1 6 . 3 1 1 7  . 39
C 1 7 - N 1 6 - C 1 5 - C 1 4 - 2 . 0 5 1 .  4 7
HI 6 - N 1 6 - C l  5 - C 1 4 - 1 7 4 . 8 5 1 5  . 1 7
C l  7 - N 1 6 - C l  5 - H I  5 - 1 7 0 . 8 9 8 . 4 2
N1 - C 2 - C 8 - H 8 1 9 6 . 2 8 9.  0 2
N1 - C 2 - C 8 - H8 2 - 1 4 8  . 32 1 0 . 42
N1 - C 2 - C 8 -Cl - 2 9 . 1 4 1 . 2 0
N1 - C 2 - C 3 - H 3 1 - 1 6 4 . 1 8 9.  67
N1 - C 2 - C 3 - H 3 2 - 5 9 . 4 2 7 . 2 3
N1 - C 2 - C 3 - C 4 5 7 . 5 1 1 . 2 1
C3 - C 2 - C 8 - H 8 1 - 1 4 6 . 3 1 9 . 0 1
H2 - C 2 - C 8 - H 8 1  - - - 2 3 . 2 6 1 1 . 8 0
C3 - C 2 - C 8 - H8 2 - 3 0 . 9 1 1 0 . 49
H2 - C 2 - C 8 - H 8 2  - 9 2 . 1 5 1 2 .  91
C3 - C 2 - C 8 -Cl 8 8  . 2 7 1 . 2 4
H2 - C 2 - C 8 -Cl - 1 4 8 . 6 7 7 .  64
H2 - C 2 - C 3 - H 3 1  — ' - 3 2 . 9 5 1 2 . 7 3
H2 - C 2 - C 3 - H 3 2  — 7 1 . 8 0 1 0 .  93
H2 - C 2 - C 3 - C 4 - 1 7 1 . 2 6 8 . 24
C 8 - C 2 - C 3 - C 4 - 5 6 . 0 4 1 . 3 5
C 8 - C 2 - C 3 - H 3 2 - 1 7 2 . 9 7 7 . 2 1
C 8 - C 2 - C 3 - H 3 1 8 2 . 2 7 9 .  72
C2 - C 3 - C 4 - N I O - 1 5 8 . 4 9 0 . 9 3
H32 - C 3 - C 4 - N I O - 4 4 . 6 4 7 . 4 2
H31 - C 3 - C 4 - N I O 5 7  . 63 8 . 60
C2 - C 3 - C 4 - C 5 - 3 8 . 1 5 1 . 2 9
C2 - C 3 - C 4 - C l  3 9 1 . 1 7 1 . 2 0
H32 - C 3 - C 4 - C 5 7 5 . 7 0 7 . 4 2
' H31 - C 3 - C 4 - C 5 1 7 7 . 9 7 8 . 5 7
H32 - C 3 - C 4 - C 1 3 - 1 5 4 . 9 7 7 . 3 9
H31 - C 3 - C 4 - C 1 3 - 5 2 . 7 0 8 . 62
NIO - C 4 - C 1 3 - N 1 2 3 . 7 7 1 . 1 8
C3 - C 4 - C 1 3 - N 1 2 1 1 8  . 7 8 1 . 0 9
C5 - C 4 - C l  3 - N 1 2 - 1 1 1 . 9 4 1 . 1 1
C3 - C 4 - C l  3 - H 1 3 1 1 5 . 9 0 1 0 . 7 8
NIO - C 4 - C 1 3 - H 1 3 1 - 9 9 . 1 1 1 0 . 7 3
C3 - C 4 - C 1 3 - H 1 3 2 - 1 2 3 . 3 3 8 . 5 8
NIO - C 4 - C 1 3 - H 1 3 2 1 2 1 . 6 6 8 . 5 8
C3 - C 4 - C 5 - H 5 1 - 8 4 . 4 2 1 0 . 0 2
NIO - C4 - C5 - H 5 1 3 5 . 1 5 1 0 . 0 4
XII
C3 - C 4 - C 5 - H5 2 1 5 9 . 1 0 0 .
N10 - C 4 - C 5 - H 5 2 - 8 1 . 3 3 1 .
C3 - C 4 - C 5 - C 6 3 9 . 9 6 1 .
N l  0 - C 4 - C 5 - C 6 1 5 9 . 5 3 0 .
C5 - C 4 - C l  3 - H 1 3 1 1 4 5 . 1 8 1 0 .
C5 - C 4 - C l  3 - H 1 3 2 5 . 9 4 8 .
C l  3 - C 4 - C 5 - C 6 - 9 0 . 4 4 1 .
C 1 3 - C 4 - C 5 - H 5 2 28 . 70 1 .
C 1 3 - C 4 - C 5 - H 5 1 1 4 5 . 1 8 1 0  .
C4 - C 5 - C 6 - N l - 5 8 . 1 5 1 .
H52 - C 5 - C 6 - N l - 1 7 4  . 0 5 0 .
H51 - C 5 - C 6 - N l 64 . 0 0 1 0  .
C4 - C 5 - C 6 - H 6 - 1 6 6 . 0 7 8 .
C4 - C 5 - C 6 - C l 5 3 . 2 3 1 .
H52 - C 5 - C 6 - H 6 7 8 . 0 3 8 .
H51 - C 5 - C 6 - H 6 - 4 3 . 9 3 1 3 .
H52 - C 5 - C 6 - C l - 6 2 . 6 7 1 .
H51 - C 5 - C 6 - C l 1 7 5 . 3 7 1 0 .
C5 - C 6 - C 7 - H 7 1 28 . 2 8 1 0  .
N l - C 6 - C l - H 7 1 1 4 2  . 2 5 1 0 .
C5 - C 6 - C l - H 7 2 1 5 6 . 7 4 1 0 .
N l - C 6 - C l - H 7 2 - 8 9 . 2 9 1 0 .
C5 - C 6 - C l - C 8 - 8 6 . 3 2 1 .
N l - C 6 - C l - C 8 2 7  . 6 6 1 .
H6 - C 6 - C l - H 7 1 - 9 2 . 7 1 1 5  .
H6 - C 6 - C l - H 7 2 3 5 . 7 4 1 5 .
H6 - C 6 - C l - C 8 1 5 2 . 6 9 1 1 .
C 6 - C l - C 8 - C 2 0 . 8 0 1 .
H72 - C l - C 8 - C 2 1 3 1 . 0 6 8 .
H71 - C l - C 8 - C 2 - 1 1 6 . 8 5 9 .
C 6 - C l - C 8 - H 8 1 - 1 1 5 . 8 4 9.
C 6 - C l - C 8 - H 8 2 1 2 6 . 3 4 9.
H7 2 - C l - C 8 - H 8 1 1 4 . 4 2 1 3 .
H7 1 - C l - C 8 - H 8 1 1 2 6 . 5 1 1 3 .
H7 2 - C l - C 8 - H8 2 - 1 0 3 . 4 0 1 2 .
H71 - C l - C 8 - H8 2 8 . 69 1 3 .
N1 2 - C l l - C 1 4 - C 1 5 - 1 5 4 . 2 9 1 .
N10 - C l l - C l  4 - C 1 5 2 7 . 4 1 1 .
N1 2 - C l l - C 1 4 - C l  8 2 0 . 8 2 2 .
N10 - C l l - C 1 4 - C 1 8 - 1 5 7 . 4 8 1 .
C l l - C 1 4 - C 1 5 - N 1 6 1 7 8 . 2 6 1 .
C l l - C 1 4 - C l  8 - C 1 9 5 . 0 6 2 .
C l l - C 1 4 - C l  8 - C 1 7 - 1 7 7 . 2 1 1 .
C l l - C 1 4 - C 1 5 - H 1 5 - 1 3 . 1 8 8 .
C l  8 - C 1 4 - C l  5 - N 1 6 2 . 1 4 1 .
C 1 5 - C 1 4 - C 1 8 - C 1 9 - 1 7 9 . 1 9 1 .
C l  5 - C 1 4 - C l  8 - C 1 7 - 1 . 4 6 1 .
C l  8 - C 1 4 - C 1 5 - H 1 5 1 7 0 . 7 0 3 .
N 1 6 - C 1 7 - C 1 8 - C 1 4 0 . 2 7 1 .
N l  6 - C 1 7 - C 2 2 - H 2 2 - 3 1 . 1 0 1 1 .
N 1 6 - C 1 7 - C 2 2 - C 2 1 - 1 7 7 . 7 0 1 .
N l  6 - C 1 7 - C 1 8 - C l  9 1 7 8 . 4 6 1 .
0.22 - C 1 7 - C 1 8 - C 1 4 - 1 7 9 . 5 5 1 .
C l  8 - C 1 7 - C 2 2 - H 2 2 1 4 8 . 6 7 1 1 .
C 1 8 - C 1 7 - C 2 2 - C 2 1 2 . 0 8 1 .
C22 - C 1 7 - C 1 8 - C 1 9 - 1 . 3 6 1 .
C l  7 - C 1 8 - C l  9 - H 1 9 1 6 2 . 3 7 1 2 .
C l  4 - C 1 8 - C 1 9 - H I  9 - 2 0 . 0 9 1 2 .
C 1 7 - C 1 8 - C l  9 - C 2 0 - 0 . 3 5 1 .
C l  4 - C 1 8 - C l  9 - C 2 0 1 7 7 . 1 9 1 .
C 1 8 - C 1 9 - C 2 0 - H2 0 1 7 8 . 5 3 1 2 .
C 1 8 - C 1 9 - C 2 0 - C 2 1 1 . 2 4 2 .
HI 9 - C l  9 - C 2 0 - H2 0 1 6 . 8 9 1 8 .
HI 9 - C 1 9 - C 2 0 - C 2 1 - 1 6 0 . 4 0 1 3 .
C l  9 - C 2 0 - C 2 1 - H 2 1 1 7 4 . 9 8 1 1 .
C l  9 - C 2 0 - C 2 1 - C 2 2 - 0  . 4 7 2 .
H20 - C 2 0 - C 2 1 - H 2 1 - 2 . 4 4 1 6 .
H20 - C 2 0 - C 2 1 - C 2 2 - 1 7 7 . 8 9 1 2 .
87
04
36
97
7 2
64
24
24
00
2 5
86
29
47
43
48
29
32
2 6
1 7
10
04
07
27
22
2 7
30
46
33
60
85
90
7 2
11
92
94
83
22
85
05
20
1 3
33
21
7 7
38
39
30
62
32
35
3 5
12
1 6
23
96
84
70
86
90
39
67
32
58
50
28
5 5
5 9
08
XIII
C20 - C 2 1 - C 2 2 - C 1 7 - 1 . 1 5 2 . 24
H21 - C 2 1 - C 2 2 - C 1 7 - 1 7 6 . 5 7 1 1 .  31
C20 - C 2 1 - C 2 2 - H2 2 - 1 4 2  . 5 3 1 2  . 76
H21 - C 2 1 - C 2 2 - H2 2 42 . 05 1 7 . 1 0
N u m b e r o f  t o r s i o n a n g l e s : 1 6 3
W e i g h t e d  l e a s t - s q u a r e s  p l a n e s  t h r o u g h t h e  s t a r r e d a t o m s
( N a r d e l l i ,  M u s a t t i ,  D o m i a n o  4 A n d r e e t t i  R i c . S c i . ( 1 9 6 5 ) ,  1 5 ( 1 1 -
S q u a t i o n  o f  t h e  p l a n e :  m l * X + m 2 * Y + m 3 * Z = d
P l a n e  
ml  = 
m2  = 
m3 =
D = 
A t o m
1
- 0 . 9 9 8 1 3  ( 0 . 0 0 0 3 3 )  
0 . 0 5 1 7 0  ( 0 . 0 4 2 4 4 )  
- 0 . 0 3 2 4 9  ( 0 . 0 6 1 6 2 )  
- 1  . 4 3 4 4 9  (0 . 6 5 2 4 4 )  
d s d / s ( d / s ) * * 2
C4 0 . 0 0 0 0 0 . 0 1 1 9 0 . 0 0 0 0 . 0 0 0
Nl * 0 . 0 0 0 0 0 . 0 0 9 6 0 . 0 0 0 0 . 0 0 0
C9 * 0 . 0 0 0 0 0 . 0 1 9 2 0 . 0 0 0 0 . 0 0 0
C2 - 1 . 1 7 1 6 0 . 0 1 2 4 - 9 4 . 6 0 2 8 9 4 9 . 5 2 7
CS 1 . 1 6 3 5 0 . 0 1 1 8 9 8 . 2 1 3 9 6 4 5 . 7 6 8
C3 - 1 . 2 7 8 6 0 . 0 1 2 7 - 1 0 0 . 3 8 7 1 0 0 7 7  . 644
C5 1 . 2 5 9 7 0 . 0 1 2 8 98 . 0 6 4 9 6 1 6 . 5 2 9
C7 0 . 7 2 9 0 0 . 0 1 2 8 5 7  . 1 4 5 3 2 6 5 . 5 1 1
C 8 - 0 . 8 2 0 9 0 . 0 1 2 9 - 6 3 . 8 1 8 4 0 7 2 . 7 7 5
C 1 3 0 . 0 1 6 5 0 . 0 1 8 5 0 . 8 9 1 0 . 79 4
N1 0 0 . 0 2 5 7 0 . 0 1 1 6 2  . 2 2 0 4 . 928
C l l 0 . 2 0 2 1 0 . 0 1 0 9 1 8  . 4 9 8 3 4 2  . 1 6 1
N 1 2 0 . 1 4 0 3 0 . 0 1 1 1 1 2 . 6 0 3 1 5 8 . 8 2 9
C L 2 3 - 0 . 6 3 9 5 0 . 0 0 4 0 - 1 6 1 . 5 2 4 2 6 0 8 9 . 9 3 4
C L 2 4 1 . 4 7 2 2 0 . 0 0 3 3 4 4 9  . 9 7 5 2 0 2 4 7 7 . 6 7 2
02 5 0 . 0 1 3 0 0 . 0 0 9 7 1 . 3 3 6 1 . 7 8 6
C2 6 - 0 . 8 5 3 5 0 . 0 1 8 4 - 4 6 . 4 0 0 2 1 5 2 . 9 7 0
C 1 4 0 . 3 8 1 7 0 . 0 1 2 4 3 0 . 8 7 3 9 5 3 . 1 3 4
C 1 5 0 . 9 3 8 0 0 . 0 1 2 4 7 5 . 7 5 8 5 7 3 9 . 2 5 6
N l  6 1 . 0 1 1 7 0 . 0 1 2 4 8 1 . 3 6 0 6 6 1 9 . 4 6 2
C l  7 0 . 5 5 9 2 0 . 0 1 2 1 4 6 . 4 0 0 2 1 5 2  . 9 2 5
C l  8 0 . 1 5 4 8 0 . 0 1 1 7 1 3 . 2 7 4 1 7 6 . 2 0 2
C l  9 - 0 . 3 7 3 6 0 . 0 1 5 1 - 2 4 . 6 9 4 6 09  . 8 1 3
C20 - 0 . 4 8 6 4 0 . 0 1 7 4 - 2 7  . 934 7 8 0 . 3 2 2
C 2 1 - 0 . 0 6 7 8 0 . 0 1 6 4 - 4 . 1 4 9 1 7  . 2 1 3
C2 2 0 . 4 8 0 9 0 . 0 1 3 2 3 6 . 5 3 5 1 3 3 4  . 7 7 0
Sum ( ( d / s ) * * 2 ) f o r  s t a r r e d  a t o m s 0  . 0 0 0
P l a n e  
m l  — 
m2  -  
m3 -  
D «  -  
A t o m
2
- 0 . 0 4 4 8 7  ( 0 . 0 0 5 0 1 )  
- 0 . 8 6 4 7 5 ( 0 . 0 0 4 1 8 )  
- 0  . 5 0 0 1 9  ( 0 . 0 0 7 2 2 )  
• 1 0 . 1 1 6 1 7 ( 0 . 0 0 9 1 5 )  
d 3 d / s ( d / s ) * * 2
C2 * 0 . 0 0 3 5 0 . 0 1 2 4 0 . 2 8 0 0 . 0 7 8
C3 * - 0 . 0 0 2 8 0 . 0 1 1 5 - 0 . 2 3 9 0 . 0 5 7
C5 * 0 . 0 0 3 2 0 . 0 1 2 3 0 . 2 5 8 0 . 0 6 7
C 6 * - 0 . 0 0 3 7 0 . 0 1 2 7 - 0 . 2 9 0 0 . 0 8 4
N l 0 . 8 6 5 1 0 . 0 0 9 1 9 5 . 0 7 9 9 0 4 0 . 1 0 5
C4 - 0 . 4 9 3 8 0 . 0 1 0 4 - 4 7 . 3 0 7 2 2 3 7 . 9 7 2
C7 - 1 . 3 4 0 8 0 . 0 1 5 3 - 8 7 . 8 4 3 7 7 1 6 . 3 7 5
C 8 - 1 . 3 3 3 2 0 . 0 1 4 3 - 9 3 . 5 4 5 8 7 5 0 . 7 2 6
Sum ( ( d / s ) * * 2 ) f o r  s t a r r e d  a t o m s 0  . 2 8 6
C h i - s q u a r e d  a t  95% f o r  1  d e g r e e s  o f  f r e e d o m :  3 . 8 4
T h e  g r o u p  o f  a t o m s  d o e s  n o t  d e v i a t e  s i g n i f i c a n t l y  f r o m  p l a n a r i t y
P l a n e  3
m l  -  0 . 0 5 2 5 2 ( 0 . 0 0 6 4 7 )
XIV
m2  = 0 . 8 1 2 8 9  ( 0 . 0 0 5 3 9 )
m3 = - 0  . 5 8 0 0 5  ( 0 . 0 0 7 5 6 )
D - 3 . 3 1 4 1 0  ( 0 . 0 9 3 3 5 )
A t o m d s d / s ( d / s ) * * 2
C2 * 0 . 0 0 2 4 0 . 0 1 2 3 0 . 1 9 7 0 . 039
C 6 * - 0 . 0 0 2 5 0 . 0 1 2 5 - 0  . 2 0 1 0 . 040
C l * 0 . 0 0 5 5 0 . 0 1 5 1 0 . 3 6 6 0 . 1 3 4
C 8 * - 0 . 0 0 4 8 0 . 0 1 4 1 - 0 . 3 3 9 0 . 1 1 5
N1 - 0 . 6 9 8 6 0 . 0 0 9 1 - 7 6 . 4 8 3 5 8 4 9 . 6 1 6
C4 2 . 2 2 8 7 0 . 0 1 0 4 2 1 4 . 5 3 2 4 6 0 2 3 . 7 9 3
C3 1 . 4 0 4 5 0 . 0 1 1 4 1 2 3  . 034 1 5 1 3 7 . 3 1 0
C5 1 . 3 7 6 1 0 . 0 1 2 3 1 1 2  . 1 0 1 1 2 5 6 6 . 5 5 2
Sum(  ( d / s ) * * 2 )  f o r  s t a r r e d  a t o m s 0 . 3 2 7
C h i - s q u a r e d  a t  95% f o r  1  d e g r e e s  o f  f r e e d o m :  3 . 8 4
T h e  g r o u p  o f  a t o m s  d o e s  n o t  d e v i a t e  s i g n i f i c a n t l y  f r o m  p l a n a r i t y
P l a n e  
ml  = 
m2  = 
m3 =
D =
4
0 . 9 9 9 6 8 ( 0  
0 . 0 1 2 6 1  ( 0 
- 0  . 0 2 1 7 2  (0 
1 . 9 0 6 0 5  (0
. 0 0 0 1 6 )  
. 0 0 5 9 6 )  
. 0 0 7 2 4 )  
. 0 7 1 6 7 )
A t o m d s d / s ( d / s ) * * 2
C4 * - 0 . 0 2 9 4 0 . 0 1 1 9 - 2 . 4 7 5 6 . 1 2 4
N1 0 * 0 . 0 4 1 5 0 . 0 1 1 6 3 . 5 8 2 1 2 . 8 2 9
C l l * - 0 . 0 3 3 2 0 . 0 1 0 9 - 3 . 0 4 0 9 . 2 4 4
N 1 2 ★ 0 . 0 1 4 4 0 . 0 1 1 1 1 . 2 9 0 1 .  6 6 5
C l  3 * 0 . 0 2 0 9 0 . 0 1 8 5 1 . 1 3 3 1 . 2 8 3
C L 2 3 0 . 6 4 1 3 0 . 0 0 4 0 1 6 1 . 9 1 8 2 6 2 1 7 . 5 9 6
CL2 4 - 1 . 1 9 5 2 0 . 0 0 3 3 - 3 6 5 . 2 0 8 1 3 3 3 7 6 .  984
C3 1 . 1 7 7 8 0 . 0 1 2 7 92 . 448 8 5 4 6 . 5 9 5
C5 - 1 . 3 5 6 1 0 . 0 1 2 8 - 1 0 5  . 5 5 9 1 1 1 4 2 . 6 2 1
C 1 4 - 0 . 1 1 2 0 0 . 0 1 2 4 - 9 . 0 5 6 8 2 . 0 1 8
S u m ( ( d / s ) * * 2 ) f o r  s t a r r e d  a t o m s 3 1 . 1 4 6
C h i - s q r u a r e d  a t  95% f o r  2 d e g r e e s  o f  f r e e d o m :  5 . 9 9
T h e  g r o u p  o f  a t o m s  d e v i a t e s  s i g n i f i c a n t l y  f r o m  p l a n a r i t y
P l a n e 5
ml  = 0 . 9 0 5 6 1  (0 . 0 0 2 3 6 )
m2  - - 0 . 3 4 7 0 7  (0 . 0 0 5 8 0 )
m3 = - 0  . 2 4 3 7 7  (0 . 0 0 5 4 5 )
D « - 2 . 3 8 7 2 7  (0 . 0 8 7 1 3 )
A t o m d s d / s ( d / s ) * * 2
C l  7 ★ 0 . 0 0 9 0 0 . 0 1 2 1 0.  7 4 6 0 . 5 5 7
C 1 8 ★ - 0 . 0 0 2 7 0 . 0 1 1 6 ■0.229 0 . 0 5 2
C l  9 * - 0 . 0 0 6 0 0 . 0 1 4 8 0 . 4 0 9 0 . 1 6 7
C20 * 0 . 0 0 9 4 0 . 0 1 7 2 0 . 5 4 7 0 . 2 9 9
C 2 1 * 0 . 0 0 2 8 0 . 0 1 6 5 0 . 1 7 0 0 . 0 2 9
C 2 2 ★ - 0 . 0 1 0 2 0 . 0 1 3 4 0 . 7 5 9 0 . 5 7 6
C l  4 0 . 0 3 5 2 0 . 0 1 2 2 2 . 8 8 6 8 . 3 2 9
C l  5 0 . 0 3 3 6 0 . 0 1 2 4 2 . 7 0 1 7 . 2 9 7
N 1 6 0 . 0 4 5 4 0 . 0 1 2 3 3 .  684 1 3 . 5 7 4
S u m ( ( d / s ) * * 2 ) f o r  s t a r r e d a t o m s 1 . 6 8 1
C h i - s q u a r e d  a t  95% f o r  3 d e g r e e s  o f  f r e e d o m :  7 . 8 1
T h e  g r o u p  o f  a t o m s  d o e s  n o t  d e v i a t e  s i g n i f i c a n t l y  f r o m  p l a n a r i t y
P l a n e  6
ml  -  0 . 9 1 3 0 5  ( 0 . 0 0 2 6 3 )
m2 = - 0 . 3 2 9 7 7  ( 0 . 0 0 5 8 5 )
m3 -  - 0 . 2 4 0 0 0 ( 0 . 0 0 6 0 9 )
D -  - 2 . 6 3 8 6 4 ( 0 . 0 7 6 3 9 )
A t o m  d  s  d / s  ( d / a ) * * 2
C 1 4  * 0 . 0 1 0 2  0 . 0 1 2 2  0 . 8 3 7  0 . 7 0 1
XV
C 1 5 ★ - 0 . 0 1 2 1 0 . 0 1 2 4 0 .  9 7 8 0 . 9 5 6
N l  6 ★ 0 . 0 0 8 5 0 . 0 1 2 3 0 . 6 9 2 0 . 4 7 9
C l  7 * - 0 . 0 0 1 5 0 . 0 1 2 1 ■0. 124 0 . 0 1 5
C 1 8 * - 0 . 0 0 4 8 0 . 0 1 1 6 0 . 4 1 5 0 . 1 7 3
C l  9 0 . 0 1 8 0 0 . 0 1 4 8 1 .  2 1 4 1 . 4 7 5
C20 0 . 0 5 0 0 0 . 0 1 7 2 2 . 908 3 . 4 5 5
C 2 1 0 . 0 3 4 9 0 . 0 1 6 5 2 . 1 1 8 4 . 487
C22 - 0 . 0 0 4 0 0 . 0 1 3 4 0 . 2 9 5 0 . 0 8 7
S u m ( ( d / s ) * * 2 ) f o r  s t a r r e d a t o m s 2 . 324
C h i - s q u a r e d ,  a t  95% f o r  2 d e g r e e s  o f  f r e e d o m :  5 . 9 9
T h e  g r o u p  o f  a t o m s  d o e s  n o t  d e v i a t e  s i g n i f i c a n c l y  f r o m  p l a n a r i t y
P l a n e 7
ml  = 0 . 9 0 9 5 5  ( 0 . 0 0 1 5 3 )
m2  = - 0 . 3 3 7 0 0  ( 0 . 0 0 2 8 3 )
m3 = - 0 . 2 4 3 1 9  ( 0 . 0 0 4 4 6 )
D = - 2  . 7 3 2 1 6  ( 0 . 0 3 9 7 7 )
A t o m d 3 d / s ( d / s ) * * 2
C 1 4 * 0 . 0 0 8 5 0 . 0 1 2 2 0 .  6 9 5 0 . 4 8 ?
C 1 5 * - 0 . 0 0 3 3 0 . 0 1 2 4 - 0 . 2 6 9 0 . 07 2
N l  6 *  0 . 0 1 5 4 0 . 0 1 2 3 1 . 2 5 3 1 .  5 7 0
C 1 7 * - 0 . 0 0 6 2 0 . 0 1 2 1 - 0 . 5 1 6 0 . 2 6 6
C 1 8 * - 0 . 0 1 5 4 0 . 0 1 1 6 - 1 .  3 2 1 1 .  7 4 6
C l  9 * - 0 . 0 0 4 6 0 . 0 1 4 8 - 0 . 3 0 8 0 . 0 9 5
C20 * 0 . 0 2 1 8 0 . 0 1 7 2 1 .  2 7 0 1 .  6 1 3
C 2 1 * 0 . 0 1 2 6 0 . 0 1 6 5 0.  7 6 2 0 . 5 8 1
C 2 2 * - 0 . 0 1 4 4 0 . 0 1 3 4 - 1 . 0 7 2 1 . 1 5 0
C l l - 0 . 0 4 0 6 0  . 0 1 1 0 - 3 . 6 9 1 1 3 . 6 2 3
N10 0 . 4 1 6 8 0 . 0 1 1 4 3 6 . 6 8 6 1 3 4 5  . 843
N 1 2 - 0 . 5 0 1 2 0 . 0 1 1 0 - 4 5 . 5 0 4 2 0 7 0 . 6 5 5
S u m ( ( d / s ) * * 2 ) f o r  s t a r r e d  a t o m s 7 . 5 7 6
C h i - s q u a r e d  a t  95% f o r  6 d e g r e e s  o f f r e e d o m :  1 2 . 60
T h e  g r o u p  o f  a t o m s  d o e s  n o t  d e v i a t e  s i g n i f i c a n t l y  f r o m  p l a n a r i t y  
D i h e d r a l  a n g l e s  f o r m e d  b y  L S Q - p l a n e s
a n e -  p l a n e a n g l e e . s . d . )
1 2 8 9 . 0 6 2 . 8 1 )
1 3 8 9 .  52 2 . 82)
1 4 1 7 5 . 1 8 2 . 8 3 )
1 5 1 5 6 . 0 6 2 . 80)
1 6 1 5 7 . 0 1 3 . 1 9 )
1 7 1 5 6 . 5 5 2 .  96)
2 3 1 1 4 . 5 3 0 .  5 5 )
2 4 9 2 . 5 7 0.  44)
2 5 6 7 . 5 8 0 .  4 1 )
2 6 6 8 . 64 0 . 40)
2 7 6 8 . 1 5 0 . 3 4 )
3 4 8 5 .  6 8 0 . 5 2 )
3 5 9 5 . 3 5 0 .  48)
3 6 9 4 .  64 0 .  48)
3 7 9 4 .  8 8 0 . 4 6 )
4 5 2 5 .  01 0 . 5 3 )
4 6 2 3 .  96 0 .  48)
4 7 2 4 . 4 5 0 . 4 0 )
5 6 1 . 1 0 0 . 4 2 )
5 7 0 . 62 0 .  35 )
6 7 0 . 5 0 0 . 3 5 )
I n t e r a t o m i c  c o n t a c t s  g r e a t e r  t h a n  1 . 5 0  a n d  l e s s  t h a n  3 . 3 0  A n g s t r o m ,  
i n v o l v i n g  a t o m s  o f  t h e  o r i g i n a l  s e t .
D i s t a n c e  e . s . d .
CL23 . . . H 2 3  1 . 6 6 4 8  0 . 1 7 5 1
CL23 . . . 0 2 5  3 . 0 4 5 6  0 . 0 0 9 4
CL23 . . -N10 3 . 2 4 5 5  0 . 0 1 1 0
XVI
NIO . . . C 3 2 . 4 4 3 5 0 . 0 1 4 5
N l  0 . . . H3 1 2 . 6 5 7 7 0 . 1 3 8 8
NIO . . . H32 2 . 5 5 5 8 0 . 1 3 2 6
NIO . . . C 5 2 . 4 6 8 1 0 . 0 1 6 9
NIO . . . H5 1 2 . 4 4 8 0 0 . 1 5 6 5
NIO . . . H52 2 . 8 9 1 3 0 . 0 1 1 3
NIO . . . C 1 3 2 . 3 7 5 1 0 . 0 1 6 2
NIO . . . H 1 3 1 2 . 8 0 5 6 0 . 1 4 8 6
NI O . . . H 1 3 2 3 . 2 0 3 3 0 . 1 6 8 8
NIO . . . C 1 4 2 . 4 2 1 3 0 . 0 1 5 1
NIO . . . C 1 5 2 . 9 5 7 8 0 . 0 1 4 7
NIO . .  . H I  5 2 . 8 2 4 6 0 . 1 2 7 8
HIO . . . N 1 2 3 . 1 2 8 6 0 . 1 5 8 9
HI 0 . . . C 3 2 . 7 0 3 8 0 . 1 3 5 7
HIO . . . H3 1 2 . 9 5 3 0 0 . 1 9 1 4
HIO . . . H32 2 . 3 8 7 3 0 . 1 9 2 9
HIO . . . C 4 2 . 1 2 4 4 0 . 1 4 2 9
HIO . . . C 5 2 . 7 9 9 5 0 . 1 5 2 9
HIO . . . H5 1 2 . 4 7 3 3 0 . 2 2 3 0
HIO . . . C l l 2 . 0 9 2 9 0 . 1 6 2 7
HIO . . . C 1 3 3 . 2 9 1 2 0 . 1 4 9 7
HIO . . . C 1 4 2 . 7 5 5 3 0 . 1 5 9 5
HIO . . . C 1 5 2 . 8 6 2 6 0 . 1 4 7 3
HIO . . . H1 5 2 . 3 8 3 1 0 . 1 8 8 7
N1 2 . . . C 4 2 . 3 9 8 1 0 . 0 1 5 0
N l  2 . . . H52 3 . 1 7 7 7 0 . 0 1 1 1
N 1 2 . . . H 1 3 1 1  . 8 2 7 8 0 . 1 4 9 2
N1 2 . . . H 1 3 2 2 . 1 8 7 0 0 . 1 7 1 1
N l  2 . . . C 1 4 2 . 4 3 4 8 0 . 0 1 4 2
N 1 2 . . . C 1 8 3 . 1 4 3 1 0 . 0 1 4 0
N1 2 . . . H1 9 2 . 9 2 9 3 0 . 1 5 8 7
HI 2 . . . C 4 3 . 2 1 0 2 0 . 1 5 9 3
H12 . . . C l l 2 . 0 6 3 7 0 . 1 5 0 7
H12 . . . C 1 3 2 . 0 0 9 7 0 . 1 5 0 0
H12 . . . H 1 3 1 2 . 4 0 1 1 0 . 2 1 4 2
H12 . . . H 1 3 2 2 . 2 8 2 6 0 . 2 2 1 6
H12 . . . C 1 4 2 . 8 1 2 8 0 . 1 3 5 7
HI 2 . . . C 1 8 3 . 1 9 2 1 0 . 1 3 3 1
H12 . . . C 1 9 3 . 2 0 3 8 0 . 1 4 4 2
H12 . .  . HI  9 2 . 6 4 1 1 0 . 2 2 1 2
N l  6 . . . C 1 4 2 . 2 2 8 3 0 . 0 1 4 5
N l  6 . . . H1 5 2 . 2 6 1 1 0 . 1 5 4 0
N l  6 . . . C 1 8 2 . 2 3 8 2 0 . 0 1 5 2
N l  6 . . . C 2 2 2 . 4 9 8 4 0 . 0 1 9 7
N 1 6 . . . H2 2 2 . 6 0 3 2 0 . 1 5 4 7
HI  6 . . . C 1 4 2 . 8 9 0 9 0 . 1 6 3 4
HI 6 . . . C 1 5 1 . 7 8 4 1 0 . 1 6 6 7
HI 6 . . . H1 5 2 . 3 6 9 6 0 . 2 2 6 9
HI 6 . . . C 1 7 1 . 9 5 6 2 0 . 1 7 3 6
HI 6 . . . C 1 8 2 . 9 6 2 5 0 . 1 6 6 7
H1 6 . . . C 2 2 2 . 8 2 0 5 0 . 1 8 0 7
HI  6 . . . H2 2 2 . 7 4 3 6 0 . 2 3 7 9
C2 . . . C3 1 . 5 4 4 0 0 . 0 1 6 3
C2 . . . H31 2 . 2 9 4 4 0 . 1 4 7 8
C2 . . . H32 2 . 1 2 3 4 0 . 1 3 9 4
C2 . . . C 4 2 . 5 4 6 1 0 . 0 1 5 5
C2 . . . C5 2 . 8 4 1 0 0 . 0 1 6 6
C2 . . . H5 1 3 . 2 6 8 9 0 . 1 4 0 3
C 2 . . . C 6 2 . 3 3 6 0 0 . 0 1 7 1
C2 . . . H 6 3 . 2 2 9 1 0 . 1 6 2 3
C2 . . . C 7 2 . 4 3 2 5 0 . 0 1 9 3
C2 . . . H7 1 3 . 0 2 7 1 0 . 1 6 8 0
C2 . . . H7 2 3 . 1 3 1 3 0 . 1 6 1 1
C2 . . . C 8 1 . 5 2 1 5 0 . 0 1 8 3
C2 . . . H8 1 2 . 0 0 9 7 0 . 1 4 6 7
C2 . . . H82 2 . 1 8 1 0 0 . 1 6 5 6
C2 . . . C 9 2 . 5 1 8 3 0 . 0 2 1 5
C2 . . . H92 2 . 5 7 2 6 0 . 0 1 2 7
XVII
C2 . . . H93 2 . 8 4 7 5 0 . 0 1 2 6
H2 . . . C 3 2 . 2 6 4 3 0 . 1 3 8 7
H2 . . . H31 2 . 6 5 7 1 0 . 1 9 8 9
H2 . . . H32 2 . 6 0 4 9 0 . 1 8 8 9
H2 . . .Cl 3 . 2 9 6 0 0 . 1 6 0 1
H2 . .  .ca 2 . 0 5 6 8 0 . 1 5 5 5
H2 . . . H81 2 . 0 2 9 9 0 . 2 1 5 4
H2 . . . H82 2 . 6 3 3 8 0 . 2 2 6 7
H2 . . . C 9 2 . 7 1 8 7 0 . 1 5 9 2
H2 . . . H92 2 . 4 4 1 3 0 . 1 5 3 0
H2 . . . H93 2 . 9 5 2 1 0 . 1 5 9 5
C3 . . . C 4 1 . 5 2 7 5 0 . 0 1 6 5
C3 . . . C 5 2 . 5 3 9 5 0 . 0 1 8 1
C3 . . . H5 1 2 . 8 5 4 2 0 . 1 4 8 1
C3 . . . C 6 2 . 9 1 3 4 0 . 0 1 7 7
C3 . . . C 7 3 . 2 6 7 1 0 . 0 1 9 0
C3 . . . C 8 2 . 5 8 5 5 0 . 0 1 6 8
C3 . . . H82 2 . 7 5 1 9 0 . 1 5 5 1
C3 . . . C 1 3 2 . 6 3 1 3 0 . 0 1 9 0
C3 . . . H 1 3 1 2 . 5 6 5 4 0 . 1 6 3 0
H31 . . . H32 1 . 5 9 4 7 0 . 1 9 3 9
H31 . . . C 4 2 . 1 3 4 2 0 . 1 5 3 4
H31 . . . C 8 3 . 1 6 2 0 0 . 1 4 6 9
H31 . . . H82 3 . 0 5 6 3 0 . 2 1 4 5
H31 . . . C 1 3 2 . 8 1 5 8 0 . 1 5 1 4
H31 . . . H 1 3 1 2 . 4 5 5 5 0 . 2 2 3 3
H32 . . . C4 2 . 1 7 8 0 0 . 1 4 0 3
H32 . . . C5 2 . 9 1 9 8 0 . 1 4 8 1
H32 . . . H51 2 . 8 8 0 6 0 . 2 1 1 2
C4 . . . C 5 1 . 5 3 2 6 0 . 0 1 7 6
C4 . . . H5 1 1 . 9 9 4 1 0 . 1 4 9 0
C4 . . . H52 2 . 2 0 2 0 0 . 0 1 2 0
C4 . . . C 6 2 . 5 7 5 2 0 . 0 1 6 7
C4 . . . H 6 3 . 2 8 1 9 0 . 1 5 9 5
C4 . . .Cl 3 . 0 5 8 2 0 . 0 1 8 1
C4 . .  . a n 2 . 9 4 7 7 0 . 1 5 4 1
C4 . . . C 8 3 . 0 5 5 6 0 . 0 1 5 7
C4 . . . H82 3 . 0 9 0 6 0 . 1 4 5 3
C4 . . . C l l 2 . 3 8 4 8 0 . 0 1 5 1
C4 . . . C 1 3 1 . 6 0 3 3 0 . 0 1 7 0
C4 . . . H 1 3 1 2 . 0 6 2 5 0 . 1 6 1 0
C4 . . . HI  32 2 . 2 8 9 7 0 . 1 7 3 1
C5 . . . C 6 1 . 5 2 0 1 0 . 0 1 6 7
C5 . . . H 6 1 . 8 9 3 8 0 . 1 5 4 5
C5 . . . C 7 2 . 5 5 4 2 0 . 0 1 8 1
C5 . . . H7 1 2 . 5 9 5 3 0 . 1 4 7 5
C5 . . . C 8 3 . 2 2 6 2 0 . 0 1 6 4
C5 . . . C 1 3 2 . 6 0 4 3 0 . 0 1 9 5
C5 . . . H 1 3 1 3 . 2 8 9 3 0 . 1 6 9 8
C5 . . . H 1 3 2 2 . 5 9 1 7 0 . 1 6 9 1
H5 1 . . . H52 1 . 7 8 7 0 0 . 1 5 2 3
H51 . . . C 6 2 . 0 3 0 1 0 . 1 4 4 5
H5 1 . . . H 6 2 . 0 4 9 2 0 . 2 1 3 6
H 5 1 . . . C 1 3 3 . 2 9 1 1 0 . 1 4 7 7
H52 . . . C 6 2 . 2 7 4 1 0 . 0 1 2 1
H52 . . . H6 2 . 4 4 8 9 0 . 1 4 7 4
H52 . . .Cl 2 . 8 9 6 3 0 . 0 1 3 3
H52 . . . H 7 1 2 . 5 4 8 4 0 . 1 3 9 1
H52 . . . C 1 3 2 . 5 3 8 9 0 . 0 1 7 3
H52 . . . H 1 3 2 2 . 0 7 3 6 0 . 1 6 4 9
C 6 . . . C 7 1 . 5 2 0 4 0 . 0 1 8 1
C 6 . . . H7 1 2 . 0 7 5 5 0 . 1 6 3 8
C 6 . . . H72 2 . 2 5 8 4 0 . 1 5 3 4
C 6 . . . C 8 2 . 4 3 9 9 0 . 0 1 6 5
C 6 . . . H81 3 . 1 3 1 0 0 . 1 3 6 8
C 6 . . . H82 3 . 1 3 8 7 0 . 1 5 9 5
C 6 . . . C9 2 . 5 0 2 6 0 . 0 2 0 5
C 6 . . . H91 2 . 8 6 4 8 0 . 1 8 3 7
XVIII
C 6 . . . H92 3 . 1 7 0 6 0 . 0 1 2 5
C 6 . . . H93 2 . 8 2 5 1 0 . 0 1 1 6
C 6 . . . H1 3 2 3 . 2 1 8 4 0 . 1 7 1 7
H6 . . . C 7 2 . 3 4 3 5 0 . 1 4 4 5
H6 . . . H7 1 2 . 8 3 4 6 0 . 2 1 7 6
H6 . . . H72 2 . 8 3 0 0 0 . 2 0 0 6
H6 . . . C 9 2 . 7 1 1 4 0 . 1 4 9 9
H6 . . . H9 1 2 . 6 6 7 5 0 . 2 3 1 1
H6 . . . H93 3 . 1 4 3 4 0 . 1 4 1 6
C7 . . . C 3 1 . 5 5 0 4 0 . 0 1 8 1
C7 . . . H81 2  . 1 8 8 1 0 . 1 4 0 7
C7 . . . H82 2 . 0 9 2 6 0 . 1 6 6 8
C7 . . . C9 2 . 9 7 5 9 0 . 0 2 2 5
C7 . . . H93 2 . 7 3 5 7 0 . 0 1 5 2
C7 . . . C 1 3 3 . 2 7 6 3 0 . 0 2 0 5
C7 . . . H1 3 2 2 . 8 5 2 1 0 . 1 6 7 5
H7 1 . . . H72 1 . 6 0 8 9 0 . 2 2 0 5
H7 1 . . . C S 2 . 0 4 9 0 0 . 1 6 2 6
H7 1 . . . H81 2 . 7 9 0 7 0 . 2 1 1 2
H7 1 . . . H82 2 . 1 3 5 8 0 . 2 2 8 5
H7 1 . . . C 1 3 2 . 7 2 3 2 0 . 1 5 9 7
H7 1 . . . H 1 3 1 3 . 0 9 3 3 0 . 2 3 7 6
H7 1 . . . H 1 3 2 2 . 0 5 5 4 0 . 2 2 9 2
H72 . . . C 8 2 . 0 4 2 6 0 . 1 5 6 8
H72 . . . H81 2 . 2 5 7 4 0 . 2 0 8 9
H7 2 . . . H82 2 . 5 9 5 5 0 . 2 2 9 7
H72 . . . C 9 3 . 0 6 2 4 0 . 1 5 3 4
H72 . . . H93 2 . 4 7 8 5 0 . 1 4 9 3
C 8 . . . C 9 2 . 9 7 8 4 0 . 0 2 1 9
C 8 . . . H92 3 . 2 8 3 3 0 . 0 1 4 8
C 8 . . . H93 2 . 7 4 1 6 0 . 0 1 4 6
C 8 . . . C 1 3 3 . 2 9 6 0 0 . 0 1 8 7
C 8 . . . H 1 3 1 3 . 1 9 7 3 0 . 1 5 6 8
H81 . . . H82 1 . 5 7 0 2 0 . 2 2 1 4
HS 1 . . . C 9 2 . 9 3 1 4 0 . 1 4 3 7
H81 . . . H92 3 . 1 1 8 6 0 . 1 4 4 4
H81 . . . H93 2 . 4 4 1 7 0 . 1 4 6 5
H82 . . . C 1 3 2 . 8 6 2 5 0 . 1 5 1 0
H82 . . . H 1 3 1 2 . 5 6 7 6 0 . 2 1 6 8
H82 . . . H 1 3 2 2 . 9 8 8 8 0 . 2 2 2 4
H91 . . . H92 1 . 5 9 6 8 0 . 1 8 3 4
H91 . . . H93 1 . 7 3 0 0 0 . 1 7 0 6
H92 . . . H93 1 . 6 0 8 0 0 . 0 0 0 2
C l l . . . C 1 3 2 . 3 4 1 5 0 . 0 1 6 4
C l l . . . H 1 3 1 2 . 7 5 5 3 0 . 1 4 3 5
C l l . . . H 1 3 2 3 . 1 3 4 2 0 . 1 6 6 6
C l l . . . C 1 5 2 . 4 4 0 8 0 . 0 1 5 0
C l l . . . H1 5 2 . 8 7 8 1 0 . 1 3 6 4
C l l . . . C 1 8 2 . 5 6 4 9 0 . 0 1 5 8
C l l . . . H1 9 3 . 1 6 8 8 0 . 1 5 6 4
H131 . . . H 1 3 2 1 . 8 9 0 5 0 . 2 5 5 1
C l  4 . . . H1 5 2 . 3 2 0 2 0 . 1 5 0 6
C14 . . . C 1 7 2 . 2 7 7 7 0 . 0 1 5 6
C l  4 . . . C 1 9 2 . 6 1 5 2 0 . 0 1 7 8
C l 4 . . . H19 2 . 7 9 4 1 0 . 1 5 3 8
C l  5 . . . C 1 7 2 . 2 3 1 2 0 . 0 1 8 3
C15 . . . C 1 8 2 . 2 6 7 6 0 . 0 1 7 7
C 1 7 . . . C 1 9 2 . 3 8 7 2 0 . 0 1 6 6
C l  7 . . . H19 3 . 0 7 2 6 0 . 1 4 9 9
C l  7 . . . C 2 0 2 . 7 0 9 4 0 . 0 2 0 0
C l  7 . . . C 2 1 2 . 3 5 4 7 0 . 0 2 1 8
C 1 7 . . . H2 2 1 . 8 5 3 0 0 . 1 5 5 1
C l  8 . . . H1 9 1 . 8 7 5 8 0 . 1 5 1 0
C l  8 . . . C20 2 . 3 7 3 2 0.0202
C l  8 . . . H20 3 . 2 7 1 3 0 . 1 8 7 4
C l  8 . . . C21 2 . 7 7 0 6 0 . 0 2 0 7
C l  8 . . . C22 2 . 4 5 8 4 0 . 0 1 6 3
C18 . . . H22 3 . 0 8 7 6 0 . 1 5 1 6
XIX
C l  9 . . . H20 2 . 0 5 9 7 0 . 1 8 7 6
C l  9 . . . C 2 1 2 . 4 0 0 9 0 . 02 06
C l  9 . . . C 2 2 2 . 8 1 8 4 0 . 0 1 7 1
HI 9 . . . C 2 0 1 . 9 1 6 6 0 . 1 5 8 0
HI 9 . . . H2 0 2 . 3 2 3 0 0 . 2 4 3 1
HI 9 . . . C 2 1 3 . 1 0 6 3 0 . 1 5 4 7
C20 . . . H2 1 2 . 0 8 4 1 0 . 1 7 6 4
C20 . . . C 2 2 2 . 3 9 9 9 0 . 0 2 0 3
C2 0 . . . H2 2 3 . 1 1 4 5 0 . 1 4 7 4
H2 0 . . . C 2 1 2 . 0 1 0 8 0 . 1 6 9 4
H2 0 . . . H2 1 2 . 3 1 3 0 0 . 2 3 6 5
H2 0 . . . C 2 2 3 . 2 5 6 7 0 . 1 7 3 9
C 2 1 . . . H2 2 1 .  9 7 0 9 0 . 1 4 8 0
H21 . . . C 2 2 2 . 0 9 3 2 0 . 1 8 2 5
H21 . . . H2 2 2 . 4 3 0 7 0 . 2 3 3 2
N u m b e r  o f  c o n t a c t s :  2 9 0
E q u i v a l e n t  p o s i t i o n s :
X , Y , Z
1 / 2 + X , 1 / 2 - Y , 1 / 2 + Z  
p l u s  t h e  c e n t r o s y m m e t r i c  o n e s
Ma x i mu m t r a n s l a t i o n  b y  2 u n i t  c e l l
I n t e r m o l e c u l a r  c o n t a c t s  l e s s  t h a n  3 . 3 0  A n g s t r o m
C L 2 3 . . . H 2 6 1 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2
D i s t a n c e  
2 . 8 6 4 5
e . s . d .  
0 . 1 8 4 5
C L 2 3 . . .H2 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 9 5 1 6 0 . 1 5 2 3
C L 2 3 . . . H 6 + X + 1 / 2 , - Y + l / 2 , + Z - 1 / 2 3.  0 3 7 5 0 . 1 5 4 6
C L 2 3 . . . H72 + X , + Y , +  Z - 1 3 .  0 9 7 6 0 . 1 5 2 2
C L 2 3 . . . H91 + X + 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 9 7 6 4 0 . 1 7 3 9
C L 2 3 . . . H93 + X , + Y , + Z - 1 3 . 0 6 0 3 0 . 0 0 3 4
C L 2 3 . . . H20 - X + l , - Y + l , - Z 3 . 1 7 7 2 0 . 1 9 1 7
H23 . . . H 2 6 1 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 9 7 0 1 0 . 2 2 8 0
H23 . . . H2 63 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 3 . 0 9 1 8 0 . 2 2 6 3
H2 3 . . .H2 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 7 3 5 8 0  . 2 0 1 0
H2 3 . . . C 9 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 9 2 4 4 0 . 1 6 8 3
H23 . . . H92 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 0 7 8 5 0 . 1 6 7 1
H23 . . . H93 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 3 . 2 9 1 3 0 . 1 6 8 6
CL2 4 . .  . H2  62 - X + l / 2 , + Y + l / 2 , - Z + l / 2 2 . 8 3 8 6 0 . 0 0 2 9
CL2 4 . . . N l  6 - X , - Y + l , - Z 3 . 1 8 2 2 0 . 0 1 0 8
CL2 4 . . . H 1 6 - X , - Y + l , - Z 2 . 4 6 8 8 0 . 1 6 0 5
CL2 4 . . . H31 - X + l , - Y + l , - Z + l 3 . 1 0 7 3 0 . 1 3 6 2
CL2 4 . . . H52 - X , - Y + l , - Z + l 2 . 6 6 0 6 0 . 0 0 3 2
CL2 4 . . . H7 1 - X , - Y + l , - Z + l 3 . 1 1 0 4 0 . 1 5 7 4
C L 2 4 . . . H82 - X + l , - Y + l , - Z + l 3 . 0 6 0 2 0 . 1 7 0 2
C L 2 4 . . . H 1 3 1 - X + l , - Y + l , - Z + l 3 . 1 2 1 4 0 . 1 6 9 2
C L 2 4 . . . H 1 3 2 - X , - Y + l , - Z + l 3 . 1 0 9 9 0 . 1 7 7 7
C L 2 4 . . . H2 2 + X , + Y , + Z + 1 3 . 1 0 9 8 0 . 1 5 2 7
0 2 5 . . . H2 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 4 2 8 4 0 . 1 3 6 4
0 2 5 . . . H81 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 5 8 8 1 0 . 1 4 4 1
0 2 5 . . . H92 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 3 . 1 3 8 2 0 . 0 0 8 8
0 2 5 . . . H93 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 3 . 2 2 0 2 0 . 0 0 9 6
C2 6 . . . H2 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 8 4 6 2 0 . 1 3 8 3
C2 6 . . . H72 + X + 1 / 2 , - Y + l / 2 , + Z - 1 / 2 3 . 0 2 0 3 0 . 1 4 9 3
C2 6 . . . H81 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 7 5 2 4 0 . 1 4 3 5
C2 6 . . . H1 5 + X + 1 / 2 , - Y + l / 2 , + Z + 1 / 2 2 . 8 6 0 0 0 . 1 4 5 4
H2 6 1 . .  . CL2 3 + X + 1 / 2 , - Y + l / 2 , + Z + 1 / 2 2 . 8 6 4 5 0 . 1 8 4 5
H2 6 1 . . . H23 + X + 1 / 2 , - Y + l / 2 , + Z + 1 / 2 2 . 9 7 0 1 0 . 2 2 8 0
H 2 6 1 . . . H 6 + X + 1 / 2 , - Y + l / 2 , + Z - 1 / 2 3 . 1 9 5 0 0 . 2 3 3 4
H2 6 1 . . . C 7 + X + 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 9 7 1 3 0 . 2 0 2 8
H 2 6 1 . . . H72 + X + 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 2 1 9 2 0 . 2 5 6 3
H 2 6 1 . . . H9 3 + X + 1 / 2 , - Y + l / 2 , + Z - 1 / 2 3 . 0 2 6 1 0 . 2 1 0 2
H2 6 1 . . . H1 5 + X + 1 / 2 , - Y + l / 2 , + Z + 1 / 2 2 . 4 6 9 7 0 . 2 2 6 9
H262 . . . C L 2 4 - X + l / 2 , + Y - l / 2 , - Z + l / 2 2 . 8 3 8 6 0 . 0 0 2 9
H262 . . . C 2 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 9 8 1 4 0 . 0 1 1 4
H2 62 . . . H2 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 1 8 2 0 0 . 1 4 2 9
XX
H82 . . . C 1 9 - X + l , - Y + l , - Z + l 3 . 1 8 3 7 0 . 1 5 3 8
H82 . . . H1 9 - X + l , - Y + l , - Z + l 2 . 5 3 1 8 0 . 2 1 6 9
H82 . . . H2 0 - X + l , - Y + l , - Z + l 3 . 1 2 2 4 0 . 2 2 4 3
C9 . . . H23 + X + 1 / 2 , - Y + l / 2 , + Z + l / 2 2 . 9 2 4 4 0 . 1 6 8 3
H91 . . . CL2  3 + X - 1 / 2 , - Y + l / 2 , + Z + l / 2 2 . 9 7 6 4 0 . 1 7 3 9
H91 . . . H32 + X - 1 / 2 , - Y + l / 2 , + Z + 1 / 2 3 . 0 2 6 6 0 . 2 4 0 0
H91 . . . H2 0 - X + l / 2 , + Y - 1 / 2 , - Z + l / 2 3 .  08 2 9 0 . 2 5 3 7
H91 . . . H2 1 - X + l / 2 , + Y - l / 2 , - Z + l / 2 2 . 7 3 2 9 0 . 2 5 9 7
H92 . . . H23 + X + 1 / 2 , - Y + l / 2 , + Z + 1 / 2 2 . 0 7 8 5 0 . 1 6 7 1
H92 . . . 0 2 5 + X + 1 / 2 , - Y + l / 2 , + Z + 1 / 2 3 . 1 3 8 2 0 . 0 0 8 8
H92 . . . H5 1 + X + 1 / 2 , - Y + l / 2 , + Z + l / 2 2 . 8 6 1 2 0 . 1 4 1 7
H93 . . . CL2  3 + X , + Y , + Z + 1 3 . 0 6 0 3 0 . 0 0 3 4
H93 . . . H23 + X + 1 / 2 , - Y + l / 2 , + Z + 1 / 2 3 . 2 9 1 3 0 . 1 6 8 6
H93 . . . 0 2 5 + X + 1 / 2 , - Y + l / 2 , + Z + 1 / 2 3 . 2 2 0 2 0 . 0 0 9 6
H93 . . . H2 6 1 + X - 1 / 2 , - Y + l / 2 , + Z + 1 / 2 3 . 0 2 6 1 0 . 2 1 0 2
H93 . . . H5 1 + X + 1 / 2 , - Y + l / 2 , + Z + 1 / 2 3 . 1 2 9 3 0 . 1 4 6 4
HI 3 1 . . . C L 2 4 - X + l , - Y + l , - Z + l 3 . 1 2 1 4 0 . 1 6 9 2
HI 3 1 . . . H 1 3 1 - X + l , - Y + l , - Z + l 3 . 2 6 4 0 0 . 2 2 8 1
HI 32 . . . C L 2 4 - X , - Y + l , - Z + l 3 . 1 0 9 9 0 . 1 7 7 7
HI 32 . . . HI 6 + X , + Y , + Z + 1 3 . 2 6 7 8 0 . 2 5 0 4
HI 32 . . . H2 2 + X , + Y , + Z + 1 3 . 2 2 1 9 0 . 2 2 6 9
C l  5 . . . H72 + X , + Y , + Z - 1 3 . 1 1 2 3 0 . 1 5 6 6
H1 5 . . . C2 6 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2  . 8 6 0 0 0 . 1 4 5 4
HI 5 . . . H2 6 1 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 4 6 9 7 0 . 2 2 6 9
HI 5 . . . H2  62 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 3 . 2 7 7 3 0 . 1 3 3 5
HI 5 . . . H2  63 + X - 1 / 2 , - Y + l / 2 , + Z - 1 / 2 2 . 3 6 1 3 0 . 2 3 7 4
HI 5 . . . H72 + X , + Y , + Z - 1 2 . 5 5 8 0 0 . 2 1 8 2
C l  9 . . . H82 - X + l , - Y + l , - Z + l 3 . 1 8 3 7 0 . 1 5 3 8
HI 9 . . . H81 - X + l , - Y + l , - Z + l 3 . 2 5 0 5 0 . 2 1 0 8
HI 9 . . . H82 - X + l , - Y + l , - Z + l 2 . 5 3 1 8 0 . 2 1 6 9
C2 0 . .  . H2 63 - X + l / 2 , + Y + l / 2 , - Z + l / 2 3 . 1 3 9 5 0 . 1 9 4 7
H20 . . . C L 2 3 - X + l , - Y + l , - Z 3 . 1 7 7 2 0 . 1 9 1 7
H20 . . . H263 - X + l / 2 , + Y + l / 2 , - Z + l / 2 2 . 7 8 7 4 0 . 2 7 6 0
H2 0 . . . HI O - X + l , - Y + l , - Z 3 . 2 2 6 6 0 . 2 5 2 5
H2 0 . . . C 8 - X + l , - Y + l , - Z + l 3 . 2 5 5 8 0 . 1 6 7 0
H20 . . . H81 - X + l , - Y + l , - Z + l 2 . 6 4 0 8 0 . 2 2 5 2
H20 . . . H82 - X + l , - Y + l , - Z + l 3 . 1 2 2 4 0 . 2 2 4 3
H2 0 . . . H91 - X + l / 2 , + Y + l / 2 , - Z + l / 2 3 . 0 8 2 9 0 . 2 5 3 7
C 2 1 . . . H31 - X + l , - Y + l , - Z 2 . 9 6 5 1 0 . 1 4 8 1
H21 . . . C 3 - X + l , - Y + l , - Z 3 . 0 7 0 0 0 . 1 8 6 6
H21 . . . H31 - X + l , - Y + l , - Z 2 . 1 8 6 8 0 . 2 4 0 2
H21 . . . H32 - X + l , - Y + l , - Z 2 . 9 2 8 3 0 . 2 3 3 6
H21 . . . H5 2 - X , - Y + l , - Z 2 . 9 9 0 6 0 . 1 5 9 5
H21 . . . H91 - X + l / 2 , + Y + l / 2 ,  - Z + l / 2 2 . 7 3 2 9 0 . 2 5 9 7
C 2 2 . . . H52 - X , - Y + l , - Z 3 . 1 2 6 9 0 . 0 1 3 1
H22 . . . C L 2 4 + X , + Y , + Z - 1 3 . 1 0 9 8 0 . 1 5 2 7
H22 . . . H52 - X , - Y + l , - Z 2 . 9 3 3 7 0 . 1 4 6 7
H22 . . . H1 3 2 + X , + Y , + Z - 1 3 . 2 2 1 9 0 . 2 2 6 9
N u m b e r  o f  c o n t a c t s :  1 5 7
P o s s i b l e  h y d r o g e n  b o n d s  
D o n o r - H  D o n o r . . . A c c e p t o r
c e p t o r
H. . . A c c e p t o r  D o n o r - H .................A c
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Appendix II
octan -3-y l)-3 '-(3 ,5 -D im eth oxyp h en yl)-l,2 ,4 -oxad iazo les (III c).
Table A Experimental Data and Structural Refinement Procedure for 
(III c)
Crystal Structure Data for exo-5'-(8-Methyl-8-Azabicyclo[3.2.1]-
VALUEPARAMETER
Crystal data 
Formula
Crystal size (mm)
Symmetry
Unit cell determinations:
Unit cell dimensions
Packing: V(A3), Z 
Dc (g.cnr3), M, F (000)
(I (cm4 )
Experimental data 
Technique
Scanning range for 0  
Number of reflections: 
Measured
Observed 
Range of hkl 
Absorption 
Solution and refinement 
Solution 
Refinement 
H atoms 
Variables 
w-scheme
Final max. shift /error 
Final av.shift / error 
final R and Rw 
Computer and programs
Scattering factors 
Anomalous dispersion
C 18H 23 N3 0 3 HCl 
0.38x0.24x0.21 
Triclinical, P-l
Least squares fit from 37 reflections 
(5<0 <35°)
7.113(1), 7.719(1), 18.467 (2), A 
78.10(2) 102.09(1), 112.32(1)° 
908.1(1), 2
1.3380, 365.859, 388.0 
20.562
Four circle difractometer:
Seifert XRD 3000s 
Bisecting geometry 
Grafite orientated monochromator:
Cu K a 1.5418 A
w /20  scan
2<20<12O°
2672
1589 (I>2a (I) criterion)
-7/7 -8/8 0/20 
Correction applied
Direct methods 
L.S. on Fobs 
Fourier Synthesis 
298
Empirical as to give no trends in 
<wa2F> vs. <Fobs> and <sin 0/l> 
0.192 
0.018
0.041, 0.049
Vax 11/750 , Multan80 -Difabs, 
XRAY80, PESOS, PARST 
Parst
Int.Tables for X-Ray Crystallography 
Int.Tables for X-Ray Crystallography
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Atomic parameters for non H-atoms in (inc).
C o o r d i n a t e s  and t h e r m a l  p a r a m e t e r s  as
U e q = ( l / 3 ) . S u m [ U i j . a i * . a j * . a i . a j . c o s ( a i , a j ) ] . 1 0 * * 4
Atom X Y z Ueq
CL1 - 0 . 3 0 4 9 0 ( 17) 0. 331 07 15) 0. 62472 6 ) 407 5)
Cl - 0 . 3 1 2 4 3 ( 61! 0. 83005 55) 0. 695 37 2 2 ) 318 17)
C2 - 0 . 3 1 9 7 7 ( 69) 0 . 8 3 1 7 1 65) 0 . 6 1 1 2 4 23) 377 18)
C3 - 0 . 5 3 8 7 1 ( 63) 0. 73468 56) 0. 5 7 3 92 25) 373 18)
N4 - 0 . 6 0 9 0 4 { 49) 0. 53223 43) 0 . 6 1 1 2 0 1 7) 280 13)
C5 - 0 . 6 4 7 0 2 { 63) 0 . 5 5 5 1 6 59) 0. 68566 23) 340 17)
C6 - 0 . 4 3 7 3 1 1 6 6 ) 0. 63428 61) 0. 7 325 3 23) 354 18)
C7 - 0 . 6 9 3 5 6 ( 79) 0.80842 70) 0. 58989 33) 544 23)
C8 - 0 . 7  6383( 79) 0. 69232 77) 0. 66284 33) 541 24)
C 9 - 0 . 0 9 5 5 1 ( 61) 0. 89536 53) 0 . 7 3 1 7 8 2 2 ) 313 17)
N10 - 0 . 0 0 2 9 3  ( 49) 0. 8281 3 45) 0. 7 92 36 18) 332 15)
C l l 0 . 1 9 7 7 8  ( 61) 0. 95290 54) 0. 79440 23) 337 18)
N12 0. 22658 ( 55) 1 . 08978 52) 0. 73932 2 2 ) 494 17)
013 0. 03070 ( 43) 1 . 0 5 2 4 3 40) 0. 6 9 6 1 6 1 7 ) 491 13)
C14 0 . 3 68 5 9  ( 63) 0. 93566 56) 0. 85248 23) 352 18)
Cl  5 0 . 3 2 9 6 7 ( 72) 0.80030 63) 0 . 9 1 5 1 2 24) 385 19)
Cl  6 0 . 4 9 2 6 6 ( 72) 0. 78939 61) 0. 96985 24) 424 2 1 )
C l  7 0. 69030( 76) 0. 91 036 6 8 ) 0 . 961 46' 28) 471 2 2 )
C l  8 0 . 7 2 7 3 2 { 67) 1 . 043 7 8 63) 0. 89819 26) 422 2 0 )
C l  9 0 . 5 6 7 4 5  ( 6 8 ) 1 . 0 5 8 1 6 61) 0. 84208 26) 397 19)
0 2 0 0 . 4 7 3 7 5 ( 50) 0. 66365 48) 1 . 03398 1 7 ) 562 16)
C21 0. 2 7 4 6 4  { 91) 0. 53278 83) 1 . 0 4 3 5 7 33) 585 26)
0 2 2 0 . 9 2 9 9 1  ( 47) 1 . 1 5 7 5 9 48) 0. 896 1 7 2 0 ) 606 16)
C23 0 . 9 8 1 0 1 ( 87) 1 . 2 9 9 7 6 85) 0. 83378 33) 587 26)
C24 - 0 . 7 9 4 2 0  ( 71) 0. 4051 4 65) 0. 567 78 28) 393 19)
Thermal parameters for non H-atoms in (IIIc).
Thermal p a r a m e t e r s as  e x p [ - 2 . p i * * 2 . Sum ( U i j . a i * . a j * . h i . h j )  . 1 0 * *4]
Atom U l l 0 2 2 U33 U1 2 U13 U23
C l l 438 ( 6 ) 423(  6 ) 424(  7) 203(  5) 96( 5) - 6 5 (  5)
Cl 338 (23) 2 5 4 ( 2 1 ) 345( 25) 87 ( 1 8) 50( 18) - 3 6 ( 1 8 )
C2 409 (26) 326( 23) 286( 25) 39(20) 67(20) 3 7 ( 1 9 )
C3 3 7 7 ( 25 ) 278( 22) 333( 25) 2 8( 1 9) 1 5 ( 1 9 ) 30( 1 9 )
N4 309( 18) 2 6 1 ( 1 7 ) 262 (18) 7 4 ( 1 5 ) 70( 14) - 4 4 ( 1 4 )
C5 355( 24) 339(23) 317 (23) 62( 1 9) 1 2 1 ( 1 9 ) - 7 3 ( 1 9 )
C6 389(26) 366(24) 264 (23) 77( 20) 7 2 ( 1 9 ) - 3 5 ( 1 9 )
C7 447(30) 376(28) 778 (40) 1 9 1 ( 2 4 ) - 1 3 3  (27) - 1 4 7  (27)
C8 381( 28) 561 ( 32) 801( 39) 1 7 2 ( 2 5 ) 98 (26) - 3 2 9 ( 3 0 )
C9 3 7 7( 24) 230(20) 3 1 1  (24) 88( 19) 4 1 ( 1 9 ) - 4 3 ( 1 8 )
N10 352(20) 33 4( 1 9) 284(20) 82( 1 6) 42( 1 6) - 6 4 ( 1 6 )
C l l 369( 25) 264 (23) 388 (25) 9 7 ( 1 9 ) 47 (20) - 1 0 5 ( 2 0 )
N12 345( 22) 396(22) 5 7 6( 26) 7 2 ( 1 7 ) - 6 6 ( 1 8 ) 42(20)
013 36 5( 1 8) 3 7 3 ( 1 7 ) 532( 20) 43 ( 14) - 6 0 ( 1 5 ) 8 1 ( 1 5 )
Cl  4 389(25) 3 1 7 ( 2 3 ) 3 7 1 ( 2 5 ) 1 23( 2 0) 24 ( 1 9) - 1 2 6 ( 1 9 )
Cl  5 423( 26) 388(25) 367( 26) 1 4 6 ( 2 1 ) 39( 21 ) - 1 1 2 (2 1 )
C l  6 552( 32) 399( 26) 367 (27) 2 4 1 ( 24) - 8 (2 2 ) - 8 4 ( 2 1 )
Cl  7 430 (31) 478( 29) 5 05( 32) 1 9 1 ( 2 5 ) - 5 6 ( 2 3 ) - 1 3 3 ( 2 4 )
C l  8 388(27) 402(25) 477 (28) 1 4 6 ( 2 1 ) - 1 4 ( 2 1 ) - 1 3 2 ( 2 2 )
C19 446(28) 330(24) 41 4( 28) 1 3 9 ( 2 1 ) 39(22) - 7 2  (20)
0 2 0 583(22) 622(22) 410 (20) 204( 1 8) 33( 1 6 ) 2 3 ( 1 7 )
C21 684( 37) 590(34) 47 4( 33) 238(30) 1 83( 28) 69( 27)
0 2 2 342( 1 9) 610( 22) 721  (25) 7 3 ( 1 7 ) - 2 0  (16) - 6 4 ( 1 9 )
C23 466( 32) 660(37) 5 8 7 ( 3 7 ) 81 ( 28) 1 5 3 ( 2 7 ) - 1 3 6 ( 3 0 )
C24 380 (26) 3 1 7 ( 2 4) 398( 27) 1 3( 20) 48(20) - 9 1 ( 2 0 )
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Atomic parameters for H-atoms in (Hie).
C o o r d i n a t e s  and t h e r m a l  p a r a m e t e r s  as
e x p [ - 8 . p i * * 2 . U . ( s i n ( t h e t a ) / l a m b d a ) * * 2 . 1 0 * * 3 ]
Atom X y z U
HI - 0 . 3 6 4  ( 7) 0. 934 ( 7) 0 . 702 ( 3) 30 { 0 )
821 - 0 . 2 7 0  ( 8 ) 0 . 9 6 1  ( 8 ) 0. 5 89  ( 3) 38 ( 0 )
H22 - 0 . 2 3 6 ( 8 ) 0 . 7 5 5  ( 8 ) 0. 605  ( 3) 38 ( 0 )
H3 - 0 . 5 4 2  ( 8 ) 0 . 7 3 8 ( 7) 0. 5 22 ( 3) 34 ( 0 )
H4 - 0 . 4 9 8  ( 8 ) 0 . 4 7 4  ( 7) 0 . 6 2 1  ( 3) 27 ( 0 )
H5 - 0 . 7 2 6  ( 8 ) 0. 422 ( 7) 0 . 7 0 9 { 3) 33 ( 0 )
H61 - 0 . 4 6 5 ( 8 ) 0 . 6 5 2  ( 7) 0. 7 83 ( 3) 36 ( 0 )
H62 - 0 . 3 6 5 { 8 ) 0 . 5 4 5  ( 8 ) 0. 7 38 ( 3) 36 ( 0 )
H71 - 0 . 6 1 9 ( 9) 0 . 9 5 7  ( 9) 0. 5 93  ( 3) 53 ( 0 )
H72 - 0 . 8 0 2  ( 1 0 ) 0 . 7 8 9  { 9) 0. 5 5 3  ( 3) 53 ( 0 )
H81 - 0 . 7 2 3 ( 8 ) 0 . 7 7 2  ( 8 ) 0 . 7 07  ( 3) 50 ( 0 )
H82 - 0 . 9 1 1 ( 1 0 ) 0 . 6 1 4  ( 8 ) 0. 658 ( 3) 50 ( 0 )
HI 5 0 . 1 9 1  ( 9) 0 . 7 2 2  ( 8 ) 0 . 9 2 1  ( 3) 38 ( 0 )
HI 7 0. 800 ( 9) 0. 9 06  ( 8 ) 0. 998 ( 3) 47 ( 0 )
HI 9 0. 5 98 ( 8 ) 1 . 1 5 7  ( 8 ) 0 . 7 9 7  ( 3) 37 ( 0 )
H211 0 . 2 1 5 ( 9) 0 . 4 5 3  ( 9) 1 . 0 0 0  ( 4) 55 { 0 )
H212 0 . 1 8 1  ( 9) 0 . 6 1 4  ( 9) 1 . 0 4 4  < 3) 55 { 0 )
H213 0 . 2 9 1 ( 9) 0 . 4 5 7  ( 9) 1 .0 9 4 ( 4) 55 ( 0 )
H231 1 . 1 3 1  ( 1 0 ) 1 . 3 5 2  ( 8 ) 0. 842 ( 3) 57 ( 0 )
H232 0 . 9 3 5  { 9) 1 . 2 3 8  ( 9) 0. 7 82 ( 4) 57 ( 0 )
H233 0 . 9 1 7 ( 9) 1 . 3 9 2  ( 9) 0. 8 3 3 { 3) 57 ( 0 )
H241 - 0 . 9 1 6  ( 9) 0 . 4 2 1  ( 8 ) 0 . 5 7 9  ( 3) 37 ( 0 )
H242 - 0 . 8 1 0  ( 8 ) 0 . 2 7 9  ( 8 ) 0 . 5 9 1  ( 3) 37 ( 0 )
H243 - 0 . 7 6 9 ( 8 ) 0 . 4 4 1  ( 7) 0 . 5 1 5  ( 3) 37 { 0 )
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IR2 COORD. FINALES.  R=0.0 RW=0.0 
P - l
C r y s t a l  d a t a
a -  7 . 1 1 3 0 ( 0 . 0 0 1 0 )
b = 7 . 7 1 9 0 ( 0 . 0 0 1 0 )
c = 1 3 . 4 6 7 0 ( 0 . 0 0 2 0 )
V = 9 0 8 . 1 3 (  0. 22)
a l p h a = 7 8 . 1 0 0 ( 0 . 0 2 0 )  
b e t a  = 1 0 2 . 0 9 0 ( 0 . 0 1 0 )  
gamma= 1 1 2 . 3 2 0 ( 0 . 0 1 0 )
c u b i c - A n g s t r o m
N i g g l i  r e d u c e d  c e l l :  7 . 1 1 3  7 . 7 1 9  1 8 . 3 4 7  9 3. 46  1 0 0 . 1 9  1 1 2 . 3 2
N i g g l i  m a t r i x :  50. 5948 5 9. 5 830 336. 6005
- 8 . 5 4 1 9  - 2 3 . 0 8 2 6  - 2 0 . 8 5 1 9
T r a n s f o r m a t i o n  m a t r i x : 1 . 0 0  0 . 0 0 0 . 0 0
0 . 0 0  - 1 . 0 0 0 . 0 0
1 . 0 0  0 . 0 0 1 . 0 0
C 18. O 3.  N 3.  CL 1 . H 24.
M = 36 5 . 85 9 (At omi c  w e i g h t s  1977)
Z = 2 . 0 0
D ( c a l c ) = 1 . 3 3 8 0 Mg/m**3
F (0 0 0 ) = 388. 0
mu = 20. 562 c m * * - l  ( I n t . T a b . V o l . I V , p.  55)
Lambda = 1 . 5 4 1 8000 A n g s t r o m
Number o f at oms:  4 9
At omi c c o o r d i n a t e s
Atom X/a Y/b Z/c
CL1 - 0. 3049 0 ( 17 0 . 3 3 1 0 7 15) 0. 6 2 4 7 2  ( 6 )
C l -0 . 31 243 ( 61 0. 83005 55) 0 . 6 9 5 3 7  ( 2 2 )
HI - 0 . 3 6 3 6 4  ( 723 0. 93420 706) 0 . 7 0 1 5 6  ( 263)
C2 - 0 . 3 1 9 7 7 ( 69 0 . 8 3 1 7 1 65) 0 . 6 1 1 2 4  ( 23)
H21 - 0 . 2 6 9 6 4  ( 789 0 . 9 6 1 3 3 817) 0. 5 88 5 5  ( 296)
H22 - 0 . 2 3 6 1 2 ( 798 0. 7 5 4 84 757) 0. 605 43 ( 288)
C3 - 0 . 5 3 8 7 1 ( 63 0. 7 3468 56) 0. 5 7 3 9 2  ( 25)
H3 -0 . 5 4 1 7 8  ( 756 0. 7 3805 714) 0 . 5 2 1 6 4 ( 302)
N4 - 0. 6 09 0 4  ( 49 0 . 5 3 2 2 3 43) 0 . 61120 ( 17)
H4 - 0 . 4 9 8 0 3  ( 762 0. 47430 694) 0 . 6 2 1 0 5  ( 264)
C5 - 0 . 6 4 7 0 2  { 63 0 . 5 5 5 1 7 59) 0. 685 66 ( 23)
H5 - 0 . 7 2 5 7 2  ( 752 0. 4 222 4 747) 0 . 7 0 9 0 9 ( 277)
C 6 - 0 . 4 3 7 3 1  ( 66 0. 63428 61) 0 . 7 3 2 5 3  ( 23)
H61 - 0 . 4 6 4 7 9  ( 758 0. 6 52 28 713) 0 . 7 8 2 6 1  ( 305)
H62 - 0 . 3 6 5 3 9  ( 790 0 . 5 4 4 9 1 753) 0. 7 3 7 8 8  ( 286)
C l - 0 . 6 9 3 5 6  ( 79 0. 80842 70) 0. 5 8989 ( 33)
H71 - 0 . 6 1 9 1 2  ( 867 0 . 9 5 7 3 1 878) 0 . 5 9 3 4 7  ( 312)
H72 - 0 . 8 0 1 6 2  ( 957 0 . 7 8 8 8 1 852) 0. 5 5 3 20 ( 349)
C8 - 0 . 7 6 3 8 3  { 79 0. 6 92 32 77) 0. 66284 { 33)
H81 -0 , 72292 ( 843 0 . 7 7 2 3 8 813) 0. 7 06 9 2  { 333)
H82 - 0 . 9 1 1 3 6  ( 966 0 . 6 1 4 3 9 837) 0. 65830 ( 320)
C9 - 0 . 0 9 5 5 1  ( 61 0. 8 95 3 6 53) 0 . 7 3 1 7 8  ( 2 2 )
N10 -0 . 00293 ( 49 0 . 8 2 8 1 3 45) 0 . 7 9 2 3 6  ( 18)
C l l 0 . 1 9 7 7 8  ( 61 0. 95290 54) 0. 7 94 40 ( 23)
N12 0. 22658 ( 55 1 . 0 8 9 7 8 52) 0 . 7 3 9 3 2  ( 2 2 )
013 0 . 03070 ( 43 1 . 0 5 2 4 3 40) 0 . 6 9 6 1 6  ( 17)
Cl  4 0 . 36859 ( 63 0 . 9 3 5 6 6 56) 0. 85248 ( 23)
C15 0. 3 29 67  ( 72 0. 80030 63) 0 . 9 1 5 1 2  ( 24)
HI 5 0 . 1 9 1 3 1  ( 857 0 . 7 222 0 772) 0 . 9 205 4 ( 293)
C16 0 . 49266 ( 72 0. 7 89 3 9 61) 0 . 9 6 9 85  ( 24)
C17 0. 69030 ( 76 0 . 9 1 0 3 6 6 8 ) 0 . 9 6 1 4 6  ( 28)
H17 0. 80007 ( 890 0. 9 05 67 782) 0. 9 97 68 ( 336)
C18 0 . 7 2 7 3 2  ( 66 1 . 0 4 3 7 8 63) 0 . 8 9 8 1 9  ( 26)
C19 0 . 5 6 7 4 5  ( 68 1 . 0 5 8 1 6 61) 0. 84208 ( 26)
H19 0. 59824 { 774 1 . 1 5 7 1 5 753) 0 . 7 9 7 4 1  ( 306)
0 2 0 0 . 4 7 3 7 5  ( 50 0 . 6 63 65 48) 1 . 0 3 3 9 8  ( 17)
C21 0. 2 7  464 ( 91 0 . 5 3 2 7 8 83) 1 . 0 4 3 5 7  ( 33)
H211 0 . 2 1 5 4 8  ( 891 0. 45304 862) 1 . 0 0 0 2 3  ( 353)
H212 0. 1 80 5 4  ( 893 0 . 6 1 3 7 3 860) 1 . 0 4 3 5 6  ( 321)
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H213 0 . 2 9 1 3 5 ( 882) 0 . 4 5 7 1 7 ( 861) 1 . 0 9 3 9 2  ( 361)
0 2 2 0 . 9 2 9 9 1 ( 47) 1 . 1 5 7 5 9  ( 48) 0 . 8 9 6 1 7  ( 2 0 )
C23 0 . 9 8 1 0 1  ( 87) 1 . 2 9 9 7 6  ( 85) 0. 8337 8 ( 32)
H231 1 . 1 3 1 3 4  ( 1019) 1 . 3 5 1 8 2  ( 845) 0. 84247  ( 336)
H232 0. 9 34 7 9  ( 915) 1 . 2 3 8 2 8  ( 878) 0 . 7 8 1 6 3  ( 363)
H233 0. 9 1 680 ( 948) 1 . 3 9 1 5 3  ( 906) 0. 83300 ( 349)
C24 - 0 . 7 9 4 2 0  ( 71) 0 . 4 0 5 1 4  ( 65) 0. 5 6 7 7 8 ( 28)
H241 - 0 . 9 1 6 3 9  ( 874) 0 . 4 2 1 3 8  ( 750) 0. 5 7868 ( 292)
H242 - 0 . 8 0 9 5 6  ( 790) 0. 27890 ( 819) 0. 5 907 2 ( 303)
H243 - 0 . 7 6 8 8 8  ( 762) 0 . 4 4 1 0 1  ( 727) 0 . 5 1 4 7 3 ( 318)
O r t h o g o n a l  c o o r d i n a t e s  (Angstrom) 
O r t h o g o n a l i z a t i o n  m a t r i x :
a b cosgamma c  c o s b e t a  7 . 1 1 3 0 0
0 b singamma - c  s i n b e t a  c o s a l p h a *  0 . 0 0 0 0 0
0 0 c s i n b e t a  s i n a l p h a *  0 . 0 0 0 0 0
- 2 . 9 3 1 5 1  - 3 . 8 6 7 8 7
7 . 1 4 0 6 7  2. 52848
0. 00000 1 7 . 8 7 9 5 0
Atom X Y z
CL1 - 5 . 5 5 5 6 0. 0015) 3 . 9 4 3 7 0. 0014) 1 1 . 1 6 9 7 0 . 0 0 1 1 )
Cl - 7 . 3 4 5 2 0. 0048) 7 . 6 8 5 3 0. 0041 ) 1 2 . 4 3 2 9 0. 0039)
HI - 8 . 0 3 8 7 0. 0564) 8 . 444 7 0. 0509) 1 2 . 5 4 3 5 0. 0470)
C2 - 7 . 0 7 6 9 0. 0054) 7 . 4 8 4 5 0. 0048) 1 0 . 9 2 8 7 0. 0041)
H21 - 7 . 0 1 2 5 0. 0621 ) 8 . 3 5 2 7 0. 0588) 1 0. 5 2 3 0 0. 0529)
H22 - 6 . 2 3 4 1 0. 0620) 6. 9209 0. 0546) 1 0. 82 48 0. 0 5 1 5 )
C3 - 8 . 2 0 5 4 0. 0049) 6. 6 9 7 3 0. 0042) 1 0 . 2 6 1 4 0. 0045)
H3 - 8 . 0 3 4 9 0. 0589) 6 . 5 8 9 1 0. 0 5 1 6 ) 9 . 3 2 6 7 0. 0540)
N4 - 8 . 2 5 6 4 0. 0038) 5 . 3 4 5 9 0. 0032) • 1 0 . 9 2 7 9 0. 0031 )
H4 - 7 . 3 3 5 0 0. 0588) 4 . 9 5 7 1 0. 0500) 1 1 . 1 0 4 1 0. 0472)
C5 - 8 . 8 8 1 8 0. 0049) 5. 6980 0. 0044) 1 2 . 2 5 9 3 0. 0041)
H5 - 9 . 1 4 2 5 0. 0588) 4. 8080 0. 0538) 1 2 . 6 7 8 2 0. 0495)
C 6 - 7 . 8 0 3 3 0. 0052) 6 . 3 8 1 4 0. 0045) 1 3 . 0 9 7 3 0. 0041 )
H61 - 8 . 2 4 5 3 0. 0590) 6. 63 65 0 . 0 5 1 5 ) 1 3 . 9 9 2 7 0. 0545)
H62 - 7 . 0 5 0 5 0. 061 4) 5 . 7 5 6 7 0. 0543) 1 3 . 1 9 2 9 0 . 0 5 1 1 )
C7 - 9 . 5 8 4 8 0. 0062) 7 . 2 6 4 2 0. 0052) 1 0 . 5 4 6 9 0. 0059)
H71 - 9 . 5 0 5 6 0. 0679) 8. 3364 0. 0632) 1 0 . 6 1 0 9 0. 0558)
H72 - 1 0 . 1 5 4 0 0. 0738) 7 . 0 3 1 4 0. 0 6 1 5 ) 9. 8909 0. 0624)
C8 - 1 0 . 0 2 6 5 0. 0062) 6 . 6 1 9 6 0. 0056) 1 1 . 8 5 1 2 0. 0059)
H81 - 1 0 . 1 4 0 7 0. 0658) 7 . 3 0 2 7 0. 0587) 1 2 . 6 3 9 4 0. 0595)
H82 - 1 0 . 8 2 9 8 0. 0740) 6 . 0 5 1 7 0. 0603) 1 1 . 7 7 0 1 0. 0572)
C9 - 6 . 1 3 4 6 0. 0047) 8. 2438 0. 0039) 1 3 . 0 8 3 9 0. 0039)
NIO - 5 . 5 1 3 3 0. 0039) 7 . 9 1 6 9 0. 0034) 1 4 . 1 6 7 0 0. 0032)
C l l - 4 . 4 5 9 3 0. 0048) 8. 81 30 0. 0040) 1 4 . 2 0 3 5 0. 0041)
N12 - 4 . 4 4 2 6 0. 0043) 9 . 6 5 1 1 0. 0039) 1 3 . 2 1 8 7 0. 0039)
013 - 5 . 5 5 9 5 0. 0034) 9 . 2 7 5 3 0. 0030) 1 2 . 4 4 7 0 0. 0031 )
C14 - 3 . 4 1 8 4 0.0049) 8. 8367 0. 0042) 1 5 . 2 4 1 9 0. 0041 )
C15 - 3 . 5 4 0 7 0. 0056) 8. 0285 0. 0046) 1 6 . 3 6 1 9 0. 0043)
H15 - 4 . 3 1 6 9 0. 0660) 7 . 4 8 4 6 0. 0556) 1 6 . 4 5 8 8 0. 0524)
C16 - 2 . 5 6 1 1 0. 0056) 8. 0890 0. 0045) 1 7 . 3 4 0 4 0. 0043)
C17 - 1 . 4 7 7 4 0. 0059) 8 . 9 3 1 6 0. 0050) 1 7 . 1 9 0 4 0. 0050)
H17 - 0. 8230 0. 0686) 8. 9897 0. 0565) 1 7 . 8 3 8 0 0. 0601 )
C18 - 1 . 3 6 0 5 0. 0052) 9. 7 2 4 3 0. 0046) 1 6 . 0 5 9 2 0. 0047)
C19 - 2 . 3 2 2 8 0. 0053) 9. 6852 0. 0045) 1 5 . 0 5 6 0 0. 0047)
H19 - 2 . 2 2 1 2 0. 0605) 1 0 . 2 7 9 1 0. 0543) 1 4 . 2 5 7 3 0. 0547 )
0 2 0 - 2 . 5 7 5 0 0. 0039) 7 . 3 5 3 3 0. 0036) 1 8 . 4 8 7 0 0. 0031 )
C21 - 3 . 6 4 4 7 0. 007 1 ) 6. 4430 0. 0061 ) 1 8 . 6 5 8 5 0. 0059)
H211 - 3 . 6 6 4 1 0. 0696) 5 . 7 6 4 1 0. 0622) 1 7 . 8 8 3 6 0. 0 6 3 1 )
H212 - 4 . 5 5 1 3 0. 0695) 7 . 0 2 1 1 0. 0620) 1 8 . 6 5 8 3 0. 0574)
H213 - 3 . 4 9 9 0 0. 0691) 6. 0305 0. 0622) 1 9 . 5 5 8 7 0. 0645)
0 2 2 - 0 . 2 4 5 3 0. 0038) 1 0 . 5 3 1 9 0. 0036) 1 6 . 0 2 3 1 0. 0036)
C23 - 0 . 0 5 7 3 0. 0068) 1 1 . 3 8 9 4 0. 0062) 1 4 . 9 0 7 6 0. 0057 )
H231 0. 8258 0 . 0 7 7 7 ) 1 1 . 7 8 3 1 0. 0609) 1 5 . 0 6 2 9 0. 0601 )
H232 - 0 . 0 0 4 1 0. 0 7 1 4 ) 1 0 . 8 1 8 5 0. 0634) 1 3 . 9 7 5 2 0. 0649)
H233 - 0 . 7 8 0 0 0. 0737 ) 1 2 . 0 4 2 7 0. 0653) 1 4 . 8 9 3 6 0. 0624)
C24 - 9 . 0 3 2 9 0. 0056) 4. 3286 0. 0048) 1 0 . 1 5 1 6 0. 0050)
H241 - 9 . 9 9 1 8 0. 0669) 4 . 4 7 2 1 0. 0 5 4 1 ) 1 0 . 3 4 6 5 0. 0522)
H242 - 8. 8608 0. 0622) 3 . 4 85 2 0. 0590) 1 0 . 5 6 1 8 0. 0542)
H243 - 8 . 7 5 2 8 0. 0595) 4. 4506 0. 0525) 9 . 2 0 3 1 0. 0569)
XXVI
o O O W w tc O  O o DO 55 O O O O O O O O O O O O O o o O Oh-* h-» M h-» ro ro <T \ (D O ro ro ro ro ro ro to ro to ro ro M h-1h-* I-*Ma 3 § •* •u CO CO CO to M o VO OO OO -J cr»CO a 6*■ CDQ. P» M1 1 1 i 1 1 i i 1 ■ t3 O i 1 i i i i I i 1 1 i 1 1 1 1 I ip o o o o o O  O O H» h- hhN tO tO h-» h-4h-* H* »-* i-1 O CD tc ta cc tZ2 EC O tc a CE O w O O O tc OH* CO tr ro to ro ro to to to to to to to H-* to H* M t - * rof—' o it* a* CO CO CO CO H-* M h-4h-»vo ro VO CO -J oO D CO ro M CO to »-» CO to M< D. CL1 1 1 1 1 1 1 1 l H-tJ a
ffl w o Q o o o  o o vO H-tO M CO N) <T\VO cn vo VO <5 coH* tO O CD rfrN CO P*
C >— S3H- On a>
** COCO ••
tr
£
?v cnI—1H o o O O H-4o H4 H4*-* H* »-* *-* o H*ia • • • « ■ • • • • a a • a • • • •H*H-*i-» »-» H* h-» »-• h-» rt vo VO vo VO o vo ifctO O o o CO CO CO vo COO O M O H4o H» O H-* 5 ft> VO Cn GO -J VO -J »-*O *•>4CO r—1o -J vo OO to cn-J OO H4GO to K> f—1 vo m v q H <T\ CO VO vo vo »-»cn o cn o -4 o cn to to■ a * • • « • • • H* O Cn cn O *u Cn CO Cn o ro Cn o cn —J Co Cn »£*
CD CO CO vo co cn vo (D PCO vo CD -J VO ►t* Cn vo ft
H o O O o O o o Q o o o o o o o o o• • • * • • • a a ■ • a • a • » a
& o o o o o o o o o o o o o o o o o
CO CO O N3 ro to o  o O  CD M Cn cn -J OO -J cn o cn —J cn o cn o o o Cn o
• • • • • • • • • • CD CO vo o ro o Cn cn o CD <Ti c ry o lU c r \ cr> -4 cnCO o CO ON CD VO CO CO CO CO CO OO o CD ro o cn CO H-4OO to cn vo to CO -J o
v>OJa\OJQ3HiUcn»^‘
P-• M
vo
Cn
vo
*d
CO
CO
O O O O O z O O 25 O O O O O O o o O O O O Z 2J O O  O o O O O o o o
»-*cn »-»Cn >-*cn »-* h-»ro »-» »-•H1♦-»O vo vo CD OO -J cn cn Cn Cn Cn •tk, »U >£k. CO CO CO to to to h-* t-*H1h -*
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
o o O O O o O o 2J rs O W W O O EC O O O 25 O W EC O O O 33
h-1 
— 1cn h-1cn vo h-1 cn H-*CO J-* H-*to *-*H* I—1CO O CDto OOH-* OO -oro -oh-4 cnto cni—4OO cn cn to Cn 0^ -j CO CO toto to VO cn to
oM-
COr+&
h-» o j—1 H-* H-4)—4 H-4h—* H4I-4o f—4 M CD j—4o M i—1 H4M i-4 I-4t-4H 4 o H4I-4o i-4I—4t-4J—4D a a a ■ a a • . • • a • . a • • • • a • • • - a • • • • ■ • • ■ a
CO CO to co CO •U ro CO co ro vo o Cn OO o vo O cn Cn O cn O Cn cn vo Cn o vo >£» Cn Cn o
OO OO cn vo OO o -J vo OD vo OO to vo -J CD CO to to r—4vo i—4H-4 f—4o Cn to I—4cn OO CO CO
O cn ro OO cn OO o CO CO h-4 O -J VO o VO -J to o Cn -j cn ro Cn OO -J cn vo vo o CO CO I—4£*
OO o OO M cn cn cn u> vo OO OO ro ro ro o VO cn ro ro cn vo -J CO to IO Cn cn l—4 CO
CD
co
O o o o o o o o o o O o o o o o o o o o O o o o o o o o O o o o o o •
. a a a « • a a a a a a a a • • ■ a a • • • ■ a a • • • a • ■ • * • ao o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o •
o o Cn o o o o o o o o Cn cn o cn cn cn cn o o £* o o cn o o Cn o --J cn o o o cn
cn cn to cn cn Cn cn l U cn -J cn -J CO H-* -J CO oo Cn cn cn cn ro oo —J Cn o ►c* Cn cn cn COco CO cn cn cn cn - J to cn CO o vo to vo cn CO cn h-4CO »£» cn H 4 o o -J oo cn cn h-4 o CO to i—4vo
Bond 
d
ista
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(A
n
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)
H22 - C2 -  C3 1 06 . 3 3 3 . 1 5
H21 - C2 -  C3 1 09 . 30 3. 48
H21 - C2 -  H22 1 1 3 . 6 7 4. 92
C2 - C3 -  Cl 1 1 3 . 3 4 0. 39
C2 - C3 -  N4 1 0 7 . 0 6 0. 35
C2 - C3 -  H3 1 1 0 . 6 8 3. 43
N4 - C3 -  C7 1 0 2 . 7 6 0. 36
H3 - C3 -  C l 1 1 2 . 8 3 3 . 4 7
H3 - C3 -  N4 1 09 . 68 3 . 1 1
C3 - N4 -  C24 1 1 3 . 4 2 0. 33
C3 - N4 -  C5 1 0 1 . 2 1 0. 30
C3 - N4 -  H4 1 1 2 . 9 0 3. 09
C5 - N4 -  C24 1 1 3 . 5 9 0. 34
H4 - N4 -  C24 1 0 7 . 4 9 2. 83
H4 - N4 -  C5 1 0 8 . 1 6 2 . 6 9
N4 - C5 -  C 8 1 0 2 . 4 5 0. 36
N4 - C5 -  C 6 1 0 7 . 1 7 0. 3 6
N4 - C5 -  H5 1 0 5 . 3 5 2 . 9 9
C 6 - C5 -  C 8 1 1 3 . 9 8 0. 39
H5 - C5 -  C8 1 1 6 . 5 1 3 . 3 1
H5 - C5 -  C 6 1 1 0 . 2 7 3 . 0 1
Cl - C6 -  C5 1 1 0 . 7 2 0. 35
C5 - C6 -  H62 1 08 . 0 5 3 . 1 5
C5 - C6 -  H61 1 0 6 . 5 4 3. 2 7
Cl - C6 -  H62 1 1 0 . 7 2 3 . 4 7
C l - C6 -  H61 1 0 7 . 1 0 2. 90
H61 - C6 -  H62 1 1 3 . 6 6 4. 34
C3 - Cl -  C8 1 0 5 . 4 8 0. 45
C3 - Cl -  H72 1 0 9 . 9 5 4. 08
C3 - Cl -  H71 1 0 8 . 4 3 3. 5 8
H72 - Cl -  C 8 1 09 . 40 4 . 1 6
H71 - Cl -  C8 1 1 3 . 1 0 3. 04
H71 - Cl -  H72 1 1 0 . 3 4 5. 20
C5 - C8 -  Cl 1 0 5 . 5 3 0. 46
C7 - C8 -  H82 1 1 4 . 1 9 3 . 4 7
C7 - C8 -  H81 1 1 3 . 5 8 3. 26
C5 - C8 -  H82 1 0 6 . 5 6 3 . 5 3
C5 - C8 -  H81 1 0 5 . 9 1 3. 40
H81 - C8 -  H82 1 1 0 . 3 5 5 . 2 5
Cl - C9 -  013 1 1 5 . 5 2 0. 36
C l - C9 -  NIO 1 3 1 . 7 3 0. 39
NIO - C9 -  013 1 1 2 . 7 5 0. 38
C9 - NIO -  C l l 1 0 2 . 9 9 0. 34
NIO - C l l -  C14 1 2 4 . 6 2 0. 36
NIO - C l l -  N12 1 1 4 . 1 6 0. 40
N12 - C l l -  C14 1 2 1 . 2 1 0. 40
C l l - N12 -  013 1 0 3 . 5 4 0. 3 5
C9 - 013 -  N12 1 0 6 . 5 5 0. 32
C l l - C l  4 -  C19 1 1 8 . 0 7 0. 38
C l l - C l  4 -  C l  5 1 1 9 . 9 1 0. 42
C l  5 - Cl  4 -  C l  9 1 2 2 . 0 2 0. 42
C14 - Cl  5 -  C l  6 1 1 8 . 8 5 0. 44
C l  4 - C15 -  H15 1 1 9 . 1 3 3 . 4 7
H15 - C l  5 -  C l  6 1 2 1 . 9 3 3 . 2 6
C15 - Cl  6 -  0 2 0 1 2 4 . 2 9 0. 46
C l  5 - C l  6 -  C17 1 2 0 . 3 1 0. 43
C17 - C l  6 -  0 2 0 1 1 5 . 4 0 0. 45
C l  6 - C l  7 -  C18 1 2 0 . 2 5 0. 49
C16 - C l  7 -  H17 1 2 1 . 2 6 3. 69
H17 - C l  7 -  C18 1 1 8 . 4 9 3 . 7 6
C17 - Cl  8 -  0 2 2 1 1 5 . 1 5 0. 43
C17 - C l  8 -  C19 1 2 0 . 9 4 0. 46
C19 - Cl  8 -  0 2 2 1 2 3 . 9 1 0. 42
C14 - Cl  9 -  C18 1 1 7 . 6 1 0. 42
C l  8 - C l  9 -  HI 9 1 1 9 . 2 7 3 . 3 7
C l  4 - Cl  9 -  H19 1 2 3 . 0 9 3. 3 4
C l  6 - 0 2 0 -  C21 1 1 7 . 2 0 0 . 4 1
0 2 0 - C21 -  H213 1 0 5 . 3 1 3. 8 7
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0 2 0 - C21 -  H212 1 06 . 9 5 3. 34
0 2 0 - C21 -  H211 1 1 0 . 3 0 3 . 7 1
H212 - C21 -  H213 1 1 0 . 1 5 4. 92
H211 - C21 -  H213 1 1 4 . 0 5 5. 02
H211 - C21 -  H212 1 0 9 . 7 7 5 . 1 1
C18 - 0 2 2 -  C23 1 1 8 . 8 2 0 . 4 1
0 2 2 - C23 -  H233 1 08. 5 4 3. 98
0 2 2 - C23 -  H232 1 1 1 . 1 5 3 . 36
0 2 2 - C23 -  H231 1 0 3 . 7 5 3 . 7 6
H232 - C23 -  H233 1 1 1 . 9 3 5 . 29
H231 - C23 -  H233 1 1 3 . 6 8 5 . 3 7
H231 - C23 -  H232 1 0 7 . 5 2 5 . 1 3
N4 - C24 -  H243 1 0 5 . 3 4 3. 22
N4 - C24 -  H242 1 0 6 . 5 3 3. 44
N4 - C24 -  H241 1 0 7 . 5 9 3 . 1 5
H242 - C24 -  H243 1 1 7 . 8 4 4. 63
H241 - C24 -  H243 1 1 6 . 2 6 4. 53
H241 - C24 -  H242 1 0 2 . 6 3 4 . 7 3
Number o f  a n g l e s :  95
T o r s i o n  a n g l e s  ( d e g r e e s )
( r i g h t - h a n d  r u l e ,  K l y n e  & P r e l o g . ( 1 9 6 0 ) .  E x p e r i e n t i a , 1 6 , 5 2 1 )  
( e . s . d .  f o l l o w i n g  S t a n f o r d  & Waser ,  A c t a  C r y s t . ( 1 9 7 2 ) . A 2 8 , 213)
A n g l e e . s . d .
C 6 - C l -C9 -NIO - 8 . 9 0 0 . 6 6
C2 - C l -C9 -N10 - 1 3 2 . 9 5 0. 49
HI - C l -C9 -NIO 1 1 1 . 7 8 2. 97.
C 6 - C l -C9 - 01 3 1 7 0 . 8 4 0. 3 6  '
C2 - C l -C9 - 0 1 3 46 . 7 9 0. 49
HI - C l -C9 - 01 3 - 6 8 . 4 8 2 . 9 7
C2 - C l - C 6 -H61 - 1 6 2 . 2 7 3 . 2 3
HI - C l - C 6 -H61 - 4 0 . 4 7 4. 48
C2 - C l - C 6 -H62 7 3 . 3 2 3 . 5 1
HI - C l - C 6 -H62 - 1 6 4 . 8 8 4. 66
C9 - C l - C 6 -C5 - 1 6 9 . 5 6 0. 36
C2 - C l - C 6 -C5 - 4 6 . 4 9 0. 49
HI - C l - C 6 -C5 7 5 . 3 0 3 . 1 2
HI - C l -C2 -H21 42. 05 4 . 7 5
HI - C l -C2 -H22 1 6 5 . 5 0 4. 50
HI - C l -C2 -C3 - 7 7 . 8 6 3 . 0 5
C 6 - C l -C2 -C3 46. 06 0. 50
C 6 - C l -C2 -H22 - 7 0 . 5 8 3 . 3 6
C 6 - C l -C2 -H21 1 6 5 . 9 7 3 . 6 6
C9 - C l -C2 -C3 1 7 0 . 4 6 0. 36
C9 - C l -C2 -H22 53. 82 3 . 3 7
C9 - C l -C2 -H21 - 6 9 . 6 3 3 . 6 7
C9 - C l - C 6 -H62 - 4 9 . 7 4 3 . 5 1
C9 - C l - C 6 -H61 7 4 . 6 7 3. 24
C l -C2 -C3 -H3 1 7 9 . 2 0 3 . 5 4
C l -C2 -C3 -N4 - 6 1 . 3 0 0. 4 5
C l -C2 -C3 - C l 5 1 . 2 8 0 . 5 3
H22 -C2 -C3 -H3 - 6 2 . 9 1 4. 84
H21 -C2 -C3 -H3 6 0. 1 6 5 . 1 1
H22 -C2 -C3 -N4 5 6 . 5 9 3. 3 2
H21 -C2 -C3 -N4 1 7 9 . 6 7 3. 6 9
H22 -C2 -C3 - C l 1 6 9 . 1 7 3 . 3 2
H21 -C2 -C3 - C l - 6 7 . 7 5 3 . 7 1
C2 -C3 - C l -H71 34. 50 3 . 5 6
C2 -C3 - C l -H72 1 5 5 . 2 2 4 . 5 1
C2 - C3 - C l - C 8 - 8 6 . 9 3 0 . 5 1
C2 -C3 -N4 -H4 - 4 1 . 2 2 3 . 2 3
C2 -C3 -N4 - C5 7 4 . 1 7 0. 39
C2 -C3 -N4 -C24 - 1 6 3 . 7 9 0. 36
N4 -C3 - C l -H71 1 4 9 . 6 8 3 . 5 3
H3 -C3 - C l -H71 - 9 2 . 2 9 5. 03
N4 -C3 - C l -H72 - 8 9 . 6 1 4 . 5 1
H3 -C3 - C l -H72 28. 43 5 . 7 7
N4 -C3 - C l - C 8 28 . 2 5 0. 50
XXIX
o  o O o o z Z z Z Z Q O O 2! O o W » CP o O tc tc o o o tc tc n W O PG O O Z Z Z z z re Z O O O cc w PC sa a W O tc O O O O O O O O o o w w sc
M
K-*
M
M
h-»
h-»
h-» I-*
ro
M
IO
h-*
O
M
O o vo vo h-»co i-»o M M h-» -JN) -JM co u> -jH* ro CO OO oo Cn cn cn cn Cn CT\ cn Cn oo 4* 4* 4* 4* 4* Cn .£» K>4* toJ* K>4* 4* 4*. 4*.Cn 4*. Cn 4* cn CO CO CO CO CO CO —1 CO CO CO CO
I I I I I I I I I I I I I I I I I I I I 1 I I I I I I I I I I I I I I I I I I I I I I 1 I I I I I I I I I I I I I I I I I I I I I I I I
O  O o z O o o o o o z Z O O O O o O o o o o o o o o O O O O O O O O O O O O O O n O O Z z z Z Z z z z z z z z z z z z z z O O O o o o o
M4* h-*4* 4* MN) h-» M I-1h-* H* I-*H* MM MO h-»o VO vo VO VO -J -J -J -J -4 -J -J Cn Cn cn cn cn Cn Cn Cn cn cn cn cn cn cn Cn Cn Cn Cn 4* 4* 4* 4^ 4k 4*. 4*. 4* 4* J* 4* 4* 4* 4^. 4* CO CO CO CO CO co CO
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
O  O O o Z O O Z o n O o z O Z o O O a O O O a O a O O O a O O O a a o O O O O O O n o n O O O O O O o O o O O O O O O O O Z z z z z z o
h-» h-» 
c n  vo MVO h-»c o h-*ro H *4^ H *ro h-»4 * 4 * I—*h-» »-»h-* Mo MCO O MCO CD CO CO oo CO oo oo oo CD < T\ CT\ CT* CTv OO C D oo OO OO CD cn cn a> oo oo o o Cn cn cn Cn Cn Cn Cn cn ro4* ro to4* ro4* ro4* to4* cn Cn Cn tot£ t to4* to4^ 4 * 4 * 4 * . 4 * 4* >£» ' J
I I  I I  I I I I  I I I  I t l  I I I  I I  I I I  I I I I I I I I I I I  I I I I I I I I I  I I  I I  I I I  I Iw n w o o o n o o o o z o z o z s t i J i i i w a i u n o o f f l w a i i J o o i s w w w o t i J W O w i B O O f f i O o o o f f i w i E S i s i E W O o t E K f f i t t K n o o o w o
H H H ^ H H H h , H H H H I - J P H H a 3 0 D O D C D C D O D O l O i ( j i < T » « j \ c T i a \ ' J * J O O O O C D O O H O \ c r > ' J O o a ) H H O l ( ^ C O a ) C ^ L n N ) N ) N ) N ) N ) N ) C D ( T ^ L n N ) N ) N ) ^ ( / l N ) r O U l lU O D
Cn CD VO W t O ^ U t O W r f i N ) H N ) H W N ) N ) H P N ) H  H  N )  N )  P  N )  N )  H  H  N )  H  f O  M  4^  4*. 4 *  4 *  4 *  4 *  4 *. 4 *  4 ^  4 *  4 *
W O )  M  N ) H  H  W  t o  H
I I I I I I I I I I I
f—* H-* H* I-4 H* h-* h-4h-* 1-* I-1 1 H-* 1 h-* 1 i 1 H-1 1 h-* h-1 >-* 1 i—1 1 1 h-1 1 h-» 1 J—1 H-* 1 f—* 1 1 h-* t-*1 -J -J l —J 1 -J 1 -4 I 1 -J -4 ro 1 ro h-» l—* h-* 1 cr» -J Cn CT> oo to Cn vo CO Cn Cn -J to vo ■^i CT* »£* cn -J CTk *c* -J oo cn cn CO 4^ -J CT» cn oo cn 4^ -j 4* cn -j 4^
H* CO o o OO "j ro f—1H* -J CD O o O VO VO CO <Tt Cn CD O <TiM cn -4 h-» o o -J ro O CO OO -J OO cr» ro cn to CT* CO CO CO ro oo CO cn CO CO Cn cn -J CO VO f-* o Cn cn CO Cn CO cn
a « • • ♦ • • ■ • • • » • • • • • • * • * • • • a • ■ • > • » a • ■ • • • • a a • • ■ a a • - « a • • - • « * * • • * * • ■ • - • *
VO 4* cn —j ro CO oo o VO CO Co VO »-* CO VO CT, »-* J—* Cn O to CT. OO CO i—1 CO VO oo »“» CO CO CD o CO-4Cn to ro -j Cn VO OO VO cn —ICO o Cn o o o i—*CO H-* t-* »c* CD 4*. Cn cn cn VO roCn <r\ »-* OJ VO <Tt O VO CTi Cn K* VO oo to VO ro Cn Co VO oo cn l-» h-* <T\to cr> CD oo cr> M H* h-* 4^- h-» -j CT» vo -j H-* CO CD cn Cn -J •Cfc ro -J CD VO VO o 4s. 4^ cn oo cn vo to CD
4*> o CO O O o o O O o o O o O O o c n c n C n c n 4 ^ c o CO 4 ^ o CO CO 4 * 4 ^ C o O c n CO 4 * CO O CO CO o CO CO CO o CO o o CO CO 4^. 4 ^ CO 4 ^ CO 4 ^ CO o o CO CO CO CO CO o o CO CO 4 ^ CO
* a a a * a • a • a ■ ■ • a • ■ • • * • ■ a a ■ a a a • • • . a • a a a • • a a • a a ■ a • * « • a • • • • * * • ■ • * • * ■ ' ■ • *
o 4 ^ VO 4 ^ CO c n 4 ^ 4 i . 4 * c n 4 ^ C n 4 ^ 4 ^ 4 ^ CO 4 * h-» t o o o >-* - J c n C n C n r o 4 * —J c n 4s» c n r o VO VO c n C n 4 * r o c n VO c n t o 4*. r o CO 4 * J—1J—* 4 ^ C n CO CO -J c n CO I—* 4 * cn C n t o 4 * 4 * c n c n -J cn
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C l l -C14 - C l  5 - C l  6 - 1 7 8 . 6 6 0. 43
C15 -C14 - C l  9 -H19 - 1 7 9 . 6 0 3. 90
C15 -C14 - C l  9 - C l  8 - 1 . 7 4 0. 70
C19 -C14 - C l  5 - C l  6 1 . 5 5 0 . 7 1
C19 -C14 - C l  5 -HI 5 1 7 8 . 2 6 4. 04
C14 - C15 - C l  6 - C l  7 - 0 . 6 5 0. 7 3
C14 - C15 - C l  6 - 0 2 0 1 7 9 . 5 2 0. 44
H15 - C15 - C l  6 - C l  7 - 1 7 7 . 2 6 4 . 1 6
H15 - C15 - C l  6 - 0 2 0 2. 90 4 . 2 1
C15 - C16 - 0 2 0 -C21 1 . 9 6 0. 70
C15 - C l  6 - C l  7 -H17 1 7 9 . 2 7 4. 5 3
C15 - C16 - C l  7 - C l  8 0 . 0 0 0 . 7 7
C17 - C l  6 - 0 2 0 - C21 - 1 7 7 . 8 8 0. 47
0 2 0 - C l  6 - C17 - C l  8 1 7 9 . 8 5 0. 4 5
0 2 0 - C16 - C l  7 -HI 7 - 0 . 8 8 4 . 5 7
C16 - C17 - C l  8 - C l  9 - 0 . 2 2 0 . 7 7
C16 - C1 7 - C l  8 - 0 2 2 1 7 9 . 5 0 0. 4 5
H17 - C17 - C l  8 - C l  9 - 1 7 9 . 5 0 4. 40
H17 - C l l - C l  8 - 0 2 2 0 . 2 2 4. 44
C17 -C18 - C l  9 - C l  4 1 . 0 6 0. 7 2
C17 - C l  8 - 0 2 2 -C23 - 1 7 9 . 1 8 0. 47
C17 -C18 - C19 -HI 9 1 7 9 . 0 0 3 . 7 4
0 2 2 - C l  8 - C l  9 - C l  4 - 1 7 8 . 6 4 0. 43
C l  9 -C18 - 0 2 2 -C23 0 . 5 3 0 . 7 1
0 2 2 - C l  8 - C l  9 -HI 9 - 0 . 7 0 3 . 7 9
C16 - 0 2 0 - C21 - H211 5 8. 5 3 3 . 9 1
C16 - 0 2 0 -C21 -H212 - 60. 80 3 . 5 7
C16 - 0 2 0 - C21 -H213 - 1 7 7 . 9 8 3. 90
C18 - 0 2 2 -C23 -H231 - 1 7 4 . 5 0 4. 04
C18 - 0 2 2 -C23 -H232 - 5 9 . 2 3 3. 80
C l  8 - 0 2 2 -C23 -H233 64. 29 4. 23
Number o f  t o r s i o n  a n g l e s :  143
We i g h t e d  l e a s t - s q u a r e s  p l a n e s  t h r o u g h  t h e  s t a r r e d  atoms
( N a r d e l l i ,  M u s a t t i ,  Domiano & A n d r e e t t i  R i c . S c i .  ( 1 9 6 5 ) ,  15 ( I I - A ) , 8 0 7 ) .
E q u a t i o n  o f  t h e  p l a n e :  ml*X+m2*Y+m3*Z=d
P l a n e  1
ml - 0 . 6 2 5 1 9 ( 0 . 0 0 2 3 9 )
m2  - - 0 . 7 6 0 9 7 ( 0 . 0 0 1 8 0 )
m3 - - 0 . 1 7 3 3 6 ( 0 . 0 0 2 3 2 )
D - - 1 2 . 0 0 9 5 6 ( 0 . 0 2 1 6 1 )
Atom d s d / s ( d / s ) * * 2
C2 * - 0 . 0 0 4 9 0. 0050 - 0 . 9 7 9 0. 959
C3 * 0. 0043 0. 0045 0. 954 0 . 9 1 1
C5 * - 0 . 0 0 4 5 0. 0046 - 0 . 9 7 9 0. 958
C 6 * 0. 0044 0. 0048 0. 932 0. 869
Cl - 0 . 5 8 6 3 0. 0044 - 1 3 4 . 6 0 1 1 8 1 1 7 . 3 0 1
N4 0. 8852 0. 0035 25 4 . 2 6 6 6 4 6 5 1 . 3 5 5
C9 - 0 . 3 6 7 2 0. 0043 - 8 5 . 9 2 1 7382. 428
C24 1 . 3 0 8 5 0. 005 1 25 6 . 1 0 0 6 5 5 87 . 023
Sum( ( d/s) * * 2 ) f o r  s t a r r e d  atoms 3 . 6 9 7
C h i - s q u a r e d  a t  95% f o r  1 d e g r e e s  o f  f r e e d o m:  3. 84
The g r o u p  o f  at oms d o e s  n o t  d e v i a t e  s i g n i f i c a n t l y  f r om p l a n a r i t y
P l a n e 2
ml - - 0 . 4 1 6 7 4 ( 0 . 0 0 2 9 4 )
m2  • - 0 . 7 4 9 1 4 ( 0 . 0 0 2 0 5 )
m3 - - 0 . 5 1 4 8 9 ( 0 . 0 0 2 1 8 )
D - - 6 . 8 8 0 2 5 ( 0 . 0 4 2 1 8 )
At om d s d / s ( d / s ) * * 2
C3 * - 0. 0009 0. 0044 - 0 . 2 0 6 0. 042
C5 * 0. 0009 0. 0044 0. 206 0. 042
C l * 0 . 0 0 2 2 0. 0055 0. 399 0 . 1 5 9
C8 * - 0 . 00 2 4 0. 0050 - 0 . 4 1 7 0 . 1 7 4
XXXI
N4 0. 6 89 5  0. 0033 208. 548 43 49 2 . 3 9 1
C24 2 . 1 7 4 9  0. 0050 435. 809 1 8 9 9 2 9 . 3 1 3
C2 - 1 . 4 0 4 5  0. 0047 - 2 9 7 . 1 4 9  88 29 7 . 4 1 4
C 6 - 1 . 3 9 2 0  0. 0045 - 3 0 7 . 6 8 1  94667. 805
S u m ( ( d / s ) **2)  f o r  s t a r r e d  atoms 0. 4 1 8
C h i - s q u a r e d  a t  95% f o r  1 d e g r e e s  o f  f r e e d o m:  3. 84
The g r o u p  o f  a t oms d o e s  n o t  d e v i a t e  s i g n i f i c a n t l y  f r om p l a n a r i t y
P l a n e 3
ml = 0 . 5 6 8 1 5 ( 0 . 0 0 2 0 2 )
m2  = - 0 . 6 3 7 0 5 ( 0 . 0 0 1 6 0 )
m3 = - 0 . 5 2 0 9 4 ( 0 . 0 0 1 8 5 )
D = ■ 1 5. 5 53 24 ( 0. 01 501 )
Atom d s d/ s ( d / s ) * * 2
C9 * 0. 0004 0. 0042 0.084 0. 007
N10 * - 0 . 0 0 2 7 0. 0035 - 0 . 7 5 8 0 . 5 7 5
C l l * 0. 0063 0. 0043 1 . 4 6 3 2 . 1 5 4
N12 * - 0 . 0 0 5 2 0. 0041 - 1 . 2 7 5 1 . 6 2 6
013 * 0 . 0 0 1 7 0. 0032 0. 538 0. 290
Cl 0. 0074 0. 0043 1 . 7 2 6 2 . 9 7 9
C2 1 . 0 7 1 4 0.0048 22 2. 249 49394. 824
C 6 0 . 2 3 1 7 0. 0046 50. 092 2 5 0 9 . 2 3 1
C14 0 . 0 4 1 6 0. 0044 9 . 443 8 9 . 1 7 5
C15 - 0 . 0 9 6 5 0. 0049 - 1 9 . 7 9 1 3 91 . 688
C19 0. 2204 0.0048 4 5 . 7 4 6 . 2092. 687
Sum( ( d / s ) **2)  f o r  s t a r r e d  atoms 4. 65 2
C h i - s q u a r e d  a t  95% f o r  2 d e g r e e s  o f  f r e e d o m:  5 . 9 9
The g r o u p  o f  a t oms d o e s  n o t  d e v i a t e  s i g n i f i c a n t l y  f r o m p l a n a r i t y
P l a n e 4
ml = 0 . 5 0 1 7 2 ( 0 . 0 0 1 8 7 )
m2  = - 0 . 7 3 1 5 3 ( 0 . 0 0 1 4 3 )
m3 = - 0 . 4 6 1 6 7 ( 0 . 0 0 1 8 1 )
D = -• 1 5 . 2 08 6 0( 0. 02 1 8 3 )
Atom d s d/ s ( d / s ) * * 2
C14 * - 0 . 0 0 7 6 0. 0043 - 1 . 7 4 4 3. 043
C15 * 0. 0052 0.0048 1 . 0 7 5 1 . 1 5 7
C16 * 0. 0007 0. 0047 0. 1 4 4 0 . 0 2 1
C1 7 * - 0 . 00 2 8 0. 0052 - 0 . 5 2 5 0. 2 7 5
C18 * - 0 . 0 0 1 7 0. 0048 - 0 . 3 6 1 0 . 1 3 1
C19 * 0. 0073 0.0048 1 . 5 3 6 2 . 3 5 9
C l l - 0 . 0 3 3 0 0. 0042 - 7 . 7 9 3 60. 723
0 2 0 0. 0025 0. 0036 0. 706 0. 498
C21 0. 0 5 2 5 0. 0063 8. 340 6 9. 5 5 9
0 2 2 - 0 . 0 1 6 3 0. 0036 - 4 . 4 7 7 20. 045
C23 - 0 . 0 3 4 2 0. 0063 - 5 . 4 5 8 2 9 . 7 9 1
Sum( ( d/s ) * * 2 ) f o r  s t a r r e d atoms 6. 985
C h i - s q u a r e d  a t  95% f o r  3 d e g r e e s  o f  f r e e do m:  7 . 8 1
The g r o u p  o f  a t oms d o e s  n o t  d e v i a t e  s i g n i f i c a n t l y  f r o m p l a n a r i t y
D i h e d r a l  a n g l e s  f o r me d by  L S Q - p l a n e s  
P l a n e  -  p l a n e  a n g l e  ( e . s . d . )
1  2 6 6 .50 ( 0 . 2 0 )
1 3 2 1 . 5 2  ( 0 . 1 8 )
1 4 1 8 . 1 3  ( 0 . 1 7 )
2 3 5 9. 4 2  ( 0 . 1 8 )
2 4 5 4 . 7 9 (  0 . 2 1 )
3 4 7 . 4 4  ( 0 . 1 3 )
R i n g  p u c k e r i n g  c o o r d i n a t e s
f o l l o w i n g  Cremer  D. & P o p l e  J . A . ,  JACS ( 1 9 7 5 ) . 9 7 , 1 3 5 4
XXXII
R i n g  1 
Atom
Cl 0.0000
C2 1 . 2 7 1 2
C3 1 . 1 6 7 5
■N4 - 0. 00 4 4
C5 - 1 . 1 6 6 4
C 6 - 1 . 2 6 7 9
q 2 = 0 . 2 1 6 1 ( 0
q3 = - 0 . 6 3 6 9 ( 0  
p h i 2 = 2 . 1 1
T o t a l  p u c k e r i n g  
S p h e r i c a l  p o l a r  
T h et a 2 = 1 6 1 .
X
I n t e r n a l
( 0 . 0 0 0 0 ) 
(0.0046) 
(0.0043)  ■ 
( 0 . 0 0 41 )  ■ 
(0.0039) • 
(0.0045)  
.0044) 
.0044)
( 1 . 3 6 )
a m p l i t u d e  
a n g l e s :
26 ( 0. 39)
c a r t e s i a n  
Y
1 . 4 9 1 4 ( 0 . 0 0 4 0 )
0 .6 8 4 8 ( 0 .0 0 5 2 )
0 . 7 5 2 4 ( 0 . 0 0 4 9 )
1 . 3 8 9 1 ( 0 . 0 0 3 3 )
0 . 7 3 2 1 ( 0 . 0 0 4 9 )
0 . 6 9 7 4 ( 0 . 0 0 5 2 )
c o o r d i n a t e s
Z
- 0 . 1 3 5 3 ( 0 . 0 0 3 4 )  
0 . 1 9 3 7  (0.0037)  
- 0 . 3 1 8 4 ( 0 . 0 0 3 3 )  
0 . 3 8 4 7  (0.0029) 
- 0 . 3 2 6 3 ( 0 . 0 0 3 2 )  
0 . 2 0 1 6 ( 0 . 0 0 3 3 )
QT = 0 . 6 7 2 6 ( 0 . 0 0 4 2 )
Asymmetry  p a r a m e t e r s
F o l l o w i n g  N a r d e l l i  M. ,  A c t a  C r y s t . ( 1 9 8 3 ) . C 3 9 , 1 1 4 1
Cl C2 C3 N4 C5 C6
DS (Cl ) = 0 . 006 2( 0.0024) DS (Cl - C 6 ) = 0 . 3 7 6 3 ( 0 . 0 0 1 9 )
D2(C1 ) = 0 . 2 9 9 6 ( 0 . 0 0 1 6 ) D2 (Cl - C 6 ) = 0 . 0676 (0.0020)
DS (C2 )-=0.1310 (0.0023) DS (C2 - C l  > =0. 37 77 (0.0019)
D2(C2 ) = 0 . 2 8 8 6 ( 0 . 0 0 1 5 ) D2 (C2 - C l  ) = 0 . 0 5 9 0( 0 .0 01 9 )
DS (C3 ) = 0 . 1 3 7 1 ( 0 . 0 0 2 4 ) DS (C3 -C2 ) = 0 . 3 6 0 8( 0 .0 01 9)
D2(C3 ) = 0 . 2 8 8 0 ( 0 . 0 0 1 6 ) D2 (C3 -C2 ) = 0 . 1 2 6 4 ( 0 . 0 0 1 9 )
R i n g 2
Atom I n t e r n a l  c a r t e s i a n  c o o r d i n a t e s
X Y Z
C3 0 .0 000( 0. 0000)  1 . 2 3 5 3 ( 0 . 0 0 4 4 ) 0 . 2 3 2 3 ( 0 . 0 0 5 3 )
N4 1 . 1 4 4 1 ( 0 . 0 0 3 8 )  0. 40 41 ( 0. 006 0) - 0 . 2 9 0 3  (0.0027)
C5 0 . 7 7 7 8 ( 0 . 0 0 5 4 )  - 0. 9 65 2( 0. 0 04 7 ) 0 . 2 3 7 3 ( 0 . 0 0 5 3 )
C l - 1 . 2 1 1 9 ( 0 . 0 0 5 0 )  0. 3805(0 .006 6) - 0 . 0 9 3 7  (0.0079)
C8 - 0 . 7 1 0 1 ( 0 . 0 0 4 8 )  - 1 . , 05 4 7( 0. 005 6) - 0 . 0 8 5 7  (0.0078)
q 2  = 0 .4590 (0.0043)
p h i 2 3 6 . 8 3  ( 1 .  61)
Asymmet ry  p a r a m e t e r s
F o l l o w i n g  N a r d e l l i  M.,  A c t a  C r y s t . (1983) . C 3 9 , 1 1 4 1
C3 N4 C5 C7 C8
DS (C3 ) = 0 . 2 1 8 8 ( 0 . 0 0 5 2 ) D2 (C3 ) = 0 . 2 1 3 9 ( 0 . 0 0 3 6 )
DS (N4 ) = 0. 0 0 5 0 ( 0 . 0 0 5 8 ) D2 (N4 ) = 0 . 2 6 6 4 ( 0 . 0 0 3 3 )
DS (C5 ) = 0 . 2 1 0 8 ( 0 . 0 0 5 1 ) D2 (C5 ) = 0 . 2 1 8 3 ( 0 . 0 0 3 6 )
DS (C7 ) = 0 . 3 4 6 0 ( 0 . 0 0 4 1 ) D2 {Cl ) = 0. 0 8 6 2 ( 0 . 0 0 4 0 )
DS (C8 ) = 0 . 3 4 9 1 ( 0 . 0 0 4 1 ) D2 (C8 ) = 0 . 0 7 9 4 ( 0 . 0 0 4 0 )
R i n g  3
Atom I n t e r n a l
X
C9 0. 0 000(0. 0000)
N10 1 . 0 9 4 8 ( 0 . 0 0 3 5 )
C l l  0 . 6 4 4 3 ( 0 . 0 0 4 0 )  ■
N12 - 0 . 6 4 3 6 ( 0 . 0 0 3 9 )  ■
013 - 1 . 0 9 5 5 ( 0 . 0 0 3 2 )
q2 = 0 . 0 0 8 6 ( 0 . 0 0 3 7 )
p h i 2  = 8 3 . 8 9 (  2 4 . 0 1 )
c a r t e s i a n  
Y
1 . 1 1 1 9 ( 0 . 0 0 3 9 )  
0.4282 (0.0045) 
• 0.8803(0.0049)  
■0.9969(0.0039) 
0 . 3 3 7 2 ( 0 . 0 0 4 3 )
c o o r d i n a t e s
Z
0 . 0 0 06 ( 0 .0 02 4 )  
- 0 . 0 0 3 7  (0.0024) 
0. 0053 (0.0025)  
- 0 . 0 0 5 0  (0.0024) 
0.0027 (0.0025)
Asymmetry  p a r a m e t e r s
F o l l o w i n g  N a r d e l l i  M.,  A c t a  C r y s t . ( 1 9 8 3 ) . C 3 9 , 1 1 4 1
C9 N10 C l l  N12 013
XXXIII
DS (C9 ) = 0 . 0 0 7 5 ( 0 . 0 0 2 1 ) D2 (C9 ) = 0 . 0 0 0 7 ( 0 . 0 0 1 6 )
DS (NIO ) = 0 . 0 0 5 6 ( 0 . 0 0 2 1 ) D2(N10 ) = 0 . 0 0 3 8 ( 0 . 0 0 1 7 )
D S ( C l l ) = 0 . 0 0 1 5 ( 0 . 0 0 2 1 ) D 2 ( C l l ) = 0 . 0 0 5 3 ( 0 . 0 0 1 6 )
DS(N12 ) = 0 . 0 0 3 1 ( 0 . 0 0 2 1 ) D2(N12 ) = 0 . 0 0 5 1 ( 0 . 0 0 1 7 )
DS (013 ( = 0 . 0 0 6 6 ( 0 . 0 0 2 1 ) D 2 (013 ) = 0 . 0 0 2 7 ( 0 . 0 0 1 6 )
Ring 4
Atom I n t e r n a l  c a r t e s i a n  c o o r d i n a t e s
X Y Z
C14 0 . 0 0 0 0 ( 0 . 0 0 0 1 )  1 . 3 7 1 1 ( 0 . 0 0 4 8 )  ■-0.0084 (0 .0032)
C15 1 . 2 1 0 7 ( 0 . 0 0 5 1 )  0 . 6 9 5 5 ( 0 . 0 0 5 1 ) 0. 0046 (0 .0037)
C16 1 . 2 0 3 2 ( 0 . 0 0 5 0 )  - 0 . 6 9 0 5 ( 0 . 0 0 5 9 ) 0.0007 (0 .0035)
C17 0 . 0 0 7 3 ( 0 . 0 0 6 2 )  - 1 . 3 8 0 8 ( 0 . 0 0 5 2 ) - 0. 00 2 3 (0 .0038)
C18 1 . 1 9 6 2 ( 0 . 0 0 4 9 )  - 0 . 6 9 2 8 ( 0 . 0 0 6 5 )  ■- 0 . 0 0 1 5  (0 .0040)
C19 1 . 2 2 5 1 ( 0 . 0 0 5 4 )  0 . 6 9 7 5 ( 0 . 0 0 7 3 ) 0.0069 (0 .0034)
q 2 = 0 . 0095(0 .004 9)
q3 = - 0 . 0 0 7 5( 0 . 00 43 )
p h i 2 = 1 6 6 . 2 7 (  3 1 . 1 4 )
T o t a l  p u c k e r i n g  a m p l i t u d e :  QT = 0 . 0 1 2 1 ( 0 . 0 0 4 3 )
S p h e r i c a l  p o l a r  a n g l e s :
T h e t a 2  == 1 2 8 . 1 5  ( 2 3 . 1 8 )
Asymmetry p a r a m e t e r s
F o l l o w i n g  N a r d e l l i  M. ,  A c t a  C r y s t . ( 1 9 8 3 ) . C 3 9 , 1 1 4 1
C14 C l  5i C l 6 C 1 7  C l 8 C l  9
DS(C14 1 = 0. 00 1 6 (0.0026) DS ( C l 4 - C l  9 1 = 0 . 0 07 0 (0 . 0 02 0)
D2(C14 1 = 0 . 0 0 5 2 ( 0 . 0 0 1 6 )  D 2 ( C l 4 - C l  9 ) = 0 . 0 0 1 6 ( 0 . 0 0 2 2 )
DS(C15 1 = 0 . 0 0 6 6 ( 0 . 0 0 2 5 )  DS(C15 - C l  4 1 = 0 .006 0( 0. 002 0)
D2(C15 1 = 0 . 0 0 3 7 ( 0 . 0 0 1 7 )  D2(C15 - C l  4 ) = 0 . 0 0 3 9 ( 0 . 0 0 2 1 )
DS(C16 ) = 0 . 0050 (0.0026) D S ( C l 6 - C l  5 1 = 0 . 0 0 4 6 ( 0 . 0 0 2 1 )
D2(C16 ) = 0 . 0 0 4 4 ( 0 . 0 0 1 7 )  D2(C16 - C l  5 ) = 0 . 0 0 5 5 ( 0 . 0 0 2 1 )
I n t e r a t o m i c  c o n t a c t s  g r e a t e r  t h a n  0 .5 0 and l e s s  t h a n  3 . 5 0  A n gs t r om ,  
i n v o l v i n g  atoms o f  t h e  o r i g i n a l  s e t .
D i s t a n c e  e . s . d .
CL1 . . .H22 3 .0 7 30 0.0588
CL1 . . .N4 3 . 0 5 2 7 0.0043
CL1 . . .H4 2. 0488 0 . 0 64 1
CL1 . . .H62 3 . 1 0 0 9 0.0659
CL1 . . .H242 3 . 3 9 1 8 0.0569
C l . . .HI 1 . 0 3 4 3 0.0639
C l . . . C 2 1 . 5 4 1 1 0. 0061
C l . . . H2 1 2 . 0 50 3 0.0520
C l . . .H22 2. 0988 0.0650
C l . . .C3 2 . 5 36 0 0.0056
C l . . .H3 3 . 3 6 5 4 0 .0 527
C l . . .N4 2 . 9 2 7 1 0.0047
C l . . .H4 3 . 0 34 6 0.0522
C l . . .C5 2 . 5 1 8 1 0.0049
C l . . . H5 3 . 4 0 1 4 0 . 0 4 4 1
C l . . . C 6 1 . 5 3 3 5 0.0052
C l . . .H61 2. 0840 0 .0 51 0
C l . . .H62 2. 093 8 0.0544
C l . . .C7 2. 95 80 0.0065
C l . . .H71 2 . 9 0 0 1 0. 061 8
C l . . . C 8 2 . 9 4 3 3 0.0065
C l . . .H81 2. 829 0 0.0 635
C l . . ,C9 1 . 4 8 3 7 0.0053
C l . . .N10 2 . 5 3 3 2 0.0050
C l . . . 0 1 3 2 . 3 9 1 0 0.0044
HI . . . C2 2 . 1 1 0 7 0.0594
XXXIV
HI . . . H2 1 2 . 2 6 8 1 0.0803
HI . . .H22 2 . 9 2 1 1 0.0928
HI . .  .C3 2 . 8 7 9 1 0.0505
HI . . .C5 2 . 8 8 7 2 0.0454
HI . . , C 6 2 . 1 4 9 3 0 . 0 5 1 4
HI . .  .H61 2 . 3 2 6 4 0.0658
HI . . . H62 2 . 9 3 6 6 0. 081 8
HI . . .C7 2 . 7 8 7 5 0.0 435
HI . . .H71 2 . 4 2 8 7 0.0708
HI . . . C 8 2 . 7 8 5 9 0.0422
HI . . ,H81 2 . 3 94 0 0 . 0 7 1 0
HI . . .C9 1 . 9 8 9 5 0. 055 4
HI . . .NIO 3. 0483 0. 0523
HI . . . 0 1 3 2 . 6 1 6 4 0.0498
C2 . . .H21 0. 960 5 0.0540
C2 . . . H2 2 1 . 0 1 9 2 0 . 0 7 0 1
C2 . . .C3 1 . 5 2 9 2 0.0 055
C2 . . .H3 2 . 0 70 2 0.0486
C2 . . ,N4 2 . 4 4 2 3 0.0048
C2 . . .H4 2 . 5 4 6 5 0 .0 4 77
C2 . . . C5 2 . 86 7 0 0.0056
C2 . . . C 6 2 . 5 3 9 2 0.0057
C2 . . . H61 3 . 3 8 7 1 0. 055 2
C2 . . . H62 2 . 84 8 3 0.0490
C2 . . . C7 2 . 5 4 6 3 0. 0077
C2 . . .H71 2 . 5 9 3 4 0 .0 736
C2 . . .H72 3 . 2 7 8 9 0.0663
C2 . . . C 8 3 . 209 2 0.0076
C2 . . .C9 2 . 4 7 1 7 0.0054
C2 . . . 0 1 3 2 . 7 9 5 5 0.0047
H21 . . . H2 2 1 . 6 5 7 4 0 .0 92 1
H21 . . .C3 2 . 0 5 7 1 0.0469
H21 . . ,H3 2 . 3 6 3 6 0.0679
H21 . . .N4 3 . 2 7 9 0 0.0495
H21 . . ,H4 3.4600 0.0726
H21 . . , C 6 3 . 3 3 7 4 0.0505
H21 . . .C7 2 . 7 9 3 2 0.0526
H21 . . . H71 2 . 4 9 4 7 0.0923
H21 . . .H72 3 . 4 6 62 0.0800
H21 . . .C9 2 . 7 0 9 4 0.0506
H21 . . . 0 1 3 2 . 5 8 1 5 0.0483
H22 . .  .C3 2 . 06 2 4 0 . 056 7
H22 . . . H3 2 . 3 6 5 9 0.0709
H22 . . ,N4 2 . 5 6 5 3 0. 0479
H22 . . .H4 2 . 2 6 8 6 0.0624
H22 . . . C5 3 . 2 5 0 2 0.0548
H22 . .  , C 6 2 . 8 1 3 9 0.0564
H22 . . . H62 2 . 7 6 2 2 0.0706
H22 . . . C l 3 . 3 7 9 7 0.0634
H22 . . .C9 2 . 6 1 9 8 0 .0 547
H22 . . . 0 1 3 2 . 9 3 7 7 0 . 0 51 4
C3 . . . H3 0 . 9 5 6 3 0 . 0 57 5
C3 . . . N4 1 . 5 0 7 7 0.0048
C3 . . .H4 2 . 1 2 0 3 0.0548
C3 . . .C5 2 . 3 3 4 0 0.0058
C3 . . .H5 3 . 2 0 7 5 0.0470
C3 . . . C 6 2 . 8 8 1 6 0.0059
C3 . . .H62 3. 288 2 0. 0501
C3 . . . C l 1 . 5 1 8 4 0.0087
C3 . . . H71 2 . 1 2 1 2 0 . 0 78 1
C3 . . .H72 2 . 0 1 1 5 0.0746
C3 . . .  C8 2 . 4 1 8 6 0.0083
C3 . . .H81 3 . 1 2 5 1 0 . 0 7 1 4
C3 . . . H82 3 . 0 9 5 2 0.0695
C3 . . .C24 2 . 5 1 1 4 0.0055
C3 . . . H241 2 . 8 5 4 8 0 .0 481
C3 . . . H242 3 . 2 9 2 0 0.0536
C3 . . . H243 2 . 5 4 3 0 0 . 0 5 1 4
XXXV
H3 . . .N4 2 . 0 3 9 3 0.0489
H3 . . .H4 2 . 5 1 2 4 0.0706
H3 . . ,C5 3 . 1 7 9 9 0.0536
H3 . . .C7 2 . 0 8 49 0 . 0 6 7 1
H3 . . .H71 2 . 6 2 0 2 0 . 1 0 1 8
H3 . . .H72 2 . 2 3 7 1 0 . 1 0 2 6
H3 . . . C 8 3 . 2 1 5 7 0 . 0 6 1 7
H3 . . .C24 2 . 6 0 5 1 0.0445
H3 . . .H241 3.0580 0 .0676
H3 . . . H242 3 . 4 4 1 3 0.0686
H3 . . .H243 2 . 2 5 9 2 0.0648
N4 . . ,H4 1 . 0 1 5 4 0.0620
N4 . .  .C5 1 . 5 1 2 4 0.0060
N4 . .  .H5 2 . 0 3 4 2 0 . 0 51 4
N4 . . . C 6 2 . 4 4 6 1 0. 0 05 1
N4 . . .H61 3 . 3 2 5 4 0.0568
N4 . . .H62 2 . 5 9 8 7 0.0484
N4 . . .C7 2 . 3 6 4 3 0.0072
N4 . . .H71 3 . 2 5 6 4 0 . 0 7 1 9
N4 . . . H72 2 . 7 4 1 8 0.0728
N4 . . . C 8 2 . 3 6 8 1 0.0084
N4 . . .H81 3 . 2 1 0 7 0 .0 7 53
N4 . . .H82 2 . 7 9 8 2 0.0798
N4 . . .C24 1 . 4 9 6 9 0 .0 051
N4 . . .H241 2 . 0 2 8 1 0 . 0 54 1
N4 . . .H242 1 . 9 9 0 4 0.0522
N4 . . .H243 2 . 0 0 5 7 0.0543
H4 . . .C5 2 . 0 6 7 8 0.0639
H4 . . . H5 2 . 4 0 1 5 0 . 0 8 1 7
H4 . . . C 6 2 . 4 9 4 1 0.0552
H4 . . .H61 3 . 4 6 3 1 0.0835
H4 . . .H62 2 . 2 5 4 7 0.0704
H4 . . . C l 3 . 2 7 0 2 0.0620
H4 . . . C 8 3 . 2 5 0 5 0.0660
H4 . . .C24 2 . 0 4 5 7 0.0478
H4 . . .H241 2 . 8 0 4 9 0.0799
H4 . . .H242 2 . 1 8 8 3 0.0635
H4 . . .H243 2 . 4 2 4 9 0.0678
C5 . .  ,H5 1 . 0 1 7 6 0.0466
C5 . . . C 6 1 . 5 2 7 2 0.0054
C5 . . . H61 2 . 0 7 1 4 0 . 0 51 4
C5 . . .H62 2 . 0 5 6 4 0 . 0 55 1
C5 . . . C l 2 . 4 2 4 7 0.0067
C5 .. .H71 3 . 1 7 2 9 0.0620
C5 . . .H72 3.0 009 0 . 0 61 9
C5 . . . C 8 1 . 5 2 5 2 0.0083
C5 . . .H81 2 . 0 7 4 7 0.0743
C5 . . .H82 2 . 0 3 9 4 0.0740
C5 . . .C24 2 . 5 1 8 0 0.0067
C5 . . .H241 2 . 5 2 8 5 0.0498
C5 . . .H242 2 . 7 8 9 0 0.061 0
C5 . . .H243 3 . 3 0 3 4 0.0599
H5 .. . C6 2 . 1 0 8 2 0.0437
H5 . . .H61 2 . 4 2 4 2 0.0672
H5 . . .H62 2 . 3 5 4 1 0.0693
H5 . . .C l 3 . 2 8 1 9 0.0507
H5 .. . C 8 2 . 1 7 8 8 0.0584
H5 . . .H81 2 . 6 8 7 3 0 . 0 91 6
H5 . . .H82 2 . 2 8 4 4 0.0943
H5 . . .C24 2 . 5 7 4 0 0. 051 8
H5 . . .H241 2 . 5 0 4 2 0.0690
H5 . . .H242 2 . 5 1 1 6 0. 0831
C 6 . . .H61 1 . 0 3 0 6 0. 0 63 1
C 6 . . .H62 0 . 9 82 9 0.0675
C6 . . .C7 3 . 2 3 3 8 0.0069
C 6 . . . C 8 2 . 5 5 9 6 0.0074
C 6 . . .H81 2 . 5 5 3 8 0.0699
C 6 . . .H82 3 . 3 2 1 1 0. 0661
XXXVI
C 6 . .  .C9 2 . 5 0 0 7 0 .0 0 51
C6 . . .NIO 2 . 9 5 7 4 0.0049
H61 . . .H62 1 . 6 8 5 6 0 . 0 9 7 1
H61 . . . C 8 2 . 7 8 5 4 0.0507
H61 . . .H81 2 . 4 2 2 4 0. 0831
H61 . . .H82 3 . 4 5 8 6 0. 0 7 7 3
H61 . . .C9 2 . 8 0 4 3 0.0483
H61 . . .NIO 3. 0 22 2 0 . 0 49 1
H62 . . . C 8 3 . 3 7 6 6 0.0606
H62 . . .H81 3 . 4 9 9 4 0.0968
H62 . . .C9 2 . 6 5 2 6 0 . 0 4 7 1
H62 . . .NIO 2 . 8 2 4 5 0. 0457
Cl . . .H71 1 . 0 7 7 0 0 .0 61 8
C l . . .H72 0.8 99 2 0.0585
C l . . . C 8 1 . 5 2 0 4 0.0079
C l . . .H81 2 . 1 6 5 4 0.0636
Cl . . .H82 2 . 1 2 5 2 0 . 0 5 7 5
C l . . .C24 3 . 0 1 3 1 0 .0 07 7
Cl . . .H241 2 . 8 2 8 7 0 . 0 5 1 6
Cl . . . H243 3 . 2 2 7 1 0.0629
H71 . . .H72 1 . 6 2 5 4 0 . 0 7 7 5
H71 . . . C 8 2 . 1 8 1 1 0.0540
H71 . . . H81 2 . 3 6 3 5 0.0786
H71 . . .H82 2 . 8 8 3 9 0.0742
H72 . . , C 8 2 . 0 0 7 1 0.0604
H72 . . .H81 2 . 7 6 1 8 0. 0873
H72 . . .H82 2 . 2 2 4 3 0 . 0 82 1
H72 . . .C24 2 . 9 3 7 7 0 . 0 7 1 1
H72 . . .H241 2 . 6 0 4 6 0 . 0 8 1 9
H72 . . . H243 3 . 0 1 6 1 0.1 004
C8 . . .H81 1 . 0 4 9 2 0.0662
C 8 . . . H82 0 . 9 8 7 2 0 . 0 57 9
C8 . . .C24 3 .0 2 0 7 0.0090
C 8 . . .H241 2 . 6 2 2 4 0 .0 57 4
H81 . . .H82 1 . 6 7 2 1 0 . 0 75 5
H82 . . .C24 2 . 9 6 9 4 0 . 0 7 8 1
H82 . . .H241 2 . 2 8 5 5 0 .0 9 77
H82 . . .H242 3 . 4 5 3 1 0 . 10 6 4
C9 . . .NIO 1 . 2 9 0 8 0.0050
C9 . . . C l l 2 . 0 9 3 8 0.0054
C9 . . .N12 2 . 2 0 4 9 0.0048
C9 . . . 0 1 3 1 . 3 4 1 8 0.0043
NIO . . . C l l 1 . 3 8 3 9 0.0046
NIO . . .N12 2 . 2 4 7 9 0.0043
NIO . . . 0 1 3 2 . 1 9 2 2 0. 0041
NIO . . ,C1 4 2 . 5 2 7 8 0.0050
NIO . . . C1 5 2 . 9 5 3 1 0.0054
NIO . . .H15 2 . 6 2 1 2 0 . 0 5 2 1
C l l . . .N12 1 . 2 9 3 3 0.0052
C l l . . . 0 1 3 2 . 1 2 3 6 0.0049
C l l . . . C l  4 1 . 4 7 0 5 0.0057
C l l . . . C 1 5 2 . 4 7 3 4 0.0058
C l l . . .HIS 2 . 6 2 1 3 0.0503
C l l . . . C l  9 2 . 4 6 0 1 0.0058
C l l . . . H I 9 2 . 6 7 6 1 0 .0 477
N12 . . . 0 1 3 1 . 4 0 8 6 0.0045
N12 . . . C l 4 2 . 4 0 9 5 0.0055
N12 . . . C l  9 2 . 80 5 4 0.0058
N12 . . .H19 2 . 5 3 1 4 0.0508
C l  4 . . . C 1 5 1 . 3 8 6 5 0.0056
C14 . . . H I 5 2 . 0 28 9 0.0495
C14 . . . C l  6 2 . 3 8 7 0 0.0058
C14 . . .C1 7 2 . 7 5 1 9 0.0064
C14 . . . C l 8 2 . 3 8 5 5 0.0058
C14 . . . C19 1 . 3 9 8 1 0.0056
C14 . . . H I 9 2 . 1 1 7 3 0.0478
C15 . . .H15 0 .9 52 8 0. 0526
C15 . . . C l  6 1 . 3 8 6 0 0.0063
XXXVII
C15 . . . C l 7 2 . 3 9 98 0.0066
C15 . . .H17 3 . 2 3 8 7 0. 056 7
C15 . . .CIS 2 . 7 7 8 6 0.0059
C15 . . . C l 9 2 . 4 3 5 8 0.0058
C15 . . . H I 9 3 . 3 5 1 9 0.0488
C15 . . . 0 2 0 2. 4 30 0 0. 0053
C15 . . .C21 2 . 7 9 2 7 0.0069
C15 . . .H211 2 . 7 3 1 1 0 .0 5 76
C15 . . .H212 2 . 7 0 3 7 0 . 0 5 7 5
H15 . . . C l 6 2 . 0 5 5 6 0 . 0545
H15 . . . C l 7 3. 2 69 8 0. 05 36
HI 5 . . . C l 9 3. 2 8 4 3 0 . 0 5 0 1
H15 . . . 0 2 0 2 . 6 7 6 8 0 . 0539
H15 . . .C21 2 . 5 2 4 9 0 . 0 5 1 9
H15 . . .H211 2 . 3 2 7 3 0.0833
HI 5 . . .H212 2 . 260 0 0. 0 76 9
C16 . . . C 1 7 1 . 3 8 0 8 0.0063
C16 . . . H I 7 2 . 0 1 9 8 0. 055 4
C16 . . .C18 2 . 3 9 9 4 0.0058
C l  6 . . . C1 9 2 . 7 9 7 0 0.0059
C l  6 . . . 0 2 0 1 . 3 6 2 4 0.0050
C16 . . . C2 1 2 . 3 7 0 8 0.0067
C16 . . .H211 2 . 6 3 0 1 0 . 0525
C16 . . .H212 2 . 6 1 5 1 0.0602
C l  6 . . . H213 3 . 1 6 8 3 0. 0574
C17 . . . H I7 0 . 9 2 2 5 0 . 0 5 7 7
C17 . . .C18 1 . 3 8 6 3 0.0063
C l  7 . . . C l 9 2 . 4 1 6 3 0.0065
C17 . . .HI 9 3 . 3 1 2 4 0 .0 5 2 1
C17 . . . 0 2 0 2 . 3 1 8 8 0.0054
C17 . . . 0 2 2 2 . 3 3 2 8 0.0054
H17 . . . C l 8 1 . 9 9 8 2 0 .0 56 7
H17 . . . C l 9 3 . 2 3 6 2 0 . 0 5 7 5
H17 . . . 0 2 0 2 . 4 8 3 7 0.0529
H17 . . . 0 2 2 2 . 4 5 0 7 0.0538
C18 . . . C l 9 1 . 3 9 0 7 0.0062
C18 . . .H19 2 . 0 7 2 5 0.0524
C18 . . . 0 2 2 1 . 3 7 7 4 0.0049
C l  8 . . .C23 2 . 4 0 7 7 0.0066
C18 . . .H231 3 . 1 6 4 0 0.0 59 3
C l  8 . . .H232 2 . 7 1 6 6 0.0636
C18 . . .H233 2 . 6 5 9 0 0 . 0 5 7 5
C19 . . .H19 1 . 0 0 0 5 0.0505
C l  9 . . . 0 2 2 2 . 4 4 3 0 0.0052
C19 . . .C23 2 . 8 3 8 8 0.0067
C19 . . .H232 2 . 7 9 8 0 0.0635
C19 . . .H233 2 . 8 2 2 1 0. 0543
HI 9 . . . 0 2 2 2 . 6 6 2 0 0 .0 5 10
H19 . . . C23 2 . 5 1 7 6 0.0484
H19 . . .H231 3 . 4 9 2 2 0.0801
HI 9 . . .H232 2 . 2 9 9 1 0.0870
H19 . . .H233 2 . 3 6 4 8 0.0704
0 2 0 . . .C21 1 . 4 1 5 0 0.0062
0 2 0 . . .H211 2 . 0 1 8 9 0.0523
0 2 0 . . .H212 2 . 0 1 1 4 0.0661
0 2 0 . . .H213 1 . 9 3 7 0 0 .0 55 7
C21 . . .H2 1 1 1 . 0 3 0 5 0.0668
C21 . . .H212 1 . 0 7 5 2 0 .0 781
C21 . . .H213 1 . 0 0 1 0 0.0607
H211 . . .H212 1 . 7 2 2 6 0 . 1 0 9 7
H211 . . .H213 1 . 7 0 4 2 0.0898
H212 . . . H213 1 . 7 0 2 8 0. 09 51
0 2 2 . . . C23 1 . 4 1 9 5 0.0063
0 2 2 . . .H231 1 . 9 0 6 4 0 .0 579
0 2 2 . . .H232 2 . 0 8 1 9 0.0650
0 2 2 . . .H233 1 . 9 6 0 6 0.0653
C23 . . .H231 0 . 9 7 9 3 0.0656
C23 . . .H232 1 . 0 9 4 6 0.0700
XXXVIII
C23 . . H233 0 . 9 7 4 4 0.0822
H231 . .H232 1 . 6 7 4 0 0.0802
H231 . .H233 1 . 6 3 5 4 0.1098
H232 . .H233 1 . 7 1 5 9 0 . 1 1 2 8
C24 . . H241 0.9890 0.0708
C24 . .H242 0 . 9 5 3 5 0.0590
C24 . .H243 0 . 9 9 6 5 0.0588
H241 . .H242 1 . 5 1 6 4 0.0987
H241 . .H243 1 . 6 8 6 1 0 . 0 9 1 7
H242 . .H243 1 . 6 7 0 2 0.0729
Number o f  c o n t a c t s : 308
E q u i v a l e n t  p o s i t i o n s :
X , Y , Z
p l u s  t h e  c e n t r o s y m m e t r i c  ones 
Maximum t r a n s l a t i o n  by 2 u n i t  c e l l
I n t e r m o l e c u l a r  c o n t a c t s  l e s s  t h a n  3 . 5 0  A n g s tr o m
C l l . . .HI + X , + Y - 1 , +Z
D i s t a n c e
3.0094
e . s . d .
0.0500
CL1 . . . H2 1 + X , + Y - 1 , + Z 3 . 1 7 0 9 0.0704
CL1 . . .H3 - x - i , - y +i , - z +i 2 . 7 7 4 4 0.0540
CL1 . . .H71 +x , + y - i , + z 2. 98 3 4 0.0550
CL1 . . . H82 +X+1, +Y, +Z 2 . 8 6 1 0 0. 0534
CL1 . . .H19 + X - 1 , + Y - 1 , +Z 3 . 3 0 1 4 0 .0 547
CL1 . . . H232 + X - 1 , + Y - 1 , + Z 3 . 1 3 3 4 0.0609
CL1 . . . H241 +X+1, +Y,+Z 2 . 84 9 9 0.0642
CL1 . . .H243 - X - l , - Y + l , - Z + l 2. 82 8 2 0.0529
C l . . . H232 + X - 1 , + Y , + Z 3 . 4 99 6 0. 065 5
HI . . . CL1 +X ,+ Y+ 1, +Z 3.0094 0.0500
HI . . . C1 9 + X - 1 , + Y , + Z 3 . 1 3 0 9 0.0585
HI . . . H I 9 + X - 1 , +Y,+Z 2 . 8 24 9 0 . 0 91 2
HI . . . H232 + X - 1 , + Y , + Z 2 . 9 2 1 3 0 .0 7 45
H21 . . . CL1 + X , + Y + 1 , +Z 3 . 1 7 0 9 0.0704
H21 . . .H3 - X - l , - Y + 2 , - Z + l 3 . 2 5 5 5 0. 081 4
H21 . . . C l - X - l , - Y + 2 , - Z + l 3 . 4 1 5 1 0 . 0 5 1 5
H21 . . .H71 - X - l ,  - Y + 2 , - Z + l 3 . 2 7 2 9 0. 0752
H21 . . .H72 - X - l , - Y + 2 , - Z + l 2 . 9 2 5 8 0 .0 7 74
H21 . . . H241 +X+1, + Y +1 , +Z 3 . 4 7 9 2 0.0693
H21 . . .H242 +X+1, + Y +1 , +Z 3 . 2 5 7 7 0.0660
H22 . . .H72 +X+1, +Y,+Z 3 . 3 28 6 0 . 0 98 1
H22 . . . C 8 +X+1 , +Y,+Z 3 .4 88 7 0.0603
H22 . . . H82 +X +1 ,+ Y, +Z 2 . 8 2 5 9 0.0965
H22 . . . H243 - X - l , - Y + l , - Z + l 2 . 9 4 4 1 0.0920
H3 . . . CL1 - X - l , - Y + l , - Z + l 2 . 7 7 4 4 0.0540
H3 . . .H21 - X - l , - Y + 2 , - Z + l 3 . 2 5 5 5 0. 081 4
H3 . . .H4 - X - l , - Y + l , - Z + l 3. 4 86 7 0.0879
H3 . . .H71 - X - l , - Y + 2 , - Z + l 2. 8 76 0 0 . 0 71 8
H3 . . . H243 - X - l , - Y + l , - Z + l 3 . 2 5 1 0 0.0952
H4 . . ,H3 - X - l , - Y + l , - Z + l 3 . 4 86 7 0.0879
H4 . . .N12 + X - 1 , + Y - 1 , +Z 3 . 4 8 1 3 0.0439
H4 . . . H243 - X - l , - Y + l , - Z + l 3 . 2 7 0 2 0.0 835
C5 . . .N12 + X - 1 , + Y - 1 , +Z 3 . 3 3 87 0.0056
C5 . . .H231 + X - 2 , + Y - l , + Z 3. 3902 0.0636
H5 . . .N12 + X - 1 , + Y - 1 , +Z 2 . 4 1 6 5 0.0568
H5 . . . 0 1 3 + X - 1 , + Y - 1 , +Z 2 . 7 4 9 3 0.0494
H5 . . . C23 + X - 2 , + Y - l , + Z 3 . 1 8 8 1 0.0558
H5 . . .H231 + X - 2 , + Y - l , + Z 2 . 7 3 3 7 0 .0879
H5 . . .H232 + X - 2 , + Y - 1 , +Z 2 . 7 5 8 3 0 . 0 8 1 5
C 6 . . .H213 - X , - Y + l , -Z+2 3 . 1 7 4 5 0. 061 8
H61 . . . C14 + X - 1 , +Y,+Z 3. 4 10 0 0 .0 679
H61 . . . C l  9 + X - 1 , + Y , +Z 3 . 4 4 1 2 0.0623
H61 . . ,C21 - X , - Y + l , - Z + 2 3 . 4 5 4 2 0 . 0 5 1 5
H61 . . . H213 - X , - Y + l , - Z + 2 2 . 5007 0. 0792
H61 . . . H231 + X - 2 , + Y - 1 , + Z 3 . 1 7 2 7 0 . 0 7 6 1
H62 . . . H I 9 + X - 1 , + Y - 1 , +Z 2 . 8 9 97 0.0790
XXXIX
H62 . . . H213 - x , - y + i , - z +2 3 . 0 3 7 5 0.0848
H62 . . .H233 + X - 1 , + Y - 1 , + Z 2 . 8 2 6 1 0.0886
Cl . . .H2 1 - X - l , - Y + 2 , - Z + l 3 . 4 1 5 1 0 . 0 5 1 5
n i l . . .CL1 + X, +Y+1 ,+Z 2. 98 3 4 0.0 55 0
H71 . . .H21 - x - l , - y + 2 , - z + l 3 . 2 7 2 9 0 . 0 7 5 2
H71 . . . H3 - X - l , - Y + 2 , - Z + l 2 . 8 7 6 0 0 . 0 7 1 8
H71 . . .H242 +X ,+ Y+ 1, +Z 3 . 2 3 6 2 0 . 1 0 5 5
H72 . . .H21 - X - l , - Y + 2 , - Z + l 2 . 9 2 5 8 0 . 0 7 7 4
H72 . . .H22 + X - 1 , +Y,+Z 3 . 3 2 8 6 0 . 0 9 8 1
H72 . . .C24 - X - 2 , - Y + l , - Z + l 3 .3 0 4 2 0 .0 56 4
H72 . . .H241 - X - 2 ,  - Y + l ,  - Z + l 3 . 1 1 4 2 0 . 0 7 8 5
H72 . . .H242 - X - 2 , - Y + l , - Z + l 3 . 3 7 3 7 0 . 0 7 6 3
H72 . . . H243 - X - 2 , - Y + l , - Z + l 3 . 0 4 1 4 0 . 0 7 1 3
C8 . . .H22 + X - 1 , +Y,+Z 3 . 4 88 7 0.0603
H81 . . . C9 + X - 1 , + Y , +Z 3 . 2 7 6 6 0 . 0 7 2 9
H81 . . .NIO + X - 1 , +Y,+Z 2 . 9 8 1 5 0 . 0 7 3 3
H81 . . . C l l + X - 1 , + Y , +Z 2 . 60 3 2 0 . 0 7 4 7
H81 . . .N12 + X - 1 , + Y , + Z 2 . 8 0 23 0 . 0 7 2 7
H81 . . . 0 1 3 + X - 1 , +Y,+Z 3 . 2 1 5 3 0 . 0 7 3 1
H81 . . . C14 + X - 1 , +Y,+Z 3 . 0 4 6 1 0. 0 65 9
H81 . . . C1 9 + X - 1 , + Y , + Z 3 . 4 6 5 9 0.0 583
H81 . . .H19 + X - 1 , +Y,+Z 3 . 4 8 2 3 0 .0 7 64
H82 . . . C Ll + X - 1 , + Y , + Z 2 . 8 6 1 0 0.0 534
H82 . . .H22 + X - 1 , + Y , + Z 2 . 8 2 5 9 0. 0 96 5
H82 . . . H232 + X - 2 , + Y - 1 , +Z 3 . 2 7 3 7 0. 0789
C9 . . .H81 + X +1 ,+ Y ,+ Z 3 . 2 7 6 6 0 . 0 7 2 9
C9 . . . H232 + X - 1 , + Y , +Z 2 . 8 9 6 4 0 . 0 75 8
NIO . . .H81 + X+1 , +Y,+Z 2 . 9 8 1 5 0. 0 7 3 3
NIO . . . H213 - X , - Y + l , -Z+2 3 . 1 5 1 9 0.0588
NIO . . .H232 + X - 1 , + Y , + Z 3 . 3 2 0 9 0 . 0 7 5 1
NIO . . .H233 + X - 1 , + Y - 1 , + Z 3 . 1 4 9 9 0. 0678
C l l . . .H81 +X+1, +Y,+Z 2 . 6 0 3 2 0 . 0 7 4 7
C l l . . . H232 + X - 1 , +Y, +Z 3 . 3 3 7 4 0. 0790
N12 . . . H4 +X+1, + Y + 1 , +Z 3 . 4 8 1 3 0. 0439
N12 . . .C5 +X+1, + Y +1 , +Z 3 . 3 3 8 7 0. 0056
N12 . . . H5 +X+1 , + Y +1 , +Z 2 . 4 1 6 5 0.0568
N12 . . .H81 +X+1, +Y,+Z 2 . 8 02 3 0 . 0 7 2 7
N12 . . . H231 + X - 1 , +Y, +Z 3. 3 68 8 0. 0 79 6
N12 . . . H232 + X - 1 , +Y,+Z 3 . 0 1 4 6 0 . 0 8 1 4
N12 . . . H242 +X+1, + Y + 1 , +Z 2 . 8 3 9 9 0 . 0 5 2 3
013 . . . H5 +X+1 , + Y + 1 , +Z 2 . 7 4 9 3 0.0494
013 . . .H81 +X+1, + Y , +Z 3 . 2 1 5 3 0 . 0 7 3 1
013 . . .H232 + X - 1 , + Y , +Z 2 . 6 7 2 6 0 . 0 8 1 5
013 . . . C24 +X+1, + Y + 1 , +Z 3 . 2 5 3 2 0.0052
013 . . .H241 + X + 1 , + Y + 1 , +Z 3 . 1 5 2 6 0 .0 506
013 . . . H242 +X+1 , + Y + 1 , +Z 2 . 4 8 0 5 0 . 0 5 1 4
C14 . . .H61 +X+1, + Y , +Z 3 . 4 1 0 0 0 .0 6 7 9
C14 . . .H81 + X +1 ,+ Y, +Z 3 . 0 4 6 1 0. 065 9
E15 . . .H17 - X + l , - Y + 2 , - Z + 2 3.4860 0 . 0 9 7 5
H15 . . . C2 1 - X , - Y + l , - Z + 2 3 . 2 7 4 9 0 . 0 5 4 1
H15 . . . H2 1 1 - X , - Y + l , - Z + 2 3 . 2 1 3 6 0. 0874
H15 . . .H212 - X , - Y + l , - Z + 2 2 . 9 9 5 9 0. 0 7 0 7
H15 . . .H213 - X , - Y + l , - Z + 2 3 . 1 5 1 6 0.0794
H15 . . . H231 + X - 1 , + Y - 1 , +Z 3 . 3 0 9 1 0 .0 974
H15 . . .H233 + X - 1 , + Y - 1 , +Z 3 . 0 8 7 9 0 . 0 8 1 6
C l  6 . . . H2 1 1 - X + l , - Y + l , - Z + 2 3 . 1 8 7 6 0 . 0 7 5 5
C16 . . .H213 - X + l , - Y + l , - Z + 2 3 . 3 5 7 4 0 .0 81 0
C17 . . .H17 - X + 2 , - Y + 2 , - Z + 2 3 . 3 3 3 6 0. 056 2
C17 . . .H211 - X + l , - Y + l , - Z + 2 3 . 0 3 7 9 0 . 0 7 2 1
C17 . . .H212 - X + l , - Y + 2 , - Z + 2 3 . 4 1 7 5 0 . 0 6 5 5
C17 . . . H213 - X + l , - Y + l , - Z + 2 3 . 2 6 2 7 0 . 0 7 6 7
C l l . . . 0 2 2 - X + 2 , - Y + 2 , - Z + 2 3 . 4  6 6 6 0. 0059
n i l . . . H15 - X + l , - Y + 2 , - Z + 2 3.4860 0 . 0 9 7 5
m i . . . C l 7 - X + 2 , - Y + 2 , - Z + 2 3 . 3 3 3 6 0.0562
n i l . . .H17 - X + 2 , - Y + 2 , - Z + 2 2 . 6 4 9 7 0 .0 782
H17 . . . C18 - X + 2 , - Y + 2 , - Z + 2 3 . 4 2 8 7 0 . 0 57 8
H17 . . . C2 1 - X + l , - Y + l , - Z + 2 3 . 4 4 1 6 0.0660
H17 . . . H2 1 1 - X + l , - Y + l , - Z + 2 2 . 7 2 1 3 0.0964
XL
H17 . . . H213 - X + l , “ Y + l , - Z + 2 3 . 3 5 2 4 0 . 0 9 9 1
HI 7 . . . 0 2 2 -X+2,  -Y+2,  -Z+2 2 . 5 5 1 6 0.0584
H17 . . .H231 - X + 2 , - Y + 2 , - Z + 2 3 . 2 5 8 2 0.0805
C18 . . . H I7 - X + 2 , - Y + 2 , - Z + 2 3 . 4 2 8 7 0. 0578
C18 . . . H2 1 2 - X + l , - Y + 2 , - Z + 2 2 . 8 5 2 6 0.0 69 6
'C19 . . .HI +X+1, +Y,+Z 3 . 1 3 0 9 0 .0 585
C19 . . .H61 +X+1, +Y,+Z 3 . 4 4 1 2 0.0 623
C l  9 . . .H81 +X+1 , +Y,+Z 3 . 4 6 5 9 0.0 583
C l  9 . . .H212 - X + l , - Y + 2 , - Z + 2 3 . 3 5 5 5 0 . 0 61 0
HI 9 . . .CL1 +X+1, + Y +1 , +Z 3 . 3 0 1 4 0 . 0 54 7
H19 . . .HI +X+1, + Y , +Z 2 . 8 2 4 9 0 . 0 9 1 2
H19 . . .H62 +X+1, + Y+ 1, +Z 2 . 8 9 9 7 0.0790
H19 . . .H81 +X+1, +Y,+Z 3 . 4 8 2 3 0 . 0 76 4
0 2 0 . . . 0 2 0 - X + l , - Y + l , - Z + 2 3 . 2 1 2 2 0.0060
0 2 0 . . .C21 - X + l , - Y + l , - Z + 2 3. 4 03 4 0.0090
0 2 0 . . .H211 - X + l , - Y + l , - Z + 2 2 . 90 3 2 0. 0782
0 2 0 . . .H231 - X + 2 , - Y + 2 , - Z + 2 3 . 2 5 0 9 0 . 0 6 35
C21 . . .H61 - X , - Y + l , - Z + 2 3 .4 5 4 2 0 . 0 5 1 5
C21 . . .H15 - X , - Y + l , - Z + 2 3 . 2 7 4 9 0 . 0 5 4 1
C2 1 . . ,H17 - X + l , - Y + l , - Z + 2 3 . 4 4 1 6 0.0660
C21 . . . 0 2 0 - X + l , - Y + l , - Z + 2 3. 4 034 0.0090
C21 . . . H2 1 1 - X , - Y + l , - Z + 2 3 . 4 4 8 5 0. 066 7
C21 . . .H212 - X , - Y + l , - Z + 2 3 . 1 8 4 0 0.0544
C21 . . .H233 - X + l , - Y + 2 , - Z + 2 3 . 1 3 7 7 0 . 0 7 9 3
H211 . . .H15 - X , - Y + l , - Z + 2 3 . 2 1 3 6 0.0874
H211 . . .C16 - X + l , - Y + l , - Z + 2 3 . 1 8 7 6 0 . 0 7 5 5
H211 . . ,C17 - X + l , - Y + l , - Z + 2 3 . 0 3 7 9 0 . 0 7 2 1
H211 . . .H17 - X + l , - Y + l , - Z + 2 '  2 . 7 2 1 3 0.0964
H211 . . . 0 2 0 - X + l , - Y + l , - Z + 2 2 . 9 0 3 2 0.0782
H211 . . . C2 1 - X , - Y + l , - Z + 2 3 . 4 4 8 5 0. 0 66 7
H211 . . .H211 - X , - Y + l , - Z + 2 3 . 4 0 5 4 0 . 1 0 4 4
H211 . . .H212 - X , - Y + l , - Z + 2 2. 6 40 0 0.0852
H211 . . . 0 2 2 + X - 1 , + Y - 1 , +Z 3 . 1 1 0 2 0 .0 601
H211 . . .C23 + X - 1 , + Y - 1 , +Z 3 . 3 8 8 7 0.0628
H211 . . . H231 + X - 1 , + Y - 1 , +Z 3 . 0 5 1 1 0.0944
H211 . . .H233 + X - 1 , + Y - 1 , +Z 3 . 3 7 1 4 0. 0831
H212 . . .H15 - X , - Y + l , - Z + 2 2 . 9 9 5 9 0. 0707
H212 . . . C17 - X + l , - Y + 2 , - Z + 2 3 . 4 1 7 5 0 .0 6 55
H212 . . .C18 - X + l , - Y + 2 , - Z + 2 2 . 8 5 2 6 0.0696
H212 . . , C19 - X + l , - Y + 2 , - Z + 2 3 . 3 5 5 5 0 .0 61 0
H212 . . . C2 1 - X , - Y + l , - Z + 2 3 . 1 8 4 0 0.0544
H212 . . .H211 - X , - Y + l , - Z + 2 2. 640 0 0.0852
H212 . . .H212 - X , - Y + l , - Z + 2 2 . 8 7 6 9 0. 0738
H212 . . . 0 2 2 - X + l , - Y + 2 , - Z + 2 2 . 6 8 3 6 0 .0784
H212 . . . C23 - X + l , - Y + 2 , - Z + 2 3 .0 3 2 2 0.0738
H212 . . . H231 - X + l , - Y + 2 , - Z + 2 3 . 4 7 2 2 0 .1 08 6
H212 . . .H233 - X + l , - Y + 2 , - Z + 2 2 . 5 0 5 8 0.0983
H213 . . . C 6 - X , - Y + l , - Z + 2 3 . 1 7 4 5 0 . 0 61 8
H213 . . .H61 - X , - Y + l , - Z + 2 2 . 5 0 0 7 0. 0792
H213 . . .H62 - X , - Y + l , - Z + 2 3 . 0 3 7 5 0.0848
H213 . . .N10 - X , - Y + l , - Z + 2 3 . 1 5 1 9 0.0588
H213 . . .H15 - X , - Y + l , - Z + 2 3 . 1 5 1 6 0 .0 794
H213 . . .C16 - X + l , - Y + l , - Z + 2 3 . 3 5 7 4 0. 081 0
H213 . . . C1 7 - X + l , - Y + l , - Z + 2 3 . 2 6 2 7 0 . 0 7 6 7
H213 . . . H17 - X + l , - Y + l , - Z + 2 3 . 3 5 2 4 0. 099 1
H213 . . .H233 - X + l , - Y + 2 , - Z + 2 2 . 8 5 9 7 0 . 1 1 5 9
0 2 2 . . .C17 - X + 2 , - Y + 2 , - Z + 2 3 . 4 6 6 6 0.0059
0 2 2 . . .H17 - X + 2 , - Y + 2 , - Z + 2 2 . 5 5 1 6 0.0584
0 2 2 . . .H211 +X+1, + Y + 1 , +Z 3 . 1 1 0 2 0. 0601
0 2 2 . . . H2 1 2 - X + l , - Y + 2 , - Z + 2 2 . 6 8 3 6 0.0784
C23 . . .H5 +X+2, + Y + 1 , +Z 3 . 1 8 8 1 0.0558
C23 . . . H2 1 1 +X+1, + Y + 1 , +Z 3 . 3 88 7 0.0628
C23 . . .H212 - X + l , - Y + 2 , - Z + 2 3. 0 3 2 2 0.0738
H231 . . .C5 + X +2 , +Y+ l , +Z 3. 3 90 2 0.0636
H231 . . .HS +X+2, + Y + 1 , +Z 2 . 7 3 3 7 0.0879
H231 . . .H61 +X+2, + Y + 1 , +Z 3 . 1 7 2 7 0 . 0 7 6 1
H231 . . .N12 +X+1, +Y,+Z 3 .3 68 8 0. 0796
H231 . . ,H15 +X+1, + Y + 1 , +Z 3 . 3 0 9 1 0.0974
XLI
H231 . . H I7 -X+2 - Y + 2 , - Z + 2 3 . 2 5 8 2 0.0805
H231 . . 0 2 0 -X+2 - Y + 2 , - Z + 2 3 . 2 5 0 9 0 . 0635
H231 . .H211 +X+1 + Y + 1 , +Z 3 . 0 5 1 1 0.0944
H231 . . H2 1 2 - X+l - Y + 2 , - Z + 2 3 . 4 7 2 2 0 . 1 0 8 6
H232 . .CL1 +X+1 + Y + 1 , +Z 3 . 1 3 3 4 0.0609
H232 . . C l +X+1 +Y,+Z 3 . 4 9 96 0 .0 6 55
H232 . .HI +X+1 +Y,+Z 2 . 9 2 1 3 0 . 0 7 4 5
H232 . . H5 +X+2 + Y+ 1, +Z 2 . 7 5 8 3 0 . 0 8 1 5
H232 . .H82 +X+2 + Y +1 , +Z 3 . 2 7 3 7 0.0789
H232 . . C9 +X+1 +Y,+Z 2 . 8 96 4 0. 0758
H232 . .NIO +X+1 +Y,+Z 3. 3 209 0 . 0 7 5 1
H232 . . C l l +X+1 +Y,+Z 3 . 3 3 7 4 0.0790
H232 . .N12 +X+1 +Y,+Z 3 . 0 1 4 6 0 . 0 81 4
H232 . .013 +X+1 +Y,+Z 2 . 6 7 2 6 0 . 0 8 1 5
H233 . . H62 +X+1 + Y +1 , +Z 2 . 8 2 6 1 0.0886
H233 . .N10 +X+1 + Y + 1 , +Z 3 . 1 4 9 9 0 .0 678
H233 . . HI 5 +X+1 + Y+ 1, +Z 3 .0 8 79 0 . 0 8 1 6
H233 . .C21 - X +l -Y+2,  -Z+2 3 . 1 3 7 7 0 . 0 7 93
H233 . .H211 +X+1 +Y+1,+Z 3 . 3 7 1 4 0 .0 8 3 1
H233 . .H212 - X +l - Y + 2 , - Z + 2 2 . 5 0 5 8 0.0983
H233 . . H213 - X+l - Y + 2 , - Z + 2 2 . 8 5 9 7 0 . 1 1 5 9
C24 . .H72 - X-2 - Y + l , - Z + l 3. 3 04 2 0.0564
C24 . .013 +X-1 + Y - 1 , +Z 3 . 2 5 3 2 0.0052
C24 . .H241 - X -2 - Y + l , - Z + l 3 . 4 0 7 9 0 . 0 5 5 3
H241 . . CL1 +X-1 +Y,+Z 2. 8 49 9 0.0642
H241 . . H21 +X-1 + Y - 1 , +Z 3 . 4 7 9 2 0. 0693
H241 . . H72 - X -2 - Y + l , - Z + l 3 . 1 1 4 2 0 . 0 7 8 5
H241 . .013 +X-1 + Y - 1 , +Z '  3 . 1 5 2 6 0.0506
H241 . . C24 - X -2 - Y + l , - Z + l 3 .4 0 7 9 0 . 0 5 5 3
H241 . .H241 - X-2 - Y + l , - Z + l 3. 0 86 5 0 . 0 72 2
H241 . .H243 -X-2 - Y + l , - Z + l 2 . 92 3 8 0.0824
H242 . .H21 +X-1 + Y - 1 , +Z 3 . 2 5 7 7 0.0660
H242 . .H71 + X , + Y - 1 , + Z 3 . 2 3 6 2 0 . 1 0 5 5
H242 . .H72 - X -2 - Y + l , - Z + l 3 . 3 7 3 7 0 . 0 7 63
H242 . .N12 +X-1 + Y - 1 , +Z 2 . 8 3 9 9 0. 0 52 3
H242 . .013 +X-1 + Y - 1 , +Z 2. 4 80 5 0 . 0 5 1 4
H243 . . CL1 - X - l - Y + l , - Z + l 2. 82 8 2 0 .0 529
H243 . ,H22 - X - l - Y + l , - Z + l 2 . 9 4 4 1 0.0920
H243 . . H3 - X - l - Y + l , - Z + l 3 . 2 5 1 0 0 . 095 2
H243 . . H4 - X - l - Y + l , - Z + l 3 . 2 7 0 2 0. 0835
H243 . .H72 - X-2 - Y + l , - Z + l 3 . 0 4 1 4 0 . 0 7 1 3
H243 . .H241 - X-2 - Y + l , - Z + l 2 . 92 3 8 0.0824
Number o f  c o n t a c t s : 225
P o s s i b l e  h y d r o g e n  b ond s  
Donor-H D o n o r . , . A c c e p t o r
C2 -H21
0.960 ( .054)  
1 .080
N4 -H4
1 .  015 (.  062) 
1 . 0 3 0
C5 -H5
1 . 0 1 8  ( .047)  
1 . 08 0
C17 -HI 7 
0 . 9 2 3 ( . 0 5 8 )  
1 . 08 0
C2 ------ 01 3 (0)
2 . 7 9 5  ( .005)
N4  CL1 (0)
3 . 0 5 3  ( .004)
C5 ___ N12 (1)
3 . 3 3 9 ( . 0 0 6 )
C24 -H242 C24  013 (1)
0. 954 (.  059) 3 . 2 5 3  ( .005)
1 .080
C 17  ------ 022 (2)
3 . 4 6 7  ( .006)
H. . . A c c e p t o r  D o n o r - H  A c c e p t o r
H21 . . . 0 1 3  (0) C2 -H21 . . . 0 1 3  (0)
2 . 5 8 2  (.  04 8 ) 9 2 . 6 3  ( 3 . 7 2 )
2 . 5 7 9  89. 98 (**)
H4 . . . C L l  (0) N4 -H4 . . . C L 1  (0)
2 .049 ( .064)  1 6 9 . 4 2  ( 4 . 1 1 )
2 . 0 3 4  1 6 9 . 3 4  (**)
H5 . . . N 1 2  (1) C5 -H5 . . .N12 (1)
2 . 417 ( . 0 5 7 )  1 5 0 . 3 0  ( 4 . 4 1 )
2 . 3 6 3  1 4 9 . 5 5  (**)
H 2 4 2 . . . 0 1 3  (1) C24 - H 2 4 2 . . . 0 1 3  (1)
2 .480 ( . 0 5 1 )  1 3 8 . 1 2  ( 4 . 7 5 )
2 . 3 88  1 3 6 . 0 9  (**)
HI7 . . . 0 2 2  (2) C l 7 -H17 . . . 0 2 2  (2)
2 .552 (.  058) 1 7 1 . 5 0  ( 4 . 8 9)
2 . 3 9 6  1 7 0 . 9 5  (**)
XLII
Number o f  p o s s i b l e  h y d r o g e n  b ond s 5
(**)  V a l u e s  n o r m a l i z e d  f o l l o w i n g  G . A . J e f f r e y  S L . L e w i s ,  C a r b o h y d r . R e s .  
( 1 9 7 8 ) . 6 0 , 1 7 9 ;  R . T a y l o r ,  O . Ke n na rd ,  A c t a  C r y s t . ( 1 9 8 3 ) . B 3 9 , 1 3 3 .
E q u i v a l e n t  p o s i t i o n s :  
( 0) X, Y,  Z
( 1)  + X - 1 , + Y - 1 , + Z
( 2) - X + 2 , - Y + 2 ,  -Z+2
Reference for the program:
Parst: a system of computer routines for calculating molecular parameters 
from results of crystal structure analyses 
Computer and Chemistry (1983) 7, 95-98
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Appendix III 
!H  NMR Spectra
Spectrum 1 NMR of the impurity isolated from the synthesis of l//-indole-3- 
carbonitrile (126a, CD3OD, 300 MHz).
XLV
Spectrum 2 *H NMR of f$-Amino-8-methyl-8-azabicyclo[3.2.1]octane-3a-carbo-
nitrile (124, CDCI3, 300 MHz).
XLVI
Spectrum 3 *H NMR of 3a-Aminomethyl-8-methyl-8-azabicyclo[3.2.1]-octane-
3p-amine (122, CDCI3, 300 MHz)
XLVII
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Spectrum 4 *H NMR of 2'(l//-indol-3-yl)-8-mcthyl-8-azabicyclo[3.2.1]octanc-3- 
spiro-4'(5)-imidazoline dihydrochloride (above) and the expansion of 
section 5 = 2.2-2.8 ppm. dg, CD3OD, 300 MHz).
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Spectrum 5 *H NMR of 2'-Phenyl-8-methyl-8-azabicyclo[3.2.1]octane-3-spiro- 
4'(5)-imidazoline (above) and the expansion of section 8 = 1.80 - 2.20 
ppm (la, CD3OD, 300 MHz).
XLIX
Spectrum 6 lH NMR of 3-amino-l-azabicyclo[2.2.2]octane-3-carbonitrile (158
CDCI3, 300 MHz).
L
Spectrum 7 *H NMR of 2'(3-methoxyphenyl)-l-azabicyclo[2.2.2]octane-3-spiro- 
4'(5')-imidazoline dihydrochloride (lib, CD3OD, 600 MHz).
LI
Spectrum 8 *H NMR of 2'-Phenyl-l-azabicyclo[2.2.2]octane-3-spiro-4'(5')-
imidazoline (Ila, CD3OD, 300 MHz).
Lll
Spectrum 9 NMR of 3-(l,3-dithiane-2-ylidene)-8-methyl-8-azabicyclo[3.2.1]-
octane (170, CDCI3 , 300 MHz).
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Spectrum 10 *H NMR of exo-3-carbomethoxy-8-methyl-8-azabicyclo[3.2.1]octane
(163, CDCI3 , 300 MHz).
LIV
Spectrum 11 NMR of tropane-3(3-carboxylic acid zwitterion (184, CD3OD, 300
MHz).
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Spectrum  12 !H NMR of exo-5’-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-3'-(3,5- 
dichlorophenyl)-l,2,4-oxadiazole hydrochloride and the corresponding 
NOE spectrum (IHd, CD3OD, 300 MHz).
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Appendix IV
13C NMR Spectra.
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Spectrum  13 13C NMR of 2'-(3,5-dimethoxyphenyl)-8-methyl-8-azabicyclo[3.2.1]- 
octane-3-spiro-4'(5)-imidazoline (Ic, CD3OD, 75.4 MHz)
LVIII
Spectrum  14 13C - -^H coupled NMR spectrum of 2'-(3,5-dimethoxyphenyl)-8-
methyl-8-azabicyclo[3.2.1]-octane-3-spiro-4'(5)-imidazoline (Ic,
CD3OD, 75.4 MHz)
LIX
Spectrum 15 13C NMR of 2'-Phenyl-l-azabiGyclo[2.2.2]octane-3-spiro-4'(5')-
imidazoline (Ila, CD3OD, 75.4 MHz)
LX
Spectrum 16 13C NMR of exo-5'-(8-Methyl-8-Azabicyclo-£.2.1]-octan-3-yl)-3'-
(3,5-dichlorophenyl)-1,2,4-oxadiazole hydrochloride (Hid, CD3OD,
75.4 MHz)
LXI
Spectrum 17 13C - lU coupled NMR spectrum of exo-5'-(8-methyl-8-azabicyclo-
3.2.1]-octan-3-yl)-3'-(3,5-dichlorophenyl)-l,2,4-oxadiazole hydro­
chloride (Hid, CD3OD, 75.4 MHz)
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Appendix V 
Mass Spectra*
* El = Electron Impact; Cl = Chemical Ionisation
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Spectrum 18 Mass spectrum (El) of the indole-2-mtropropene impurity 126a (M+ = 
202).
LXIV
Spectrum 19 Mass spectrum (Cl) of 3a-aminomethyl-8-methyl-8-azabicyclo[3.2.1]-
octane-3 (3-amine 122 (M++1 = 170).
Spectrum 20 Mass spectrum (El) of the aluminium complex of 3a-aminomethyl-8- 
methyl-8-azabicyclo[3.2.1]octane-3p-amine (154, M+ = 195).
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Spectrum  21 Mass spectrum (El) of the phenyl carboximidate 129a (M+ = 135).
LXVII
Spectrum 22 Mass spectrum (El) of 2'-Phenyl-8-methyl-8-azabicyclo[3.2.1]- 
octane-3-spiro-4'(5)-imidazoline la (M+ = 255).
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Spectrum  23 Mass spectrum (El) of the 2'-(N-oxido-4-pyridyl)-8-methyl-8-
azabicyclo[3.2.1]octane-3-spiro-4'(5)-imidazoline dihydrochloride 
(Ig, M+ = 272).
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Spectrum 24 Mass spectrum (Cl) of 3-aminomethyl-l-azabicyclo[2.2.2]octyl-3-amine
(159, M++1 = 156)
LXX
QJO
c
Tjc
-Q
a:
1 0 0 - 
80- 
G0' 
40- 
20 
0-
2.0E+5 
11 1.0E+5 
0.0E+0
# s  1 3 5 3 S c a n  1 . 3 1 7 *  m i n .  o f  OUT I I :  Qf l M. 0
1 10 
/
96
/
155
/
. ,i
168
I r ' I 1 fTT—I—r^ T—r—I—*1—i--r*-j—I- -i— i-- 1--;— |— ■ r 1*!
100 120 140 160 180 200 220 240
Mass/Charge
Spectrum  25 Mass spectrum (Cl) of the hydrogenolysis impurity (160) from the 
LiAlH4 reduction of quinuclidine aminonitrile (M++1 = 127)
LXXl
Spectrum 26 Mass spectrum (Cl) of the dimerisation impurity (161) from the 
LiAlH4 reduction of quinuclidine aminonitrile (M++ l = 303)
LXXII
Spectrum 27 Mass spectrum (Cl) of 2'(2-methoxyphenyl)-l-azabicyclo[2.2.2]octane- 
3-spiro-4’(5’)-imidazoline (Ob, M++1 = 272)
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Spectrum  28 Mass spectrum (El) of 3a-chlorotropane (166, M+ = 173)
LXX IV
Spectrum  29 Mass spectrum (El) of 3-(l,3-dithiane-2-ylidene)-8-methyl-8-aza- 
bicyclo[3.2.1]octane (170, M+ = 241).
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Spectrum  30 Mass spectrum (El) of the dimeric impurity 171 isolated from the
synthesis of 3-(l,3-dithiane-2-ylidene)-8-methyl-8-azabicyclo[3.2.1]- 
octane 170 (M+ = 382)
LXXVI
OJo
c
-Qcc
90
G0
40
20
0
100
* s ( 5 )  S c a n  0 . 3 0 3  mi n.  o f  DflTfl: TR-ES.D•j/ \
32 u
; 59 i
/  j il
j  iiln 11 t lL] i < id i . iiilf
124
/
152
G0 80
T r-
100
-1 1--
120
i— i— i-
140 1G0
Mass /Cha rge
183
180
TIC o f  Df iTf i:TR-ES.D
IDOCiO
T3
C
_Q
CC
G.0E+G 
5 . 0E+6 
4 . 0E+G 
3.0E+G 
2 . 0 E + S 
1 . 0E + G 
0 . 0 E + 0
4 £
Ti me ( m i n . ^
—i—
10
Spectrum  31 Mass spectrum (El) of exo-3-carbomethoxy-8-methyl-8-azabicyclo-
[3.2.1]octane (163, M+ = 183)
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Spectrum  32 Mass spectrum (El) of exo-5'-(8-methyl-8-azabicyclo[3.2.1]octan-3- 
yl)-3'-(3-aminophenyl)-l,2,4-oxadiazole dihydrochloride (IHe, M+ = 
284)
LXXVIII
Spectrum 33 Mass spectrum (El) of exo-5'-(8-methyl-8-azabicyclo[3.2.1]octan-3- 
yl)-3'-(4-aminophenyl)-l,2,4-oxadiazole dihydrochloride (Illg , M+ = 
284)
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Appendix VI 
Infrared spectra.
Spectrum  34 IR spectrum of l//-indole-3-carboximidate hydrochloride I29h  (KBr)
LXXXI
Spectrum  35 IR spectrum of 2'-Phenyl-8-methyl-8-azabicyclo[3.2.1]octane-3- 
spiro-4'(5')-imidazoline la  (KBr)
LXXXII
LXXXIII
Spectrum  37 IR spectrum of 2'-(3,5-Dichlorophenyl)-8-methyl-8-azabicyclo-
[3.2.1]octane-3-spiro-4'(5')-imidazoline Id (KBr)
LXXXIV
Spectrum  38 IR spectrum of the mixture of 2-allyl-4-cyano-l-methylpyrrolidines 
(Fig.4.1) from the ring opening of 3(3-chlorotropane with CN’.
LXXXV
Spectrum 39 IR spectrum of 3,5-dimethoxyphenyl-carboxamide oxime (164c).
(KBr)
LXXXVI
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Spectrum 40 IR spectrum of exo-5'-(8-methyl-8-azabicyclo[3.2.1]octane-3-yl)-3'- 
(3,5-dichlorophenyl)-l,2,4-oxadiazole hydrochloride I lld  (KBr).
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